grepcent / static financial knowledge base

GENWORTH FINANCIAL INC (GNW)

CIK: 0001276520. SIC: 6311 Life Insurance. Latest 10-K as of: 2026-02-27.

SIC breadcrumb: Finance, Insurance, And Real Estate > Insurance Carriers > SIC 6311 Life Insurance

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1276520. Latest filing source: 0001628280-26-012828.

Informational only - descriptive public-record data, not investment advice.

Peer comparisons including GNW

Selected Fundamentals

MetricValueUnitFYFiled
Revenue7,301,000,000USD20252026-02-27
Net income223,000,000USD20252026-02-27
Assets88,083,000,000USD20252026-02-27

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-27. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001276520.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2007200820092016201720182019202020212022202320242025
Revenue8,369,000,0007,513,000,0007,901,000,0007,705,000,0008,284,000,0007,822,000,0007,495,000,0007,488,000,0007,295,000,0007,301,000,000
Net income-277,000,000817,000,000119,000,000343,000,000178,000,000850,000,000916,000,00076,000,000299,000,000223,000,000
Diluted EPS-0.561.630.240.670.351.651.790.160.680.54
Operating cash flow1,872,000,0002,554,000,0001,633,000,0002,079,000,0001,960,000,000437,000,0001,049,000,000597,000,00088,000,000327,000,000
Share buybacks1,124,000,00076,000,0000.000.000.0064,000,000296,000,000189,000,000247,000,000
Assets104,658,000,000105,297,000,000100,923,000,000101,342,000,000105,747,000,000122,346,000,00089,714,000,00090,817,000,00086,821,000,00088,083,000,000
Liabilities90,191,000,00089,969,000,00086,734,000,00086,710,000,00089,927,000,000120,269,000,00081,328,000,00082,482,000,00077,440,000,00078,316,000,000
Stockholders' equity12,644,000,00013,418,000,00012,450,000,00014,185,000,00015,318,000,0001,575,000,0007,631,000,0007,480,000,0008,444,000,0008,750,000,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2007200820092016201720182019202020212022202320242025
Net margin-3.31%10.87%1.51%4.45%2.15%10.87%12.22%1.01%4.10%3.05%
Return on equity-2.19%6.09%0.96%2.42%1.16%53.97%12.00%1.02%3.54%2.55%
Return on assets-0.26%0.78%0.12%0.34%0.17%0.69%1.02%0.08%0.34%0.25%
Liabilities / equity7.136.716.976.115.8776.3610.6611.039.178.95

Industry Peer Context

Each number-line places GNW against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

GNW Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.GNW Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.13 SIC peersMin -2.0%Median 5.7%Max 22.8%GNW 3.1%

ROE peer context

GNW ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.GNW ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.13 SIC peersMin -2.8%Median 8.8%Max 30.7%GNW 2.5%

ROA peer context

GNW ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.GNW ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6311; peer count 13.13 SIC peersMin -0.1%Median 0.4%Max 5.0%GNW 0.3%

Financial Charts

GNW revenue, last 5 periods. Source: SEC companyfacts FY2025.GNW revenue, last 5 periods. Source: SEC companyfacts FY2025.GNW RevenueLatest point: FY2025 = $7.3BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$4.0B$8.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001628280-26-012828; filed 2026-02-27. Concept: Revenues. Source concepts: us-gaap:Revenues.

GNW net income, last 5 periods. Source: SEC companyfacts FY2025.GNW net income, last 5 periods. Source: SEC companyfacts FY2025.GNW Net incomeLatest point: FY2025 = $223.0MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$500.0M$1.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001628280-26-012828; filed 2026-02-27. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

GNW diluted eps, last 5 periods. Source: SEC companyfacts FY2025.GNW diluted eps, last 5 periods. Source: SEC companyfacts FY2025.GNW Diluted EPSLatest point: FY2025 = $0.54/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$2.00/share$4.00/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001628280-26-012828; filed 2026-02-27. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

GNW operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.GNW operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.GNW Operating cash flowLatest point: FY2025 = $327.0MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001628280-26-012828; filed 2026-02-27. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

GNW share buybacks, last 5 periods. Source: SEC companyfacts FY2025.GNW share buybacks, last 5 periods. Source: SEC companyfacts FY2025.GNW Share buybacksLatest point: FY2025 = $247.0MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001628280-26-012828; filed 2026-02-27. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

GNW assets, last 5 periods. Source: SEC companyfacts FY2025.GNW assets, last 5 periods. Source: SEC companyfacts FY2025.GNW AssetsLatest point: FY2025 = $88.1BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$62.5B$125.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001628280-26-012828; filed 2026-02-27. Concept: Assets. Source concepts: us-gaap:Assets.

GNW liabilities, last 5 periods. Source: SEC companyfacts FY2025.GNW liabilities, last 5 periods. Source: SEC companyfacts FY2025.GNW LiabilitiesLatest point: FY2025 = $78.3BSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$62.5B$125.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001628280-26-012828; filed 2026-02-27. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

GNW stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.GNW stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.GNW Stockholders' equityLatest point: FY2025 = $8.8BSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$5.0B$10.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001628280-26-012828; filed 2026-02-27. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-05-06. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001276520.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q22022-06-300.35reported discrete quarter
2022-Q32022-09-300.20reported discrete quarter
2023-Q12023-03-310.12reported discrete quarter
2023-Q22023-03-31122,000,0000.24reported discrete quarter
2023-Q22023-06-301,892,000,000reported discrete quarter
2023-Q32023-09-301,831,000,00029,000,0000.06reported discrete quarter
2023-Q42023-12-311,911,000,000-212,000,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-03-311,864,000,000139,000,0000.31reported discrete quarter
2024-Q22024-06-301,769,000,00076,000,0000.17reported discrete quarter
2024-Q32024-09-301,880,000,00085,000,0000.19reported discrete quarter
2024-Q42024-12-311,782,000,000-1,000,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-311,786,000,00054,000,0000.13reported discrete quarter
2025-Q22025-06-301,796,000,00051,000,0000.12reported discrete quarter
2025-Q32025-09-301,935,000,000116,000,0000.28reported discrete quarter
2025-Q42025-12-311,784,000,0002,000,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-311,777,000,00047,000,0000.12reported discrete quarter

Quarterly Charts

GNW quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q1.GNW quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q1.GNW Quarterly RevenueLatest point: 2026-Q1 = $1.8BSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Revenue$0.0B$1.0B$2.0B2023-Q22023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001628280-26-031374; filed 2026-05-06. Concept: Revenues. Source concepts: us-gaap:Revenues.

GNW quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q1.GNW quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q1.GNW Quarterly Net incomeLatest point: 2026-Q1 = $47.0MSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Net income-$250.0M$0.0B$250.0M2023-Q22023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001628280-26-031374; filed 2026-05-06. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

GNW quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q1.GNW quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q1.GNW Quarterly Diluted EPSLatest point: 2026-Q1 = $0.12/shareSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Diluted EPS (USD/share)$0.00/share$0.25/share$0.50/share2022-Q22022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001628280-26-031374; filed 2026-05-06. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Macro Cross-References

Latest quarter (10-Q)

Latest 10-Q source: 0001628280-26-031374.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2026-05-06. Report date: 2026-03-31.

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included herein and with our 2025 Annual Report on Form 10-K. Unless the context otherwise requires, references to “Genworth,” the “Company,” “we” or “our” herein are to Genworth Financial, Inc. on a consolidated basis. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries.

Cautionary note regarding forward-looking statements

This report contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “seeks,” “estimates,” “will,” “may” or words of similar meaning and include, but are not limited to, statements regarding the outlook for our future business and financial performance. Examples of forward-looking statements include statements we make relating to potential dividends or share repurchases; future return of capital by Enact Holdings, Inc. (“Enact Holdings”), including share repurchases, and quarterly and special dividends; the cumulative economic benefit of approved and future rate increases and benefit reductions included in our multi-year in-force rate action plan and other reduced benefit options associated with the long-term care insurance products in our Closed Block segment; planned investments in and our outlook for new lines of business or new insurance and other products and services, such as those we are pursuing with our CareScout business (“CareScout”), including through our CareScout services business (“CareScout Services”) and our CareScout insurance business (“CareScout Insurance”); the expected benefits and/or synergies of the Seniorly, Inc. (“Seniorly”) acquisition; future financial performance, including the expectation that quarterly adverse variances between actual and expected experience could persist resulting in future remeasurement losses in our long-term care insurance products in our Closed Block segment; the resolution of the appeal or any potential litigation recovery amounts in connection with the AXA S.A. (“AXA”) and Santander Cards UK Limited (“Santander”) litigation, and Genworth’s planned use of proceeds from any recovery in connection with the litigation, including share repurchases, debt repurchases and investments in new businesses; future financial condition and liquidity of our businesses; and statements we make regarding the outlook of the U.S. economy.

Forward-looking statements are based on management’s current expectations and assumptions, which are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those in the forward-looking statements due to global political, economic, inflation, business, competitive, market, regulatory and other factors and risks, including but not limited to, the following:

•the inability to successfully launch new lines of business, including long-term care insurance and other products and services we are pursuing with CareScout;

•our failure to maintain the self-sustainability of Genworth Life Insurance Company and its subsidiaries, collectively referred to as “Closed Block” or our “legacy insurance subsidiaries,” including as a result of the inability to achieve desired levels of in-force management actions and/or the timing of future premium rate increases and associated benefit reductions taking longer to achieve than originally assumed; other regulatory actions negatively impacting our life insurance businesses;

•inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections and/or models, which result in inadequate reserves or other adverse results (including as a result of any changes in connection with quarterly, annual or other reviews);

•the impact on holding company liquidity caused by an inability to receive dividends or any other returns of capital from Enact Holdings, and limited sources of capital and financing and the need to seek additional capital on unfavorable terms;

•the impact on any potential recovery in the AXA and Santander litigation resulting from a successful appeal, significant delays or any other adverse development in the litigation;

•adverse changes to the structure or requirements of Federal National Mortgage Association (“Fannie Mae”), Federal Home Loan Mortgage Corporation (“Freddie Mac”) or the U.S. mortgage insurance market; an increase in the number of loans insured through federal government mortgage insurance programs, including those offered by the Federal Housing Administration (“FHA”); the inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet the requirements mandated by the private mortgage insurer eligibility requirements (“PMIERs”) (or any adverse changes thereto), the inability to meet minimum statutory capital requirements of applicable regulators or the mortgage insurer eligibility requirements of Fannie Mae or Freddie Mac;

71

Table of Contents

•changes in economic, market and political conditions, labor shortages and fluctuating interest rates; unanticipated financial events, which could lead to market-wide liquidity problems and other significant market disruption resulting in losses, defaults or credit rating downgrades of other financial institutions; deterioration in economic conditions, a recession or a decline in home prices, all of which could be driven by many potential factors, including a U.S. federal government shutdown; an increase in the cost of care impacting our long-term care insurance products included in our Closed Block segment; changes in international trade policy, including the potential impact of new or increased tariffs, retaliatory policies or actions from other countries, and trade wars or other events that lead to political and economic instability; changes in government or monetary policies; changes within regulatory agencies; changes in immigration policy; and fluctuations in international securities markets;

•downgrades in financial strength and credit ratings and potential adverse impacts to liquidity; counterparty credit risks; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of invested assets, including private equity and private credit;

•changes in tax rates or tax laws, or changes in accounting and reporting standards;

•litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties;

•the inability to retain, attract and motivate qualified employees or senior management;

•changes in the composition of Enact Holdings’ business or undue concentration by customer or geographic region;

•the impact from deficiencies in our disclosure controls and procedures or internal control over financial reporting;

•the occurrence of natural or man-made disasters, including geopolitical tensions and war (including the Russian invasion of Ukraine, instability in the Middle East and economic competition between the United States and China, among others), a public health emergency, including pandemics, or climate change;

•the inability to effectively manage technology systems (including artificial intelligence), cyber incidents or other failures, disruptions or security breaches of us or our third-party vendors, as well as unknown risks and uncertainties associated with artificial intelligence;

•the inability of third-party vendors to meet their obligations to us;

•the lack of availability, affordability or adequacy of reinsurance to protect us against losses;

•a decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations;

•unanticipated claims resulting from Enact Holdings’ delegated underwriting and loss mitigation programs;

•the impact of medical advances such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation; and

•other factors described in the risk factors contained in Item 1A of our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on February 27, 2026.

We provide additional information regarding these risks and uncertainties in our Annual Report on Form 10-K. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Accordingly, for the foregoing reasons, we caution the reader against relying on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required under applicable securities laws.

Overview

Genworth Financial offers mortgage insurance products through its principal mortgage insurance subsidiaries. Genworth Financial also has start-up businesses whereby it offers fee-based services, advice, consulting and other aging care services through CareScout Services and long-term care insurance products through CareScout Insurance. Genworth Financial’s legacy insurance subsidiaries no longer offer or sell long-term care insurance, life insurance or annuity products. However, these subsidiaries continue to service and manage their in-force blocks of business and may still issue a limited number of certificates under existing group long-term care insurance policies.

72

Table of Contents

We report our business results through two segments: Enact, comprised primarily of mortgage insurance products, and Closed Block, comprised of long-term care insurance, life insurance and annuity products previously sold through our legacy insurance subsidiaries. In addition to our two reportable segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings, Inc. (“Genworth Holdings”) level, unallocated corporate income and expenses, and eliminations of inter-segment transactions. Corporate and Other also includes the results of other businesses that are not individually reportable, such as CareScout Services, CareScout Insurance and certain international businesses.

Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Enact Holdings is a public company traded on the Nasdaq Global Select Market exchange under the ticker symbol “ACT.” Genworth Financial maintains control of Enact Holdings through an indirect majority voting interest and accordingly, Enact Holdings remains a consolidated subsidiary of Genworth Financial. Enact Holdings and its mortgage insurance subsidiaries comprise, and can therefore generally be viewed as, our Enact segment, or commonly referred to as “Enact.”

Strategic Update

Create value

We continue to create shareholder value through Enact’s growing market value and capital returns. Enact Holdings provided $99 million of capital returns to Genworth Holdings in the first quarter of 2026. We expect capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services, as well as share repurchases and opportunistic debt reduction. Since the initial authorization of Genworth Financial’s share repurchase program in May 2022 and through April 30, 2026, we have repurchased $875 million worth of shares of Genworth Financial’s common stock. For additional information on our share repurchase program, see “—Liqui

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2026-02-27. Report date: 2025-12-31.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.”

Item 7 of our Annual Report on Form 10-K generally discusses year-to-year comparisons between the years ended December 31, 2025 and 2024. In addition, this Form 10-K also includes discussions of information related to 2023 and year-to-year comparisons between 2024 and 2023 for our Closed Block segment, which has been recast to reflect the change in our reportable segments. All other detailed comparative discussions between 2024 and 2023 that were not

60

Table of Contents

impacted by the change in reportable segments, including our Enact segment, can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2024.

Overview

Our business

Genworth Financial offers mortgage insurance products through its majority-owned subsidiary, Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial also has start-up businesses whereby it offers fee-based services, advice, consulting and other aging-care services through CareScout Services and long-term care insurance products through CareScout Insurance. Genworth Financial’s legacy insurance subsidiaries no longer offer or sell long-term care insurance, life insurance or annuity products. However, these subsidiaries continue to service and manage their in-force blocks of business and may still issue a limited number of certificates under existing group long-term care insurance policies.

We report our business results through two segments: Enact and Closed Block. In addition to our two reportable segments, we disclose other business activities and operating results in Corporate and Other, including our start-up businesses, CareScout Services and CareScout Insurance.

Our financial information

The financial information in this Annual Report on Form 10-K has been derived from our consolidated financial statements.

Revenues and expenses

Our revenues consist primarily of the following:

•Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance.

•Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.”

•Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, and unrealized gains and losses on equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

•Policy fees and other income. Policy fees and other income consist primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker-dealer commission revenues, fee revenue from contract underwriting services and other fees.

Our expenses consist primarily of the following:

•Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense and other reserve activity related to future policy benefits for long-term care insurance, life insurance, and fixed and variable annuities, and claim costs incurred related to mortgage insurance products.

•Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual variances from expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts.

•Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments that support our market risk benefits.

61

Table of Contents

•Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances.

•Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate certain corporate expenses to each of our segments using various methodologies.

•Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of capitalized acquisition costs, present value of future profits and capitalized software.

•Interest expense. Interest expense primarily represents interest incurred on borrowings of Genworth Holdings and Enact Holdings.

•Provision (benefit) for income taxes. We allocate tax to our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other.

The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers.

•Net income (loss) attributable to noncontrolling interests. Net income (loss) attributable to noncontrolling interests represents third-party ownership interests in income (loss) of Enact Holdings, a consolidated subsidiary of Genworth Financial.

62

Table of Contents

Consolidated Results of Operations

The following table sets forth the consolidated results of operations for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2025202420232025 vs. 20242024 vs. 2023
Revenues:
Premiums$3,499$3,480$3,636$191%$(156)(4)%
Net investment income3,1253,1603,183(35)(1)%(23)(1)%
Net investment gains (losses)59132346NM⁽¹⁾(10)(43)%
Policy fees and other income618642646(24)(4)%(4)(1)%
Total revenues7,3017,2957,4886%(193)(3)%
Benefits and expenses:
Benefits and other changes in policy reserves4,8214,7664,783551%(17)%
Liability remeasurement (gains) losses313153587160105%(434)(74)%
Changes in fair value of market risk benefits and associated hedges3(13)(12)16123%(1)(8)%
Interest credited386453503(67)(15)%(50)(10)%
Acquisition and operating expenses, net of deferrals1,009977942323%354%
Amortization of deferred acquisition costs and intangibles231249264(18)(7)%(15)(6)%
Interest expense105115118(10)(9)%(3)(3)%
Total benefits and expenses6,8686,7007,1851683%(485)(7)%
Income (loss) from continuing operations before income taxes433595303(162)(27)%29296%
Provision (benefit) for income taxes84158104(74)(47)%5452%
Income (loss) from continuing operations349437199(88)(20)%238120%
Income (loss) from discontinued operations, net of taxes1(10)11110%(10)NM⁽¹⁾
Net income (loss)350427199(77)(18)%228115%
Less: net income (loss) attributable to noncontrolling interests127128123(1)(1)%54%
Net income (loss) available to Genworth Financial, Inc.’s common stockholders$223$299$76$(76)(25)%$223NM⁽¹⁾

_____________

(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.

Use of non-GAAP measures

Reconciliation of net income (loss) to adjusted operating income (loss)

Our chief operating decision maker (“CODM”) evaluates performance and allocates resources based on a non-GAAP financial measure entitled “adjusted operating income (loss).” Our CODM evaluates adjusted operating income (loss) as a key measure to assess performance and support new business initiatives because the measure more accurately reflects

63

Table of Contents

overall operating performance, as it minimizes the impact of macroeconomic volatility. Our legacy insurance subsidiaries, which comprise our Closed Block segment, are managed on a standalone basis; therefore, we do not allocate capital to our Closed Block segment.

We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance.

While some of these items may be significant components of net income (loss) determined in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Adjusted operating income (loss) is not a substitute for net income (loss) determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% current tax rate, plus any associated deferred taxes, and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.

64

Table of Contents

The following table presents a reconciliation of net income (loss) to adjusted operating income (loss) for the years ended December 31:

(Amounts in millions)202520242023
Net income (loss) available to Genworth Financial, Inc.’s common stockholders$223$299$76
Add: net income (loss) attributable to noncontrolling interests127128123
Net income (loss)350427199
Less: income (loss) from discontinued operations, net of taxes1(10)
Income (loss) from continuing operations349437199
Less: net income (loss) from continuing operations attributable to noncontrolling interests127128123
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders22230976
Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)(62)(17)(25)
Changes in fair value of market risk benefits attributable to changes in interest rates, equity markets and associated hedges (2)(5)(43)(22)
(Gains) losses on early extinguishment of debt, net (3)(1)2(2)
Expenses related to restructuring124
Taxes on adjustments (4)(10)1010
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$144$273$41

_____________

(1)For the years ended December 31, 2025, 2024 and 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $3 million, $4 million and $2 million, respectively.

(2)Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(8) million, $(30) million and $(10) million for the years ended December 31, 2025, 2024 and 2023, respectively.

(3)(Gains) losses on early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million for the year ended December 31, 2024.

(4)The year ended December 31, 2025 included a $24 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets.

65

Table of Contents

Earnings (loss) per share

The following table provides basic and diluted earnings (loss) per common share for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions, except per share amounts)2025202420232025 vs. 20242024 vs. 2023
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.54$0.71$0.16$(0.17)(24)%$0.55NM⁽¹⁾
Diluted$0.54$0.70$0.16$(0.16)(23)%$0.54NM⁽¹⁾
Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.54$0.69$0.16$(0.15)(22)%$0.53NM⁽¹⁾
Diluted$0.54$0.68$0.16$(0.14)(21)%$0.52NM⁽¹⁾
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.35$0.63$0.09$(0.28)(44)%$0.54NM⁽¹⁾
Diluted$0.35$0.62$0.09$(0.27)(44)%$0.53NM⁽¹⁾
Weighted-average common shares outstanding:
Basic409.0433.9468.8
Diluted414.0439.4474.9

_____________

(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards.

The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2025202420232025 vs. 20242024 vs. 2023
Enact segment$558$585$552$(27)(5)%$336%
Closed Block segment:
Long-term care insurance(326)(176)(242)(150)(85)%6627%
Life insurance(66)(94)(275)2830%18166%
Annuities7556871934%(31)(36)%
Closed Block segment(317)(214)(430)(103)(48)%21650%
Corporate and Other(97)(98)(81)11%(17)(21)%
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$144$273$41$(129)(47)%$232NM⁽¹⁾

_______________________

(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Executive Summary of Consolidated Financial Results

Below is an executive summary of our consolidated financial results for the periods indicated. Amounts within this “Executive Summary of Consolidated Financial Results” and in our discussion of adjusted operating income (loss) within

66

Table of Contents

“—Results of Operations and Selected Financial and Operating Performance Measures by Segment” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%.

For a discussion of selected financial information and detailed descriptions of operating performance measures see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”

2025 compared to 2024

•Net income in 2025 and 2024 was $223 million and $299 million, respectively, and adjusted operating income was $144 million and $273 million, respectively.

•Enact segment

•Adjusted operating income decreased primarily due to lower reserve releases and higher new delinquencies, partially offset by higher net investment income and lower operating expenses in 2025.

•Closed Block segment

•The adjusted operating loss in our long-term care insurance products increased primarily driven by unfavorable cash flow assumption updates in 2025 compared to favorable updates in 2024, net insurance recoveries of $22 million in 2024 that did not recur and aging of the in-force block. These adverse developments were partially offset by higher limited partnership income and a $21 million gain related to a third-party reinsurance recapture in 2025.

•The adjusted operating loss in our life insurance products decreased largely due to continued block runoff.

•Adjusted operating income in our annuity products increased primarily from favorable assumption updates of $20 million in 2025 largely related to mortality assumptions compared to unfavorable updates of $14 million in 2024 largely related to lapse assumptions, partially offset by lower spread income in 2025 driven mostly by block runoff.

•Corporate and Other

•The adjusted operating loss decreased primarily from a $17 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets, mostly offset by higher expenses related to CareScout growth initiatives in 2025.

2024 compared to 2023

•Net income in 2024 and 2023 was $299 million and $76 million, respectively, and adjusted operating income was $273 million and $41 million, respectively.

•Enact segment

•Adjusted operating income increased primarily attributable to higher net investment income and premiums, partially offset by higher new delinquencies in 2024.

•Closed Block segment

•The adjusted operating loss in our long-term care insurance products decreased primarily driven by lower liability remeasurement losses, net insurance recoveries and higher income from limited partnerships, partially offset by lower renewal premiums in 2024.

•The adjusted operating loss in our life insurance products decreased primarily from liability remeasurement gains in 2024 compared to losses in 2023, partially offset by lower premiums and a less favorable change in reserves in 2024 in our term life insurance products related to block runoff.

•Adjusted operating income in our annuity products decreased primarily from unfavorable assumption updates of $14 million in 2024 largely related to lapse assumptions compared to favorable assumption updates in 2023 and lower net spreads primarily related to block runoff.

67

Table of Contents

•Corporate and Other

•The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives, partially offset by a higher benefit for income taxes in 2024.

Significant Developments and Key Highlights

Enact segment

•Mortgage insurance portfolio. Enact’s primary persistency rate remained slightly elevated at 82% during 2025, though down from 83% during 2024. Elevated persistency and an increase in new insurance written led to primary insurance in-force growth of $4.3 billion in 2025.

•Loss performance. Enact recorded pre-tax net reserve releases of $200 million in 2025 primarily related to strong cure performance and loss mitigation activities, compared to pre-tax reserve releases of $252 million in 2024.

•PMIERs compliance. Enact’s PMIERs sufficiency ratio was 162% or $1,919 million above the PMIERs requirements as of December 31, 2025.

•Liquidity and financial flexibility. On September 30, 2025, Enact Holdings entered into a $435 million five-year unsecured revolving credit facility (“2025 Credit Facility”), which replaced the previous $200 million revolving credit facility dated June 30, 2022 (“2022 Credit Facility”). The 2025 Credit Facility remained undrawn as of December 31, 2025.

•New share repurchase program. On February 3, 2026, Enact Holdings announced the authorization of a new share repurchase program under which it may repurchase up to $500 million of its common stock.

Closed Block segment

•Long-term care insurance in-force management actions

•Based on our current updated assumptions, we estimate that the cumulative economic benefit of approved rate increases and benefit reductions from 2012 through 2025 was approximately $34.5 billion, on a net present value basis. This reflects meaningful progress toward our latest estimate of approximately $39.5 billion total net present value included in our multi-year in-force rate action plan, and an estimated $5.0 billion remaining to be achieved, based on our current updated assumptions.

•Annual assumption reviews

•Long-term care insurance. Our long-term care insurance products had an unfavorable pre-tax impact of $47 million from our annual review of cash flow assumptions in the fourth quarter of 2025. Unfavorable benefit utilization and healthy life assumption updates were largely offset by favorable assumption updates reflecting in-force rate action approval experience and benefit reductions as well as favorable claim termination assumption updates. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our long-term care insurance cash flow assumptions.

•Life insurance. As part of our annual review of cash flow assumptions in the fourth quarter of 2025, our universal and term universal life insurance products had a favorable pre-tax impact of $15 million reflecting updates to interest rate assumptions given the recent rate environment. See “—Critical Accounting Estimates—Policyholder account balances—additional insurance liabilities” for additional information on the impact of changes in our life insurance cash flow assumptions.

•Annuities. As part of our annual review of cash flow assumptions in the fourth quarter of 2025, our annuity products had a favorable pre-tax impact of $25 million to adjusted operating income primarily from fixed annuity mortality assumption updates.

•Capital of legacy insurance subsidiaries

•As of December 31, 2025, the consolidated RBC ratio on a company action level basis of our legacy insurance subsidiaries was approximately 300%, down from 306% as of December 31, 2024

68

Table of Contents

primarily due to higher required capital as our limited partnership portfolio grows, partially offset by statutory earnings in 2025.

Capital and liquidity

•Holding company liquidity. Genworth Holdings had $234 million of unrestricted cash and cash equivalents as of December 31, 2025, which included approximately $127 million of cash held for future obligations, including advance cash payments from our subsidiaries.

•Share repurchases. During 2025, Genworth Financial executed $245 million of share repurchases, before excise taxes and other associated costs. On September 18, 2025, Genworth Financial announced that its Board of Directors had authorized a new share repurchase program under which Genworth Financial may purchase up to $350 million of its outstanding common stock.

•Capital returns. During 2025, Genworth Holdings received $407 million of capital returns from Enact Holdings. Enact Holdings expects to return approximately $500 million of capital to its shareholders in 2026. Based on our approximately 81% ownership, we expect to receive approximately $405 million in capital returns from Enact Holdings for the full year 2026.

Results of Operations and Selected Financial and Operating Performance Measures by Segment

Enact segment

Trends and conditions

Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.

Macroeconomic environment

Throughout 2025, the U.S. economy was subject to significant volatility and uncertainty, largely related to changing economic policies, including new and variable tariffs, continued inflationary pressure, the U.S. federal government shutdown, and certain domestic and geopolitical tensions. The ancillary effects of these factors on the domestic and global economies could materially impact the U.S. housing market and Enact’s business.

The U.S. Bureau of Labor Statistics reported that the Consumer Price Index decreased to 2.7% year-over-year in December 2025 compared to 2.9% year-over-year in December 2024. The unemployment rate increased to 4.4% in December 2025 compared to 4.1% in December 2024.

Purchase originations in the U.S. mortgage origination market remained relatively slow in response to elevated mortgage rates. Over the past few years, housing affordability has deteriorated as elevated mortgage rates and home price appreciation outpaced median family income, according to the National Association of Realtors Housing Affordability Index. Affordability pressures eased slightly toward the end of 2025 as mortgage rates began to decline and national home price growth has slowed, according to the FHFA Monthly Purchase-Only House Price Index (seasonally adjusted).

Regulatory developments

Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products.

69

Table of Contents

In July 2025, the FHFA announced that it will implement the acceptance of VantageScore 4.0 for mortgages delivered to Fannie Mae and Freddie Mac. The GSEs have not yet released implementation details and timelines, and the full impact of this initiative on Enact’s business, processes and financial results remains uncertain.

Competitive environment

The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk-adjusted return appetite, enabling it to write new business at returns it views as attractive.

Mortgage insurance portfolio

New insurance written of $51.5 billion in 2025 increased 1% compared to 2024. Changes in new insurance written are primarily impacted by the size of the mortgage insurance market and Enact’s market share. Enact’s primary persistency rate decreased to 82% during 2025 compared to 83% during 2024. Persistency remained slightly elevated due to high interest rates but decreased compared to 2024 due to rate volatility throughout 2025. Elevated persistency and modest new insurance written growth led to an increase in primary insurance in-force of $4.3 billion, or 2%, since December 31, 2024.

Net earned premiums in 2025 were consistent with 2024 as higher average insurance in-force and higher assumed premiums were offset by higher ceded premiums and slightly lower average premium rates.

Loss experience

Enact’s loss ratio was 11% for the year ended December 31, 2025 compared to 4% for the year ended December 31, 2024. Both periods were impacted by net favorable reserve adjustments due to strong cure performance and loss mitigation activities. Enact released reserves of $200 million in 2025, the majority of which were related to prior year delinquencies. A portion of the releases also related to lower expected claim rates on 2025 delinquencies reflecting sustained favorable cure performance and current market expectations. This compares to reserve releases of $252 million in 2024 primarily on delinquencies from prior years.

New primary delinquencies in 2025 increased slightly compared to 2024 primarily due to the normal loss development pattern on newer books of business. New primary delinquencies of 50,481 contributed $299 million of loss expense in 2025, while Enact incurred $287 million of loss expense from 48,537 new primary delinquencies in 2024. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and prospective economic conditions.

The severity of loss on loans that go to claim may be negatively impacted by extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. The majority of Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.

Reinsurance transactions

During 2025, Enact executed excess of loss reinsurance transactions that provide approximately $225 million of reinsurance coverage on a portion of new insurance written for the 2025 book year, and $260 million and $170 million of coverage on a portion of expected new insurance written for the 2026 and 2027 book years, respectively. Enact also entered into a quota share reinsurance agreement with a panel of reinsurers under which it will cede approximately 34% of a portion of its expected new insurance written for the 2027 book year. See note 7 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on Enact’s reinsurance transactions. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.

70

Table of Contents

Capital requirements

As of December 31, 2025, EMICO’s risk-to-capital ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 10.1:1, compared with a risk-to-capital ratio of 10.5:1 as of December 31, 2024. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.

Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. As of December 31, 2025, Enact had estimated available assets of $5,015 million against $3,096 million net required assets under PMIERs, compared to available assets of $5,095 million against $3,043 million net required assets as of December 31, 2024. The sufficiency ratio as of December 31, 2025 was 162% or $1,919 million above the PMIERs requirements, compared to 167% or $2,052 million above the PMIERs requirements as of December 31, 2024. Enact’s PMIERs required assets benefited from a reinsurance credit of $1,932 million and $1,885 million as of December 31, 2025 and 2024, respectively, related to third-party reinsurance transactions. Enact’s PMIERs required assets as of December 31, 2024 benefited $28 million from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans as defined under PMIERs. Per guidance released by the GSEs, use of the multiplier was discontinued effective March 31, 2025.

On August 21, 2024, the GSEs and the FHFA released updated PMIERs requirements phasing in a revision to the available assets standards between March 31, 2025 and September 30, 2026. Enact expects to hold capital sufficiency well in excess of these requirements and does not expect the impact of these updates to be material to its sufficiency. For additional details, see “Item 1—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. regulation and agency qualification requirements.”

Capital returns

EMICO paid dividends to Enact Holdings during each quarter of 2025 that support Enact Holdings’ ability to return capital to shareholders. On May 1, 2024, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $250 million of its common stock. Enact Holdings completed the repurchase of shares under this authorization in the second quarter of 2025. On April 30, 2025, Enact Holdings announced the authorization of a new share repurchase program that allows for the repurchase of up to an additional $350 million of its common stock. Genworth Holdings entered into an agreement with Enact Holdings to participate in the share repurchase program in order to maintain its ownership interest in Enact Holdings. In addition to its share repurchase program, Enact Holdings pays a quarterly dividend. As the majority shareholder, Genworth Holdings received $407 million of capital returns from Enact Holdings during 2025, comprised of $309 million of share repurchases and $98 million of quarterly dividends.

On February 3, 2026, Enact Holdings announced the authorization of a new share repurchase program under which it may repurchase up to $500 million of its common stock. Genworth Holdings entered into an agreement with Enact Holdings to participate in the new share repurchase program in order to maintain its ownership interest in Enact Holdings.

Returning capital to shareholders, balanced with growth and risk management priorities, remains a key commitment for Enact Holdings as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, which sets the following priorities: supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.

71

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2025202420232025 vs. 2024
Revenues:
Premiums$980$980$957$%
Net investment income2662402082611%
Net investment gains (losses)(16)(22)(14)627%
Policy fees and other income542125%
Total revenues1,2351,2021,153333%
Benefits and expenses:
Benefits and other changes in policy reserves110392771182%
Acquisition and operating expenses, net of deferrals208224212(16)(7)%
Amortization of deferred acquisition costs and intangibles91011(1)(10)%
Interest expense505152(1)(2)%
Total benefits and expenses3773243025316%
Income (loss) from continuing operations before income taxes858878851(20)(2)%
Provision (benefit) for income taxes184190186(6)(3)%
Income (loss) from continuing operations674688665(14)(2)%
Less: net income (loss) attributable to noncontrolling interests127128123(1)(1)%
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders547560542(13)(2)%
Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)131812(5)(28)%
(Gains) losses on early extinguishment of debt, net (2)9(9)(100)%
Expenses related to restructuring14(3)(75)%
Taxes on adjustments(3)(6)(2)350%
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$558$585$552$(27)(5)%

_______________________

(1)For the years ended December 31, 2025, 2024 and 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $3 million, $4 million and $2 million, respectively.

(2)For the year ended December 31, 2024, (gains) losses on the early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million.

2025 compared to 2024

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income decreased primarily due to lower reserve releases and higher new delinquencies, partially offset by higher net investment income and lower operating expenses in 2025.

Revenues

Premiums were flat as insurance-in force growth and higher assumed premiums were offset by higher ceded premiums and slightly lower average premium rates in 2025.

Net investment income increased primarily from higher investment yields and higher average invested assets in 2025.

72

Table of Contents

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves increased largely from lower reserve releases and higher new delinquencies in 2025. Both periods were impacted by favorable reserve adjustments due to strong cure performance and loss mitigation activities. Enact released reserves of $200 million in 2025, the majority of which were related to prior year delinquencies. A portion of the releases also related to lower expected claim rates on 2025 delinquencies reflecting sustained favorable cure performance and current market expectations. During 2024, Enact recorded reserve releases of $252 million.

Acquisition and operating expenses, net of deferrals, decreased primarily due to an $11 million loss in 2024 on the early redemption of Enact Holdings’ 6.50% senior notes due in August 2025 (“2025 Notes”) that did not recur. The decrease was also driven by lower restructuring expenses and operating costs in 2025.

Provision (benefit) for income taxes. The effective tax rate was 21.5% and 21.6% for the years ended December 31, 2025 and 2024, respectively, consistent with the U.S. corporate federal income tax rate.

Enact selected operating performance measures

Management regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. These metrics are presented on a direct basis and exclude reinsurance. We consider insurance in-force and risk in-force to be measures of Enact’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period.

Management also regularly monitors and reports new insurance written for our Enact segment as a measure of volume of new business generated in a period. We consider new insurance written to be a measure of Enact’s operating performance because it represents a measure of new sales of mortgage insurance policies during a specified period, rather than a measure of revenues or profitability during that period.

The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2025202420232025 vs. 2024
Primary insurance in-force$273,147$268,825$262,937$4,3222%
Risk in-force:
Primary$71,363$69,985$67,529$1,3782%
Pool515769(6)(11)%
Total risk in-force$71,414$70,042$67,598$1,3722%
New insurance written$51,506$51,002$53,081$5041%

2025 compared to 2024

Primary insurance in-force and risk in-force

Primary insurance in-force increased mainly from new insurance written and elevated persistency, partially offset by lapses and cancellations. The primary persistency rate was 82% and 83% for the years ended December 31, 2025 and 2024, respectively. Total risk in-force increased primarily as a result of higher primary insurance in-force.

73

Table of Contents

New insurance written

Changes in new insurance written are primarily impacted by the size of the mortgage insurance market and Enact’s market share.

Loss and expense ratios

Management regularly monitors and reports a loss ratio and an expense ratio for our Enact segment. We consider the loss ratio, which is the ratio of benefits and other changes in policy reserves to net earned premiums, to be a measure of underwriting performance. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles. We believe these ratios help to enhance the understanding of Enact’s operating performance.

The following table sets forth the loss and expense ratios for Enact for the dates indicated:

Years ended December 31,Increase (decrease)
2025202420232025 vs. 2024
Loss ratio11%4%3%7%
Expense ratio22%24%23%(2)%

The loss ratio increased largely from lower net favorable reserve adjustments and higher new delinquencies in 2025.

The expense ratio decreased primarily due to an $11 million loss in 2024 on the early redemption of Enact Holdings’ 2025 Notes that did not recur, which increased the expense ratio by one percentage point in 2024. The decrease was also driven by lower restructuring expenses and operating costs in 2025.

74

Table of Contents

Mortgage insurance loan portfolio

The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31:

(Amounts in millions)202520242023
Primary insurance in-force by loan-to-value ratio at origination:
95.01% and above$54,221$50,318$44,955
90.01% to 95.00%114,315112,362109,227
85.01% to 90.00%78,74679,93277,887
85.00% and below25,86526,21330,868
Total$273,147$268,825$262,937
Primary risk in-force by loan-to-value ratio at origination:
95.01% and above$15,608$14,428$12,878
90.01% to 95.00%33,26032,68631,781
85.01% to 90.00%19,41019,72919,163
85.00% and below3,0853,1423,707
Total$71,363$69,985$67,529
Primary insurance in-force by FICO(1) score at origination:
Over 760$120,093$115,554$110,635
740-75944,89843,95543,053
720-73937,89737,71737,020
700-71929,48629,81929,766
680-69920,77321,35521,835
660-679 (2)11,09111,24511,357
640-6595,9886,1476,137
620-6392,3982,4612,504
620523572630
Total$273,147$268,825$262,937
Primary risk in-force by FICO(1) score at origination:
Over 760$31,186$29,985$28,363
740-75911,76511,49411,096
720-73910,0499,9499,621
700-7197,7277,7467,623
680-6995,4125,5235,557
660-679 (2)2,9132,9242,908
640-6591,5641,5891,565
620-639615629635
620132146161
Total$71,363$69,985$67,529

_______________________

(1)Fair Isaac Company.

(2)Loans with unknown FICO scores are included in the 660-679 category.

The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance in-force was 746 as of December 31, 2025.

75

Table of Contents

Delinquent loans and claims

Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy.

The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31:

202520242023
Primary insurance:
Insured loans in-force950,670962,849974,516
Delinquent loans24,88523,56620,432
Percentage of delinquent loans (delinquency rate)2.62%2.45%2.10%

The delinquency rate as of December 31, 2025 increased compared to December 31, 2024 primarily due to new delinquencies exceeding cures and paid claims.

The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of December 31:

2025
(Dollar amounts in millions)DelinquenciesDirect primarycase reserves (1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less12,647$104$86712%
4 - 11 payments8,59120664132%
12 payments or more3,64720527076%
Total24,885$515$1,77829%

_______________________

(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

2024
(Dollar amounts in millions)DelinquenciesDirect primarycase reserves (1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less12,712$108$84913%
4 - 11 payments7,70119154535%
12 payments or more3,15317321381%
Total23,566$472$1,60729%

_______________________

(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Total reserves as a percentage of risk in-force as of December 31, 2025 was flat compared to December 31, 2024.

Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro

76

Table of Contents

Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property rather than the location of the lender.

% of primary risk in-force as of December 31, 2025% of direct primary case reserves as of December 31, 2025⁽¹⁾Delinquency rate as of December 31,
202520242023
By State:
California12%13%2.84%2.53%2.22%
Texas9%9%2.81%2.64%2.22%
Florida (2)8%13%3.35%3.67%2.39%
New York (2)5%9%3.38%3.30%3.05%
Illinois (2)4%5%3.15%2.96%2.61%
Arizona4%4%2.78%2.35%1.93%
Michigan4%3%2.33%2.14%1.94%
Georgia3%4%3.33%3.02%2.23%
North Carolina3%2%2.07%2.14%1.56%
Pennsylvania3%3%2.29%2.17%2.19%

_______________________

(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

(2)Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed.

% of primary risk in-force as of December 31, 2025% of direct primary case reserves as of December 31, 2025⁽¹⁾Delinquency rate as of December 31,
202520242023
By MSA or MD:
Phoenix, AZ MSA3%3%2.85%2.41%2.01%
Chicago-Naperville, IL MD3%4%3.31%3.29%2.88%
Atlanta, GA MSA3%3%3.59%3.02%2.40%
Dallas, TX MD2%2%2.49%2.38%1.92%
Houston, TX MSA2%3%3.54%3.58%2.67%
New York, NY MD2%5%3.70%3.53%3.60%
Washington-Arlington, DC MD2%2%2.62%2.03%2.01%
Riverside-San Bernardino, CA MSA2%3%3.53%3.25%2.83%
Los Angeles-Long Beach, CA MD2%3%3.26%2.65%2.39%
Denver-Aurora-Lakewood, CO MSA2%1%1.85%1.38%1.12%

_______________________

(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance, pre-foreclosure sale and deed-in-lieu. These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts.

77

Table of Contents

The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, as well as weighted average mortgage interest rate and delinquency rate as of December 31, 2025:

(Amounts in millions)Weightedaveragerate(1)% of direct primarycase reserves(2)Primary insurance in-force% of totalPrimary risk in-force% of totalDelinquency rate
Policy Year
2008 and prior5.36%8%$4,2192%$1,0922%7.96%
2009 to 20174.02%76,50321,68025.08%
20184.86%43,91711,01015.31%
20194.24%59,53942,49943.45%
20203.26%1128,074107,739112.41%
20213.12%1945,9451712,482172.63%
20224.89%2246,1731711,884172.98%
20236.59%1538,250149,967142.75%
20246.67%842,0431510,812151.73%
20256.57%148,4841812,198170.32%
Total portfolio5.21%100%$273,147100%$71,363100%2.62%

_______________________

(1)Average annual mortgage interest rate weighted by insurance in-force.

(2)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination, particularly 2005 through 2008, combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. The concentration of loss reserves has shifted to newer book years in line with changes in risk in-force. As of December 31, 2025, Enact’s 2018 and newer policy years represented approximately 96% of its primary risk in-force and 85% of its total direct primary case reserves.

The ratio of the claim paid to the current risk in-force for a loan is referred to as “claim severity.” The current risk in-force is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws. Pre-foreclosure sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 96%, 99% and 97% for the years ended December 31, 2025, 2024 and 2023, respectively, and was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on non-performing loans.

Closed Block segment

We no longer solicit sales of the long-term care insurance, life insurance and annuity products included in our Closed Block segment. However, our legacy insurance subsidiaries continue to service and manage their in-force blocks of business and may still issue a limited number of certificates under existing group long-term care insurance policies.

Trends and conditions

Many factors can affect the results of our long-term care insurance, life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Results of the products in our Closed Block segment depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our

78

Table of Contents

reserves. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for these products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.

For a discussion of potential impacts of assumption updates and actual variances from expected experience on our results of operations, see “Item 1A—Risk Factors—We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition.”

Results of our life insurance and annuity products and the financial condition of our long-term care insurance products are also impacted by interest rates. We remeasure our liability for future policy benefits and the related reinsurance recoverables at the single-A bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued volatility to our reserve balances and equity. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates could materially adversely affect our business and profitability.”

Fourth quarter assumption review

We completed the required annual review of our cash flow assumptions for our long-term care insurance, life insurance and annuity products in the fourth quarter of 2025. While our 2025 assumption review considered trends during and following the pandemic years, our updates to long-term assumptions generally exclude or adjust experience data from 2020 to 2022, as we do not have sufficient information around the long-term effects of COVID-19.

In our long-term care insurance products, we had an unfavorable pre-tax impact of $47 million from cash flow assumption updates in the fourth quarter of 2025. Unfavorable benefit utilization and healthy life assumption updates were largely offset by favorable assumption updates reflecting in-force rate action approval experience and benefit reductions as well as favorable claim termination assumption updates. Our benefit utilization assumption updates included near-term experience related to cost of care inflation, and our healthy life assumptions were updated to better align with recent mortality and incidence trends, incorporating post-COVID-19 trends. Our claim termination assumption updates also incorporated post-COVID-19 trends.

In our universal and term universal life insurance products, we had a favorable pre-tax impact of $15 million from cash flow assumption updates reflecting favorable updates to interest rate assumptions given the recent rate environment. Certain of our universal life insurance products with secondary guarantees are subject to additional reserves on a statutory basis using regulatory prescribed assumptions, including mortality improvement and the reinvestment rate. The updates to the prescribed mortality improvement assumption had a favorable impact from a statutory income (loss) perspective.

In our annuity products, we had a favorable pre-tax impact of $25 million to adjusted operating income primarily from mortality assumption updates in our fixed annuity products.

We also completed statutory cash flow testing for our legacy insurance subsidiaries in the fourth quarter of 2025 and concluded that the margin in those companies was positive.

Long-term care insurance

The results of our long-term care insurance products depend upon how our actual experience compares with our valuation assumptions, including but not limited to in-force rate actions, morbidity, mortality and persistency. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance products are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, also impact our long-term care insurance products either positively or negatively.

Our actual claims experience will emerge over many years, or decades. Average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on certain of our oldest long-term

79

Table of Contents

care insurance blocks of business have reached their peak claim years and will decrease as the blocks run off, we expect overall claims costs to continue to increase as the approximately 592,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 78 and 75, respectively, reach their peak claim years, which are age 85 and over.

Additionally, we have observed an increase in the cost of care in our long-term care insurance products, due in part to elevated inflation. Increases in cost of care have resulted in higher claim payments, which could have a material adverse impact on our liquidity, results of operations and financial condition if the increases persist.

The impacts of assumption updates and actual variances from expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. Our profitable uncapped cohorts have had a more modest earnings impact related to assumption updates and actual variances from expected experience, to date, as a portion of the impact is reflected in current period results with the remaining majority of the impact recognized over the life of the cohort. However, we may see increased volatility as the uncapped cohorts continue to age, with more of the impact related to assumption updates and actual variances from expected experience recognized immediately in net income (loss). It is important to note that quarterly variations resulting from assumption updates and actual variances from expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $44.1 billion, at the locked-in discount rate, for our long-term care insurance products as of December 31, 2025.

In-force management actions

Given the ongoing challenges in our long-term care insurance products, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium increases and benefit reductions on our in-force policies. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our in-force long-term care insurance policies is critical to Closed Block. Although approvals in 2025 were lower than previous years due to past successes in achieving approvals, this does not impact our overall strategy for rate actions. In some cases, we received large approvals that either materially completed the current multi-year rate action plan or resulted in multi-year implementations. For an update on in-force rate actions, refer to the selected operating performance measures below.

In addition, we previously reached three legal settlements regarding alleged disclosure deficiencies in premium increases for certain long-term care insurance policies. These legal settlements covered approximately 70% of our long-term care insurance in-force in Closed Block and accelerated benefit reductions. The legal settlements resulted in an overall net favorable economic impact to our long-term care insurance products as they reduced tail risk on these long-duration liabilities.

While we expect renewal premiums to decline over time as the block runs off, benefit reductions elected by policyholders in connection with our in-force rate actions and legal settlements have accelerated that decline. However, we expect this decline to be partially offset by future approved rate actions.

We also plan to continue to offer existing, and to design and implement additional, reduced benefit options outside of in-force rate actions to enhance sustainability of our legacy insurance subsidiaries and to reduce the risk on certain product features of our long-term care insurance policies.

Life insurance

Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors.

Mortality levels may deviate each period from historical trends; however, we typically experience seasonally unfavorable mortality in the first quarter of each year. Mortality improved slightly during the fourth quarter of 2025 compared to third quarter of 2025 but was in line with the fourth quarter of 2024. We have also experienced unfavorable mortality compared to our then-current and priced-for assumptions in recent years for our universal life insurance block. Reinsurance costs typically increase due to natural aging of the yearly renewable term reinsured blocks. In prior periods, we have received some yearly renewable term reinsurance premium increases from some of our reinsurance partners that reflect unfavorable mortality.

80

Table of Contents

Annuities

Results of our fixed and variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency, expense and commission levels, surrenders and scheduled maturities.

We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.

Equity market volatility and interest rate movements have caused, and may continue to cause, fluctuations in the results of our fixed indexed and variable annuity products and can significantly impact our regulatory capital requirements and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate these impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.

Equity market performance was more favorable in 2025 compared to 2024. Interest rate performance had an unfavorable impact in 2025 compared to a favorable impact in 2024.

81

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Closed Block segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2025202420232025 vs. 20242024 vs. 2023
Revenues:
Premiums$2,508$2,489$2,670$191%$(181)(7)%
Net investment income2,8402,8992,956(59)(2)%(57)(2)%
Net investment gains (losses)103466557124%(19)(29)%
Policy fees and other income612638646(26)(4)%(8)(1)%
Total revenues6,0636,0726,337(9)%(265)(4)%
Benefits and expenses:
Benefits and other changes in policy reserves4,7194,7364,765(17)%(29)(1)%
Liability remeasurement (gains) losses313153587160105%(434)(74)%
Changes in fair value of market risk benefits and associated hedges3(13)(12)16123%(1)(8)%
Interest credited386453503(67)(15)%(50)(10)%
Acquisition and operating expenses, net of deferrals688658665305%(7)(1)%
Amortization of deferred acquisition costs and intangibles217235252(18)(8)%(17)(7)%
Total benefits and expenses6,3266,2226,7601042%(538)(8)%
Income (loss) from continuing operations before income taxes(263)(150)(423)(113)(75)%27365%
Provision (benefit) for income taxes(31)(5)(62)(26)NM⁽¹⁾5792%
Income (loss) from continuing operations(232)(145)(361)(87)(60)%21660%
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses(103)(46)(65)(57)(124)%1929%
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2)(5)(43)(22)3888%(21)(95)%
Expenses related to restructuring1(1)(100)%1NM⁽¹⁾
Taxes on adjustments231918421%16%
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$(317)$(214)$(430)$(103)(48)%$21650%

_______________________

(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

(2)For the years ended December 31, 2025, 2024 and 2023, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(8) million, $(30) million and $(10) million, respectively.

82

Table of Contents

The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Closed Block segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2025202420232025 vs. 20242024 vs. 2023
Long-term care insurance$(326)$(176)$(242)$(150)(85)%$6627%
Life insurance(66)(94)(275)2830%18166%
Annuities7556871934%(31)(36)%
Total adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$(317)$(214)$(430)$(103)(48)%$21650%

2025 compared to 2024

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

•The adjusted operating loss in our long-term care insurance products increased primarily driven by unfavorable cash flow assumption updates in 2025 compared to favorable updates in 2024, net insurance recoveries of $22 million in 2024 that did not recur and aging of the in-force block. These adverse developments were partially offset by higher limited partnership income and a $21 million gain related to a third-party reinsurance recapture in 2025.

•The adjusted operating loss in our life insurance products decreased largely due to continued block runoff.

•Adjusted operating income in our annuity products increased primarily from favorable assumption updates of $20 million in 2025 largely related to mortality assumptions compared to unfavorable updates of $14 million in 2024 largely related to lapse assumptions, partially offset by lower spread income in 2025 driven mostly by block runoff.

Revenues

Premiums

•Our long-term care insurance products increased $34 million primarily driven by $97 million of higher premiums in 2025 from newly implemented in-force rate actions, partially offset by lower renewal premiums from prior benefit reduction elections made by policyholders in connection with our in-force rate actions and legal settlements. Policy terminations also drove lower renewal premiums in 2025.

•Our life insurance products decreased $15 million largely due to the continued runoff of our in-force blocks.

Net investment income

•Our long-term care insurance products increased $28 million largely due to $44 million of higher income from limited partnerships, partially offset by lower investment yields in 2025.

•Our life insurance products decreased $52 million primarily from lower policy loan rates in our corporate-owned life insurance products in 2025.

•Our annuity products decreased $35 million primarily attributable to lower average invested assets in 2025 driven mostly by block runoff.

Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Policy fees and other income. The decrease was primarily driven by our life insurance and annuity products principally due to block runoff.

83

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves

•Our long-term care insurance products increased $74 million primarily from a higher unfavorable change in reserves due to an increase in net premiums collected and from aging of the in-force block, including higher interest accretion, in 2025.

•Our life insurance products decreased $87 million largely due to continued block runoff.

Liability remeasurement (gains) losses

•Our long-term care insurance products had a liability remeasurement loss of $316 million in 2025 largely due to unfavorable actual variances from expected experience primarily driven by higher claims and lower terminations, partially offset by a $26 million gain related to a third-party recapture of a block of long-term care insurance policies. For additional information on the third-party reinsurance recapture, see note 22 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” The liability remeasurement loss also included unfavorable cash flow assumption updates primarily related to benefit utilization and healthy life assumptions, largely offset by favorable assumption updates reflecting in-force rate action approval experience and benefit reductions as well as favorable claim termination assumption updates.

Our long-term care insurance products had a liability remeasurement loss of $172 million in 2024 mainly attributable to adverse actual variances from expected experience principally driven by lower terminations and higher claims. This was partially offset by net favorable cash flow assumption updates largely related to approval amounts and implementation timing of our in-force rate action plan and a favorable update to our short-term incidence assumption for IBNR claims.

See “—Critical Accounting Estimates—Liability for future policy benefits—Long-term care insurance” for a discussion of the fourth quarter annual review of assumptions.

•Our life insurance products had a liability remeasurement loss of $28 million in 2025 primarily driven by unfavorable actual variances from expected experience largely due to unfavorable mortality. This was partially offset by favorable cash flow assumption updates primarily related to interest rate assumptions given the recent rate environment. Our life insurance products had a gain of $12 million in 2024, which included a $58 million model refinement related to certain universal life insurance products with secondary guarantees, partially offset by $28 million of unfavorable updates to our mortality assumptions for universal life insurance contracts and our interest rate assumptions. See “—Critical Accounting Estimates—Policyholder account balances – additional insurance liabilities” for a discussion of the fourth quarter annual review of assumptions.

•The liability remeasurement gain in our annuity products increased $24 million largely due to favorable cash flow assumption updates in 2025 related to fixed annuity mortality assumptions.

Changes in fair value of market risk benefits and associated hedges. The change to a loss in 2025 from a gain in 2024 was primarily attributable to unfavorable interest rate impacts in our annuity products in 2025 compared to favorable impacts in 2024, partially offset by lower derivative losses and more favorable equity market impacts in 2025. We also had favorable interest rate assumption updates in 2025 compared to unfavorable lapse assumption updates in 2024.

Interest credited

•Our life insurance products decreased $54 million primarily driven by lower policy loan rates in our corporate-owned life insurance products in 2025.

•Our annuity products decreased $13 million largely due to block runoff.

Acquisition and operating expenses, net of deferrals. The increase was primarily driven by our long-term care insurance products principally from $28 million of net insurance recoveries in 2024 that did not recur related to previously incurred legal settlement expenses. The increase was also driven by higher operating costs, including higher employee-related expenses, in 2025.

Amortization of deferred acquisition costs and intangibles. The decrease was primarily driven by lower DAC amortization in our life insurance products in 2025 due to block runoff.

84

Table of Contents

Provision (benefit) for income taxes. The tax benefit in 2025 and 2024 was primarily attributable to the tax benefit on the pre-tax loss, partially offset by tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income.

2024 compared to 2023

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

•The adjusted operating loss in our long-term care insurance products decreased primarily driven by lower liability remeasurement losses, net insurance recoveries and higher income from limited partnerships, partially offset by lower renewal premiums in 2024.

•The adjusted operating loss in our life insurance products decreased primarily from liability remeasurement gains in 2024 compared to losses in 2023, partially offset by lower premiums and a less favorable change in reserves in 2024 in our term life insurance products related to block runoff.

•Adjusted operating income in our annuity products decreased primarily from unfavorable assumption updates of $14 million in 2024 largely related to lapse assumptions compared to favorable assumption updates in 2023 and lower net spreads primarily related to block runoff.

Revenues

Premiums

•Our long-term care insurance products decreased $153 million primarily driven by lower renewal premiums from benefit reduction elections made by policyholders in connection with our in-force rate actions and legal settlements and from policy terminations in 2024. The decrease was partially offset by $7 million of higher premiums in 2024 from newly implemented in-force rate actions.

•Our life insurance products decreased $28 million largely due to the continued runoff of our in-force blocks.

Net investment income

•Our long-term care insurance products increased $26 million largely due to higher income from limited partnerships in 2024.

•Our life insurance products decreased $38 million largely from lower policy loan rates in our corporate-owned life insurance products in 2024.

•Our annuity products decreased $45 million primarily attributable to lower average invested assets in 2024 driven mostly by block runoff.

Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves

•Our long-term care insurance products decreased $28 million primarily due to lower net premiums collected resulting from benefit reduction elections made by policyholders in connection with our in-force rate actions and legal settlements and from policy terminations. This was partially offset by aging of the in-force block, including higher interest accretion, and higher loss adjustment expenses in 2024.

•Our life insurance products increased $21 million primarily from a less favorable change in reserves in our term life insurance products in 2024 related to block runoff and a favorable flooring adjustment in 2023 that did not recur. These increases were partially offset by an increase in cost of reinsurance reserves related to a ceded reinsurance transaction in 2023 that did not recur.

•Our annuity products decreased $22 million largely attributable to block runoff and higher reserve releases in 2024.

85

Table of Contents

Liability remeasurement (gains) losses

•Our long-term care insurance products had a liability remeasurement loss of $172 million in 2024 largely due to adverse actual variances from expected experience primarily driven by lower terminations and higher claims. This was partially offset by net favorable cash flow assumption updates primarily related to approval amounts and implementation timing of our in-force rate action plan and a favorable update to our short-term incidence assumption for IBNR claims.

Our long-term care insurance products had a liability remeasurement loss of $321 million in 2023 largely driven by adverse actual variances from expected experience primarily related to higher claims and unfavorable timing impacts from the second legal settlement. In addition, cash flow assumption updates were unfavorable in 2023 primarily driven by unfavorable updates to our healthy life assumptions to better reflect near-term experience, partially offset by a favorable update to our disabled life mortality assumptions.

•Our life insurance products had a liability remeasurement gain of $12 million in 2024 compared to a $276 million loss in 2023. The liability remeasurement gain in 2024 included a $58 million model refinement related to certain universal life insurance products with secondary guarantees, partially offset by $28 million of unfavorable updates to our mortality assumptions for universal life insurance contracts and our interest rate assumptions.

The liability remeasurement loss in our life insurance products in 2023 was principally driven by unfavorable cash flow assumption updates of $256 million primarily related to our persistency assumptions for certain universal life insurance products with secondary guarantees and unfavorable mortality updates, including more modest mortality improvement. These unfavorable updates were partially offset by net favorable impacts related to a ceded reinsurance transaction.

Changes in fair value of market risk benefits and associated hedges. The gain increased slightly as favorable interest rate impacts were mostly offset by unfavorable lapse assumption updates of $13 million in our annuity products in 2024 compared to favorable assumption updates in 2023. Our variable annuity products also had higher derivative losses in 2024.

Interest credited

•Our life insurance products decreased $37 million primarily driven by lower policy loan rates in our corporate-owned life insurance products in 2024.

•Our annuity products decreased $13 million largely due to block runoff, partially offset by higher crediting rates in 2024.

Acquisition and operating expenses, net of deferrals

•Our long-term care insurance products decreased $29 million principally from $28 million of net insurance recoveries in 2024 related to previously incurred legal settlement expenses, as well as a $13 million accrual for legal settlement costs in 2023 that did not recur. These decreases were partially offset by higher employee-related expenses in 2024.

•Our life insurance products increased $13 million primarily driven by higher operating costs and a $5 million legal settlement accrual in 2024.

•Our annuity products increased $9 million mainly from higher operating costs in 2024.

Amortization of deferred acquisition costs and intangibles. The decrease was largely due to block runoff in our term life insurance products.

Provision (benefit) for income taxes. The tax benefit decreased primarily due to a lower pre-tax loss in 2024. The tax benefit in 2024 and 2023 was partially offset by tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income.

86

Table of Contents

Closed Block selected operating performance measures

Long-term care insurance

Liability remeasurement (gains) losses

We include expectations for benefit reductions related to in-force rate actions in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. In the fourth quarter of 2025, we also included estimates of other benefit reductions outside of in-force rate actions in our assumptions. We update the net premium ratio quarterly for actual variances from expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions will be reflected in liability remeasurement (gains) losses in our operating results on a quarterly basis.

The following table sets forth the pre-tax components of the liability remeasurement (gains) losses, net of reinsurance, of our long-term care insurance products for the periods indicated:

Years ended December 31,(Favorable) unfavorable change and percentage change
(Amounts in millions)2025202420232025 vs. 20242024 vs. 2023
Cash flow assumption updates$60$(69)$52$129187%$(121)NM⁽¹⁾
Actual variances from expected experience256241269156%(28)(10)%
Total liability remeasurement (gains) losses$316$172$321$14484%$(149)(46)%

_______________________

(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

For additional discussion of liability remeasurement (gains) losses, see the comparison for this line item above.

In-force management actions

As part of our strategy for our long-term care insurance products in our Closed Block segment, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions as well as other reduced benefit options outside of in-force rate actions in order to maintain the self-sustainability of our legacy insurance subsidiaries and reduce the strain on earnings and capital in our Closed Block segment.

Management regularly monitors and reports in-force rate actions, including state filing approvals; impacted in-force premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved for the long-term care insurance products included in our Closed Block segment.

We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan on a net present value basis, discounted at our investment portfolio yield. This is based on current assumptions and is defined as the net present value of historical and future expected premium increases and benefit reductions as a result of rate increases approved on our long-term care insurance policies. It also includes the net present value of reserve reductions related to prior legal settlements less cash payments made to policyholders who elected certain reduced benefit options in connection with the legal settlements, referred to as settlement payments. We monitor these selected operating performance measures for in-force management actions to track our progress on maintaining the self-sustainability of our legacy insurance subsidiaries. We consider these in-force management action metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Closed Block segment.

We estimate that the cumulative economic benefit of approved rate increases and benefit reductions from 2012 through 2025 was approximately $34.5 billion, on a net present value basis. This represents a significant increase in estimated rate increases and benefit reductions achieved since December 31, 2024, including $1.0 billion of value from rate action approvals in 2025 and an increase of $2.3 billion in the value of benefit reductions connected with our previously achieved rate actions and legal settlements from the impact of our assumption updates.

87

Table of Contents

The following table sets forth filing approvals as part of our multi-year in-force rate action plan for the years ended December 31:

(Dollar amounts in millions)202520242023
State filings approved8397117
Impacted in-force premiums$549$870$697
Weighted-average percentage rate increase approved38%39%51%
Gross incremental premiums approved$209$343$354

During the year ended December 31, 2025, we also submitted 83 new filings on approximately $763 million in annualized in-force premiums.

The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state and product. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase, and increases are generally applied on the insured’s next policy anniversary date. At that time, policyholders make an election to either pay the full increase or reduce their benefits, and therefore, mitigate some or all of the rate increase. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.

We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims and reduces cross-state premium inequities, we will consider litigation against states that decline to approve those actuarially justified rate increases. As of December 31, 2025, we were in litigation with one state that has refused to approve actuarially justified rate increases for certain products.

Life insurance

Liability remeasurement (gains) losses

The following table sets forth the pre-tax components of the liability remeasurement (gains) losses, net of reinsurance, of our life insurance products for the periods indicated:

Years ended December 31,(Favorable) unfavorable change and percentage change
(Amounts in millions)2025202420232025 vs. 20242024 vs. 2023
Cash flow assumption updates$(15)$28$256$(43)(154)%$(228)(89)%
Actual variances from expected experience43(40)2083NM⁽¹⁾(60)NM⁽¹⁾
Total liability remeasurement (gains) losses$28$(12)$276$40NM⁽¹⁾$(288)(104)%

_______________________

(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

For additional discussion of liability remeasurement (gains) losses, see the comparison for this line item above.

88

Table of Contents

Annuities

Liability remeasurement (gains) losses

The following table sets forth the pre-tax components of the liability remeasurement (gains) losses, net of reinsurance, of our annuity products for the periods indicated:

Years ended December 31,(Favorable) unfavorable change and percentage change
(Amounts in millions)2025202420232025 vs. 20242024 vs. 2023
Cash flow assumption updates$(22)$(1)$$(21)NM⁽¹⁾$(1)NM⁽¹⁾
Actual variances from expected experience(9)(6)(10)(3)(50)%440%
Total liability remeasurement (gains) losses$(31)$(7)$(10)$(24)NM⁽¹⁾$330%

_______________________

(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

For additional discussion of liability remeasurement (gains) losses, see the comparison for this line item above.

Corporate and Other

Results of operations

The following table sets forth the results of operations relating to Corporate and Other for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2025202420232025 vs. 2024
Revenues:
Premiums$11$11$9$%
Net investment income192119(2)(10)%
Net investment gains (losses)(28)(11)(28)(17)(155)%
Policy fees and other income1(2)1NM⁽¹⁾
Total revenues321(2)(18)(86)%
Benefits and expenses:
Benefits and other changes in policy reserves(8)(9)(9)111%
Acquisition and operating expenses, net of deferrals11395651819%
Amortization of deferred acquisition costs and intangibles541125%
Interest expense556466(9)(14)%
Total benefits and expenses165154123117%
Income (loss) from continuing operations before income taxes(162)(133)(125)(29)(22)%
Provision (benefit) for income taxes(69)(27)(20)(42)(156)%
Income (loss) from continuing operations(93)(106)(105)1312%
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses28112817155%
(Gains) losses on early extinguishment of debt(1)(7)(2)686%
Expenses related to restructuring(1)74(8)(114)%
Taxes on adjustments (2)(30)(3)(6)(27)NM⁽¹⁾
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$(97)$(98)$(81)$11%

_______________________

(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

(2)The year ended December 31, 2025 included a $24 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets.

89

Table of Contents

2025 compared to 2024

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily from a $17 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets, mostly offset by higher expenses related to CareScout growth initiatives in 2025.

Revenues

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives in 2025.

Interest expense decreased from a lower floating interest rate on Genworth Holdings’ junior subordinated notes in 2025 and from the repurchase of Genworth Holdings’ debt in 2024.

The increase in the benefit for income taxes was primarily related to a $41 million release of a portion of the valuation allowance on certain deferred tax assets in 2025.

Investments and Derivative Instruments

Trends and conditions

Investments

During the year ended December 31, 2025, our investment portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends:

•The U.S. Federal Reserve decreased interest rates by 75 basis points in 2025 while it continued to monitor labor market conditions and inflation, including any impacts from rising tariffs, which will influence its plan for any additional changes to interest rates in 2026.

•During the fourth quarter of 2025, the U.S. Treasury yield curve steepened compared to both September 30, 2025 and December 31, 2024 as short-term yields decreased more than changes experienced in long-term yields driven by mixed economic data and increased concerns with the U.S. federal government’s fiscal deficit.

•Credit spreads ended the fourth quarter of 2025 wider compared to September 30, 2025 as the U.S. federal government shutdown and expectations for high artificial intelligence-driven data center capital expenditures resulted in periods of credit spread widening during the quarter. However, the market shifted towards a more positive sentiment towards the end of the fourth quarter of 2025, and credit spreads began to tighten as the U.S. federal government shutdown ended and strong demand from yield-focused investors supported a renewed shift toward a willingness to take on higher risk. Equity markets mirrored these trends and fluctuations, achieving all-time highs by the end of the fourth quarter of 2025.

•As of December 31, 2025, our fixed maturity securities portfolio, which was 97% investment grade, comprised 75% of our total invested assets and cash.

Derivatives

•As of December 31, 2025, $1.0 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”).

•The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2025, we posted initial margin of $76 million to our clearing agents, which represented $38 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations

90

Table of Contents

to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings.

•As of December 31, 2025, $12.7 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $585 million and are holding collateral from counterparties in the amount of $17 million.

Investment results

The following table sets forth information about investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31:

Increase (decrease)
2025202420232025 vs. 2024
(Amounts in millions)YieldAmountYieldAmountYieldAmountYieldAmount
Fixed maturity securities—taxable4.6%$2,2554.6%$2,2384.5%$2,244%$17
Fixed maturity securities—non-taxable4.2%15.7%24.2%3(1.5)%(1)
Equity securities2.5%132.9%133.0%11(0.4)%
Commercial mortgage loans4.6%2944.5%2974.4%3020.1%(3)
Policy loans6.2%1448.3%18910.2%224(2.1)%(45)
Limited partnerships (1)5.8%1955.1%1524.5%1170.7%43
Other invested assets (2)40.9%24845.7%27050.5%279(4.8)%(22)
Cash, cash equivalents, restricted cash and short-term investments4.0%804.8%994.7%95(0.8)%(19)
Gross investment income before expenses and fees5.1%3,2305.1%3,2605.1%3,275%(30)
Expenses and fees(0.2)%(105)(0.2)%(100)(0.2)%(92)%(5)
Net investment income4.9%$3,1254.9%$3,1604.9%$3,183%$(35)
Average invested assets and cash$63,636$64,055$64,637$(419)

_______________________

(1)Limited partnership investments are primarily equity-based and do not have fixed returns by period.

(2)Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.

Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments.

Gross annualized weighted-average investment yields were unchanged for 2025 compared to 2024 from lower net investment income on lower average invested assets in 2025. Net investment income decreased as higher income from limited partnerships was more than offset by lower policy loan rates in our corporate-owned life insurance products, lower amortization of terminated cash flow hedges and lower returns on our short-term investments due to a decrease in interest rates in 2025.

91

Table of Contents

The following table sets forth net investment gains (losses) for the years ended December 31:

(Amounts in millions)202520242023
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains$29$49$29
Realized losses(79)(106)(154)
Net realized gains (losses) on available-for-sale fixed maturity securities(50)(57)(125)
Net realized gains (losses) on equity securities sold59(1)
Total net realized investment gains (losses)(45)(48)(126)
Net change in allowance for credit losses on available-for-sale fixed maturity securities(13)(3)(7)
Write-down of available-for-sale fixed maturity securities(4)(9)(1)
Net unrealized gains (losses) on equity securities still held568353
Net unrealized gains (losses) on limited partnerships11243111
Commercial mortgage loans(23)(16)(5)
Derivative instruments(17)(18)7
Other(7)(19)(9)
Net investment gains (losses)$59$13$23

2025 compared to 2024

•We recorded $69 million of higher unrealized gains on limited partnerships driven by more favorable private equity market performance in 2025. We recorded $27 million of lower net unrealized gains on equity securities driven by less favorable public equity market performance in 2025.

•During 2025, we increased the provision for credit losses for commercial mortgage loans primarily as a result of updates to the analytical model used to determine the adequacy of the allowance for credit losses. During 2024, we increased the provision for credit losses for both commercial mortgage loans and bank loan investments as a result of annual updates to the underlying metrics included in the analytical model used to determine the adequacy of the allowance for credit losses, as well as updates to certain assumptions for bank loan investments. We also recorded a higher net change in the allowance for credit losses on available-for-sale fixed maturity securities of $10 million in 2025.

Investment portfolio

The following table sets forth our cash, cash equivalents and invested assets as of December 31:

20252024
(Amounts in millions)Carrying value% of totalCarrying value% of total
Available-for-sale fixed maturity securities:
Public$31,25151%$30,65051%
Private14,5112414,25224
Equity securities55515151
Commercial mortgage loans, net6,304106,41111
Policy loans2,29742,3104
Limited partnerships3,48463,1425
Other invested assets77016481
Cash, cash equivalents and restricted cash2,03632,0483
Total cash, cash equivalents and invested assets$61,208100%$59,976100%

92

Table of Contents

For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 4 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio.

We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2025, approximately 6% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 19 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value.

The following table presents our public, private and total fixed maturity securities by the Nationally Recognized Statistical Rating Organizations (“NRSRO”) designations and/or equivalent ratings, as well as the percentage, based upon fair value that each designation comprises. Certain fixed maturity securities that are not rated by an NRSRO are shown based upon internally prepared credit evaluations.

As of December 31,
(Amounts in millions)20252024
NRSRO designationAmortized costFair value% of totalAmortized costFair value% of total
Public fixed maturity securities
AAA$1,551$1,4665%$2,760$2,4148%
AA7,8777,250236,5895,98820
A9,6889,373309,0588,53728
BBB13,21512,6424014,27013,20842
BB53950425214762
B17162927
CCC and lower
Total public fixed maturity securities$32,887$31,251100%$33,227$30,650100%
Private fixed maturity securities
AAA$553$5404%$808$7775%
AA1,7831,690121,6551,52711
A4,7354,484314,4094,01528
BBB7,3166,949487,5646,94849
BB75574759048506
B877192811
CCC and lower19154639
Not rated15151515
Total private fixed maturity securities$15,263$14,511100%$15,493$14,252100%
Total fixed maturity securities
AAA$2,104$2,0064%$3,568$3,1917%
AA9,6608,940208,2447,51517
A14,42313,8573013,46712,55228
BBB20,53119,5914321,83420,15645
BB1,2941,25131,4251,3263
B10487121108
CCC and lower19154639
Not rated15151515
Total fixed maturity securities$48,150$45,762100%$48,720$44,902100%

93

Table of Contents

We invest in privately placed fixed maturity securities to increase diversification and obtain higher yields than can ordinarily be obtained with comparable public market securities. Generally, private placements provide us with protective covenants, call protection features and, where applicable, a higher level of collateral. However, our private placements are not as freely transferable as public securities because of restrictions imposed by federal and state securities laws, the terms of the securities and the characteristics of the private market. Based upon fair value, public and private fixed maturity securities represented 68% and 32%, respectively, of total fixed maturity securities as of both December 31, 2025 and 2024.

We diversify our corporate securities by industry and issuer. As of December 31, 2025, our combined holdings in the 10 corporate issuers to which we had the greatest exposure was $1.6 billion, which was approximately 3% of our total cash, cash equivalents and invested assets. The exposure to the largest single corporate issuer held as of December 31, 2025 was $256 million, which was less than 1% of our total cash, cash equivalents and invested assets. See note 4 to our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on diversification by sector.

Other invested assets

The following table sets forth the carrying values of our other invested assets as of December 31:

20252024
(Amounts in millions)Carrying value% of totalCarrying value% of total
Bank loan investments$52768%$53582%
Corporate-owned life insurance investments11515
Derivatives395569
Short-term investments37541
Other investments527538
Total other invested assets$770100%$648100%

In 2025, we purchased corporate-owned life insurance to protect against the loss of key employees and to help fund future employee-related expenses. Short-term investments increased from net purchases in 2025.

94

Table of Contents

Derivatives

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of and for the periods indicated:

(Notional in millions)MeasurementDecember 31, 2024AdditionsMaturities/ terminationsDecember 31, 2025
Derivatives designated as hedges
Cash flow hedges:
Interest rate swapsNotional$8,757$$(699)$8,058
Foreign currency swapsNotional14412156
Forward bond purchase commitmentsNotional2,639425(100)2,964
Total cash flow hedges11,540437(799)11,178
Total derivatives designated as hedges11,540437(799)11,178
Derivatives not designated as hedges
Equity index optionsNotional604490(591)503
Financial futuresNotional1,1024,189(4,302)989
Forward bond purchase commitmentsNotional500500
Foreign currency forward contractsNotional521521
Total derivatives not designated as hedges2,2065,200(4,893)2,513
Total derivatives$13,746$5,637$(5,692)$13,691
(Number of policies)MeasurementDecember 31, 2024AdditionsMaturities/ terminationsDecember 31, 2025
Derivatives not designated as hedges
Fixed indexed annuity embedded derivativesPolicies4,867(696)4,171
Indexed universal life embedded derivativesPolicies717(29)688

The decrease in the notional value of derivatives was primarily attributable to a decrease in interest rate swaps that support our long-term care insurance products, partially offset by the addition of foreign currency forward contracts to mitigate foreign currency exchange risk.

The number of policies with embedded derivatives decreased as these products are no longer being offered and continue to run off.

Critical Accounting Estimates

The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” For a detailed discussion of our significant accounting policies, see note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

The sensitivities in the tables below are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products. The impacts are discrete and do not reflect the impact one factor may have on another. In any period and over time, our actual experience may have a positive or negative variance from our long-term assumptions, either singularly or collectively, and these variances may offset each other.

95

Table of Contents

Liability for future policy benefits

The measurement of the liability for future policy benefits reflects estimates and actuarial assumptions and methodologies which involve the exercise of significant judgment and are inherently uncertain. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Establishing assumptions for the liability for future policy benefits is complex and involves many factors. Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding loss recognized in net income (loss). Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our liability for future policy benefits. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.

The liability for future policy benefits is equal to the present value of expected future benefits and claim-related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity) and insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates). Cash flow assumptions associated with our long-term care insurance products in our Closed Block segment also include expected impacts of our in-force management actions, such as future in-force rate actions (including premium rate increases and associated benefit reductions) and other reduced benefit options outside of our in-force rate actions. The liability is measured for each group of contracts, or cohorts, using best estimate cash flow assumptions, which are reviewed at least annually in the fourth quarter or more frequently if actual experience indicates a change is required. The change in the liability for future policy benefits, at the locked-in discount rate, resulting from cash flow assumption updates and actual variances from expected experience is reflected as liability remeasurement (gains) losses in the consolidated statements of operations.

See notes 2 and 8 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the liability for future policy benefits.

Long-term care insurance

The liability for future policy benefits for our long-term care insurance products is estimated using assumptions related to both insured individuals on claim (disabled life assumptions) and insured individuals not on claim (healthy life assumptions). Key cash flow assumptions used to estimate the liability for future policy benefits include claim termination rates, incidence and benefit utilization rates, mortality, lapse rates and in-force rate actions. Claim termination rates represent the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates represent how much of the available policy benefits are expected to be used. In-force rate actions represent the remaining premium rate increases and associated benefit reductions not yet achieved in our long-term care insurance multi-year in-force rate action plan in Closed Block and are based on our best estimate given our current plans for rate increase filings and our historical experience regarding rate increase approvals.

In the fourth quarter of 2025, liability remeasurement gains (losses) within net income (loss) included unfavorable cash flow assumption updates of $47 million. Unfavorable benefit utilization and healthy life assumption updates were largely offset by favorable assumption updates reflecting in-force rate action approval experience and benefit reductions as well as favorable claim termination assumption updates. Our benefit utilization assumption updates included near-term experience related to cost of care inflation, and our healthy life assumptions were updated to better align with recent mortality and incidence trends, incorporating post-COVID-19 trends. Our claim termination assumption updates also incorporated post-COVID-19 trends. While our 2025 assumption review considered trends during and following the pandemic years, our updates to long-term assumptions generally exclude or adjust experience data from 2020 to 2022, as we do not have sufficient information around the long-term effects of COVID-19.

In the fourth quarter of 2024, liability remeasurement gains (losses) within net income (loss) included unfavorable cash flow assumption updates of $20 million primarily related to updates to healthy life and near-term benefit utilization assumptions to better align with recent experience, including cost of care inflation. These unfavorable impacts were partially offset by favorable assumption updates for future in-force rate action approvals given our plans for rate increase filings and our recent experience regarding approvals and regulatory support. The unfavorable impacts were also partially

96

Table of Contents

offset by favorable updates to our short-term incidence assumptions for IBNR claims, reducing sufficiency held through a period of heightened uncertainty around incidence during and immediately following COVID-19.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202520242025 vs. 2024
Present value of expected net premiums (1)$13,676$14,720$(1,044)(7)%
Present value of expected future policy benefits (1)$49,811$50,031$(220)%

_______________________

(1)At the locked-in discount rate.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated approximate impact it would have on liability remeasurement gains (losses) within pre-tax income (loss) for the year ended December 31, 2025:

(Amounts in millions)
5% increase in future claim costs (1)$(1,640)
Decrease in claim termination rates (2)$(270)
10% decrease in benefit of future in-force rate actions (3)$(240)

_______________________

(1)Reflects the impact of an unfavorable assumption change for claim terminations, incidence or benefit utilization rates (any discrete adverse assumption changes therefrom or in combination with, that results in our future claim costs increasing by 5%).

(2)Reflects the impact of a 3% decrease in mortality and 8% decrease in lapse rates.

(3)Reflects the impact of an unfavorable change to our assumptions for future premium rate increases and benefit reductions.

Life insurance

Key cash flow assumptions used to estimate the liability for future policy benefits for our life insurance products include mortality and lapse rates.

In the fourth quarters of 2025 and 2024, our annual review of cash flow assumptions did not have a significant impact on liability remeasurement gains (losses) within net income (loss) for our life insurance products.

A summary of certain of our significant estimates used in the calculation of our life insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202520242025 vs. 2024
Present value of expected net premiums (1)$1,633$1,551$825%
Present value of expected future policy benefits (1)$1,729$1,816$(87)(5)%

_______________________

(1)At the locked-in discount rate and excluding the impacts of flooring adjustments. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

97

Table of Contents

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated approximate impact it would have on liability remeasurement gains (losses) within pre-tax income (loss) for the year ended December 31, 2025:

(Amounts in millions)
2% increase in mortality$(20)
10% increase in lapses$(70)

Fixed annuities

The key cash flow assumption used to estimate the liability for future policy benefits for our fixed annuity products is mortality.

In the fourth quarter of 2025, liability remeasurement gains (losses) within net income (loss) included favorable cash flow assumption updates of $22 million primarily as a result of updates to our mortality assumptions. In the fourth quarter of 2024, our annual review of cash flow assumptions did not have a significant impact on liability remeasurement gains (losses) within net income (loss) for our fixed annuity products.

A summary of certain of our significant estimates and assumptions used in the calculation of our fixed annuities liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202520242025 vs. 2024
Present value of expected future policy benefits (1)$2,322$2,518$(196)(8)%

_______________________

(1)At the locked-in discount rate.

A hypothetical decrease of 10% to our mortality assumption would have an unfavorable impact of approximately $50 million on liability remeasurement gains (losses) within pre-tax income (loss) for the year ended December 31, 2025.

Policyholder account balances – additional insurance liabilities

The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims, commonly referred to as the additional insurance liability. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality, interest rates and policyholder persistency or lapses, among other assumptions.

We perform an annual review of assumptions for our universal and term universal life insurance products in the fourth quarter. Our 2025 review resulted in a benefit recorded to pre-tax income (loss) of $15 million primarily as a result of favorable updates to interest rate assumptions. Our 2024 review resulted in an expense recorded to pre-tax income (loss) of $28 million largely associated with an unfavorable update to our mortality assumptions for universal life insurance contracts originating from term life insurance conversions and an unfavorable update to interest rate assumptions given the recent rate environment.

98

Table of Contents

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated approximate impact it would have on liability remeasurement gains (losses) within pre-tax income (loss) for the year ended December 31, 2025:

(Amounts in millions)
100 basis point decrease in projected crediting rates$(30)
10% decrease in lapses$(225)
2% increase in mortality$(45)

Liability for policy and contract claims

The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.

Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss).

Mortgage insurance

Estimates and actuarial assumptions used for establishing loss reserves involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on Enact’s loss reserves and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. The sources of uncertainty affecting the estimates are numerous and include factors internal and external to Enact. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external influences include changes in home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on Enact’s reserves, results of operations and financial condition.

Enact establishes reserves to recognize the estimated liability for losses and loss adjustment expenses related to defaults on insured mortgage loans. Loss reserves are established by estimating the number of loans in the inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase.

Enact’s management monitors actual experience, and where circumstances warrant, will revise its assumptions. The liability for loss reserves is reviewed regularly, with changes in estimates of future claims recorded through net income (loss). Estimation of losses is based on historical claim and cure experience and covered exposures and is inherently judgmental. Future developments may result in losses greater or less than the liability for loss reserves provided.

Enact’s loss reserves were $572 million and $525 million as of December 31, 2025 and 2024, respectively. In considering the potential sensitivity of the factors underlying Enact’s best estimate of its mortgage insurance reserves, it is possible that even a relatively small change in the estimated claim or severity rate could have a significant impact on loss reserves and, correspondingly, on our results of operations. For example, based on Enact’s actual experience during the three-year period ended December 31, 2025, a quarterly change of 4% in its average claim rate would change the gross loss reserve amount for such quarter by approximately $79 million, and a change of 3% in its average severity rate would change the gross loss reserve amount for such quarter by approximately $16 million.

99

Table of Contents

Valuation of fixed maturity securities. Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value.

The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the period-to-period changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. Additionally, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investment portfolio.

Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2025, 6% of our total fixed maturity securities related to Level 3 fixed maturity securities valued using internal pricing models. See notes 2, 4 and 19 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments.

The following tables summarize the primary sources of data considered when determining the fair value of fixed maturity securities as of December 31:

2025
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Third-party pricing services$40,342$$40,101$241
Broker quotes184184
Internal models5,2362,5902,646
Total fixed maturity securities$45,762$$42,691$3,071
2024
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Third-party pricing services$39,752$$39,752$
Broker quotes247247
Internal models4,9032,3572,546
Total fixed maturity securities$44,902$$42,109$2,793

Consolidated Balance Sheets

Total assets. Total assets increased $1,262 million from $86,821 million as of December 31, 2024 to $88,083 million as of December 31, 2025.

•Invested assets increased $1,244 million primarily attributable to increases of $860 million in fixed maturity securities, $342 million in limited partnerships and $122 million in other invested assets, partially offset by a decrease of $107 million in commercial mortgage loans. The increase in fixed maturity securities was predominantly related to lower interest rates and tightening credit spreads increasing the fair value of our fixed maturity investment portfolio, partially offset by net sales and maturities in 2025. Limited partnerships increased largely from capital calls, and other invested assets increased primarily driven by the purchase of

100

Table of Contents

corporate-owned life insurance in 2025. Commercial mortgage loans decreased mostly due to payments outpacing originations in 2025.

•Deferred acquisition costs decreased $193 million largely driven by amortization in our life and long-term care insurance products in 2025.

•Reinsurance recoverable increased $245 million primarily due to a decrease in the single-A interest rate used to discount the reinsurance recoverable in 2025.

Total liabilities. Total liabilities increased $876 million from $77,440 million as of December 31, 2024 to $78,316 million as of December 31, 2025.

•The liability for future policy benefits increased $1,618 million primarily from a decrease in the single-A interest rate used to discount the liability for future policy benefits. Our long-term care insurance reserves also increased largely driven by the unfavorable impact of actual variances from expected experience and cash flow assumption updates, as well as aging of the in-force block, including higher interest accretion, partially offset by benefit payments outpacing premiums collected in 2025. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of cash flow assumption updates. These increases were partially offset by the runoff of our fixed annuity and life insurance products.

•Policyholder account balances decreased $751 million largely driven by net benefit payments, surrenders and withdrawals in our fixed annuity and universal and term universal life insurance products in 2025.

Total equity. Total equity increased $386 million from $9,381 million as of December 31, 2024 to $9,767 million as of December 31, 2025.

•We reported net income available to Genworth Financial, Inc.’s common stockholders of $223 million for the year ended December 31, 2025.

•Unrealized gains (losses) on investments increased total equity by $1,169 million primarily due to a decrease in interest rates and tightening credit spreads in 2025.

•Derivatives qualifying as hedges decreased total equity by $305 million largely due to amortization of forward starting swap gains into net investment income and an increase in interest rates compared to contracted notional interest rates in 2025.

•The change in the discount rate used to measure future policy benefits and related reinsurance recoverables decreased total equity by $559 million largely attributable to a decrease in the single-A interest rate in 2025.

•Treasury stock increased $248 million due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other associated costs, resulting in a decrease to total equity in 2025.

Liquidity and Capital Resources

Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.

Overview of cash flows—Genworth and subsidiaries

Our principal sources of cash include premiums and other payments received on our insurance products and services, income from our investment portfolio and proceeds from sales and maturities of investments. Cash flows related to operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Cash flows from operating activities have been invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions.

101

Table of Contents

The following table sets forth our condensed consolidated cash flows for the years ended December 31:

(Amounts in millions)202520242023
Net cash from (used by) operating activities$327$88$597
Net cash from (used by) investing activities5188611,261
Net cash from (used by) financing activities(857)(1,115)(1,443)
Net increase (decrease) in cash and cash equivalents before foreign exchange effect$(12)$(166)$415

2025 compared to 2024

We had higher net cash inflows from operating activities in 2025 primarily driven by lower benefit payments on the long-term care insurance products in our Closed Block segment resulting from lower settlement payments as the implementation of the third legal settlement was materially completed in the fourth quarter of 2024.

Net cash inflows from investing activities were lower in 2025 mainly due to commercial mortgage loan payments outpacing originations at a lower rate than in 2024.

Net cash outflows related to financing activities were lower primarily due to lower net withdrawals from our investment contracts and lower repurchases of Genworth Holdings’ debt in 2025.

Genworth—holding company liquidity

In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (or, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, investments in CareScout, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 16 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. We manage our legacy insurance subsidiaries on a standalone basis and accordingly, do not expect to receive any dividends or other returns of capital from them. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to Enact Holdings’ board of directors; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. In addition, insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details.

Enact Holdings’ capital allocation strategy includes supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to its shareholders. On May 1, 2024, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $250 million of its common stock. Enact Holdings completed the repurchase of shares under this authorization in the second quarter of 2025. On April 30, 2025, Enact Holdings announced the authorization of a new share repurchase program that allows for the repurchase of up to an additional $350 million of its common stock. Genworth Holdings entered into an agreement with Enact Holdings to participate in the share repurchase program in order to maintain its ownership interest in Enact Holdings. In addition to its share repurchase program, Enact Holdings pays a

102

Table of Contents

quarterly dividend. As the majority shareholder, Genworth Holdings received $407 million of capital returns from Enact Holdings in 2025, comprised of share repurchases and quarterly dividends.

On February 3, 2026, Enact Holdings announced the authorization of a new share repurchase program under which it may repurchase up to $500 million of its common stock. Genworth Holdings entered into an agreement with Enact Holdings to participate in the share repurchase program in order to maintain its ownership interest in Enact Holdings. Enact Holdings expects the timing and amount of any future share repurchases will be opportunistic and will depend on a variety of factors, including Enact Holdings’ stock price, capital availability, business and market conditions, regulatory requirements and debt covenant restrictions, among other factors. Future dividend payments will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations.

Enact Holdings expects to return approximately $500 million of capital to its shareholders in 2026. Based on our approximately 81% ownership, we expect to receive approximately $405 million in capital returns from Enact Holdings for the full year 2026.

On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under Genworth Financial’s existing share repurchase program that began in May 2022. On September 18, 2025, Genworth Financial announced that its Board of Directors had authorized a new share repurchase program under which Genworth Financial may purchase up to $350 million of its outstanding common stock. Under the new program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the new share repurchase program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

Pursuant to the programs, during 2025, Genworth Financial repurchased 30,662,006 shares of its common stock at an average price of $7.99 per share for a total of $245 million, before excise taxes and other costs, and finalized repurchases under the July 2023 authorization.

During the period January 1 through February 20, 2026, Genworth Financial repurchased 4,344,376 shares of its common stock through a Rule 10b5-1 trading plan at an average price of $8.75 per share, leaving approximately $222 million available for repurchase under the new share repurchase program as of February 20, 2026. Future share repurchases will be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings.

Our future use of liquidity and capital will prioritize strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. In addition, we also expect to repurchase or redeem outstanding debt from time to time (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise.

Genworth Holdings had $234 million and $294 million of unrestricted cash and cash equivalents as of December 31, 2025 and 2024, respectively. The decrease was principally driven by repurchases of Genworth Financial’s common stock, capital contributions to CareScout and interest payments on Genworth Holdings’ debt, partially offset by capital returns from Enact Holdings. The $234 million of Genworth Holdings’ cash and cash equivalents included approximately $127 million of cash held for future obligations, including advance cash payments from our subsidiaries. We do not consider this cash held for future obligations when evaluating holding company liquidity for the purposes of allocating capital or computing our cash position relative to the cash management target discussed below. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months as well as in the longer term. We expect Genworth Holdings’ liquidity to continue to be impacted by the amounts and timing of Genworth Financial’s share repurchases, investments in CareScout, and future dividends and other forms of capital returns from Enact Holdings. In addition, we anticipate lower intercompany cash tax payments to be retained by Genworth Holdings from its subsidiaries going forward.

We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or as a result of planned future actions.

103

Table of Contents

Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.

Capital resources and financing activities

Our current capital resource plans do not include any additional debt offerings by Genworth Holdings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them to meet their obligations,” and “Item 1A—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.”

During 2025 and 2024, Genworth Holdings repurchased $7 million and $66 million, respectively, principal amount of its debt. As of December 31, 2025, Genworth Holdings had $783 million aggregate principal amount of outstanding debt, with no maturities due until June 2034.

In 2024, given the current interest rate environment, Genworth Holdings entered into an interest rate swap designed to hedge the variable interest payments on $100 million aggregate principal amount of its floating rate junior subordinated notes due in 2066 (“2066 Notes”), locking in an approximate 5.5% fixed interest rate for a period of five years from the hedge origination date.

On September 30, 2025, Enact Holdings entered into a five-year unsecured revolving credit facility with a syndicate of lenders in the initial aggregate principal amount of $435 million, which replaced the 2022 Credit Facility. Enact Holdings may use any future borrowings under the 2025 Credit Facility for working capital needs and general corporate purposes, including the execution of dividends to its shareholders and capital contributions to its insurance subsidiaries. The 2025 Credit Facility includes customary representations, warranties, covenants, terms and conditions. As of December 31, 2025, Enact Holdings was in compliance with all covenants and the 2025 Credit Facility remained undrawn.

On May 28, 2024, Enact Holdings issued $750 million aggregate principal amount of unsecured senior notes, maturing on May 28, 2029 (“2029 Notes”). The 2029 Notes bear interest at an annual rate of 6.25% payable semi-annually in arrears on May 28 and November 28 of each year. On June 3, 2024, Enact Holdings redeemed all $750 million aggregate principal amount outstanding of its 2025 Notes for a pre-tax loss of $11 million. Enact Holdings funded the redemption primarily through the net proceeds from the issuance of its 2029 Notes.

For further information about Genworth Holdings’ and Enact Holdings’ borrowings, refer to note 15 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Regulated insurance subsidiaries

Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 20 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends and distributions are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. Based on estimated statutory results as of December 31, 2025, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $3 million in 2026 without affirmative regulatory approval.

The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. Our insurance subsidiaries’ principal cash inflows from operating activities are derived from premiums, annuity deposits and insurance and investment product fees and other income, including commissions, cost of insurance, mortality, expense and surrender charges, contract underwriting fees, investment management fees, investment income, and

104

Table of Contents

dividends and distributions from their subsidiaries. We manage our legacy insurance subsidiaries on a standalone basis. Accordingly, these subsidiaries will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and other management actions, including our long-term care insurance in-force rate actions, to satisfy policyholder obligations.

For long-duration coverage products, we generally anticipate a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form 10-K. In our long-term care insurance products in Closed Block, we expect overall claims costs to continue to increase over time as our blocks age, with peak claim years over a decade away. For information on discounted and undiscounted expected future benefit payments, see note 8 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” We also expect renewal premiums on the in-force block of our long-term care insurance products in Closed Block to decline over time as the block runs off and as policyholders elect benefit reductions in connection with our in-force rate actions; however, we expect this decline to be partially offset by future approved rate actions.

Given the challenging macroeconomic environment in 2024 and 2025, employee costs have increased driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance products, we have observed an increase in the cost of care due in part to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these conditions persist, they could have a material adverse impact on our liquidity, results of operations and financial condition.

The U.S. economy also faces uncertainty and volatility due to variable tariff policies and negotiations taking place across global markets. The insurance industry and our insurance subsidiaries are not directly impacted by tariffs. However, if the ultimate outcome of the global tariff negotiations significantly impacts the U.S. and global economies and equity and fixed income markets, this could have an adverse impact on the housing industry or our investment income, and as a result, may adversely affect our results of operations and liquidity. We will continue to monitor macroeconomic trends, including inflation and any ancillary effects of tariff policies, to help mitigate any potential adverse impacts to our liquidity.

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain long-term care and life insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2025, our total cash, cash equivalents and invested assets were $61.2 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, limited partnership investments, select mortgage-backed and asset-backed securities, bank loans and corporate-owned life insurance are relatively illiquid. These asset classes represented approximately 45% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2025.

Off-balance sheet commitments

As of December 31, 2025, we were committed to fund $1,916 million in limited partnership investments, $362 million in private placement investments, $118 million of bank loan investments and $7 million in commercial mortgage loan investments.

Genworth—holding company guarantees

As previously disclosed, in connection with pending litigation between AXA and Santander related to the payment protection insurance (“PPI”) mis-selling losses, Genworth has certain rights to share in any recoveries by AXA to recoup payments it previously made to AXA for the underlying PPI mis-selling losses. Genworth is not a named party in the litigation with Santander, and, therefore, does not ultimately control the litigation. In order to better align the interests of AXA and Genworth in the litigation, in March 2025, Genworth agreed to provide AXA a guarantee for the recovery of certain of AXA’s PPI mis-selling losses not previously reimbursed by Genworth, regardless of the ultimate outcome of the litigation. The guarantee was provided through a stand-by letter of credit (“LC”) issued by a third-party financial institution for the benefit of AXA and a reimbursement agreement between Genworth and the third-party financial institution. Whether AXA could draw upon the LC was subject to the amount of any settlement between AXA and Santander, or certain milestones in the court proceedings. The LC was terminated in November 2025. Prior to the termination, no amounts were recorded in 2025 related to the guarantee. On July 25, 2025, the High Court issued a liability judgment in

105

Table of Contents

favor of AXA in the legal proceedings against Santander. The judgment finds Santander liable for AXA’s losses resulting from Santander’s mis-selling. The judge awarded AXA damages, interest and costs of approximately £680 million ($911 million based on the exchange rates at that point in time). Santander subsequently applied for permission to appeal, and the Court of Appeal granted that request on October 21, 2025. AXA sought permission to cross-appeal certain aspects of the High Court judgment and was granted permission in January 2026. The hearing before the Court of Appeal has been scheduled for July 21 to July 23, 2026. Under prior agreements between Genworth and AXA, Genworth is entitled to share in funds that AXA recovers from third parties related to the mis-selling losses. If the appeal is resolved in favor of AXA, Genworth could be entitled to receive a total recovery of approximately $750 million, depending upon the applicable exchange rate at that time. In November 2025, we received £15 million ($20 million) from AXA related to a portion of the liability judgment not subject to dispute. We recorded this loss recovery to income (loss) from discontinued operations, net of taxes, in the consolidated statement of operations. See note 2 for a discussion of our policy for recognizing loss recoveries. Loss recoveries have not been factored into our capital allocation plans, including the sizing of the September 2025 share repurchase authorization discussed above. We would expect to deploy any loss recoveries in line with our stated capital allocation priorities, which are investing in growth through CareScout, returning cash to shareholders through our share repurchase program and opportunistically paying down debt.

Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. Based on the risk in-force of policies subject to the guarantee, we estimate that Genworth Holdings’ exposure under the guarantee was approximately $135 million as of December 31, 2025. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations.

Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2025, the risk in-force of active policies was approximately $800 million.

Supplemental Condensed Consolidating Financial Information

Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933), on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial.

Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in accordance with Rule 13-01 of Regulation S-X, we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. The latest 10-K appears above; prior years are below.

FY 2024 10-K MD&A

SEC filing source: 0001193125-25-041860.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2025-02-28. Report date: 2024-12-31.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.”

68

Table of Contents

Item 7 of our Annual Report on Form 10-K generally discusses year-to-year comparisons between the years ended December 31, 2024 and 2023. Discussions of information related to 2022 and year-to-year comparisons between 2023 and 2022 are not included in this Form 10-K. Comparative discussions between 2023 and 2022 can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2023.

Overview

Our business

Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products which are no longer sold. We report our business results through three segments: Enact; Long-Term Care Insurance; and Life and Annuities. In addition to our three segments, we report certain of our results of operations in Corporate and Other.

Our financial information

The financial information in this Annual Report on Form 10-K has been derived from our consolidated financial statements.

Revenues and expenses

Our revenues consist primarily of the following:

Column 1Column 2Column 3Column 4
Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance.
Column 1Column 2Column 3Column 4
Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, and unrealized gains and losses on equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker-dealer commission revenues, fee revenue from contract underwriting services and other fees.

Our expenses consist primarily of the following:

Column 1Column 2Column 3Column 4
Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense, and other reserve activity related to future policy benefits for long-term care insurance, life insurance, and fixed and variable annuities, and claim costs incurred related to mortgage insurance products.
Column 1Column 2Column 3Column 4
Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual variances from expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts.

69

Table of Contents

Column 1Column 2Column 3Column 4
Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments that support our market risk benefits.
Column 1Column 2Column 3Column 4
Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances.
Column 1Column 2Column 3Column 4
Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate certain corporate expenses to each of our segments using various methodologies.
Column 1Column 2Column 3Column 4
Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of capitalized acquisition costs, present value of future profits and capitalized software.
Column 1Column 2Column 3Column 4
Interest expense. Interest expense primarily represents interest incurred on borrowings of Genworth Holdings and Enact Holdings.
Column 1Column 2Column 3Column 4
Provision (benefit) for income taxes. We allocate tax to our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other.

The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers.

Column 1Column 2Column 3Column 4
Net income attributable to noncontrolling interests. Net income attributable to noncontrolling interests represents third-party ownership interests in income of Enact Holdings, a consolidated subsidiary of Genworth Financial.

70

Table of Contents

Consolidated Results of Operations

The following table sets forth the consolidated results of operations for the periods indicated:

Increase (decrease) and
Years ended December 31,percentage change
(Amounts in millions)2024202320222024 vs. 20232023 vs. 2022
Revenues:
Premiums$3,480$3,636$3,680$(156)(4)%$(44)(1)%
Net investment income3,1603,1833,146(23)(1)%371%
Net investment gains (losses)1323(2)(10)(43)%25NM(1)
Policy fees and other income642646671(4)(1)%(25)(4)%
Total revenues7,2957,4887,495(193)(3)%(7)%
Benefits and expenses:
Benefits and other changes in policy reserves4,7664,7834,303(17)%48011%
Liability remeasurement (gains) losses153587(290)(434)(74)%877NM(1)
Changes in fair value of market risk benefits and associated hedges(13)(12)(104)(1)(8)%9288%
Interest credited453503504(50)(10)%(1)%
Acquisition and operating expenses, net of deferrals9779421,285354%(343)(27)%
Amortization of deferred acquisition costs and intangibles249264326(15)(6)%(62)(19)%
Interest expense115118106(3)(3)%1211%
Total benefits and expenses6,7007,1856,130(485)(7)%1,05517%
Income from continuing operations before income taxes5953031,36529296%(1,062)(78)%
Provision for income taxes1581043195452%(215)(67)%
Income from continuing operations4371991,046238120%(847)(81)%
Loss from discontinued operations, net of taxes(10)(10)NM(1)%
Net income4271991,046228115%(847)(81)%
Less: net income attributable to noncontrolling interests12812313054%(7)(5)%
Net income available to Genworth Financial, Inc.’s common stockholders$299$76$916$223NM(1)$(840)(92)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.

Use of non-GAAP measures

Reconciliation of net income (loss) to adjusted operating income (loss)

Our chief operating decision maker (“CODM”) evaluates performance and allocates resources based on a non-GAAP financial measure entitled “adjusted operating income (loss).” Our CODM evaluates adjusted

71

Table of Contents

operating income (loss) as a key measure to assess performance and support new business initiatives because the measure more accurately reflects overall operating performance, as it minimizes the impact of macroeconomic volatility. Our legacy U.S. life insurance subsidiaries, which comprise our Long-Term Care Insurance and Life and Annuities segments, are managed on a standalone basis; therefore, we do not allocate capital to our Long-Term Care Insurance and Life and Annuities segments.

We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance.

While some of these items may be significant components of net income (loss) determined in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Adjusted operating income (loss) is not a substitute for net income (loss) determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.

72

Table of Contents

The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31:

(Amounts in millions)202420232022
Net income available to Genworth Financial, Inc.’s common stockholders$299$76$916
Add: net income attributable to noncontrolling interests128123130
Net income4271991,046
Less: loss from discontinued operations, net of taxes(10)
Income from continuing operations4371991,046
Less: net income from continuing operations attributable to noncontrolling interests128123130
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders30976916
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)(17)(25)2
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2)(43)(22)(142)
(Gains) losses on early extinguishment of debt (3)2(2)6
Expenses related to restructuring1242
Pension plan termination costs8
Taxes on adjustments101026
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$273$41$818
Column 1Column 2
(1)For the years ended December 31, 2024 and 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $4 million and $2 million, respectively.
Column 1Column 2
(2)Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(30) million, $(10) million and $(38) million for the years ended December 31, 2024, 2023 and 2022, respectively.
Column 1Column 2
(3)(Gains) losses on early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million for the year ended December 31, 2024.

Other than pension plan termination costs incurred in 2022 related to one of our defined benefit pension plans, there were no infrequent or unusual items excluded from adjusted operating income during the periods presented.

73

Table of Contents

Earnings per share

The following table provides basic and diluted earnings per common share for the periods indicated:

Increase (decrease) and
Years ended December 31,percentage change
(Amounts in millions, except per share amounts)2024202320222024 vs. 20232023 vs. 2022
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.71$0.16$1.82$0.55NM(1)$(1.66)(91)%
Diluted$0.70$0.16$1.79$0.54NM(1)$(1.63)(91)%
Net income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.69$0.16$1.82$0.53NM(1)$(1.66)(91)%
Diluted$0.68$0.16$1.79$0.52NM(1)$(1.63)(91)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.63$0.09$1.62$0.54NM(1)$(1.53)(94)%
Diluted$0.62$0.09$1.60$0.53NM(1)$(1.51)(94)%
Weighted-average common shares outstanding:
Basic433.9468.8504.4
Diluted439.4474.9510.9
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards.

The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other for the periods indicated:

Increase (decrease) and
Years ended December 31,percentage change
(Amounts in millions)2024202320222024 vs. 20232023 vs. 2022
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Enact segment$585$552$578$336%$(26)(4)%
Long-Term Care Insurance segment(176)(242)3206627%(562)(176)%
Life and Annuities segment:
Life insurance(94)(275)(111)18166%(164)(148)%
Fixed annuities305062(20)(40)%(12)(19)%
Variable annuities263721(11)(30)%1676%
Life and Annuities segment(38)(188)(28)15080%(160)NM(1)
Corporate and Other(98)(81)(52)(17)(21)%(29)(56)%
Adjusted operating income available to Genworth
Financial, Inc.’s common stockholders$273$41$818$232NM(1)$(777)(95)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

74

Table of Contents

Executive Summary of Consolidated Financial Results

Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%.

For a discussion of selected financial information and detailed descriptions of operating performance measures see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”

2024 compared to 2023

Column 1Column 2Column 3Column 4
Net income in 2024 and 2023 was $299 million and $76 million, respectively, and adjusted operating income was $273 million and $41 million, respectively.
Column 1Column 2Column 3Column 4
Enact segment
Column 1Column 2Column 3Column 4
Adjusted operating income increased primarily attributable to higher net investment income and premiums, partially offset by higher new delinquencies in 2024.
Column 1Column 2Column 3Column 4
Long-Term Care Insurance segment
Column 1Column 2Column 3Column 4
The adjusted operating loss decreased primarily driven by lower liability remeasurement losses, net insurance recoveries and higher income from limited partnerships, partially offset by lower renewal premiums in 2024.
Column 1Column 2Column 3Column 4
Life and Annuities segment
Column 1Column 2Column 3Column 4
Life insurance
Column 1Column 2Column 3Column 4
The adjusted operating loss decreased primarily from liability remeasurement gains in 2024 compared to losses in 2023, partially offset by lower premiums and a less favorable change in reserves in 2024 in our term life insurance products related to block runoff.
Column 1Column 2Column 3Column 4
Fixed annuities
Column 1Column 2Column 3Column 4
Adjusted operating income decreased mainly from unfavorable assumption updates of $9 million primarily related to our fixed indexed annuity lapse assumptions in 2024, as well as lower net spreads primarily related to block runoff.
Column 1Column 2Column 3Column 4
Variable annuities
Column 1Column 2Column 3Column 4
Adjusted operating income decreased largely from an unfavorable lapse assumption update of $5 million in 2024 compared to favorable assumption updates in 2023.
Column 1Column 2Column 3Column 4
Corporate and Other
Column 1Column 2Column 3Column 4
The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives, partially offset by a higher benefit for income taxes in 2024.

Significant Developments and Strategic Highlights

Enact segment

Column 1Column 2Column 3Column 4
Mortgage insurance portfolio. Enact’s primary persistency rate of 83% for the year ended December 31, 2024 decreased from 85% for the year ended December 31, 2023 due to rate volatility throughout 2024. Elevated persistency continued to offset the decline in new insurance written, contributing to primary insurance in-force growth of $5.9 billion in 2024. New insurance written decreased 4% during 2024 compared to 2023.

75

Table of Contents

Column 1Column 2Column 3Column 4
Loss performance. Enact recorded pre-tax reserve releases of $252 million in 2024 primarily related to favorable cure performance and loss mitigation activities compared to pre-tax reserve releases of $241 million in 2023. New primary delinquencies in 2024 increased compared to 2023 largely due to the aging of large, newer books of business.
Column 1Column 2Column 3Column 4
PMIERs compliance. Enact’s PMIERs sufficiency ratio was 167% or $2,052 million above the PMIERs requirements as of December 31, 2024. On August 21, 2024, the GSEs and the FHFA released updated PMIERs requirements phasing in a revision to the available assets standards between March 31, 2025 and September 30, 2026. Enact expects to hold capital sufficiency well in excess of these requirements and does not expect the impact of these updates to be material to its sufficiency. For additional details on the updated requirements, see “Item 1—Regulation—Enact—Mortgage Insurance Regulation— Other U.S. Regulation and Agency Qualification Requirements.”

Long-Term Care Insurance segment

Column 1Column 2Column 3Column 4
In-force rate actions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan since 2012 through 2024 was approximately $31.2 billion, on a net present value basis, based on our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements as described in “Results of Operations and Selected Financial and Operating Performance Measures by Segment.” This estimated cumulative economic benefit reflects meaningful progress toward reaching our latest estimate of approximately $35.8 billion for the total net present value included in our multi-year in-force rate action plan, based on our current updated assumptions. As a result, the remaining estimated amount to be achieved through future rate action approvals under our in-force rate action plan is approximately $4.6 billion.
Column 1Column 2Column 3Column 4
Actual variances from expected experience. Unfavorable variances between actual and expected experience resulted in a pre-tax impact of $241 million primarily driven by lower terminations and higher claims.
Column 1Column 2Column 3Column 4
Annual assumption review. As part of our annual review of cash flow assumptions in the fourth quarter of 2024, our long-term care insurance business had an unfavorable pre-tax impact of $20 million reflecting updates to better align healthy life and near-term benefit utilization assumptions with recent experience. These unfavorable impacts were largely offset by favorable assumption updates for future in-force rate action approvals based on recent experience and favorable updates to our short-term incidence assumptions for IBNR claims. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our long-term care insurance cash flow assumptions.

Life and Annuities segment

Column 1Column 2Column 3Column 4
Annual assumption review. As part of our annual review of cash flow assumptions in the fourth quarter of 2024, our universal life insurance products had an unfavorable pre-tax impact of $28 million reflecting updates to mortality and interest rate assumptions. See “—Critical Accounting Estimates—Policyholder account balances – additional insurance liabilities” for additional information on the impact of changes in our life insurance cash flow assumptions. Our annuity products had an unfavorable pre-tax impact of $22 million primarily from updates to our lapse assumptions.

Capital of U.S. life insurance subsidiaries

Column 1Column 2Column 3Column 4
As of December 31, 2024 and 2023, the consolidated RBC ratio on a company action level basis of our U.S. domiciled life insurance subsidiaries was approximately 306% and 303%, respectively. The increase was primarily attributable to statutory earnings during 2024 and an increase in the value of our

76

Table of Contents

Column 1Column 2
limited partnership portfolio, partially offset by higher required capital as the portfolio grows. Statutory earnings reflected favorable impacts as a result of premium increases and benefit reductions from in-force rate actions and legal settlements in our long-term care insurance products and a benefit from the impact of interest rate and equity market performance in our variable annuity products.

Capital and liquidity

Column 1Column 2Column 3Column 4
Capital returns and share repurchases. During 2024, Genworth Holdings received $289 million of capital returns from Enact Holdings, and Genworth Financial executed $186 million of share repurchases, before excise taxes and other associated costs.
Column 1Column 2Column 3Column 4
Borrowings. Genworth Holdings repurchased $66 million principal amount of its debt in 2024. In June 2024, Enact Holdings redeemed all $750 million aggregate principal amount outstanding of its 6.50% senior notes due in 2025 (“2025 Notes”). Enact Holdings funded the redemption primarily through the net proceeds from the issuance of its $750 million 6.25% senior notes due in 2029 (“2029 Notes”).
Column 1Column 2Column 3Column 4
Capital contributions. We plan to invest additional capital in CareScout Services in 2025 as we continue to build out the offering. We also plan to contribute capital to our CareScout Insurance subsidiary in 2025 to meet the regulatory requirements of a new start-up insurer as we re-enter the long-term care insurance market. See “Part I—Item 1—Business—Strategic Priorities—CareScout growth initiatives.”

Results of Operations and Selected Financial and Operating Performance Measures by Segment

Enact segment

Trends and conditions

Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.

Macroeconomic environment

During 2024, the U.S. economy continued to show positive signs but faced lingering uncertainty due to inflationary pressure, the geopolitical environment and other macroeconomic concerns. Mortgage origination activity increased modestly in 2024 but remained relatively slow due to elevated mortgage rates and sustained low housing supply. Over the past few years, housing affordability has deteriorated as elevated mortgage rates and home price appreciation outpaced median family income, according to the National Association of Realtors Housing Affordability Index. National home prices continued to rise in 2024, according to the FHFA Monthly Purchase-Only House Price Index.

The unemployment rate increased to 4.1% in December 2024, compared to 3.7% in December 2023. As of December 31, 2024, the number of unemployed Americans was approximately 6.9 million, and the number of long-term unemployed over 26 weeks was approximately 1.6 million.

Forbearance and loss mitigation programs

Borrowers’ ability to utilize extended forbearance timelines permitted through the Coronavirus Aid, Relief, and Economic Security Act and the GSEs’ COVID-19 servicing-related policies ended in 2023. Borrowers that

77

Table of Contents

meet general hardship and program guidelines continue to have access to standard forbearance policies as a loss mitigation option. In addition, in March 2023, the GSEs announced new loss mitigation programs that allow six-month payment deferrals for borrowers facing financial hardship.

Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of December 31, 2024, approximately 1.1% or 10,943 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 34% were reported as delinquent. Approximately 9% of Enact’s primary new delinquencies in 2024 were subject to a forbearance plan compared to 13% in 2023.

Regulatory developments

Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products.

On October 24, 2022, the FHFA announced its validation and approval of certain credit score models for anticipated use by the GSEs and proposed changing the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores is currently expected to require lenders to deliver both credit scores for each loan sold to the GSEs. Implementation, which has been delayed beyond 2025, will require system and process updates.

Competitive environment

The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite, enabling it to write new business at returns it views as attractive.

Mortgage insurance portfolio

New insurance written of $51.0 billion in 2024 decreased 4% compared to 2023. Changes in new insurance written are primarily impacted by the size of the mortgage insurance market and Enact’s market share. Enact’s primary persistency rate was 83% for the year ended December 31, 2024 compared to 85% for the year ended December 31, 2023. Persistency remained elevated in 2024 but decreased compared to 2023 due to rate volatility. Elevated persistency continued to offset lower new insurance written, contributing to an increase in primary insurance in-force of $5.9 billion during 2024.

Net earned premiums increased in 2024 compared to 2023 primarily driven by insurance in-force growth and higher assumed premiums, mostly consisting of Enact Re’s GSE credit risk transfer participation and multifamily reinsurance, partially offset by higher ceded premiums.

Loss experience

Enact’s loss ratio was 4% for the year ended December 31, 2024, compared to 3% for the year ended December 31, 2023. Enact released reserves of $252 million during 2024 primarily driven by favorable cure

78

Table of Contents

performance on delinquencies from prior years and loss mitigation activities. As part of the reserve adjustments in 2024, Enact decreased its claim rate assumptions largely as a result of sustained favorable cure performance and lessening uncertainty in the economic environment, impacting both current and prior year delinquencies. Enact released reserves of $241 million in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to COVID-19.

The severity of loss on loans that go to claim may be negatively impacted by extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.

New primary delinquencies for the year ended December 31, 2024 increased compared to the year ended December 31, 2023, primarily due to the aging of large, newer books of business. New primary delinquencies of 48,537 contributed $287 million of loss expense in 2024, while Enact incurred $265 million of losses from 41,617 new primary delinquencies in 2023. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and prospective economic conditions.

Capital requirements

As of December 31, 2024, EMICO’s risk-to-capital ratio under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 10.5:1, compared with a risk-to-capital ratio of 11.6:1 as of December 31, 2023. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.

Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. As of December 31, 2024, Enact had estimated available assets of $5,095 million against $3,043 million net required assets under PMIERs compared to available assets of $5,006 million against $3,119 million net required assets as of December 31, 2023. The sufficiency ratio as of December 31, 2024 was 167% or $2,052 million above the PMIERs requirements, compared to 161% or $1,887 million above the PMIERs requirements as of December 31, 2023.

Enact’s PMIERs required assets as of December 31, 2024 and 2023 benefited from the application of a 0.30 multiplier applied to the risk based required asset amount factor for certain non-performing loans as defined under PMIERs. The application of the 0.30 multiplier to all eligible delinquencies provided $28 million and $73 million, respectively, of benefit to Enact’s December 31, 2024 and 2023 PMIERs required assets. Enact’s third-party reinsurance transactions provided an aggregate of approximately $1,885 million and $1,714 million of PMIERs capital credit as of December 31, 2024 and 2023, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier. Per guidance released by the GSEs in the third quarter of 2024, use of the multiplier will be discontinued effective March 31, 2025.

On August 21, 2024, the GSEs and the FHFA released updated PMIERs requirements phasing in a revision to the available assets standards between March 31, 2025 and September 30, 2026. Enact expects to hold capital sufficiency well in excess of these requirements and does not expect the impact of these updates to be material to its sufficiency. For additional details, see “Item 1—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.”

79

Table of Contents

Recent transactions

During 2024, Enact executed excess of loss reinsurance transactions that provide up to $270 million of reinsurance coverage on a portion of its new insurance written in 2024 and $90 million of reinsurance coverage on a portion of its existing new insurance written between July 2023 and December 2023. Enact also executed quota share reinsurance agreements under which it ceded approximately 21% of a portion of new insurance written for its 2024 book year and will cede, subject to certain conditions, approximately 27% of a portion of expected new insurance written for each of its 2025 and 2026 book years.

On January 27, 2025, Enact executed two excess of loss reinsurance transactions that provide approximately $225 million and $260 million, respectively, of reinsurance coverage on a portion of expected new insurance written for the 2025 and 2026 book years. See note 7 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on Enact’s reinsurance transactions. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.

Capital returns

In November 2024, EMICO completed a distribution to Enact Holdings that supports its ability to pay a quarterly dividend. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition to Enact’s quarterly dividend program, Enact Holdings announced approval by its board of directors on May 1, 2024 of a share repurchase program which allows for the repurchase of up to $250 million of its common stock. Genworth Holdings has agreed to participate in share repurchases in order to maintain its overall ownership at approximately its current level. As the majority shareholder, Genworth Holdings received $289 million of capital returns from Enact Holdings during 2024, comprised of $91 million of quarterly dividends and $198 million of share repurchases.

Returning capital to shareholders, balanced with growth and risk management priorities, remains a priority for Enact Holdings as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, which sets the following priorities: supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.

80

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2024202320222024 vs. 2023
Revenues:
Premiums$980$957$940$232%
Net investment income2402081553215%
Net investment gains (losses)(22)(14)(2)(8)(57)%
Policy fees and other income4222100%
Total revenues1,2021,1531,095494%
Benefits and expenses:
Benefits and other changes in policy reserves3927(94)1244%
Acquisition and operating expenses, net of deferrals224212227126%
Amortization of deferred acquisition costs and intangibles101112(1)(9)%
Interest expense515252(1)(2)%
Total benefits and expenses324302197227%
Income from continuing operations before income taxes878851898273%
Provision for income taxes19018619442%
Income from continuing operations688665704233%
Less: net income attributable to noncontrolling interests12812313054%
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders560542574183%
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)18122650%
(Gains) losses on early extinguishment of debt, net (2)99NM(3)
Expenses related to restructuring434NM(3)
Taxes on adjustments(6)(2)(1)(4)(200)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$585$552$578$336%
Column 1Column 2
(1)For the years ended December 31, 2024 and 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $4 million and $2 million, respectively.
Column 1Column 2
(2)For the year ended December 31, 2024, (gains) losses on the early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million.
Column 1Column 2
(3)We define “NM” as not meaningful for increases or decreases greater than 200%.

2024 compared to 2023

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income increased primarily attributable to higher net investment income and premiums, partially offset by higher new delinquencies in 2024.

81

Table of Contents

Revenues

Premiums increased mainly driven by insurance in-force growth and higher assumed premiums, mostly consisting of Enact Re’s GSE credit risk transfer participation and multifamily reinsurance, partially offset by higher ceded premiums in 2024.

Net investment income increased primarily from higher investment yields and higher average invested assets in 2024.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves increased primarily driven by higher new delinquencies, partially offset by higher favorable reserve adjustments in 2024. Enact released reserves of $252 million in 2024 primarily related to favorable cure performance on delinquencies from prior years and loss mitigation activities. During 2023, Enact released $241 million of reserves primarily related to favorable cure performance on prior year delinquencies, including those related to COVID-19.

Acquisition and operating expenses, net of deferrals, increased primarily due to an $11 million loss on the early redemption of Enact Holdings’ 2025 Notes in 2024.

Provision for income taxes. The effective tax rate was 21.6% and 21.8% for the years ended December 31, 2024 and 2023, respectively, consistent with the U.S. corporate federal income tax rate.

Enact selected operating performance measures

Management’s discussion and analysis of our Enact segment contains selected operating performance measures including “new insurance written,” “insurance in-force” and “risk in-force,” which are commonly used in the insurance industry as measures of operating performance.

Management regularly monitors and reports new insurance written for our Enact segment as a measure of volume of new business generated in a period. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of mortgage insurance policies during a specified period, rather than a measure of revenues or profitability during that period.

Management also regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. These metrics are presented on a direct basis and exclude reinsurance. We consider insurance in-force and risk in-force to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period.

Management also regularly monitors and reports a loss ratio and an expense ratio for our Enact segment. We consider the loss ratio, which is the ratio of benefits and other changes in policy reserves to net earned premiums, to be a measure of underwriting performance. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles. We believe these ratios help to enhance the understanding of the operating performance of our Enact segment.

82

Table of Contents

The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2024202320222024 vs. 2023
Primary insurance in-force$268,825$262,937$248,262$5,8882%
Risk in-force:
Primary$69,985$67,529$62,791$2,4564%
Pool576979(12)(17)%
Total risk in-force$70,042$67,598$62,870$2,4444%
New insurance written$51,002$53,081$66,485$(2,079)(4)%

2024 compared to 2023

Primary insurance in-force and risk in-force

Primary insurance in-force increased mainly from new insurance written and elevated persistency, partially offset by lapses and cancellations. The primary persistency rate was 83% and 85% for the years ended December 31, 2024 and 2023, respectively. Total risk in-force increased primarily as a result of higher primary insurance in-force.

New insurance written

Changes in new insurance written are primarily impacted by the size of the mortgage insurance market and Enact’s market share.

Loss and expense ratios

The following table sets forth the loss and expense ratios for Enact for the dates indicated:

Years ended December 31,Increase (decrease)
2024202320222024 vs. 2023
Loss ratio4%3%(10)%1%
Expense ratio24%23%25%1%

The loss ratio increased largely from higher new delinquencies, partially offset by higher favorable reserve adjustments in 2024, as discussed above.

The expense ratio increased primarily due to an $11 million loss on the early redemption of Enact Holdings’ 2025 Notes, which increased the expense ratio by one percentage point in 2024.

83

Table of Contents

Mortgage insurance loan portfolio

The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31:

(Amounts in millions)202420232022
Primary insurance in-force by loan-to-value ratio at origination:
95.01% and above$50,318$44,955$39,509
90.01% to 95.00%112,362109,227103,618
85.01% to 90.00%79,93277,88772,132
85.00% and below26,21330,86833,003
Total$268,825$262,937$248,262
Primary risk in-force by loan-to-value ratio at origination:
95.01% and above$14,428$12,878$11,136
90.01% to 95.00%32,68631,78130,079
85.01% to 90.00%19,72919,16317,621
85.00% and below3,1423,7073,955
Total$69,985$67,529$62,791
Primary insurance in-force by credit quality at origination:
Over 760$115,554$110,635$102,467
740—75943,95543,05340,097
720—73937,71737,02034,916
700—71929,81929,76628,867
680—69921,35521,83521,554
660—679(1)11,24511,35710,926
640—6596,1476,1376,095
620—6392,4612,5042,630
620572630710
Total$268,825$262,937$248,262
Primary risk in-force by credit quality at origination:
Over 760$29,985$28,363$25,807
740—75911,49411,09610,154
720—7399,9499,6218,931
700—7197,7467,6237,317
680—6995,5235,5575,428
660—679(1)2,9242,9082,767
640—6591,5891,5651,540
620—639629635665
620146161182
Total$69,985$67,529$62,791
Column 1Column 2
(1)Loans with unknown FICO scores are included in the 660-679 category.

The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance in-force was 745 as of December 31, 2024.

84

Table of Contents

Delinquent loans and claims

Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31:

202420232022
Primary insurance:
Insured loans in-force962,849974,516960,306
Delinquent loans23,56620,43219,943
Percentage of delinquent loans (delinquency rate)2.45%2.10%2.08%

The delinquency rate as of December 31, 2024 increased compared to December 31, 2023 primarily from an increase in total delinquencies mostly driven by new delinquencies outpacing cures and paid claims.

The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of December 31:

2024
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less12,712$108$84913%
4 - 11 payments7,70119154535%
12 payments or more3,15317321381%
Total23,566$472$1,60729%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
2023
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less10,166$88$62914%
4 - 11 payments6,93420546944%
12 payments or more3,33218420092%
Total20,432$477$1,29837%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Reserves as a percentage of risk in-force as of December 31, 2024 decreased compared to December 31, 2023 as Enact has experienced cures among long-term delinquencies with higher reserves and has reduced the expected claim rate on new delinquencies.

85

Table of Contents

Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender.

% of primary risk in-force as of December 31, 2024% of direct primary case reserves as of December 31, 2024(1)Delinquency rate as of December 31,
202420232022
By State:
California12%12%2.53%2.22%2.09%
Texas9%9%2.64%2.22%2.12%
Florida(2)8%12%3.67%2.39%2.54%
New York(2)5%10%3.30%3.05%2.95%
Illinois(2)4%6%2.96%2.61%2.54%
Arizona4%3%2.35%1.93%1.78%
Michigan4%3%2.14%1.94%1.79%
Georgia3%4%3.02%2.23%2.23%
North Carolina3%2%2.14%1.56%1.59%
Pennsylvania3%3%2.17%2.19%2.17%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
Column 1Column 2
(2)Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed.
% of primary risk in-force as of December 31, 2024% of direct primary case reserves as of December 31, 2024(1)Delinquency rate as of December 31,
202420232022
By MSA or MD:
Phoenix, AZ MSA3%3%2.41%2.01%1.83%
Chicago-Naperville, IL MD3%4%3.29%2.88%2.84%
Atlanta, GA MSA3%3%3.02%2.40%2.42%
New York, NY MD2%6%3.53%3.60%3.75%
Houston, TX MSA2%3%3.58%2.67%2.60%
Dallas, TX MD2%2%2.38%1.92%1.86%
Washington-Arlington, DC MD2%2%2.03%2.01%1.85%
Riverside-San Bernardino, CA MSA2%3%3.25%2.83%2.89%
Los Angeles-Long Beach, CA MD2%2%2.65%2.39%2.18%
Denver-Aurora-Lakewood, CO MSA2%1%1.38%1.12%1.12%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance, pre-foreclosure sale and deed-in-lieu. These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts.

86

Table of Contents

The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, as well as weighted average mortgage interest rate and delinquency rate as of December 31, 2024:

(Amounts in millions)Weighted average rate (1)% of direct primary case reserves(2)Primary insurance in-force% of totalPrimary risk in-force% of totalDelinquency rate
Policy Year 2008 and prior5.33%10%$4,8602%$1,2562%8.17%
2009 to 20164.00%65,13821,33224.75%
20174.32%43,90711,03614.37%
20184.83%54,79021,23324.66%
20194.23%811,41542,98443.31%
20203.26%1434,940139,553142.14%
20213.11%2157,2662115,043212.25%
20224.88%2053,0632013,476192.50%
20236.62%1045,2081711,719171.83%
20246.70%248,2381812,353180.49%
Total portfolio4.88%100%$268,825100%$69,985100%2.45%
Column 1Column 2
(1)Average annual mortgage interest rate weighted by insurance in-force.
Column 1Column 2
(2)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. The concentration of loss reserves has shifted to newer book years in line with changes in risk in-force. As of December 31, 2024, Enact’s 2017 and newer policy years represented approximately 96% of its primary risk in-force and 84% of its total direct primary case reserves.

The ratio of the claim paid to the current risk in-force for a loan is referred to as “claim severity.” The current risk in-force is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws. Pre-foreclosure sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 99%, 97% and 94% for the years ended December 31, 2024, 2023 and 2022, respectively, and was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on non-performing loans.

Long-Term Care Insurance segment

Trends and conditions

The results of our long-term care insurance business depend upon how our actual experience compares with our valuation assumptions, including but not limited to in-force rate actions, morbidity, mortality and persistency. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance business are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, also impact our long-term care insurance business either positively or negatively.

87

Table of Contents

Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments as our actual claims experience will emerge over many years, or decades. For example, average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on certain of our oldest long-term care insurance blocks of business have reached their peak claim years and will decrease as the blocks run off, we expect overall claims costs to continue to increase as the approximately 609,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 77 and 74, respectively, reach their peak claim years, which are over age 85.

Additionally, we have observed an increase in the cost of care in our long-term care insurance business, due in part to elevated inflation. Increases in cost of care have resulted in higher claim payments, which could have a material adverse impact on our liquidity, results of operations and financial condition if the increases persist. We will continue to monitor our experience and make changes to our assumptions and methodologies, as appropriate, for our long-term care insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.

The impacts of assumption updates and actual variances from expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. Our profitable uncapped cohorts have to date had a more modest earnings impact related to assumption updates and actual variances from expected experience, as a portion of the impact is reflected in current period results with the remaining majority of the impact recognized over the life of the cohort. However, as we move further from the January 2021 transition date of the accounting guidance for long-duration insurance contracts adopted on January 1, 2023, we may see increased volatility from the uncapped cohorts, with more of the impact related to assumption updates and actual variances from expected experience recognized immediately in net income. It is important to note that quarterly variations resulting from assumption updates and actual variances from expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $43.0 billion, at the locked-in discount rate, for our long-term care insurance business as of December 31, 2024.

For a discussion of potential impacts of assumption updates and actual variances from expected experience on our results of operations, see “Item 1A—Risk Factors—We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition.”

The financial condition of our long-term care insurance business is also impacted by interest rates. We remeasure our liability for future policy benefits and the related reinsurance recoverables at the single-A bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued volatility to our reserve balances and equity. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates could materially adversely affect our business and profitability.”

Fourth quarter assumption review

In the fourth quarter of 2024, our long-term care insurance products had an unfavorable pre-tax impact of $20 million from cash flow assumption updates primarily related to updates to our healthy life and near-term benefit utilization assumptions to better align with recent experience, including cost of care inflation. Although we did not make significant changes to our multi-year in-force rate action plan, these unfavorable impacts were partially offset by favorable assumption updates for future in-force rate action approvals given our current plans for rate increase filings and our recent experience regarding approvals and regulatory support. The unfavorable

88

Table of Contents

impacts were also partially offset by favorable updates to our short-term incidence assumptions for IBNR claims, reducing sufficiency held through a period of heightened uncertainty around incidence during and immediately following COVID-19. While our 2024 assumption review considered trends during the pandemic years, our updates to long-term assumptions generally exclude or adjust experience data after 2019, as we do not have sufficient information around the long-term effects of COVID-19.

Under statutory cash flow testing, changes impacting active life reserves are included in our margin review and only impact statutory income if the margin falls below zero. However, changes to our claim reserve assumptions are immediately reflected in statutory income. We completed statutory cash flow testing for our life insurance subsidiaries in the fourth quarter of 2024 and concluded that the margin in GLIC was positive and within the $0.5 billion to $1.0 billion range. However, GLICNY had a negative margin and recorded additional statutory reserves of $79 million in 2024.

In-force rate actions and legal settlements

Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium rate increases and associated benefit reductions on our in-force policies. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on in-force rate actions, refer to the selected operating performance measures below.

In addition, we have reached three legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. These legal settlements cover approximately 70% of our long-term care insurance block and have had the effect of accelerating benefit reductions. We began implementing the third and final legal settlement during the second quarter of 2023, and its implementation was materially completed in the fourth quarter of 2024. These legal settlements resulted in an overall net favorable economic impact to our long-term care insurance business as they reduced tail risk on these long-duration liabilities.

While we expect renewal premiums to decline over time as the block runs off, benefit reductions elected by policyholders in connection with our in-force rate actions and legal settlements have accelerated that decline. However, we expect this decline to be partially offset by future approved rate actions.

89

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Long-Term Care Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2024202320222024 vs. 2023
Revenues:
Premiums$2,310$2,463$2,500$(153)(6)%
Net investment income1,9401,9141,900261%
Net investment gains (losses)6611419(48)(42)%
Total revenues4,3164,4914,419(175)(4)%
Benefits and expenses:
Benefits and other changes in policy reserves3,7743,8023,788(28)(1)%
Liability remeasurement (gains) losses172321(317)(149)(46)%
Acquisition and operating expenses, net of deferrals423452413(29)(6)%
Amortization of deferred acquisition costs and intangibles697174(2)(3)%
Total benefits and expenses4,4384,6463,958(208)(4)%
Income (loss) from continuing operations before income taxes(122)(155)4613321%
Provision (benefit) for income taxes3(3)1256200%
Income (loss) from continuing operations(125)(152)3362718%
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses(66)(114)(19)4842%
Expenses related to restructuring1(1)1NM(1)
Taxes on adjustments14244(10)(42)%
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$(176)$(242)$320$6627%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2024 compared to 2023

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily driven by lower liability remeasurement losses, net insurance recoveries and higher income from limited partnerships, partially offset by lower renewal premiums in 2024.

Revenues

Premiums decreased primarily driven by lower renewal premiums from benefit reduction elections made by policyholders in connection with our in-force rate actions and legal settlements and from policy terminations in 2024. The decrease was partially offset by $7 million of higher premiums in 2024 from newly implemented in-force rate actions.

Net investment income increased largely due to higher income from limited partnerships in 2024.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

90

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves decreased primarily due to lower net premiums collected resulting from benefit reduction elections made by policyholders in connection with our in-force rate actions and legal settlements and from policy terminations. This was partially offset by aging of the in-force block, including higher interest accretion, and higher loss adjustment expenses in 2024.

The liability remeasurement loss in 2024 was largely due to adverse actual versus expected experience primarily driven by lower terminations and higher claims. This was partially offset by net favorable cash flow assumption updates primarily related to approval amounts and implementation timing of our in-force rate action plan and a favorable update to our short-term incidence assumption for IBNR claims. The liability remeasurement loss in 2023 was largely driven by adverse actual variances from expected experience primarily related to higher claims and unfavorable timing impacts from the second legal settlement. In addition, cash flow assumption updates were unfavorable in 2023. See “ —Critical Accounting Estimates—Liability for future policy benefits—Long-term care insurance” for a discussion of the fourth quarter annual review of assumptions.

Acquisition and operating expenses, net of deferrals, decreased principally from $28 million of net insurance recoveries in 2024 related to previously incurred legal settlement expenses, as well as a $13 million accrual for legal settlement costs in 2023 that did not recur. These decreases were partially offset by higher employee-related expenses in 2024.

Provision (benefit) for income taxes. The tax provision in 2024 was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income, partially offset by a tax benefit related to the pre-tax loss. The tax benefit in 2023 was primarily related to the pre-tax loss, partially offset by tax expense on certain forward starting swap gains.

Long-Term Care Insurance selected operating performance measures

Liability remeasurement (gains) losses

We include expectations for benefit reductions related to in-force rate actions and legal settlements as well as cash payments made to policyholders who elect certain reduced benefit options in connection with the legal settlements, referred to as settlement payments, in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. We update the net premium ratio quarterly for actual variances from expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions will be reflected in liability remeasurement (gains) losses in our operating results on a quarterly basis.

The following table sets forth the pre-tax components of the liability remeasurement (gains) losses, net of reinsurance, for the periods indicated:

(Increase) decrease and
Years ended December 31percentage change
(Amounts in millions)2024202320222024 vs. 2023
Cash flow assumption updates$(69)$52$(335)$(121)NM(1)
Actual variances from expected experience24126918(28)(10)%
Total liability remeasurement (gains) losses$172$321$(317)$(149)(46)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

For additional discussion of liability remeasurement (gains) losses, see the comparison for this line item above.

91

Table of Contents

In-force rate actions

As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions in order to maintain the self-sustainability of our legacy U.S. life insurance subsidiaries and reduce the strain on earnings and capital.

Management regularly monitors and reports in-force rate actions, including state filing approvals; impacted in-force premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved in our Long-Term Care Insurance segment. We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan on a net present value basis, discounted at our investment portfolio yield. This is based on current assumptions and is defined as the net present value of historical and future expected premium increases and benefit reductions as a result of rate increases approved on individual and group long-term care insurance policies. It also includes the net present value of reserve reductions related to legal settlements less settlement payments. We monitor these selected operating performance measures for in-force rate actions to track our progress on maintaining the self-sustainability of our legacy U.S. life insurance subsidiaries. We consider these in-force rate action metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Long-Term Care Insurance segment.

The following table sets forth filing approvals as part of our multi-year in-force rate action plan for the years ended December 31:

(Dollar amounts in millions)202420232022
State filings approved97117139
Impacted in-force premiums$870$697$1,143
Weighted-average percentage rate increase approved39%51%48%
Gross incremental premiums approved$343$354$549

We estimate that the cumulative economic benefit of approved rate actions in our multi-year in-force rate action plan from 2012 through December 31, 2024 was approximately $31.2 billion, on a net present value basis, based on our current updated assumptions regarding future premiums and benefit reductions from approved rate actions. This represents a significant increase in estimated rate actions achieved since December 31, 2023, including $2.1 billion of value from rate action approvals and legal settlement implementations in 2024 and an increase of $1.1 billion in the value of benefit reductions connected with our previously achieved rate actions and legal settlements from the impact of our assumption updates.

During the year ended December 31, 2024, we also submitted 90 new filings on approximately $525 million in annualized in-force premiums. The total in-force premiums submitted in 2024 were lower than previous years due to past successes in achieving approvals. In some cases, we received large approvals that either materially completed the current multi-year rate action plan, which removed the need to re-file in the near-term, or resulted in multi-year implementations, which delayed the expected submission of a subsequent filing to beyond 2024.

The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state and product. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase, and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.

We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider

92

Table of Contents

litigation against states that decline to approve those actuarially justified rate increases. As of December 31, 2024, we were in litigation with two states that have refused to approve actuarially justified rate increases for certain products.

Life and Annuities segment

Trends and conditions

Many factors can affect the results of our life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our life insurance and annuity products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Results of our life insurance and annuity products depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves.

Results of our life insurance and annuity products are also impacted by interest rates. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates could materially adversely affect our business and profitability.”

We no longer solicit sales of traditional life insurance and annuity products; however, we continue to service our existing retained and reinsured blocks of business.

Life insurance

Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors.

Mortality levels may deviate each period from historical trends. Overall mortality experience during 2024 was largely consistent with 2023. We have experienced unfavorable mortality compared to our then-current and priced-for assumptions in recent years for our universal life insurance block. Reinsurance costs typically increase due to natural aging of the yearly renewable term reinsured blocks. We have also received some yearly renewable term reinsurance premium increases from some of our reinsurance partners that reflect unfavorable mortality.

In the fourth quarter of 2024, our universal life insurance products had an unfavorable pre-tax impact of $28 million from cash flow assumption updates reflecting unfavorable updates to mortality assumptions for contracts originating from term life insurance conversions and interest rate assumptions given the recent rate environment. Consistent with our long-term care insurance business, our 2024 assumption review considered trends during the pandemic years, but updates to our long-term assumptions generally exclude or adjust experience data after 2019, as we do not have sufficient information around the long-term effects of COVID-19.

Certain of our universal life insurance products with secondary guarantees are subject to additional reserves on a statutory basis using regulatory prescribed assumptions, including mortality improvement and the reinvestment rate, which is measured from July to June each year and increased from July 2023 to June 2024. The benefits from the reinvestment rate and mortality improvement more than offset negative assumption updates in these products from a statutory income perspective.

93

Table of Contents

Fixed annuities

Results of our fixed annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels.

We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.

For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.

In the fourth quarter of 2024, we had an unfavorable pre-tax impact of $16 million from assumption updates primarily related to our fixed indexed annuity lapse assumptions.

Variable annuities

Results of our variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our variable annuity products can significantly impact our regulatory capital requirements and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate these impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.

Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity market and interest rate performance and volatility could result in additional gains or losses in these products, although associated hedging activities are expected to partially mitigate these impacts.

In the fourth quarter of 2024, our variable annuity products had an unfavorable pre-tax impact of $6 million from an update to our lapse assumptions.

94

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Life and Annuities segment for the periods indicated:

Increase (decrease) and
Years ended December 31,percentage change
(Amounts in millions)2024202320222024 vs. 2023
Revenues:
Premiums$179$207$234$(28)(14)%
Net investment income9591,0421,083(83)(8)%
Net investment gains (losses)(20)(49)(4)2959%
Policy fees and other income638646669(8)(1)%
Total revenues1,7561,8461,982(90)(5)%
Benefits and expenses:
Benefits and other changes in policy reserves962963620(1)%
Liability remeasurement (gains) losses(19)26627(285)(107)%
Changes in fair value of market risk benefits and associated hedges(13)(12)(104)(1)(8)%
Interest credited453503504(50)(10)%
Acquisition and operating expenses, net of deferrals2352136042210%
Amortization of deferred acquisition costs and intangibles166181240(15)(8)%
Total benefits and expenses1,7842,1141,891(330)(16)%
Income (loss) from continuing operations before income taxes(28)(268)9124090%
Provision (benefit) for income taxes(8)(59)165186%
Income (loss) from continuing operations(20)(209)7518990%
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses20494(29)(59)%
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(1)(43)(22)(142)(21)(95)%
Expenses related to restructuring(1)%
Pension plan termination costs8%
Taxes on adjustments5(6)2811183%
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(38)$(188)$(28)$15080%
Column 1Column 2
(1)For the years ended December 31, 2024, 2023 and 2022, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(30) million, $(10) million and $(38) million, respectively.

95

Table of Contents

The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Life and Annuities segment for the periods indicated:

Increase (decrease) and
Years ended December 31,percentage change
(Amounts in millions)2024202320222024 vs. 2023
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Life insurance$(94)$(275)$(111)$18166%
Fixed annuities305062(20)(40)%
Variable annuities263721(11)(30)%
Total adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(38)$(188)$(28)$15080%

2024 compared to 2023

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance products decreased primarily from liability remeasurement gains in 2024 compared to losses in 2023, partially offset by lower premiums and a less favorable change in reserves in 2024 in our term life insurance products related to block runoff.
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuity products decreased mainly from unfavorable assumption updates of $9 million primarily related to our fixed indexed annuity lapse assumptions in 2024, as well as lower net spreads primarily related to block runoff.
Column 1Column 2Column 3Column 4
Adjusted operating income in our variable annuity products decreased largely from an unfavorable lapse assumption update of $5 million in 2024 compared to favorable assumption updates in 2023.

Revenues

Premiums. The decrease was driven by our life insurance products largely due to the continued runoff of our in-force blocks.

Net investment income

Column 1Column 2Column 3Column 4
Our fixed and variable annuity products decreased $39 million and $6 million, respectively, primarily attributable to lower average invested assets in 2024 driven mostly by block runoff.
Column 1Column 2Column 3Column 4
Our life insurance products decreased $38 million largely from lower policy loan rates in our corporate-owned life insurance products in 2024.

Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves

Column 1Column 2Column 3Column 4
Our fixed annuity products decreased $12 million largely attributable to block runoff.
Column 1Column 2Column 3Column 4
Our variable annuity products decreased $10 million largely from higher reserve releases in 2024.
Column 1Column 2Column 3Column 4
Our life insurance products increased $21 million primarily from a less favorable change in reserves in our term life insurance products in 2024 related to block runoff and a favorable flooring adjustment in 2023 that did not recur. These increases were partially offset by an increase in cost of reinsurance reserves related to a ceded reinsurance transaction in 2023 that did not recur.

96

Table of Contents

Liability remeasurement (gains) losses. The favorable variance was mainly driven by a gain in 2024 compared to a loss in 2023 primarily driven by our life insurance products. The liability remeasurement gain in 2024 was primarily due to a $58 million model refinement related to certain universal life insurance products with secondary guarantees, partially offset by $28 million of unfavorable updates to our mortality assumptions for universal life insurance contracts and our interest rate assumptions. The liability remeasurement loss in our life insurance products in 2023 was principally driven by unfavorable updates of $256 million primarily related to our persistency assumptions for certain universal life insurance products with secondary guarantees and unfavorable mortality updates, including more modest mortality improvement. The unfavorable updates in 2023 were partially offset by net favorable impacts related to a ceded reinsurance transaction.

Changes in fair value of market risk benefits and associated hedges. The higher gain in 2024 was primarily attributable to favorable interest rate impacts, partially offset by unfavorable updates to our lapse assumptions of $13 million in our fixed indexed annuity products and $6 million in our variable annuity products compared to favorable assumption updates in 2023. Our variable annuity products also included higher derivative losses in 2024.

Interest credited

Column 1Column 2Column 3Column 4
Our life insurance products decreased $37 million primarily driven by lower policy loan rates in our corporate-owned life insurance products in 2024.
Column 1Column 2Column 3Column 4
Our fixed annuity products decreased $13 million largely due to block runoff, partially offset by higher crediting rates in 2024.

Acquisition and operating expenses, net of deferrals. The increase was primarily driven by higher operating costs in our life insurance and fixed annuity products and a $5 million legal settlement accrual in 2024.

Amortization of deferred acquisition costs and intangibles. The decrease was largely due to block runoff in our term life insurance products.

Provision (benefit) for income taxes. The effective tax rate was 27.4% and 22.1% for the years ended December 31, 2024 and 2023, respectively. The increase in the effective tax rate was primarily attributable to tax benefits from tax favored items in relation to a lower pre-tax loss in 2024.

Life and Annuities selected operating performance measures

Liability remeasurement (gains) losses

The following table sets forth the pre-tax components of the liability remeasurement (gains) losses, net of reinsurance, for the periods indicated:

(Increase) decrease and
Years ended December 31,percentage change
(Amounts in millions)2024202320222024 vs. 2023
Cash flow assumption updates$27$256$(37)$(229)(89)%
Actual variances from expected experience(46)1064(56)NM(1)
Total liability remeasurement (gains) losses$(19)$266$27$(285)(107)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

For additional discussion of liability remeasurement (gains) losses, see the comparison for this line item above.

97

Table of Contents

Life insurance

The following table sets forth insurance in-force for our life insurance products as of the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2024202320222024 vs. 2023
Term and whole life insurance
Life insurance in-force, net of reinsurance$41,386$44,121$48,162$(2,735)(6)%
Life insurance in-force, before reinsurance$238,865$270,950$300,145$(32,085)(12)%
Term universal life insurance
Life insurance in-force, net of reinsurance$88,700$90,427$92,719$(1,727)(2)%
Life insurance in-force, before reinsurance$89,283$91,024$93,336$(1,741)(2)%
Universal life insurance
Life insurance in-force, net of reinsurance$27,228$28,710$29,798$(1,482)(5)%
Life insurance in-force, before reinsurance$30,583$32,199$33,622$(1,616)(5)%

The decrease in insurance in-force in our life insurance products reflects the continued runoff of our in-force blocks.

Corporate and Other

Results of operations

The following table sets forth the results of operations relating to Corporate and Other for the periods indicated:

Increase (decrease) and
Years ended December 31,percentage change
(Amounts in millions)2024202320222024 vs. 2023
Revenues:
Premiums$11$9$6$222%
Net investment income21198211%
Net investment gains (losses)(11)(28)(15)1761%
Policy fees and other income(2)2100%
Total revenues21(2)(1)23NM(1)
Benefits and expenses:
Benefits and other changes in policy reserves(9)(9)(11)%
Acquisition and operating expenses, net of deferrals9565413046%
Amortization of deferred acquisition costs and intangibles413NM(1)
Interest expense646654(2)(3)%
Total benefits and expenses154123843125%
Loss from continuing operations before income taxes(133)(125)(85)(8)(6)%
Benefit for income taxes(27)(20)(16)(7)(35)%
Loss from continuing operations(106)(105)(69)(1)(1)%
Adjustments to loss from continuing operations:
Net investment (gains) losses112815(17)(61)%
(Gains) losses on early extinguishment of debt(7)(2)6(5)NM(1)
Expenses related to restructuring741375%
Taxes on adjustments(3)(6)(5)350%
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(98)$(81)$(52)$(17)(21)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

98

Table of Contents

2024 compared to 2023

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives, partially offset by a higher benefit for income taxes in 2024.

Revenues

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives, as well as higher employee-related expenses. These increases were partially offset by $5 million of higher gains in 2024 related to the repurchase of Genworth Holdings’ debt.

Amortization of DAC and intangibles in 2024 primarily relates to amortization of capitalized software.

The increase in the benefit for income taxes was primarily related to a higher pre-tax loss, favorable provision to return adjustments and lower terminations of share-based awards in 2024.

Investments and Derivative Instruments

Trends and conditions

Investments

During the year ended December 31, 2024, our investment portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends:

Column 1Column 2Column 3Column 4
The U.S. Federal Reserve decreased the federal funds rate by 100 basis points in 2024 and continues to monitor inflation and labor market conditions, which will influence its plan for additional changes to interest rates in 2025.
Column 1Column 2Column 3Column 4
During the fourth quarter of 2024, U.S. Treasury yields increased compared to both September 30, 2024 and December 31, 2023.
Column 1Column 2Column 3Column 4
Credit spreads tightened during the fourth quarter of 2024 as credit fundamentals remained strong amidst an optimistic macroeconomic backdrop; however, future uncertainty remains as economic policies shift and international trade evolves.
Column 1Column 2Column 3Column 4
While our investment portfolio has exposure to the State of California, we have limited exposure to the areas impacted by the January 2025 Los Angeles wildfires. Therefore, we do not expect a material impact on our results of operations, nor do we believe there is a material risk to the valuation of our investment portfolio.
Column 1Column 2Column 3Column 4
As of December 31, 2024, our investment portfolio exposure to Israel was immaterial and there has been no impact on our results of operations from the Israel-Hamas conflict. At this time, we do not believe there is a material risk to the valuation of our investment portfolio due to credit losses or direct write-offs that may arise as a result of the conflict.
Column 1Column 2Column 3Column 4
As of December 31, 2024, our fixed maturity securities portfolio, which was 97% investment grade, comprised 75% of our total invested assets and cash.

99

Table of Contents

Derivatives

Column 1Column 2Column 3Column 4
As of December 31, 2024, $1.1 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”).
Column 1Column 2Column 3Column 4
The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2024, we posted initial margin of $74 million to our clearing agents, which represented $37 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings.
Column 1Column 2Column 3Column 4
As of December 31, 2024, $12.6 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $554 million and are holding collateral from counterparties in the amount of $11 million.

Investment results

The following table sets forth information about investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31:

Increase (decrease)
2024202320222024 vs. 2023
(Amounts in millions)YieldAmountYieldAmountYieldAmountYieldAmount
Fixed maturity securities—taxable4.6%$2,2384.5%$2,2444.5%$2,2960.1%$(6)
Fixed maturity securities—non-taxable5.7%24.2%34.7%51.5%(1)
Equity securities2.9%133.0%114.0%10(0.1)%2
Commercial mortgage loans4.5%2974.4%3024.6%3210.1%(5)
Policy loans8.3%18910.2%22410.0%211(1.9)%(35)
Limited partnerships (1)5.1%1524.5%1174.7%990.6%35
Other invested assets (2)45.7%27050.5%27959.9%267(4.8)%(9)
Cash, cash equivalents, restricted cash and short-term investments4.8%994.7%951.2%200.1%4
Gross investment income before expenses and fees5.1%3,2605.1%3,2755.0%3,229%(15)
Expenses and fees(0.2)%(100)(0.2)%(92)(0.2)%(83)%(8)
Net investment income4.9%$3,1604.9%$3,1834.8%$3,146%$(23)
Average invested assets and cash$64,055$64,637$65,160$(582)
Column 1Column 2
(1)Limited partnership investments are primarily equity-based and do not have fixed returns by period.
Column 1Column 2
(2)Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.

Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments.

Gross annualized weighted-average investment yields were unchanged for 2024 compared to 2023 due to lower average invested assets in 2024. Net investment income decreased largely from lower yields on a large block of policy loans in our corporate-owned life insurance products and lower amortization on interest rate swaps, partially offset by higher income from limited partnerships in 2024.

100

Table of Contents

The following table sets forth net investment gains (losses) for the years ended December 31:

(Amounts in millions)202420232022
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains$49$29$28
Realized losses(106)(154)(102)
Net realized gains (losses) on available-for-sale fixed maturity securities(57)(125)(74)
Net realized gains (losses) on equity securities sold9(1)
Total net realized investment gains (losses)(48)(126)(74)
Net change in allowance for credit losses on available-for-sale fixed maturity securities(3)(7)
Write-down of available-for-sale fixed maturity securities(9)(1)(2)
Net unrealized gains (losses) on equity securities still held8353(35)
Net unrealized gains (losses) on limited partnerships4311171
Commercial mortgage loans(16)(5)4
Derivative instruments(18)732
Other(19)(9)2
Net investment gains (losses)$13$23$(2)

2024 compared to 2023

Column 1Column 2Column 3Column 4
We recorded $68 million of lower net realized losses related to the sale of available-for-sale fixed maturity securities in 2024. The net losses in 2023 were primarily from sales related to portfolio repositioning and liquidity management, as well as reducing regional bank exposure, including a $15 million loss related to the sale of First Republic Bank U.S. corporate bonds.
Column 1Column 2Column 3Column 4
We recorded $30 million of higher net unrealized gains on equity securities driven by more favorable equity market performance in 2024. We also recorded $68 million of lower net unrealized gains on limited partnerships driven by less favorable private equity market performance in 2024. During 2024, we increased the provision for credit losses for both commercial mortgage loans and bank loan investments as a result of annual updates to underlying metrics included in the analytical models used to determine the adequacy of the allowance for credit losses, as well as updates to certain assumptions for bank loan investments.
Column 1Column 2Column 3Column 4
We had $18 million of net investment losses related to derivatives in 2024 compared to $7 million of net investments gains in 2023 primarily attributable to higher losses on forward bond purchase commitments driven by an increase in interest rates compared to contracted notional interest rates, higher losses on hedging programs that support our fixed indexed annuity products and lower gains on hedging programs that support our indexed universal life insurance products.

101

Table of Contents

Investment portfolio

The following table sets forth our cash, cash equivalents and invested assets as of December 31:

20242023
(Amounts in millions)Carrying value% of totalCarrying value% of total
Available-for-sale fixed maturity securities:
Public$30,65051%$32,18951%
Private14,2522414,59224
Equity securities51513961
Commercial mortgage loans, net6,411116,80210
Policy loans2,31042,2204
Limited partnerships3,14252,8215
Other invested assets64817311
Cash, cash equivalents and restricted cash2,04832,2154
Total cash, cash equivalents and invested assets$59,976100%$61,966100%

For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 4 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio.

We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2024, approximately 6% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 19 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value.

102

Table of Contents

The following table presents our public, private and total fixed maturity securities by the Nationally Recognized Statistical Rating Organizations (“NRSRO”) designations and/or equivalent ratings, as well as the percentage, based upon fair value that each designation comprises. Certain fixed maturity securities that are not rated by an NRSRO are shown based upon internally prepared credit evaluations.

As of December 31,
(Amounts in millions)20242023
AmortizedFair% ofAmortizedFair% of
NRSRO designationcostvaluetotalcostvaluetotal
Public fixed maturity securities
AAA$2,760$2,4148%$2,779$2,5598%
AA6,5895,988206,4616,17019
A9,0588,537289,4749,28729
BBB14,27013,2084214,34613,64542
BB52147625184982
B29273230
CCC and lower
Total public fixed maturity securities$33,227$30,650100%$33,610$32,189100%
Private fixed maturity securities
AAA$808$7775%$866$8326%
AA1,6551,527111,5741,47710
A4,4094,015284,3984,04328
BBB7,5646,948497,7097,12648
BB90485061,0379757
B928111491171
CCC and lower463977
Not rated15151515
Total private fixed maturity securities$15,493$14,252100%$15,755$14,592100%
Total fixed maturity securities
AAA$3,568$3,1917%$3,645$3,3917%
AA8,2447,515178,0357,64716
A13,46712,5522813,87213,33029
BBB21,83420,1564522,05520,77145
BB1,4251,32631,5551,4733
B121108181147
CCC and lower463977
Not rated15151515
Total fixed maturity securities$48,720$44,902100%$49,365$46,781100%

We invest in privately placed fixed maturity securities to increase diversification and obtain higher yields than can ordinarily be obtained with comparable public market securities. Generally, private placements provide us with protective covenants, call protection features and, where applicable, a higher level of collateral. However, our private placements are not as freely transferable as public securities because of restrictions imposed by federal and state securities laws, the terms of the securities and the characteristics of the private market. Based upon fair value, public fixed maturity securities represented 68% and 69%, respectively, of total fixed maturity securities as of December 31, 2024 and 2023. Private fixed maturity securities represented 32% and 31%, respectively, of total fixed maturity securities as of December 31, 2024 and 2023.

We diversify our corporate securities by industry and issuer. As of December 31, 2024, our combined holdings in the 10 corporate issuers to which we had the greatest exposure was $1.7 billion, which was approximately 3% of our total cash, cash equivalents and invested assets. The exposure to the largest single corporate issuer held as of December 31, 2024 was $274 million, which was less than 1% of our total cash, cash

103

Table of Contents

equivalents and invested assets. See note 4 to our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on diversification by sector.

Other invested assets

The following table sets forth the carrying values of our other invested assets as of December 31:

20242023
(Amounts in millions)Carrying value% of totalCarrying value% of total
Bank loan investments$53582%$52972%
Derivatives56913118
Short-term investments41274
Other investments538446
Total other invested assets$648100%$731100%

Derivatives decreased largely from an increase in current market rates compared to contracted notional interest rates in 2024. Short-term investments decreased from net maturities and sales.

Derivatives

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:

(Notional in millions)MeasurementDecember 31, 2023AdditionsMaturities/ terminationsDecember 31, 2024
Derivatives designated as hedges
Cash flow hedges:
Interest rate swapsNotional$8,975$331$(549)$8,757
Foreign currency swapsNotional13113144
Forward bond purchase commitmentsNotional1,0751,5642,639
Total cash flow hedges10,1811,908(549)11,540
Total derivatives designated as hedges10,1811,908(549)11,540
Derivatives not designated as hedges
Equity index optionsNotional702620(718)604
Financial futuresNotional1,2514,618(4,767)1,102
Forward bond purchase commitmentsNotional500500
Total derivatives not designated as hedges2,4535,238(5,485)2,206
Total derivatives$12,634$7,146$(6,034)$13,746
(Number of policies)MeasurementDecember 31, 2023AdditionsMaturities/ terminationsDecember 31, 2024
Derivatives not designated as hedges
Fixed indexed annuity embedded derivativesPolicies5,826(959)4,867
Indexed universal life embedded derivativesPolicies749(32)717

The increase in the notional value of derivatives was primarily attributable to the addition of forward bond purchase commitments that support our long-term care insurance business and universal life insurance products, partially offset by a decrease in interest rate swaps that support our long-term care insurance business.

104

Table of Contents

The number of policies with embedded derivatives decreased as these products are no longer being offered and continue to runoff.

Critical Accounting Estimates

The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” For a detailed discussion of our significant accounting policies, see note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

The sensitivities in the tables below are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products. The impacts are discrete and do not reflect the impact one factor may have on another. In any period and over time, our actual experience may have a positive or negative variance from our long-term assumptions, either singularly or collectively, and these variances may offset each other.

Liability for future policy benefits

The measurement of the liability for future policy benefits reflects estimates and actuarial assumptions and methodologies which involve the exercise of significant judgment and are inherently uncertain. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Establishing assumptions for the liability for future policy benefits is complex and involves many factors. Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding loss recognized in net income (loss). Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our liability for future policy benefits. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.

The liability for future policy benefits is equal to the present value of expected future benefits and claim-related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates), and estimates of future in-force rate actions, which include premium rate increases and benefit reductions associated with our long-term care insurance products. The liability is measured for each group of contracts, or cohorts, using best estimate cash flow assumptions, which are reviewed at least annually in the fourth quarter or more frequently if actual experience indicates a change is required. The change in the liability for future policy benefits, at the locked-in discount rate, resulting from cash flow assumption updates and variances between actual and expected experience is reflected as liability remeasurement (gains) losses in the consolidated statements of income.

See notes 2 and 8 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the liability for future policy benefits.

105

Table of Contents

Long-term care insurance

The liability for future policy benefits for our long-term care insurance products is estimated using assumptions related to both insured individuals on claim (disabled life assumptions) and insured individuals not on claim (healthy life assumptions). Key cash flow assumptions used to estimate the liability for future policy benefits include claim termination rates, incidence and benefit utilization rates, mortality, lapse rates and in-force rate actions. Claim termination rates represent the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates represent how much of the available policy benefits are expected to be used. In-force rate actions represent the remaining premium rate increases and associated benefit reductions not yet achieved in our long-term care insurance multi-year in-force rate action plan and are based on our best estimate given our current plans for rate increase filings and our historical experience regarding rate increase approvals.

In the fourth quarter of 2024, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $20 million primarily related to updates to healthy life and near-term benefit utilization assumptions to better align with recent experience, including cost of care inflation. These unfavorable impacts were partially offset by favorable assumption updates for future in-force rate action approvals given our current plans for rate increase filings and our recent experience regarding approvals and regulatory support. The unfavorable impacts were also partially offset by favorable updates to our short-term incidence assumptions for IBNR claims, reducing sufficiency held through a period of heightened uncertainty around incidence during and immediately following COVID-19. While our 2024 assumption review considered trends during the pandemic years, our updates to long-term assumptions generally exclude or adjust experience data after 2019, as we do not have sufficient information around the long-term effects of COVID-19.

In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $61 million primarily related to updates to our healthy life assumptions to better reflect near-term experience, partially offset by a favorable update to disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. Updates also included favorable assumption updates for future in-force rate action approvals and benefit reductions based on recent favorable rate increase approval experience and feedback from regulators, along with the reflection of the third legal settlement, which had a muted favorable income statement impact in the fourth quarter of 2023 because it primarily impacted profitable uncapped cohorts.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and
percentage change
(Amounts in millions)202420232024 vs. 2023
Present value of expected net premiums (1)$14,720$15,333$(613)(4)%
Present value of expected future policy benefits (1)$50,031$50,095$(64)%
Column 1Column 2
(1)At the locked-in discount rate.

106

Table of Contents

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2024:

(Amounts in millions)
5% increase in future claim costs (1)$(1,580)
Decrease in claim termination rates (2)$(300)
10% decrease in benefit of future in-force rate actions (3)$(160)
Column 1Column 2
(1)Reflects the impact of an unfavorable assumption change for claim terminations, incidence or benefit utilization rates (any discrete adverse assumption changes therefrom or in combination with, that results in our future claim costs increasing by 5%).
Column 1Column 2
(2)Reflects the impact of a 3% decrease in mortality and 8% decrease in lapse rates.
Column 1Column 2
(3)Reflects the impact of an unfavorable change to our assumptions for future premium rate increases and benefit reductions.

Life insurance

Key cash flow assumptions used to estimate the liability for future policy benefits for our life insurance products include mortality and lapse rates.

In the fourth quarter of 2024, our annual review of cash flow assumptions did not have a significant impact on liability remeasurement gains (losses) within net income for our life insurance products. In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $56 million primarily as a result of updates to our mortality assumptions, including emerging experience related to more modest mortality improvement and an expectation that mortality will continue at elevated levels in the near-term post-COVID-19.

A summary of certain of our significant estimates used in the calculation of our life insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and
percentage change
(Amounts in millions)202420232024 vs. 2023
Present value of expected net premiums (1)$1,612$1,835$(223)(12)%
Present value of expected future policy benefits (1)$1,816$2,192$(376)(17)%
Column 1Column 2
(1)At the locked-in discount rate and excluding the impacts of flooring adjustments. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2024:

(Amounts in millions)
2% increase in mortality$(25)
10% increase in lapses$(65)

Fixed annuities

The key cash flow assumption used to estimate the liability for future policy benefits for our fixed annuity products is mortality.

107

Table of Contents

In the fourth quarters of 2024 and 2023, our annual review of cash flow assumptions did not have a significant impact on liability remeasurement gains (losses) within net income for our fixed annuity products.

A summary of certain of our significant estimates and assumptions used in the calculation of our fixed annuities liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and
percentage change
(Amounts in millions)202420232024 vs. 2023
Total present value of expected future policy benefits (1)$2,518$2,691$(173)(6)%
Column 1Column 2
(1)At the locked-in discount rate.

A hypothetical decrease of 10% to our mortality assumption would have an unfavorable impact of $60 million on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2024.

Policyholder account balances – additional insurance liabilities

The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims, commonly referred to as the additional insurance liability. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality, interest rates and policyholder persistency or lapses, among other assumptions.

We perform an annual review of assumptions for our universal and term universal life insurance products in the fourth quarter. Our 2024 review resulted in an expense recorded to pre-tax income of $28 million largely associated with an unfavorable update to our mortality assumptions for universal life insurance contracts originating from term life insurance conversions and an unfavorable update to interest rate assumptions given the recent rate environment.

Our 2023 review resulted in an expense recorded to pre-tax income of $200 million primarily to reflect unfavorable persistency and mortality assumptions. We made unfavorable updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in universal and term universal life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2024:

(Amounts in millions)
100 basis point decrease in projected crediting rates$(36)
10% decrease in lapses$(226)
2% increase in mortality$(43)

108

Table of Contents

Liability for policy and contract claims

The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.

Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss).

Mortgage insurance

Estimates and actuarial assumptions used for establishing loss reserves involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on Enact’s loss reserves and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. The sources of uncertainty affecting the estimates are numerous and include factors internal and external to Enact. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external influences include changes in home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on Enact’s reserves, results of operations and financial condition.

Enact establishes reserves to recognize the estimated liability for losses and loss adjustment expenses related to defaults on insured mortgage loans. Loss reserves are established by estimating the number of loans in the inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase.

Enact’s management monitors actual experience, and where circumstances warrant, will revise its assumptions. The liability for loss reserves is reviewed regularly, with changes in estimates of future claims recorded through net income. Estimation of losses is based on historical claim and cure experience and covered exposures and is inherently judgmental. Future developments may result in losses greater or less than the liability for loss reserves provided.

Enact’s loss reserves were $525 million and $518 million as of December 31, 2024 and 2023, respectively. In considering the potential sensitivity of the factors underlying Enact’s best estimate of its mortgage insurance reserves, it is possible that even a relatively small change in the estimated claim or severity rate could have a significant impact on loss reserves and, correspondingly, on our results of operations. For example, based on Enact’s actual experience during the three-year period ended December 31, 2024, a quarterly change of 4% in its average claim rate would change the gross loss reserve amount for such quarter by approximately $72 million, and a change of 3% in its average severity rate would change the gross loss reserve amount for such quarter by approximately $15 million.

109

Table of Contents

Valuation of fixed maturity securities. Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value.

The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the period-to-period changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. Additionally, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investment portfolio.

Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2024, 6% of our total fixed maturity securities related to Level 3 fixed maturity securities valued using internal pricing models. See notes 2, 4 and 19 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments.

The following tables summarize the primary sources of data considered when determining the fair value of fixed maturity securities as of December 31:

2024
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$39,752$$39,752$
Broker quotes247247
Internal models4,9032,3572,546
Total fixed maturity securities$44,902$$42,109$2,793
2023
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$41,311$$41,311$
Broker quotes221221
Internal models5,2492,3742,875
Total fixed maturity securities$46,781$$43,685$3,096

110

Table of Contents

Consolidated Balance Sheets

Total assets. Total assets decreased $3,946 million from $90,817 million as of December 31, 2023 to $86,871 million as of December 31, 2024.

Column 1Column 2Column 3Column 4
Invested assets decreased $1,823 million primarily attributable to decreases of $1,879 million in fixed maturity securities and $391 million in commercial mortgage loans, partially offset by an increase of $321 million in limited partnerships. The decrease in fixed maturity securities was predominantly related to higher interest rates decreasing the fair value of our fixed maturity investment portfolio, as well as net sales and maturities in 2024. Commercial mortgage loans decreased mostly due to payments outpacing originations. Limited partnerships increased largely from capital calls in 2024.
Column 1Column 2Column 3Column 4
Cash and cash equivalents decreased $167 million largely due to net withdrawals from our investment contracts, federal income tax payments and repurchases of Genworth Financial’s common stock, partially offset by net sales and maturities of fixed maturity securities and commercial mortgage loan payments outpacing originations in 2024.
Column 1Column 2Column 3Column 4
Deferred acquisition costs decreased $209 million largely driven by amortization in our life and long-term care insurance products in 2024.
Column 1Column 2Column 3Column 4
Reinsurance recoverable decreased $1,370 million primarily due to an increase in the single-A interest rate used to discount the reinsurance recoverable and from the runoff of certain ceded products in 2024.
Column 1Column 2Column 3Column 4
The deferred tax asset decreased $234 million principally from the net effect of changes in the discount rate used to measure the liability for future policy benefits and related reinsurance recoverables due to an increase in the single-A interest rate. In addition, we increased our valuation allowance related to deferred tax assets that would produce capital losses by $100 million through accumulated other comprehensive income (loss) in the fourth quarter of 2024. These decreases in the deferred tax asset were partially offset by an increase in net unrealized losses on investments and derivatives due to rising interest rates and an increase related to future annuity and contract benefits in 2024.

Total liabilities. Total liabilities decreased $5,042 million from $82,482 million as of December 31, 2023 to $77,440 million as of December 31, 2024.

Column 1Column 2Column 3Column 4
The liability for future policy benefits decreased $4,045 million primarily from an increase in the single-A interest rate used to discount the liability for future policy benefits and from the runoff of our fixed annuity and life insurance products. These decreases were partially offset by an increase in our long-term care insurance reserves largely driven by aging of the in-force block, including higher interest accretion, partially offset by benefit payments outpacing premiums collected. The increase in our long-term care insurance reserves also included the effects of changes in cash flow assumptions and actual variances from expected experience. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in cash flow assumptions.
Column 1Column 2Column 3Column 4
Policyholder account balances decreased $946 million largely driven by surrenders, withdrawals and benefit payments in our fixed annuity and universal and term universal life insurance products in 2024.
Column 1Column 2Column 3Column 4
Market risk benefit liabilities decreased $160 million mostly related to favorable interest rate changes and equity market performance in 2024.
Column 1Column 2Column 3Column 4
Other liabilities increased $258 million primarily from higher derivative valuations due to an increase in interest rates in 2024.

Total equity. Total equity increased $1,096 million from $8,335 million as of December 31, 2023 to $9,431 million as of December 31, 2024.

Column 1Column 2Column 3Column 4
We reported net income available to Genworth Financial, Inc.’s common stockholders of $299 million for the year ended December 31, 2024.
Column 1Column 2Column 3Column 4
Unrealized gains (losses) on investments and derivatives qualifying as hedges decreased total equity by $1,026 million and $518 million, respectively, primarily due to an increase in interest rates in 2024.

111

Table of Contents

Column 1Column 2Column 3Column 4
Change in the discount rate used to measure future policy benefits increased total equity by $2,462 million largely attributable to an increase in the single-A interest rate used to discount the liability for future policy benefits and the related reinsurance recoverables in 2024.
Column 1Column 2Column 3Column 4
Treasury stock increased $188 million due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other associated costs, resulting in a decrease to total equity in 2024.

Liquidity and Capital Resources

Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.

Overview of cash flows—Genworth and subsidiaries

The following table sets forth our condensed consolidated cash flows for the years ended December 31:

(Amounts in millions)202420232022
Net cash from operating activities$88$597$1,049
Net cash from investing activities8611,261733
Net cash used by financing activities(1,115)(1,443)(1,554)
Net increase (decrease) in cash before foreign exchange effect$(166)$415$228

Our principal sources of cash include premiums and other payments received on our insurance products and services, income from our investment portfolio and proceeds from sales and maturities of investments. Cash flows related to operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Cash flows from operating activities have been invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions.

2024 compared to 2023

Net cash inflows from operating activities were lower in 2024 primarily driven by higher benefit payments and lower premiums collected in our long-term care insurance business, as well as higher federal income tax payments. We expect our operating cash flows to continue to be impacted by higher benefit payments and lower premiums collected on our legacy long-term care insurance products as further discussed below in “Regulated insurance subsidiaries.”

Net cash inflows from investing activities were lower in 2024 mainly due to lower net sales and maturities of fixed maturity securities and higher funding of bank loans, partially offset by commercial mortgage loan payments outpacing originations at a higher pace and lower capital calls on limited partnerships.

Net cash outflows related to financing activities were lower in 2024 primarily due to lower net withdrawals from our investment contracts and lower repurchases of Genworth Financial’s common stock, partially offset by higher repurchases of Genworth Holdings’ debt and expenses associated with Enact Holdings’ early debt redemption and issuance of new debt.

112

Table of Contents

Genworth—holding company liquidity

In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (or, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, investments in CareScout, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 16 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. We manage our legacy U.S. life insurance subsidiaries on a standalone basis and accordingly, do not expect to receive any dividends or other returns of capital from them. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations. In addition, insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details.

Enact Holdings’ capital allocation strategy includes supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to its shareholders. In addition to its quarterly cash dividend program, on August 1, 2023, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $100 million of its outstanding common stock. On May 1, 2024, Enact Holdings announced a new share repurchase authorization of $250 million. Genworth Holdings has agreed to participate in order to maintain its overall ownership at approximately its current level. As the majority shareholder, Genworth Holdings received $289 million of capital returns from Enact Holdings in 2024, comprised of quarterly dividends and share repurchases. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Enact Holdings’ stock price, capital availability, business and market conditions, regulatory requirements and debt covenant restrictions, among other factors.

On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under its existing share repurchase program that began in May 2022. Pursuant to the program, during 2024, Genworth Financial repurchased 28,566,288 shares of its common stock at an average price of $6.52 per share for a total of $186 million, before excise taxes and other associated costs. Genworth Financial also executed repurchases under its share repurchase program in 2025 through a Rule 10b5-1 trading plan under which 2,789,970 shares of its common stock were repurchased through February 20, 2025 at an average price of $7.17 per share, leaving approximately $135 million available for repurchase under the program as of February 20, 2025. Further repurchases under the program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated

113

Table of Contents

transactions, or by other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

Our future use of liquidity and capital will prioritize strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. In addition, we also expect to continue to repurchase or redeem outstanding debt from time to time (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise.

Genworth Holdings had $294 million and $350 million of unrestricted cash and cash equivalents as of December 31, 2024 and 2023, respectively. The decrease was principally driven by repurchases of Genworth Financial’s common stock, as well as interest payments on and repurchases of Genworth Holdings’ debt, partially offset by capital returns from Enact Holdings. The $294 million of Genworth Holdings’ cash and cash equivalents included approximately $186 million of advance cash payments from our subsidiaries held for future obligations, including $75 million for CareScout Insurance to meet the regulatory capital requirements of a new start-up insurer. We do not consider this cash when evaluating holding company liquidity for the purposes of allocating capital or computing our cash position relative to the cash management target discussed below. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months as well as in the longer term. We expect Genworth Holdings’ liquidity to continue to be impacted by the amounts and timing of Genworth Financial’s share repurchases, investments in CareScout, and future dividends and other forms of capital returns from Enact Holdings. In addition, we began paying federal income taxes in 2023, resulting in lower intercompany cash tax payments retained by Genworth Holdings from its subsidiaries in 2024 as compared to the amounts retained during recent prior years. We anticipate lower intercompany cash tax payments to be retained going forward as we utilized our remaining foreign tax credits in 2023.

We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or as a result of planned future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.

Capital resources and financing activities

Our current capital resource plans do not include any additional debt offerings by Genworth Holdings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them to meet their obligations,” and “Item 1A—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.”

During 2024 and 2023, Genworth Holdings repurchased $66 million and $32 million, respectively, principal amount of its debt. As of December 31, 2024, Genworth Holdings had $790 million aggregate principal amount of outstanding debt, with no maturities due until June 2034.

In 2024, given the current interest rate environment, Genworth Holdings entered into an interest rate swap designed to hedge the variable interest payments on $100 million aggregate principal amount of its floating rate

114

Table of Contents

junior subordinated notes due in 2066 (“2066 Notes”), locking in an approximate 5.5% fixed interest rate for a period of five years from the hedge origination date.

On May 28, 2024, Enact Holdings issued $750 million aggregate principal amount of unsecured senior notes, maturing on May 28, 2029. The 2029 Notes bear interest at an annual rate of 6.25% payable semi-annually in arrears on May 28 and November 28 of each year, which commenced on November 28, 2024. On June 3, 2024, Enact Holdings redeemed all $750 million aggregate principal amount outstanding of its 2025 Notes for a pre-tax loss of $11 million. Enact Holdings funded the redemption primarily through the net proceeds from the issuance of its 2029 Notes.

For further information about Genworth Holdings’ and Enact Holdings’ borrowings, refer to note 15 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Regulated insurance subsidiaries

Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 20 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. Based on estimated statutory results as of December 31, 2024, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $153 million in 2025 without affirmative regulatory approval. However, Enact Holdings may choose not to pay dividends in 2025 at this level as it may retain capital for future growth or to meet regulatory or other capital requirements.

Our insurance subsidiaries’ principal cash inflows from operations are derived from premiums, annuity deposits and insurance and investment product fees and other income, including commissions, cost of insurance, mortality, expense and surrender charges, contract underwriting fees, investment management fees, investment income and dividends and distributions from their subsidiaries. The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements.

For long-duration coverage products, we generally anticipate a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form 10-K. In our long-term care insurance business, we expect overall claim costs to continue to increase over time as our blocks age, with peak claim years over a decade away. For information on discounted and undiscounted expected future benefit payments, see note 8 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” We also expect renewal premiums on the in-force block of our legacy long-term care insurance business to decline over time as the block runs off and as policyholders elect benefit reductions in connection with our in-force rate actions and legal settlements; however, we expect this decline to be partially offset by future approved rate actions. As we manage our legacy U.S. life insurance subsidiaries on a standalone basis, they will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and long-term care insurance in-force rate actions to satisfy policyholder obligations.

Given the challenging macroeconomic environment in 2023 and 2024, employee costs have increased driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care due in part to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these

115

Table of Contents

conditions persist, they could have a material adverse impact on our liquidity, results of operations and financial condition. We will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity.

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2024, our total cash, cash equivalents and invested assets were $60.0 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2024.

Off-balance sheet commitments

As of December 31, 2024, we were committed to fund $1,761 million in limited partnership investments, $263 million in private placement investments, $140 million of bank loan investments and $2 million in commercial mortgage loan investments.

Genworth Holdings’ guarantees

Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. Based on the risk in-force of policies subject to the guarantee, we estimate that Genworth Holdings’ exposure under the guarantee was approximately $145 million as of December 31, 2024. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations.

Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2024, the risk in-force of active policies was approximately $766 million.

Supplemental Condensed Consolidating Financial Information

Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933), on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial.

Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in

116

Table of Contents

accordance with Rule 13-01 of Regulation S-X, we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities.

FY 2023 10-K MD&A

SEC filing source: 0001193125-24-051772.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2024-02-29. Report date: 2023-12-31.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.”

Item 7 of our Annual Report on Form
10-K
generally discusses

year-to-year

comparisons between the years ended December 31, 2023 and 2022. In addition, with the exception of our Enact segment, this Form
10-K
also includes discussions of information related to 2021 and

year-to-year

comparisons between 2022 and 2021, which have been
re-presented
to reflect the adoption of LDTI and the change in our operating segments. Detailed comparative discussions between 2022 and 2021 for our Enact segment, which was not impacted by the new accounting guidance or change in operating segments, can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” in our Annual Report on Form
10-K
for the year ended December 31, 2022.

Overview

Our business

Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage
in-force
blocks of life insurance and annuity products which are no longer sold. We report our business results through three operating business segments: Enact; Long-Term Care Insurance; and Life and Annuities. In addition to our three operating segments, we report certain of our results of operations in Corporate and Other.

Our financial information

The financial information in this Annual Report on Form
10-K
has been derived from our consolidated financial statements.

Revenues and expenses

Our revenues consist primarily of the following:

Column 1Column 2Column 3Column 4
Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance.
Column 1Column 2Column 3Column 4
Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees.

69

Table of Contents

Our expenses consist primarily of the following:

Column 1Column 2Column 3Column 4
Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense and other reserve activity related to current claims, as well as future policy benefits on insurance and investment products for long-term care insurance, life insurance, fixed and variable annuities, and claim costs incurred related to mortgage insurance products.
Column 1Column 2Column 3Column 4
Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual versus expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts.
Column 1Column 2Column 3Column 4
Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments associated with our market risk benefits.
Column 1Column 2Column 3Column 4
Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances.
Column 1Column 2Column 3Column 4
Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate corporate expenses to each of our operating segments using various methodologies.
Column 1Column 2Column 3Column 4
Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of acquisition costs that are capitalized, present value of future profits and capitalized software.
Column 1Column 2Column 3Column 4
Interest expense. Interest expense represents interest related to our borrowings that are incurred at Genworth Holdings or Enact Holdings, and certain reinsurance arrangements being accounted for as deposits.
Column 1Column 2Column 3Column 4
Provision (benefit) for income taxes. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other.

The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers.

Column 1Column 2Column 3Column 4
Net income from continuing operations attributable to noncontrolling interests. Net income from continuing operations attributable to noncontrolling interests represents the portion of income from continuing operations in a subsidiary attributable to third parties.

70

Table of Contents

Consolidated Results of Operations

The following table sets forth the consolidated results of operations for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Revenues:
Premiums$3,636$3,680$3,406$(44)(1)%$2748%
Net investment income3,1833,1463,370371%(224)(7)%
Net investment gains (losses)23(2)32225NM(1)(324)(101)%
Policy fees and other income646671724(25)(4)%(53)(7)%
Total revenues7,4887,4957,822(7)%(327)(4)%
Benefits and expenses:
Benefits and other changes in policy reserves4,7834,3034,57548011%(272)(6)%
Liability remeasurement (gains) losses587(290)242877NM(1)(532)NM(1)
Changes in fair value of market risk benefits and associated hedges(12)(104)(160)9288%5635%
Interest credited503504511(1)%(7)(1)%
Acquisition and operating expenses, net of deferrals9421,285998(343)(27)%28729%
Amortization of deferred acquisition costs and intangibles264326384(62)(19)%(58)(15)%
Interest expense1181061601211%(54)(34)%
Total benefits and expenses7,1856,1306,7101,05517%(580)(9)%
Income from continuing operations before income taxes3031,3651,112(1,062)(78)%25323%
Provision for income taxes104319248(215)(67)%7129%
Income from continuing operations1991,046864(847)(81)%18221%
Income from discontinued operations, net of taxes27%(27)(100)%
Net income1991,046891(847)(81)%15517%
Less: net income from continuing operations attributable to noncontrolling interests12313033(7)(5)%97NM(1)
Less: net income from discontinued operations attributable to noncontrolling interests8%(8)(100)%
Net income available to Genworth Financial, Inc.’s common stockholders$76$916$850$(840)(92)%$668%
Net income available to Genworth Financial, Inc.’s common stockholders:
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders$76$916$831$(840)(92)%$8510%
Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders19%(19)(100)%
Net income available to Genworth Financial, Inc.’s common stockholders$76$916$850$(840)(92)%$668%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

71

Table of Contents

Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.

Use of
non-GAAP
measures

Reconciliation of net income (loss) to adjusted operating income (loss)

Management uses
non-GAAP
financial measures entitled “adjusted operating income (loss)” and “adjusted operating income (loss) per share” to evaluate performance and allocate resources. Adjusted operating income (loss) per share is derived from adjusted operating income (loss). We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual
non-operating
items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual
non-operating
items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance.

While some of these items may be significant components of net income (loss) in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss), among other key performance indicators, as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.

72

Table of Contents

The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31:

(Amounts in millions)202320222021
Net income available to Genworth Financial, Inc.’s common stockholders$76$916$850
Add: net income from continuing operations attributable to noncontrolling interests12313033
Add: net income from discontinued operations attributable to noncontrolling interests8
Net income1991,046891
Less: income from discontinued operations, net of taxes27
Income from continuing operations1991,046864
Less: net income from continuing operations attributable to noncontrolling interests12313033
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders76916831
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)(25)2(322)
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2)(22)(142)(210)
(Gains) losses on early extinguishment of debt (3)(2)645
Expenses related to restructuring4234
Pension plan termination costs8
Taxes on adjustments102696
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$41$818$474
Column 1Column 2
(1)For the year ended December 31, 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million.
Column 1Column 2
(2)Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million for the years ended December 31, 2023, 2022 and 2021, respectively.
Column 1Column 2
(3)See note 17 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on (gains) losses on early extinguishment of debt during 2023 and 2022. During 2021, we paid pre-tax make-whole premiums of $26 million and incurred pre-tax losses of $19 million in connection with the early redemption and repurchase of certain of Genworth Holdings’ senior notes.

Other than pension plan termination costs incurred in 2022 related to one of our defined benefit pension plans, there were no infrequent or unusual items excluded from adjusted operating income during the periods presented.

73

Table of Contents

Earnings per share

The following table provides basic and diluted earnings per common share for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions, except per share amounts)2023202220212023 vs. 20222022 vs. 2021
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.16$1.82$1.64$(1.66)(91)%$0.1811%
Diluted$0.16$1.79$1.61$(1.63)(91)%$0.1811%
Net income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.16$1.82$1.68$(1.66)(91)%$0.148%
Diluted$0.16$1.79$1.65$(1.63)(91)%$0.148%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$0.09$1.62$0.93$(1.53)(94)%$0.6974%
Diluted$0.09$1.60$0.92$(1.51)(94)%$0.6874%
Weighted-average common shares outstanding:
Basic468.8504.4506.9
Diluted474.9510.9514.7

Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards.

The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Enact segment$552$578$520$(26)(4)%$5811%
Long-Term Care Insurance segment(242)320126(562)(176)%194154%
Life and Annuities segment:
Life insurance(275)(111)(201)(164)(148)%9045%
Fixed annuities506283(12)(19)%(21)(25)%
Variable annuities3721221676%(1)(5)%
Life and Annuities segment(188)(28)(96)(160)NM(1)6871%
Corporate and Other(81)(52)(76)(29)(56)%2432%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$41$818$474$(777)(95)%$34473%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

74

Table of Contents

Executive Summary of Consolidated Financial Results

Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated.
After-tax
amounts assume a tax rate of 21%.

For a discussion of selected financial information and detailed descriptions of operating performance measures, see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”

2023 compared to 2022

Column 1Column 2Column 3Column 4
Net income in 2023 and 2022 was $76 million and $916 million, respectively, and adjusted operating income was $41 million and $818 million, respectively. Adjusted operating income (loss) highlights were as follows:
Column 1Column 2Column 3Column 4
Enact segment
Column 1Column 2Column 3Column 4
Adjusted operating income decreased primarily attributable to higher losses on new delinquencies and lower favorable reserve adjustments, partially offset by higher net investment income, higher premiums and lower operating costs in 2023.
Column 1Column 2Column 3Column 4
Long-Term Care Insurance segment
Column 1Column 2Column 3Column 4
The change to an adjusted operating loss in 2023 from adjusted operating income in 2022 was largely driven by unfavorable cash flow assumption updates in 2023 compared to favorable updates in 2022.
Column 1Column 2Column 3Column 4
The change was also driven by adverse actual versus expected experience in 2023 primarily related to higher claims and unfavorable timing impacts related to a legal settlement.
Column 1Column 2Column 3Column 4
We also experienced higher operating costs and lower premiums in 2023.
Column 1Column 2Column 3Column 4
Life and Annuities segment
Column 1Column 2Column 3Column 4
Life insurance:
Column 1Column 2Column 3Column 4
The adjusted operating loss increased largely from $179 million of unfavorable updates to our persistency and mortality assumptions, as well as lower premiums reflecting runoff of our in-force blocks in 2023.
Column 1Column 2Column 3Column 4
These adverse developments were partially offset by lower DAC amortization related to higher lapses in 2022 and a $20 million legal settlement expense in 2022 that did not recur.
Column 1Column 2Column 3Column 4
Fixed annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality experience in 2023.
Column 1Column 2Column 3Column 4
Variable annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income increased predominantly due to aging of our in-force block, partially offset by a decrease in fee income driven by lower account value in 2023.

75

Table of Contents

Column 1Column 2Column 3Column 4
Corporate and Other
Column 1Column 2Column 3Column 4
The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives and higher interest expense attributable to Genworth Holdings’ junior subordinated notes, partially offset by higher net investment income in 2023.

2022 compared to 2021

Column 1Column 2Column 3Column 4
Net income in 2022 and 2021 was $916 million and $850 million, respectively, and adjusted operating income was $818 million and $474 million, respectively. Adjusted operating income (loss) highlights were as follows:
Column 1Column 2Column 3Column 4
Enact segment
Column 1Column 2Column 3Column 4
Adjusted operating income increased primarily attributable to lower losses largely driven by net favorable reserve adjustments of $212 million, consisting of reserve releases of $248 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening of $36 million related to 2022 delinquencies given uncertainty in the economic environment.
Column 1Column 2Column 3Column 4
This improvement was partially offset by the minority initial public offering of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6%.
Column 1Column 2Column 3Column 4
The improvement was also partially offset by lower premiums in 2022.
Column 1Column 2Column 3Column 4
Long-Term Care Insurance segment
Column 1Column 2Column 3Column 4
Adjusted operating income increased largely driven by favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of a legal settlement, partially offset by lower net investment income in 2022.
Column 1Column 2Column 3Column 4
Life and Annuities segment
Column 1Column 2Column 3Column 4
Life insurance:
Column 1Column 2Column 3Column 4
The adjusted operating loss decreased largely from favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 related to higher interest rates compared to unfavorable cash flow assumption updates in 2021 primarily driven by unfavorable pre-COVID-19 mortality.
Column 1Column 2Column 3Column 4
The decrease was also attributable to lower DAC amortization primarily driven by lapse experience in our term life insurance products.
Column 1Column 2Column 3Column 4
Fixed annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality in 2022.
Column 1Column 2Column 3Column 4
Corporate and Other
Column 1Column 2Column 3Column 4
The adjusted operating loss decreased primarily related to lower interest expense in 2022, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur.

76

Table of Contents

Significant Developments and Strategic Highlights

Enact segment

Column 1Column 2Column 3Column 4
Mortgage insurance portfolio. Enact’s primary persistency rate was 85% during 2023 compared to 80% during 2022. Elevated persistency continued to offset a decline in new insurance written, contributing to insurance in-force growth in 2023. New insurance written decreased 20% during 2023 compared to 2022 mostly from a decline in originations due to elevated interest rates.
Column 1Column 2Column 3Column 4
Loss performance. Enact recorded favorable pre-tax reserve releases of $241 million in 2023 primarily related to favorable cure performance on 2022 and prior delinquencies, including those related to COVID-19. New primary delinquencies in 2023 increased compared to 2022 largely due to the aging of large, new books of business.
Column 1Column 2Column 3Column 4
Capital. Enact’s PMIERs sufficiency ratio was 161% or $1,887 million above the PMIERs requirements as of December 31, 2023.
Column 1Column 2Column 3Column 4
Capital returns. Genworth Holdings received $245 million of capital returns from Enact Holdings during 2023.

Long-Term Care Insurance segment

Column 1Column 2Column 3Column 4
In-force rate actions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan from 2012 through 2023 was approximately $28.0 billion, on a net present value basis, which includes our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements as described in “Results of Operations and Selected Financial and Operating Performance Measures by Segment.” This estimated cumulative economic benefit reflects progress of approximately 84% toward our latest estimate of approximately $33.3 billion total net present value of premium increases and benefit reductions contemplated in our multi-year in-force rate action plan, which also takes into account our current updated assumptions. As a result, based on current assumptions, the remaining estimated amount to be achieved through future rate action approvals under our in-force rate action plan was reduced by $1.5 billion in 2023 to approximately $5.3 billion.
Column 1Column 2Column 3Column 4
Claims. We expect higher paid claims in our long-term care insurance business as our blocks age with peak claim years over a decade away. Paid claims on newer products continue to increase as policyholders approach peak claim age, while claims on our older products decline as those policyholders are past peak claim age. We also expect overall claim costs to continue to increase as the approximately 625,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 77 and 74, respectively, reach their peak claim years, which are over age 85.
Column 1Column 2Column 3Column 4
Actual to expected experience. Unfavorable pre-tax actual versus expected experience of $269 million in 2023 was primarily driven by higher claims and unfavorable timing impacts related to a legal settlement.
Column 1Column 2Column 3Column 4
Annual assumption review. As part of our annual review of assumptions in the fourth quarter of 2023, our long-term care insurance business had unfavorable pre-tax impacts of $61 million from cash flow assumption updates. We made unfavorable updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse rates, partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our long-term care insurance cash flow assumptions. Assumption updates also included changes for future in-force rate action approvals and benefit reductions based on recent favorable experience and reflect a recent legal settlement that primarily impacted uncapped cohorts.

Life and Annuities segment

Column 1Column 2Column 3Column 4
As part of our annual review of assumptions in the fourth quarter of 2023, our life insurance business had unfavorable pre-tax impacts of $226 million from cash flow assumption updates. We made

77

Table of Contents

Column 1Column 2
unfavorable cash flow assumption updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in our term universal, universal and term life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19, similar to long-term care insurance. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our life insurance cash flow assumptions.

Capital of U.S. life insurance subsidiaries

Column 1Column 2Column 3Column 4
As of December 31, 2023 and 2022, the consolidated RBC ratio on a company action level basis of our U.S. domiciled life insurance subsidiaries was approximately 303% and 291%, respectively. The increase was primarily driven by earnings in our annuity products, including a net benefit to variable annuities from the impact of equity market and interest rate performance, as well as a net favorable impact from assumption updates primarily in our life insurance products in 2023.

Genworth Financial share repurchase program

Column 1Column 2Column 3Column 4
Genworth Financial executed $295 million in share repurchases, excluding excise taxes and other associated costs, during 2023.

Results of Operations and Selected Financial and Operating Performance Measures by Segment

Management’s discussion and analysis by segment contains selected operating performance measures including “sales” and “insurance
in-force”
or “risk
in-force”
which are commonly used in the insurance industry as measures of operating performance.

Management regularly monitors and reports sales metrics as a measure of volume of new business generated in a period. Sales refer to new insurance written for mortgage insurance products included in our Enact segment. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of insurance policies during a specified period, rather than a measure of revenues or profitability during that period. Management also regularly monitors and reports insurance
in-force
and risk
in-force
for our Enact segment. Insurance
in-force
is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk
in-force
is based on the coverage percentage applied to the estimated current outstanding loan balance. We consider insurance
in-force
and risk
in-force
to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period. These metrics are presented on a direct basis and exclude reinsurance.

Management also regularly monitors and reports a loss ratio for our Enact segment. The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums, and we consider it to be a measure of underwriting performance and helps to enhance the understanding of the operating performance of our Enact segment.

Management regularly monitors and reports on
in-force
rate actions, including state filing approvals; impacted
in-force
premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved in our Long-Term Care Insurance segment. We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year
in-force
rate action plan on a net present value basis, discounted at our investment portfolio yield. This is defined as the net present value of historical and future expected premium increases and benefit reductions as a result of rate increases approved on individual and group long-term care insurance policies and reserve reductions related to legal settlements less

78

Table of Contents

cash payments made to policyholders who elect certain reduced benefit options in connection with the legal settlements, referred to as settlement payments. We monitor these selected operating performance measures for
in-force
rate actions to track our progress on ensuring the continued self-sustainability of our long-term care insurance business over time. We consider these
in-force
rate actions metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Long-Term Care Insurance segment.

These operating performance measures enable us to compare our operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources.

Enact segment

Trends and conditions

Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included herein “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.

Macroeconomic environment

Mortgage origination activity remained slow throughout 2023 in response to elevated mortgage rates and sustained low housing supply. Housing affordability continued to deteriorate due to high interest rates and elevated home prices, only marginally offset by rising median family income, according to the National Association of Realtors Housing Affordability Index. National home prices rose modestly throughout 2023, according to the FHFA Monthly Purchase-Only House Price Index.

The unemployment rate increased to 3.7% in December 2023, compared to 3.5% in December 2022. As of December 31, 2023, the number of unemployed Americans was approximately 6.3 million, and the number of long term unemployed over 26 weeks was approximately 1.2 million. Both metrics remain relatively in line with
pre-pandemic
levels in February 2020.

Forbearance and loss mitigation programs

For mortgages insured by the federal government (including those purchased by Fannie Mae and Freddie Mac),
COVID-19
forbearance allowed borrowers impacted by
COVID-19
to temporarily suspend mortgage payments up to 18 months subject to certain limits. However, the Biden Administration ended the national emergency for
COVID-19
in April 2023, and as a result, the deadline for requesting a
COVID-19
related forbearance under the CARES Act ended in August 2023. The GSEs retired their
COVID-19
servicing-related policies including with respect to forbearance effective November 1, 2023 and reverted to standard forbearance policies as a loss mitigation option for borrowers that meet general hardship and program guidelines.

In March 2023, the GSEs announced new loss mitigation programs that allow
six-month
payment deferrals for borrowers facing financial hardship and encouraged servicers to start evaluating borrowers for these programs as early as July 1, 2023 but no later than October 1, 2023. Even though most foreclosure moratoriums expired at the end of 2021, federal laws and regulations continue to require servicers to discuss loss mitigation options with borrowers before proceeding with foreclosures. These requirements could further extend foreclosure timelines, which could negatively impact the severity of loss on loans that go to claim.

79

Table of Contents

Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of December 31, 2023, approximately 1.2% or 11,536 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 31% were reported as delinquent.

The full impact of
COVID-19
and its associated economic effects on Enact’s future business results are difficult to predict. Given the maximum length of forbearance plans, the resolution of a delinquency in a plan still may not be known for several quarters or longer. Enact continues to monitor regulatory and government actions and the resolution of forbearance delinquencies. While the associated risks have moderated and delinquencies related to
COVID-19
have declined, it is possible that ancillary economic effects of
COVID-19
could have an adverse impact on Enact’s future results of operations and financial condition.

Regulatory developments

Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products.

On October 24, 2022, the FHFA announced targeted changes to the GSEs’ guarantee fee pricing by eliminating upfront fees for certain first-time home buyers with income at or below area median income and for certain GSE affordable mortgage products, while implementing targeted increases to the upfront fees for most
cash-out
refinance loans. The fee reductions went into effect in the fourth quarter of 2022 while the new fees on
cash-out
refinance loans began February 1, 2023. Enact has seen a limited impact from these price changes on the private mortgage insurance market.

The FHFA also announced in October 2022 its validation and approval of certain credit score models for use by the GSEs and changed the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores requires lenders to deliver both credit scores for each loan sold to the GSEs. The FHFA has announced preliminary implementation expectations, but this is expected to be a multiple year process that will require system and process updates.

In January 2023, the FHFA announced additional updates to its upfront fee structure and pricing matrix. The changes marked the third iteration of the FHFA’s ongoing pricing review since early 2022 and impact purchase and rate-term refinance loans. Pricing grids are now broken out by loan purpose and are recalibrated to new credit score and

loan-to-value

ratio categories, along with associated loan attributes. The new pricing matrix initially included new upfront fees for loans with

debt-to-income

ratios greater than 40% but those fees were rescinded prior to implementation. The remaining changes became effective May 1, 2023.

In February 2023, the Department of Housing and Urban Development announced a 30 basis point reduction of the annual insurance premium charged to borrowers with
FHA-insured
mortgages in order to reduce the cost of borrowing for eligible lower and middle class homebuyers. This price reduction, which went into effect on March 20, 2023, is expected to have a negative impact on the U.S. private mortgage insurance market but will be partially offset by the effects of the recent FHFA pricing changes referenced above. Enact does not believe this net impact has been or will be material.

Competitive environment

The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to

80

Table of Contents

manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite enabling it to write new business at returns it views as attractive.

Mortgage insurance portfolio

New insurance written of $53.1 billion in 2023 decreased 20% compared to 2022 mostly from a smaller estimated private mortgage insurance market as originations were impacted by elevated interest rates. Enact’s primary persistency rate was 85% for the year ended December 31, 2023 compared to 80% for the year ended December 31, 2022. The increase in persistency was primarily driven by a decline in the percentage of
in-force
policies with mortgage rates above current mortgage rates and offset the decline in new insurance written in 2023, contributing to an increase in insurance
in-force
of $14.7 billion during 2023.

Net earned premiums increased in 2023 compared to 2022 primarily driven by insurance
in-force
growth, partially offset by the lapse of older, higher priced policies and lower single premium policy cancellations in 2023. The total number of delinquent loans has declined from the
COVID-19
peak in the second quarter of 2020 as borrowers continued to exit forbearance plans and new forbearances declined. During this time and consistent with prior years, servicers continued the practice of remitting premiums during the early stages of default, and Enact refunds the post-delinquent premiums to the insured party if the delinquent loan goes to claim. Enact records a liability and a reduction to net earned premiums for the post-delinquent premiums it expects to refund. The post-delinquent premium liability recorded since the beginning of
COVID-19
in the second quarter of 2020 through December 31, 2023 was not significant to the change in earned premiums for those periods.

Loss experience

Enact’s loss ratio was 3% for the year ended December 31, 2023, compared to (10)% for the year ended December 31, 2022. Enact recorded favorable reserve adjustments of $241 million in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to
COVID-19.
During the peak of
COVID-19,
Enact experienced elevated new delinquencies subject to forbearance plans, and those delinquencies have continued to cure at levels above Enact’s reserve expectations. In addition, cure performance on delinquencies from 2022 has not been negatively impacted by uncertainty in the economic environment to the extent initially expected. During 2022, Enact recorded net favorable reserve adjustments of $268 million primarily related to favorable cure performance on
COVID-19
delinquencies from 2020 and 2021, partially offset by reserve strengthening on certain 2022 delinquencies.

Borrowers who have experienced a financial hardship including, but not limited to, the loss of income due to the closing of a business or the loss of a job continue to take advantage of available loss mitigation options, including forbearance programs, payment deferral options and other modifications. Loss reserves recorded on these delinquencies require a high degree of estimation due to the level of uncertainty regarding whether delinquencies in forbearance will ultimately cure or result in claim payments, as well as the timing and severity of those payments. The severity of loss on loans that do go to claim may be negatively impacted by the extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of the recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.

New primary delinquencies in 2023 increased compared to 2022 primarily due to the aging of large, new books of business. New primary delinquencies of 41,617 contributed $265 million of loss expense in 2023, while Enact incurred $171 million of losses from 35,996 new primary delinquencies in 2022. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and

81

Table of Contents

prospective economic conditions. Approximately 13% of Enact’s primary new delinquencies in 2023 were subject to a forbearance plan compared to 21% in 2022. Due to the declining number of new delinquencies in forbearance, Enact no longer differentiates the expected claim rates applied to new delinquencies in forbearance versus those not in forbearance.

Capital requirements

As of December 31, 2023, EMICO’s

risk-to-capital

ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 11.6:1, compared with a

risk-to-capital

ratio of 12.9:1 as of December 31, 2022. EMICO’s

risk-to-capital

ratio remains below the NCDOI’s maximum

risk-to-capital

ratio of 25:1. North Carolina’s calculation of

risk-to-capital

excludes the risk
in-force
for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing

risk-to-capital

ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.

Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. In addition, in September 2020, subsequent to the issuance of Enact Holdings’ senior notes due in 2025, the GSEs imposed certain restrictions on Enact with respect to capital. In May 2021, in connection with their conditional approval of the then potential partial sale of Enact Holdings, the GSEs confirmed the GSE Restrictions would remain in effect until certain conditions were met. These conditions were met as of December 31, 2022, and Enact is no longer subject to the GSE Restrictions and the GSE Conditions.

As of December 31, 2023, Enact had estimated available assets of $5,006 million against $3,119 million net required assets under PMIERs compared to available assets of $5,206 million against $3,156 million net required assets as of December 31, 2022. The sufficiency ratio as of December 31, 2023 was 161% or $1,887 million above the PMIERs requirements, compared to 165% or $2,050 million above the published PMIERS requirements as of December 31, 2022. Enact’s PMIERs required assets as of December 31, 2023 and 2022 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain
non-performing
loans. The application of the 0.30 multiplier to all eligible delinquencies provided $73 million and $132 million of benefit to Enact’s PMIERs required assets as of December 31, 2023 and 2022, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier.

During 2023, Enact executed excess of loss reinsurance transactions that provide up to $428 million of reinsurance coverage on a portion of its new insurance written for the 2022 and 2023 book years. Enact also executed a quota share reinsurance agreement under which it cedes 16.125% of a portion of new insurance written in the 2023 book year. Enact’s third-party reinsurance transactions provided an aggregate of approximately $1,714 million and $1,578 million of PMIERs capital credit as of December 31, 2023 and 2022, respectively.

On January 3, 2024, Enact entered into a quota share reinsurance agreement under which it will cede approximately 21% of a portion of its new insurance written in the 2024 book year. On January 30, 2024, Enact executed an excess of loss reinsurance transaction which provides up to $255 million of reinsurance coverage on a portion of current and expected new insurance written for the 2024 book year, effective January 1, 2024. See note 9 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on Enact’s reinsurance transactions.

Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.

82

Table of Contents

Capital returns and other transactions

In April 2023 and November 2023, EMICO completed distributions to Enact Holdings that support its ability to pay a quarterly dividend. Enact Holdings intends to use these proceeds and future EMICO distributions to fund the quarterly dividend as well as to bolster its financial flexibility and potentially return additional capital to shareholders. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition to Enact’s quarterly dividend program, in November 2022, Enact Holdings announced approval by its board of directors of a share repurchase program under which it could repurchase up to $75 million of its outstanding common stock, and on August 1, 2023, announced the authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. As the majority shareholder, Genworth Holdings received $245 million of capital returns from Enact Holdings during 2023 comprised of $82 million of quarterly dividends, a special dividend of $92 million and $71 million of share repurchases.

In May 2023, EMICO contributed $250 million to Enact Re, which enabled Enact Re to participate in the assumption of excess of loss reinsurance relating to GSE credit risk transfer and to reinsure EMICO’s new and existing insurance in-force under quota share reinsurance agreements. EMICO contributed an additional $250 million to Enact Re in November 2023, which will support an increase to the ceding percentage of affiliate quota share agreements, along with assumed new insurance written and new business opportunities, including the continued execution of GSE credit risk transfer.

Returning capital to shareholders, balanced with growth and risk management priorities, remains a key commitment for Enact Holdings, as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, including: supporting its existing policyholders; growing its mortgage insurance business; funding attractive new business opportunities; and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.

83

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 2022
Revenues:
Premiums$957$940$975$172%
Net investment income2081551415334%
Net investment gains (losses)(14)(2)(2)(12)NM(1)
Policy fees and other income224%
Total revenues1,1531,0951,118585%
Benefits and expenses:
Benefits and other changes in policy reserves27(94)125121129%
Acquisition and operating expenses, net of deferrals212227230(15)(7)%
Amortization of deferred acquisition costs and intangibles111215(1)(8)%
Interest expense525251%
Total benefits and expenses30219742110553%
Income from continuing operations before income taxes851898697(47)(5)%
Provision for income taxes186194148(8)(4)%
Income from continuing operations665704549(39)(6)%
Less: net income from continuing operations attributable to noncontrolling interests12313033(7)(5)%
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders542574516(32)(6)%
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (2)122210NM(1)
Expenses related to restructuring33(3)(100)%
Taxes on adjustments(2)(1)(1)(1)(100)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$552$578$520$(26)(4)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million.

2023 compared to 2022

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income decreased primarily attributable to higher losses on new delinquencies and lower favorable reserve adjustments, partially offset by higher net investment income, higher premiums and lower operating costs in 2023.

Revenues

Premiums increased mostly from higher insurance
in-force,
partially offset by the lapse of older, higher priced policies, lower single premium policy cancellations and higher ceded premiums in 2023.

Net investment income increased primarily from higher investment yields and higher average invested assets in 2023.

84

Table of Contents

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves increased largely from higher losses on new delinquencies and lower favorable reserve adjustments in 2023. Enact released $241 million of reserves in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to
COVID-19,
compared to net favorable reserve adjustments of $268 million in 2022.

Acquisition and operating expenses, net of deferrals, decreased primarily attributable to lower operating costs in 2023.

Provision for income taxes.

The effective tax rate was 21.8% and 21.6% for the years ended December 31, 2023 and 2022, respectively, consistent with the U.S. corporate federal income tax rate.

Enact selected operating performance measures

The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 2022
Primary insurance in-force$262,937$248,262$226,514$14,6756%
Risk in-force:
Primary$67,529$62,791$56,881$4,7388%
Pool6979105(10)(13)%
Total risk in-force$67,598$62,870$56,986$4,7288%
New insurance written$53,081$66,485$97,004$(13,404)(20)%

2023 compared to 2022

Primary insurance
in-force
and risk
in-force

Primary insurance
in-force
increased largely from new insurance written. In addition, lower lapses and cancellations drove higher primary persistency, largely as a result of suppressed refinancing activity due to a decline in the percentage of
in-force
policies with mortgage rates above current mortgage rates. Total risk
in-force
increased largely from higher primary insurance
in-force.

New insurance written

New insurance written decreased primarily due to a smaller estimated private mortgage insurance market in 2023 as both refinancing and purchase originations were impacted by elevated mortgage rates.

Loss and expense ratios

The following table sets forth the loss and expense ratios for Enact for the dates indicated:

Years ended December 31,Increase (decrease)
2023202220212023 vs. 2022
Loss ratio3%(10)%13%13%
Expense ratio23%25%25%(2)%

85

Table of Contents

The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles.

2023 compared to 2022

The loss ratio increased largely from higher losses on new delinquencies and lower favorable reserve adjustments in 2023, as discussed above.

The expense ratio decreased primarily attributable to lower operating costs in 2023.

86

Table of Contents

Mortgage insurance loan portfolio

The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31:

(Amounts in millions)202320222021
Primary insurance in-force by loan-to-value ratio at origination:
95.01% and above$44,955$39,509$35,455
90.01% to 95.00%109,227103,61895,149
85.01% to 90.00%77,88772,13264,549
85.00% and below30,86833,00331,361
Total$262,937$248,262$226,514
Primary risk in-force by loan-to-value ratio at origination:
95.01% and above$12,878$11,136$9,907
90.01% to 95.00%31,78130,07927,608
85.01% to 90.00%19,16317,62115,644
85.00% and below3,7073,9553,722
Total$67,529$62,791$56,881
Primary insurance in-force by credit quality at origination:
Over 760$110,635$102,467$89,982
740—75943,05340,09735,874
720—73937,02034,91631,730
700—71929,76628,86727,359
680—69921,83521,55421,270
660—679(1)11,35710,92610,549
640—6596,1376,0956,124
620—6392,5042,6302,783
620630710843
Total$262,937$248,262$226,514
Primary risk in-force by credit quality at origination:
Over 760$28,363$25,807$22,489
740—75911,09610,1549,009
720—7399,6218,9318,055
700—7197,6237,3176,907
680—6995,5575,4285,334
660—679(1)2,9082,7672,638
640—6591,5651,5401,530
620—639635665702
620161182217
Total$67,529$62,791$56,881
Column 1Column 2
(1)Loans with unknown FICO scores are included in the 660-679 category.

The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance
in-force
was 744 as of December 31, 2023.

Delinquent loans and claims

Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an

87

Table of Contents

amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31:

202320222021
Primary insurance:
Insured loans in-force974,516960,306937,350
Delinquent loans20,43219,94324,820
Percentage of delinquent loans (delinquency rate)2.10%2.08%2.65%

The delinquency rate as of December 31, 2023 increased compared to December 31, 2022 primarily from an increase in total delinquencies mostly driven by new delinquencies outpacing cures and paid claims. The delinquency rate as of December 31, 2023 decreased compared to December 31, 2021 primarily from a decline in total delinquencies as cures outpaced new delinquencies.

The following tables set forth primary delinquencies, direct primary case reserves and risk
in-force
by aged missed payment status in Enact’s loan portfolio as of December 31:

2023
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less10,166$88$62914%
4 – 11 payments6,93420546944%
12 payments or more3,33218420092%
Total20,432$477$1,29837%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
2022
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less8,920$69$50914%
4 – 11 payments6,46616639043%
12 payments or more4,55724424898%
Total19,943$479$1,14742%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Reserves as a percentage of risk
in-force
as of December 31, 2023 decreased compared to December 31, 2022 as long-term delinquencies with higher reserves have continued to cure. The number of loans that are delinquent for 12 months or more has decreased since December 31, 2022 and is more in line with

pre-COVID-19

levels. Due to continued forbearance options, foreclosure moratoriums and the uncertainty

88

Table of Contents

around the lack of progression through the foreclosure process, there is still uncertainty around the likelihood and timing of delinquencies going to claim.

Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk
in-force
as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender.

Percent of primary risk in-force as of December 31, 2023Percent of direct primary case reserves as of December 31, 2023(1)Delinquency rate as of December 31,
202320222021
By State:
California13%12%2.22%2.09%3.17%
Texas8%8%2.22%2.12%2.89%
Florida(2)8%9%2.39%2.54%2.97%
New York(2)5%12%3.05%2.95%3.80%
Illinois(2)4%6%2.61%2.54%3.09%
Arizona4%3%1.93%1.78%2.31%
Michigan4%3%1.94%1.79%1.87%
Georgia3%4%2.23%2.23%2.94%
North Carolina3%2%1.56%1.59%2.18%
Washington3%2%1.77%1.92%2.98%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
Column 1Column 2
(2)Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed.
Percent of primary risk in-force as of December 31, 2023Percent of direct primary case reserves as of December 31, 2023(1)Delinquency rate as of December 31,
202320222021
By MSA or MD:
Phoenix, AZ MSA3%2%2.01%1.83%2.36%
Chicago-Naperville, IL MD3%4%2.88%2.84%3.68%
Atlanta, GA MSA3%3%2.40%2.42%3.28%
New York, NY MD2%7%3.60%3.75%5.32%
Washington-Arlington, DC MD2%2%2.01%1.85%2.96%
Houston, TX MSA2%3%2.67%2.60%3.61%
Los Angeles-Long Beach, CA MD2%3%2.39%2.18%3.95%
Dallas, TX MD2%2%1.92%1.86%2.31%
Riverside-San Bernardino, CA MSA2%3%2.83%2.89%3.42%
Denver-Aurora-Lakewood, CO MSA2%1%1.12%1.12%1.66%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout

89

Table of Contents

specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance,
pre-foreclosure
sale and

deed-in-lieu.

These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts.

The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance
in-force
and risk
in-force
by year of policy origination, weighted average mortgage interest rate and delinquency rate as of December 31, 2023:

(Amounts in millions)Weighted average rate (1)Percent of direct primary case reserves(2)Primary insurance in-forcePercent of totalPrimary risk in-forcePercent of totalDelinquency rate
Policy Year
2008 and prior5.74%18%$5,6212%$1,4492%8.61%
2009 to 20154.34%43,383188114.55%
20163.94%44,65921,24823.20%
20174.30%55,32121,40323.59%
20184.82%65,75021,47624.42%
20194.25%813,77353,54452.77%
20203.27%1544,4861711,697171.70%
20213.11%2170,0452717,846271.65%
20224.89%1659,2672314,907221.57%
20236.68%350,6321913,078200.47%
Total portfolio4.41%100%$262,937100%$67,529100%2.10%
Column 1Column 2
(1)Average annual mortgage interest rate weighted by insurance in-force.
Column 1Column 2
(2)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk
in-force.
The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. Loss reserves have shifted to newer book years, largely 2020 and later given their significant representation of risk
in-force.
As of December 31, 2023, Enact’s 2016 and newer policy years represented approximately 97% of its primary risk
in-force
and 78% of its total direct primary case reserves.

The ratio of the claim paid to the current risk
in-force
for a loan is referred to as “claim severity.” The current risk
in-force
is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws.
Pre-foreclosure
sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 97%, 94% and 103% for the years ended December 31, 2023, 2022 and 2021, respectively. The average claim severity for the years ended December 31, 2023 and 2022 was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on
non-performing
loans.

Long-Term Care Insurance segment

Trends and conditions

The long-term profitability of our long-term care insurance business depends upon how our actual experience compares with our valuation assumptions, including but not limited to
in-force
rate actions,

90

Table of Contents

morbidity, mortality and persistency. Estimates for
in-force
rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance business are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, could also impact our long-term care insurance business either positively or negatively.

Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments as our actual claims experience will emerge over many years, or decades. For example, average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on our oldest long-term care insurance blocks of business will continue to decrease as the blocks run off, we are gaining more experience on our larger new blocks of business and fully expect continued overall growth in new claims as policyholders reach their peak claim years. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. Increases in cost of care have resulted in higher claim payments in our long-term care insurance business, which could have a material adverse impact on our liquidity, results of operations and financial condition if it persists. We will continue to monitor our experience and make changes to our assumptions and methodologies, as appropriate, for our long-term care insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.

Under LDTI, the impacts of assumption updates and actual versus expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. It is important to note that quarterly variations resulting from assumption updates and actual versus expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $42.2 billion, at the
locked-in
discount rate, for our long-term care insurance business as of December 31, 2023.

For a discussion of potential impacts of assumption updates and actual versus expected experience on our results of operations, see “Item 1A—Risk Factors—We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition.”

The financial condition of our long-term care insurance business is also impacted by interest rates. We remeasure our liability for future policy benefits and related reinsurance recoverables at the
single-A
bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued volatility to our reserve balances and equity. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.”

In-force
rate actions and legal settlements

Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium rate increases and associated benefit reductions on our
in-force
policies. Executing on our multi-year long-term care insurance
in-force
rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on
in-force
rate actions, refer to the selected operating performance measures below.

91

Table of Contents

In addition, we have reached certain legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. The first legal settlement related to certain of our long-term care insurance policies, which represents approximately 20% of our block, was implemented beginning in 2021 and its implementation was materially completed in the second quarter of 2022. A second legal settlement on certain of our long-term care insurance policies, which represents 15% of our block, was implemented beginning in August 2022 and its implementation was materially completed in the fourth quarter of 2023. On March 27, 2023, a third similar settlement on certain of our long-term care insurance policies, which represents 35% of our block, became final. We began implementation of this settlement during the second quarter of 2023.

While the legal settlements are similar, their ultimate impact will depend on the policyholder election rates and the types of reduced benefits elected. Given our experience with the first and second settlements, we expect the third legal settlement to result in an overall net favorable economic impact to our long-term care insurance business as it reduces tail risk on these long-duration liabilities. While we expect renewal premiums to decline over time, the settlements could accelerate that decline if policyholders continue to elect
non-forfeiture
and reduced benefit options, which have predominantly been the most prevalent policyholder elections for these legal settlements and which entitle the policyholder to reduced benefits in exchange for premiums already paid or a lower level of future premiums.

Fourth quarter assumption review

In the fourth quarter of 2023, our long-term care insurance products had an unfavorable
pre-tax
impact of $61 million from cash flow assumption updates, including updates to our healthy life assumptions to better reflect near-term experience for cost of care, mortality, incidence and lapse. For our 2023 assumption updates, we generally did not include data after 2019 in setting any long-term assumptions, as we do not have sufficient information around longer-term effects of the pandemic, which is consistent with the approach for our 2022 assumptions. However, we made a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and did not make significant changes to our multi-year
in-force
rate action plan. However, we did increase our assumption for future approvals and benefit reductions given our current plans for rate increase filings and our historical experience regarding approvals and regulatory support, as well as benefit reductions and legal settlement results. We also updated our assumptions for the third legal settlement in the fourth quarter of 2023; however, the changes had a muted favorable income statement impact as this settlement impacts profitable uncapped cohorts.

In the fourth quarter of 2022, our long-term care insurance business had favorable assumption updates of $303 million, which reflected an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. This settlement primarily impacts older, unprofitable capped cohorts; therefore, it had an immediate impact to the fourth quarter of 2022 earnings.

Under statutory accounting, only changes to our claim reserve assumptions are reflected in statutory income. Assumption changes impacting active life reserves are included in cash flow testing margin, which only impacts statutory income if the margin falls below zero. We completed statutory cash flow testing for our life insurance subsidiaries in the fourth quarter of 2023 and concluded that the margin in GLIC was positive and within the $0.5 billion to $1.0 billion range. However, GLICNY had a negative margin and recorded additional statutory reserves of $87 million in 2023.

COVID-19
impacts

In our long-term care insurance products, we experienced a favorable impact on reserves and our operating results related to elevated mortality during
COVID-19.
Although it is not our practice to track cause of death for long-term care insurance policyholders and claimants, we believe the favorable mortality in our long-term care

92

Table of Contents

insurance business in early 2022 was likely impacted by
COVID-19.
We expected the impacts to be temporary, with disabled life mortality remaining elevated over the near term. We saw mortality levels trending back to
pre-pandemic
levels in the latter half of 2022. In the first quarter of 2023, we experienced typical seasonally favorable mortality, but mortality was unfavorable for the remainder of 2023, consistent with seasonal trends.

We also experienced lower than expected new claims incidence in our long-term care insurance business during
COVID-19.
However, we are seeing new claims incidence trending back to
pre-pandemic
levels. In addition, during the pandemic, a larger share of our claimants sought home care instead of facility-based care, and as the impacts of the pandemic subside, we have seen that trend reverse. We will continue to monitor long-term care insurance benefit utilization so that we can evaluate any long-term impact emerging from the pandemic.

While the longer-term impacts of
COVID-19
are very difficult to predict, the related outcomes and impact on our long-term care insurance business currently depend on the after-effects indirectly caused by the pandemic, including elevated inflation, the associated impacts to the cost of care and changes in policyholder behavior. We will continue to monitor
COVID-19
associated impacts and evaluate all of our assumptions that may need updating as a result of longer-term trends related to the pandemic.

93

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Long-Term Care Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Revenues:
Premiums$2,463$2,500$2,561$(37)(1)%$(61)(2)%
Net investment income1,9141,9002,027141%(127)(6)%
Net investment gains (losses)1141925795NM(1)(238)(93)%
Policy fees and other income1— %(1)(100)%
Total revenues4,4914,4194,846722%(427)(9)%
Benefits and expenses:
Benefits and other changes in policy reserves3,8023,7883,80814— %(20)(1)%
Liability remeasurement (gains) losses321(317)68638NM(1)(385)NM(1)
Acquisition and operating expenses, net of deferrals452413451399%(38)(8)%
Amortization of deferred acquisition costs and intangibles717476(3)(4)%(2)(3)%
Total benefits and expenses4,6463,9584,40368817%(445)(10)%
Income (loss) from continuing operations before income taxes(155)461443(616)(134)%184%
Provision (benefit) for income taxes(3)125123(128)(102)%22%
Income (loss) from continuing operations(152)336320(488)(145)%165%
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses(114)(19)(257)(95)NM(1)23893%
Expenses related to restructuring(1)121100%(13)(108)%
Taxes on adjustments2445120NM(1)(47)(92)%
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$(242)$320$126$(562)(176)%$194154%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2023 compared to 2022

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

The change to an adjusted operating loss in 2023 from adjusted operating income in 2022 was largely driven by unfavorable cash flow assumption updates in 2023 compared to favorable updates in 2022. The change was also driven by adverse actual versus expected experience in 2023 primarily related to higher claims and unfavorable timing impacts related to the second legal settlement. We also experienced higher operating costs and lower premiums in 2023.

Revenues

Premiums decreased primarily driven by lower renewal premiums from policy terminations and policies entering
paid-up
status, partially offset by $70 million of higher premiums from newly implemented
in-force
rate actions in 2023.

94

Table of Contents

Net investment income increased largely due to higher investment yields and higher income from limited partnerships and bank loans, partially offset by lower income from U.S. Government Treasury Inflation Protected Securities (“TIPS”). The increase was also partially offset by lower income from bond calls and commercial mortgage loan prepayments in 2023.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves increased primarily due to aging of the
in-force
block, including higher interest accretion, as well as higher loss adjustment expenses, partially offset by policy terminations in 2023.

The liability remeasurement loss in 2023 was largely driven by adverse actual versus expected experience primarily related to higher claims and unfavorable timing impacts from the second legal settlement. In addition, cash flow assumption updates were unfavorable in 2023 primarily driven by unfavorable updates to our healthy life assumptions to better reflect near-term experience related to cost of care, mortality, incidence and lapse. This was partially offset by a favorable update to our disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
The liability remeasurement gain in 2022 resulted primarily from favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement.

Acquisition and operating expenses, net of deferrals, increased principally from higher operating costs, partially offset by a lower accrual for legal settlement costs in 2023.

Provision (benefit) for income taxes.

The effective tax rate was 2.2% and 27.2% for the years ended December 31, 2023 and 2022, respectively. The decrease in the effective tax rate was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income in relation to a
pre-tax
loss in 2023.

2022 compared to 2021

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income increased largely driven by favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement, partially offset by lower net investment income in 2022.

Revenues

Premiums decreased primarily driven by lower renewal premiums from policy terminations and policies entering
paid-up
status, partially offset by $93 million of higher premiums from newly implemented
in-force
rate actions in 2022.

Net investment income decreased largely from lower income of $169 million in 2022 mostly attributable to limited partnerships, as well as bond calls and commercial mortgage loan prepayments. The decrease was partially offset by higher income of $18 million from TIPS and higher average invested assets in 2022.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

95

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves decreased primarily due to policy terminations, partially offset by aging of the
in-force
block, including higher interest accretion, as well as higher loss adjustment expenses in 2022.

The liability remeasurement gain in 2022 was largely related to favorable cash flow assumption updates reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement. The liability remeasurement loss in 2021 was primarily driven by unfavorable cash flow assumption updates largely related to an update to the benefit utilization trend to reflect expected future increases in cost of care, which drove significant updates to the
in-force
rate action plan and related assumptions. The unfavorable assumption updates in 2021 were partially offset by favorable actual to expected experience related to claim terminations and
in-force
rate actions.

Acquisition and operating expenses, net of deferrals, decreased principally from lower operating costs in 2022 and restructuring costs of $12 million in 2021 that did not recur, partially offset by a $20 million accrual for legal settlement costs in 2022.

Provision (benefit) for income taxes.

The effective tax rate was 27.2% and 27.9% for the years ended December 31, 2022 and 2021, respectively.

Long-Term Care Insurance selected operating performance measures

Under LDTI, we now include expectations for benefit reductions related to
in-force
rate actions and legal settlements as well as settlement payments in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. There was no change in how we recognize premiums related to
in-force
rate actions due to the adoption of LDTI.

We have experienced and may continue to experience quarterly fluctuations in earnings related to the legal settlements to the extent actual experience deviates from our assumptions. However, we expect the legal settlements to result in an overall net favorable economic impact to our long-term care insurance business as they reduce tail risk on these long-duration liabilities.

Under LDTI, we elected to update the net premium ratio quarterly for actual versus expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions and settlement payments will be reflected in liability remeasurement (gains) losses in our operating results on a quarterly basis.

Remeasurement (gains) losses

The following table sets forth the
pre-tax
components of the liability remeasurement (gains) losses for the periods indicated:

Years ended December 31(Increase) decrease and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Cash flow assumption updates$52$(335)$227$387116%$(562)NM(1)
Actual to expected experience26918(159)251NM(1)177111%
Total liability remeasurement (gains) losses$321$(317)$68$638NM(1)$(385)NM(1)
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

96

Table of Contents

For additional discussion of the change in liability remeasurement (gains) losses, see the comparison for this line item above in “—Segment results of operations.”

In-force
rate actions

As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to ensure the continued self-sustainability of our long-term care insurance business over time and reduce the strain on its earnings and capital.

The following table sets forth filing approvals as part of our multi-year
in-force
rate action plan for the years ended December 31:

(Dollar amounts in millions)202320222021
State filings approved117139173
Impacted in-force premiums$697$1,143$1,095
Weighted-average percentage rate increase approved51%48%37%
Gross incremental premiums approved$354$549$403

We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year
in-force
rate action plan from 2012 through December 31, 2023 was approximately $28.0 billion, on a net present value basis, which includes our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements. The $28.0 billion net present value of progress achieved has grown significantly since December 31, 2022, including $2.0 billion of value from rate action approvals and settlement implementations in 2023 and an increase of $2.5 billion of the value of benefit reductions connected with our previously achieved rate actions and settlements, including the impact of our assumption updates.

During the year ended December 31, 2023, we also submitted 144 new filings on approximately $989 million in annualized
in-force
premiums.

The approval process for
in-force
rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.

We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider litigation against states that decline to approve those actuarially justified rate increases. In January 2022, we began litigation with two states that have refused to approve actuarially justified rate increases.

Life and Annuities segment

Trends and conditions

Many factors can affect the results of our life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our life insurance and annuity products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the

97

Table of Contents

past have had, material impacts on our reserve levels, results of operations and financial condition. Results of our life insurance and annuity products depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves.

Results of our life insurance and annuity products are also impacted by interest rates. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability.”

Life insurance

Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors.

Mortality levels may deviate each period from historical trends. Overall mortality experience was less unfavorable during 2023 as compared to 2022. In our life insurance products,
COVID-19
deaths significantly declined during 2023 from the levels in 2022. We have experienced unfavorable mortality compared to our then-current and
priced-for
assumptions in recent years for our universal life insurance block. We have also been experiencing higher mortality related charges resulting in an increase in rates charged by our reinsurance partners reflecting natural block aging and unfavorable mortality compared to expectations.

In the fourth quarter of 2023, our life insurance products had an unfavorable impact from cash flow assumption updates of $226 million reflecting updates to our persistency and mortality assumptions. We made an unfavorable update to our persistency assumptions particularly in certain universal life insurance products with secondary guarantees to better reflect emerging experience, consistent with others in the industry. However, given the relatively small size and characteristics of our closed block, we believe we experienced a smaller impact from our assumption updates relative to others in the industry with larger blocks. We also made unfavorable updates to our mortality assumption in our term universal, universal and term life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
Our 2023 assumption review considered trends during the pandemic years, but updates to our long-term assumptions generally excluded experience data after 2019, as we do not have sufficient information around the long-term effects of
COVID-19.
However, similar to our long-term care insurance products, we assessed near-term mortality trends as we continue to evaluate the long-term implications of
COVID-19.

In 2022, we made favorable cash flow assumption updates of $37 million in our universal and term universal life insurance products primarily related to higher interest rates.

Certain of our universal life insurance products with secondary guarantees are subject to additional reserves on a statutory basis using a regulatory prescribed reinvestment rate. Given the increase in rates, we experienced a favorable benefit from the reinvestment rate in 2023, which more than offset negative assumption updates from a statutory income perspective.

Fixed annuities

Results of our fixed annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels.

We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.

98

Table of Contents

As part of our fourth quarter of 2023 review of our cash flow assumptions, we focused on mortality and lapse assumptions in our fixed annuity products and made modest updates based on recent experience.

For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.

Variable annuities

Results of our variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our variable annuity products can significantly impact our regulatory capital requirements, distributable earnings and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate the impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.

Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity and interest rate market performance and volatility could result in additional gains or losses in these products although associated hedging activities are expected to partially mitigate these impacts.

99

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Life and Annuities segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Revenues:
Premiums$207$234$(136)$(27)(12)%$370NM(1)
Net investment income1,0421,0831,195(41)(4)%(112)(9)%
Net investment gains (losses)(49)(4)74(45)NM(1)(78)(105)%
Policy fees and other income646669718(23)(3)%(49)(7)%
Total revenues1,8461,9821,851(136)(7)%1317%
Benefits and expenses:
Benefits and other changes in policy reserves96362064834355%(28)(4)%
Liability remeasurement (gains) losses26627174239NM(1)(147)(84)%
Changes in fair value of market risk benefits and associated hedges(12)(104)(160)9288%5635%
Interest credited503504511(1)%(7)(1)%
Acquisition and operating expenses, net of deferrals213604233(391)(65)%371159%
Amortization of deferred acquisition costs and intangibles181240291(59)(25)%(51)(18)%
Total benefits and expenses2,1141,8911,69722312%19411%
Income (loss) from continuing operations before income taxes(268)91154(359)NM(1)(63)(41)%
Provision (benefit) for income taxes(59)1630(75)NM(1)(14)(47)%
Income (loss) from continuing operations(209)75124(284)NM(1)(49)(40)%
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses494(74)45NM(1)78105%
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(2)(22)(142)(210)12085%6832%
Expenses related to restructuring(1)51100%(6)(120)%
Pension plan termination costs8(8)(100)%8NM(1)
Taxes on adjustments(6)2859(34)(121)%(31)(53)%
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(188)$(28)$(96)$(160)NM(1)$6871%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)For the years ended December 31, 2023, 2022 and 2021, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(10) million, $(38) million and $(50) million, respectively.

100

Table of Contents

The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Life and Annuities segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage changeIncrease (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Life insurance$(275)$(111)$(201)$(164)(148)%$9045%
Fixed annuities506283(12)(19)%(21)(25)%
Variable annuities3721221676%(1)(5)%
Total adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(188)$(28)$(96)$(160)NM(1)$6871%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2023 compared to 2022

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance products increased largely from $179 million of unfavorable updates to our persistency and mortality assumptions, as well as lower premiums reflecting runoff of our in-force blocks in 2023. These adverse developments were partially offset by lower DAC amortization related to higher lapses in 2022 and a $20 million legal settlement expense in 2022 that did not recur.
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuity products decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality experience in 2023.
Column 1Column 2Column 3Column 4
Adjusted operating income in our variable annuity products increased predominantly due to aging of our in-force block, partially offset by a decrease in fee income driven by lower account value in 2023.

Revenues

Premiums

. The decrease was driven by our life insurance products largely due to the continued runoff of our
in-force
blocks in 2023.

Net investment income

.

The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products, partially offset by higher investment yields in 2023.

Net investment gains (losses)

. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Policy fees and other income.

The decrease was principally from lower fee income due mostly to a decline in average account value in our variable annuity products and from lower product charges in our life insurance products due to the runoff of our
in-force
blocks in 2023.

Benefits and expenses

Benefits and other changes in policy reserves

Column 1Column 2Column 3Column 4
Our fixed annuity products increased $352 million primarily from a third-party recapture of $372 million of certain single premium immediate annuity contracts in 2022 that did not recur, partially offset by favorable mortality in 2023.

101

Table of Contents

Column 1Column 2Column 3Column 4
Our life insurance products decreased $11 million primarily from less unfavorable mortality, partially offset by an increase in cost of reinsurance reserves related to a ceded reinsurance transaction in the fourth quarter of 2023.

Liability remeasurement (gains) losses

. The increase in the liability remeasurement loss was largely attributable to a $244 million increase in our life insurance products principally driven by unfavorable updates to our persistency assumptions for certain universal life insurance products with secondary guarantees and unfavorable mortality updates, including more modest mortality improvement, in our term universal, universal and term life insurance products. The unfavorable assumption updates were partially offset by net favorable impacts related to a ceded reinsurance transaction in the fourth quarter of 2023.

Changes in fair value of market risk benefits and associated hedges

Column 1Column 2Column 3Column 4
Our variable annuity products had an unfavorable variance of $50 million principally driven by higher derivative losses and lower interest rate increases, partially offset by favorable equity market impacts as well as lower attributed fees and higher benefit payments due to aging of our in-force block in 2023.
Column 1Column 2Column 3Column 4
Our fixed annuity products had an unfavorable variance of $42 million primarily attributable to lower interest rate increases, partially offset by favorable equity market impacts in 2023.

Acquisition and operating expenses, net of deferrals

Column 1Column 2Column 3Column 4
Our fixed annuity products decreased $363 million primarily due to a payment of $365 million in 2022 related to the recapture of certain single premium immediate annuity contracts by a third party.
Column 1Column 2Column 3Column 4
Our life insurance products decreased $23 million primarily due to a legal settlement expense of $25 million and pension plan termination costs of $8 million in 2022 that did not recur. These decreases were partially offset by higher costs associated with an outsourcing arrangement in 2023.

Amortization of deferred acquisition costs and intangibles.

The decrease was primarily related to our life insurance products largely due to higher lapses in 2022 as our
20-year
level premium period business written in 2002 entered its post-level premium period.

Provision for income taxes.

The effective tax rate was 22.1% and 18.2% for the years ended December 31, 2023 and 2022, respectively. The increase in the effective tax rate was primarily attributable to tax benefits from tax favored items in relation to a
pre-tax
loss in 2023.

2022 compared to 2021

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance products decreased largely from favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 related to higher interest rates compared to unfavorable cash flow assumption updates in 2021 primarily driven by unfavorable pre-COVID-19 mortality. The decrease was also attributable to lower DAC amortization primarily driven by lapse experience in our term life insurance products.
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuity products decreased mainly attributable to lower net spreads primarily related to block runoff, partially offset by favorable mortality in 2022.
Column 1Column 2Column 3Column 4
Adjusted operating income in our variable annuity products was relatively flat in 2022 compared to 2021.

Revenues

Premiums

. The increase was driven by our life insurance products largely due to lower ceded premiums, partially offset by the continued runoff of our
in-force
blocks in 2022. In 2021, we ceded $360 million of certain term life insurance premiums in connection with a reinsurance transaction.

102

Table of Contents

Net investment income

.

The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products, as well as lower bond calls and commercial mortgage loan prepayments in 2022.

Net investment gains (losses)

. For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Policy fees and other income.

The decrease was principally from lower product charges in our life insurance products driven mostly by the runoff of our
in-force
blocks and lower fee income in our variable annuity products driven mostly by a decline in average account value in 2022.

Benefits and expenses

Benefits and other changes in policy reserves

Column 1Column 2Column 3Column 4
Our fixed annuity products decreased $395 million primarily from a third-party recapture of $372 million of certain single premium immediate annuity contracts and from favorable mortality in 2022.
Column 1Column 2Column 3Column 4
Our life insurance products increased $352 million primarily from higher ceded reinsurance in 2021, partially offset by favorable mortality experience in 2022. We ceded $360 million of certain term life insurance reserves in connection with a reinsurance transaction in 2021.
Column 1Column 2Column 3Column 4
Our variable annuity products increased $15 million primarily from unfavorable equity market performance and aging of the in-force block in 2022.

Liability remeasurement (gains) losses

Column 1Column 2Column 3Column 4
The liability remeasurement loss in our life insurance products decreased $117 million mainly attributable to favorable cash flow assumption updates in our universal and term universal life insurance products in 2022 compared to unfavorable updates in 2021. The favorable cash flow assumption updates in 2022 were primarily related to higher interest rates. The unfavorable cash flow assumption updates in 2021 were primarily driven by unfavorable pre-COVID-19 mortality.
Column 1Column 2Column 3Column 4
Our fixed annuity products had a liability remeasurement gain of $5 million in 2022 compared to a loss of $25 million in 2021. The liability remeasurement loss in 2021 was largely driven by unfavorable mortality assumption updates.

Changes in fair value of market risk benefits and associated hedges

Column 1Column 2Column 3Column 4
Our variable annuity products had an unfavorable variance of $75 million principally driven by unfavorable equity market impacts, partially offset by higher interest rates and derivative gains in 2022.
Column 1Column 2Column 3Column 4
Our fixed annuity products had a favorable variance of $19 million primarily attributable to higher interest rates, partially offset by unfavorable equity market impacts in 2022.

Acquisition and operating expenses, net of deferrals.

The increase was largely attributable to our fixed annuity products primarily due to a payment of $365 million in 2022 related to the recapture of certain single premium immediate annuity contracts by a third party.

Amortization of deferred acquisition costs and intangibles.

The decrease was primarily driven by lapse experience in our term life insurance products.

Provision for income taxes.

The effective tax rate was 18.2% and 19.8% for the years ended December 31, 2022 and 2021, respectively.

103

Table of Contents

Life and Annuities selected operating performance measures

Life insurance

The following table sets forth selected operating performance measures regarding our life insurance products as of the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 2022
Term and whole life insurance
Life insurance in-force, net of reinsurance$44,121$48,162$47,297$(4,041)(8)%
Life insurance in-force, before reinsurance$270,950$300,145$332,793$(29,195)(10)%
Term universal life insurance
Life insurance in-force, net of reinsurance$90,427$92,719$99,471$(2,292)(2)%
Life insurance in-force, before reinsurance$91,024$93,336$100,119$(2,312)(2)%
Universal life insurance
Life insurance in-force, net of reinsurance$28,710$29,798$31,117$(1,088)(4)%
Life insurance in-force, before reinsurance$32,199$33,622$35,228$(1,423)(4)%

The decrease in insurance
in-force
in our life insurance products reflects the continued runoff of our
in-force
blocks.

104

Table of Contents

Corporate and Other

Results of operations

The following table sets forth the results of operations relating to Corporate and Other for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2023202220212023 vs. 20222022 vs. 2021
Revenues:
Premiums$9$6$6$350%$— %
Net investment income198711138%114%
Net investment gains (losses)(28)(15)(7)(13)(87)%(8)(114)%
Policy fees and other income(2)1(2)NM(1)(1)(100)%
Total revenues(2)(1)7(1)(100)%(8)(114)%
Benefits and expenses:
Benefits and other changes in policy reserves(9)(11)(6)218%(5)(83)%
Acquisition and operating expenses, net of deferrals6541842459%(43)(51)%
Amortization of deferred acquisition costs and intangibles121NM(1)(2)(100)%
Interest expense66541091222%(55)(50)%
Total benefits and expenses123841893946%(105)(56)%
Loss from continuing operations before income taxes(125)(85)(182)(40)(47)%9753%
Benefit for income taxes(20)(16)(53)(4)(25)%3770%
Loss from continuing operations(105)(69)(129)(36)(52)%6047%
Adjustments to loss from continuing operations:
Net investment (gains) losses281571387%8114%
(Gains) losses on early extinguishment of debt(2)645(8)(133)%(39)(87)%
Expenses related to restructuring41143NM(1)(13)(93)%
Taxes on adjustments(6)(5)(13)(1)(20)%862%
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders$(81)$(52)$(76)$(29)(56)%$2432%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2023 compared to 2022

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives and higher interest expense attributable to Genworth Holdings’ junior subordinated notes, partially offset by higher net investment income in 2023.

Revenues

Net investment income increased largely from higher investment yields in 2023.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

105

Table of Contents

Benefits and expenses

Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives and higher employee-related expenses, partially offset by gains on the early extinguishment of certain of Genworth Holdings’ debt in 2023 compared to losses in 2022.

Interest expense increased largely driven by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2023, partially offset by the early redemption in 2022 of Genworth Holdings’ senior notes due in 2024.

The benefit for income taxes increased primarily related to a higher
pre-tax
loss in 2023, partially offset by a state tax benefit in 2022 that did not recur.

2022 compared to 2021

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily related to lower interest expense in 2022, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur.

Revenues

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves decreased primarily related to inter-segment transactions.

Acquisition and operating expenses, net of deferrals, decreased mainly driven by $24 million of lower make-whole premiums on the early redemption of Genworth Holdings’ senior notes and $15 million of lower net losses related to the repurchase of Genworth Holdings’ senior notes in 2022, as well as $13 million of lower restructuring costs. These decreases were partially offset by higher expenses related to CareScout growth initiatives in 2022.

Interest expense decreased largely driven by the early redemption and repurchase of Genworth Holdings’ senior notes due in September 2021, August 2023 and February 2024, partially offset by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2022.

The decrease in the benefit for income taxes was primarily related to a reduction in uncertain tax positions due to the expiration of certain statute of limitations in 2021 that did not recur, as well as a lower
pre-tax
loss in 2022.

Investments and Derivative Instruments

Trends and conditions

Investments

During the year ended December 31, 2023, our investments portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends.

Column 1Column 2Column 3Column 4
The U.S. Federal Reserve increased interest rates by 100 basis points, bringing the upper end of the target range to the highest level since 2001.

106

Table of Contents

Column 1Column 2Column 3Column 4
During the fourth quarter of 2023, the ten-year U.S. Treasury yield rose to its highest level since 2007, but U.S. Treasury yields decreased compared to September 30, 2023. Although the two-year U.S. Treasury yield remained above the ten-year U.S. Treasury yield in 2023, the differential between the two-year yield and the ten-year yield declined compared to December 31, 2022.
Column 1Column 2Column 3Column 4
Credit spreads tightened and credit market performance remained resilient as macroeconomic data continued to support market optimism for a soft economic landing in 2023.
Column 1Column 2Column 3Column 4
Bank deposits stabilized in the second half of 2023 after three regional banks were taken into receivership by the Federal Deposit Insurance Corporation in early 2023. At this time, we believe our investment portfolio is well positioned and any risks to valuations as a result of the pressures in the regional banking system and commercial real estate are manageable.
Column 1Column 2Column 3Column 4
As of December 31, 2023, our fixed maturity securities portfolio, which was 96% investment grade, comprised 75% of our total invested assets and cash.

Derivatives

Column 1Column 2Column 3Column 4
As of December 31, 2023, $1.3 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”).
Column 1Column 2Column 3Column 4
The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2023, we posted initial margin of $79 million to our clearing agents, which represented $39 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings.
Column 1Column 2Column 3Column 4
As of December 31, 2023, $11.4 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $464 million and are holding collateral from counterparties in the amount of $19 million.

107

Table of Contents

Investment results

The following table sets forth information about our investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31:

Increase (decrease)
2023202220212023 vs. 20222022 vs. 2021
(Amounts in millions)YieldAmountYieldAmountYieldAmountYieldAmountYieldAmount
Fixed maturity securities— taxable4.5%$2,2444.5%$2,2964.5%$2,411%$(52)%$(115)
Fixed maturity securities— non-taxable4.2%34.7%55.6%7(0.5)%(2)(0.9)%(2)
Equity securities3.0%114.0%104.0%9(1.0)%1%1
Commercial mortgage loans4.4%3024.6%3215.5%376(0.2)%(19)(0.9)%(55)
Policy loans10.2%22410.0%2119.3%1890.2%130.7%22
Limited partnerships (1)4.5%1174.7%9915.7%223(0.2)%18(11.0)%(124)
Other invested assets (2)50.5%27959.9%26769.7%241(9.4)%12(9.8)%26
Cash, cash equivalents, restricted cash and short-term investments4.7%951.2%20%13.5%751.2%19
Gross investment income before expenses and fees5.1%3,2755.0%3,2295.2%3,4570.1%46(0.2)%(228)
Expenses and fees(0.2)%(92)(0.2)%(83)(0.1)%(87)%(9)(0.1)%4
Net investment income4.9%$3,1834.8%$3,1465.1%$3,3700.1%$37(0.3)%$(224)
Average invested assets and cash$64,637$65,160$66,099$(523)$(939)
Column 1Column 2
(1)Limited partnership investments are primarily equity-based and do not have fixed returns by period.
Column 1Column 2
(2)Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.

Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments and securities lending activity, which was included in other invested assets prior to the suspension of our securities lending program in the third quarter of 2021 and was calculated net of the corresponding securities lending liability.

Gross annualized weighted-average investment yields increased in 2023 compared to 2022 primarily driven by higher investment income on lower average invested assets. Net investment income included higher returns of $75 million primarily on our short-term investments due to higher interest rates, $18 million of higher limited partnership income and $15 million of higher income from bank loans, partially offset by $41 million of lower income related to inflation-driven volatility on TIPS and $26 million of lower bond calls and commercial mortgage loan prepayments.

Gross annualized weighted-average investment yields decreased in 2022 compared to 2021 primarily driven by lower net investment income on lower average invested assets. Net investment income included $124 million of lower limited partnership income and $106 million of lower bond calls and commercial mortgage loan prepayments, partially offset by $18 million of higher income related to inflation-driven volatility on TIPS in 2022.

108

Table of Contents

The following table sets forth net investment gains (losses) for the years ended December 31:

(Amounts in millions)202320222021
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains$29$28$67
Realized losses(154)(102)(10)
Net realized gains (losses) on available-for-sale fixed maturity securities(125)(74)57
Net realized gains (losses) on equity securities sold(1)(7)
Net realized gains (losses) on limited partnerships3
Total net realized investment gains (losses)(126)(74)53
Net change in allowance for credit losses on available-for-sale fixed maturity securities(7)(6)
Write-down of available-for-sale fixed maturity securities(1)(2)(1)
Net unrealized gains (losses) on equity securities still held53(35)1
Net unrealized gains (losses) on limited partnerships11171264
Commercial mortgage loans(5)4(3)
Derivative instruments73213
Other(9)21
Net investment gains (losses)$23$(2)$322

2023 compared to 2022

Column 1Column 2Column 3Column 4
We recorded $125 million of net losses related to the sale of available-for-sale fixed maturity securities in 2023 compared to $74 million in 2022. The net losses in 2023 were primarily related to portfolio repositioning and liquidity management, as well as regional bank exposure management, including a $15 million loss related to the sale of First Republic Bank U.S. corporate bonds.
Column 1Column 2Column 3Column 4
We recorded net unrealized gains on equity securities of $53 million in 2023 driven by favorable equity market performance compared to net unrealized losses of $35 million in 2022 from unfavorable performance. We recorded $40 million of higher net unrealized gains on limited partnerships driven by more favorable private equity market performance in 2023. We also recorded an allowance for credit losses on available-for-sale fixed maturity securities of $7 million in 2023.
Column 1Column 2Column 3Column 4
Net investment gains related to derivatives decreased in 2023 primarily from losses on hedging programs that support our fixed indexed annuity products compared to gains in 2022, lower gains on hedging programs that support our indexed universal life insurance products and losses from forward bond purchase commitments in 2023. These decreases were partially offset by gains on equity index options in 2023 compared to losses in 2022.

2022 compared to 2021

Column 1Column 2Column 3Column 4
We recorded net realized losses related to the sale of available-for-sale fixed maturity securities of $74 million in 2022 compared to net realized gains of $57 million in 2021 primarily driven by sales of U.S. corporate securities to manage asset exposure and to optimize cash at Genworth Holdings in 2022.
Column 1Column 2Column 3Column 4
We recorded $193 million of lower net unrealized gains on limited partnerships in 2022 compared to 2021 primarily from less favorable private equity market performance in 2022. We also recorded $35 million of net unrealized losses on equity securities during 2022 driven by unfavorable equity market performance.

109

Table of Contents

Investment portfolio

The following table sets forth our cash, cash equivalents and invested assets as of December 31:

20232022
(Amounts in millions)Carrying value% of totalCarrying value% of total
Available-for-sale fixed maturity securities:
Public$32,18951%$31,75753%
Private14,5922414,82624
Equity securities39613191
Commercial mortgage loans, net6,802107,01011
Policy loans2,22042,1393
Limited partnerships2,82152,3314
Other invested assets73115661
Cash, cash equivalents and restricted cash2,21541,7993
Total cash, cash equivalents and invested assets$61,966100%$60,747100%

For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 5 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio.

We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2023, approximately 7% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 21 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value.

110

Table of Contents

The following table presents our public, private and total fixed maturity securities by the Nationally Recognized Statistical Rating Organizations (“NRSRO”) designations and/or equivalent ratings, as well as the percentage, based upon fair value that each designation comprises. Certain fixed maturity securities that are not rated by an NRSRO are shown based upon internally prepared credit evaluations.

As of December 31,
(Amounts in millions)20232022
NRSRO designationAmortized costFair value% of totalAmortized costFair value% of total
Public fixed maturity securities
AAA$2,779$2,5598%$6,394$6,06719%
AA6,4616,170193,1462,8599
A9,4749,287298,8608,39827
BBB14,34613,6454214,96413,62343
BB51849828397762
B32303734
CCC and lower
Total public fixed maturity securities$33,610$32,189100%$34,240$31,757100%
Private fixed maturity securities
AAA$866$8326%$876$8256%
AA1,5741,477101,5621,42110
A4,3984,043284,6754,17028
BBB7,7097,126488,1297,22148
BB1,03797571,2171,0767
B14911711351131
CCC and lower77
Not rated1515
Total private fixed maturity securities$15,755$14,592100%$16,594$14,826100%
Total fixed maturity securities
AAA$3,645$3,3917%$7,270$6,89215%
AA8,0357,647164,7084,2809
A13,87213,3302913,53512,56827
BBB22,05520,7714523,09320,84445
BB1,5551,47332,0561,8524
B181147172147
CCC and lower77
Not rated1515
Total fixed maturity securities$49,365$46,781100%$50,834$46,583100%

We invest in privately placed fixed maturity securities to increase diversification and obtain higher yields than can ordinarily be obtained with comparable public market securities. Generally, private placements provide us with protective covenants, call protection features and, where applicable, a higher level of collateral. However, our private placements are not as freely transferable as public securities because of restrictions imposed by federal and state securities laws, the terms of the securities and the characteristics of the private market. Based upon fair value, public fixed maturity securities represented 69% and 68%, respectively, of total fixed maturity securities as of December 31, 2023 and 2022. Private fixed maturity securities represented 31% and 32%, respectively, of total fixed maturity securities as of December 31, 2023 and 2022.

We diversify our corporate securities by industry and issuer. As of December 31, 2023, our combined holdings in the 10 corporate issuers to which we had the greatest exposure was $1.8 billion, which was

111

Table of Contents

approximately 3% of our total cash, cash equivalents and invested assets. The exposure to the largest single corporate issuer held as of December 31, 2023 was $273 million, which was less than 1% of our total cash, cash equivalents and invested assets. See note 5 to our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on diversification by sector.

Other invested assets

The following table sets forth the carrying values of our other invested assets as of December 31:

20232022
(Amounts in millions)Carrying value% of totalCarrying value% of total
Bank loan investments$52972%$46782%
Derivatives13118509
Short-term investments27431
Other investments446468
Total other invested assets$731100%$566100%

Bank loan investments increased from funding of additional investments, partially offset by principal payments in 2023. Derivatives increased largely from higher contracted notional interest rates on forward bond purchase commitments in excess of current market rates.

112

Table of Contents

Derivatives

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:

(Notional in millions)MeasurementDecember 31, 2022AdditionsMaturities/ terminationsDecember 31, 2023
Derivatives designated as hedges
Cash flow hedges:
Interest rate swapsNotional$8,542$1,857$(1,424)$8,975
Foreign currency swapsNotional144(13)131
Forward bond purchase commitmentsNotional1,0751,075
Total cash flow hedges8,6862,932(1,437)10,181
Total derivatives designated as hedges8,6862,932(1,437)10,181
Derivatives not designated as hedges
Equity index optionsNotional936729(963)702
Financial futuresNotional1,4035,488(5,640)1,251
Forward bond purchase commitmentsNotional500500
Total derivatives not designated as hedges2,3396,717(6,603)2,453
Total derivatives$11,025$9,649$(8,040)$12,634
(Number of policies)MeasurementDecember 31, 2022AdditionsMaturities/ terminationsDecember 31, 2023
Derivatives not designated as hedges
Fixed indexed annuity embedded derivativesPolicies7,315(1,489)5,826
Indexed universal life embedded derivativesPolicies771(22)749

The increase in the notional value of derivatives was primarily attributable to the addition of forward bond purchase commitments and interest rate swaps that support our long-term care and universal life insurance businesses, partially offset by a decrease in equity index options used to support our fixed indexed annuity products.

The number of policies with embedded derivatives decreased as these products are no longer being offered and continue to runoff.

Critical Accounting Estimates

The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” For a detailed discussion of our significant accounting policies, see note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

113

Table of Contents

The sensitivities in the tables below are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products. The impacts are discrete and do not reflect the impact one factor may have on another. In any period and over time, our actual experience may have a positive or negative variance from our long-term assumptions, either singularly or collectively, and these variances may offset each other.

Liability for future policy benefits

The measurement of the liability for future policy benefits reflects estimates and actuarial assumptions and methodologies which involve the exercise of significant judgment and are inherently uncertain. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Establishing assumptions for the liability for future policy benefits is complex and involves many factors. Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding loss recognized in net income (loss). Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our liability for future policy benefits. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Moreover, for our long-term care insurance products, we may not be able to mitigate the impact of unexpected adverse experience by increasing premiums and/or other charges to policyholders (where we have the right to do so) or by offering benefit reductions as an alternative to increasing premiums.

The liability for future policy benefits is equal to the present value of expected future benefits and claim-related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain
in-force
from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates), estimates of future
in-force
rate actions, which include premium rate increases and benefit reductions associated with our long-term care insurance products. The liability is measured for each group of contracts, or cohorts, using best estimate cash flow assumptions, which are reviewed at least annually in the fourth quarter or more frequently if actual experience indicates a change is required. The change in the liability for future policy benefits, at the
locked-in
discount rate, resulting from cash flow assumption updates and variances between actual and expected experience is reflected as liability remeasurement (gains) losses in the consolidated statements of income.

See notes 2 and 10 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the liability for future policy benefits.

Long-term care insurance

Key cash flow assumptions used to estimate the liability for future policy benefits for our long-term care insurance products include claim termination rates, incidence and benefit utilization rates, mortality, lapse rates and
in-force
rate actions. Claim termination rates represent the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates represent how much of the available policy benefits are expected to be used.
In-force
rate actions represent the remaining premium rate increases and associated benefit reductions not yet achieved in our long-term care insurance multi-year
in-force
rate action plan and are based on our best estimate given our current plans for rate increase filings and our historical experience regarding rate increase approvals.
In-force
rate actions also include cash payments made to policyholders who elect certain reduced benefit options in connection with legal settlements, referred to as settlement payments.

114

Table of Contents

In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $61 million primarily related to updates to our healthy life assumptions to better reflect near-term experience, partially offset by a favorable update to disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
Updates also included favorable assumption updates for future
in-force
rate action approvals and benefit reductions based on recent favorable rate increase approval experience and feedback from regulators, along with the reflection of the third legal settlement, which had a muted favorable income statement impact in the fourth quarter of 2023 because it primarily impacted profitable uncapped cohorts. In the fourth quarter of 2022, liability remeasurement gains (losses) within net income included favorable cash flow assumption updates of $303 million reflecting an expected reserve reduction, net of estimated settlement payments, attributable to the inclusion of the second legal settlement, which primarily impacted capped cohorts.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202320222023 vs. 2022
Present value of expected net premiums (1)$15,333$16,691$(1,358)(8)%
Present value of expected future policy benefits (1)$50,095$50,551$(456)(1)%
Column 1Column 2
(1)At the locked-in discount rate.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within
pre-tax
income for the year ended December 31, 2023:

(Amounts in millions)
5% increase in future claim costs (1)$(1,490)
Reduction in claim termination rates (2)$(290)
10% reduction in benefit of future in-force rate actions (3)$(175)
Column 1Column 2
(1)Reflects the impact of an unfavorable assumption change for claim terminations, incidence or benefit utilization rates (any discrete adverse assumption changes therefrom or in combination with, that results in our future claim costs increasing by 5%).
Column 1Column 2
(2)Reflects the impact of a 3% decrease in mortality and 8% decrease in lapse rates.
Column 1Column 2
(3)Reflects the impact of an unfavorable change to our assumptions for future premium rate increases and benefit reductions.

Life insurance

Key cash flow assumptions used to estimate the liability for future policy benefits for our life insurance products include mortality and lapse rates.

In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $56 million primarily as a result of updates to our mortality assumptions, including emerging experience related to more modest mortality improvement and an expectation that mortality will continue at elevated levels in the near-term
post-COVID-19.
There were no cash flow assumption changes for our life insurance products in the fourth quarter of 2022.

115

Table of Contents

A summary of certain of our significant estimates used in the calculation of our life insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202320222023 vs. 2022
Present value of expected net premiums (1)$1,835$1,573$26217%
Present value of expected future policy benefits (1)$2,192$2,127$653%
Column 1Column 2
(1)At the locked-in discount rate and excluding the impacts of flooring adjustments. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within
pre-tax
income for the year ended December 31, 2023:

(Amounts in millions)
2% higher mortality$(20)
10% increase in lapses$(60)

Fixed annuities

The key cash flow assumption used to estimate the liability for future policy benefits for our fixed annuity products is mortality.

In the fourth quarters of 2023 and 2022, our annual review of cash flow assumptions had no impact on liability remeasurement gains (losses) within net income for our fixed annuity products.

A summary of certain of our significant estimates and assumptions used in the calculation of our fixed annuities liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)202320222023 vs. 2022
Total present value of expected future policy benefits (1)$2,691$2,897$(206)(7)%
Column 1Column 2
(1)At the locked-in discount rate.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within
pre-tax
income for the year ended December 31, 2023:

(Amounts in millions)
10% lower mortality$(60)

Policyholder account balances – additional insurance liabilities

The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product

116

Table of Contents

features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims, commonly referred to as the additional insurance liability. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality, interest rates and policyholder persistency or lapses, among other assumptions.

We perform an annual review of assumptions for our universal and term universal life insurance products in the fourth quarter. Our 2023 review resulted in an expense recorded to
pre-tax
income of $200 million primarily to reflect unfavorable persistency and mortality assumptions. We made unfavorable updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in universal and term universal life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term
post-COVID-19.
Our 2022 review resulted in a benefit recorded to
pre-tax
income of $37 million largely associated with higher interest rates.

The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within
pre-tax
income for the year ended December 31, 2023:

(Amounts in millions)
100 basis point decrease in projected crediting rates$(50)
10% increase in persistency$(213)
2% higher mortality$(42)

Liability for policy and contract claims

The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.

Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss).

Mortgage insurance

Estimates and actuarial assumptions used for establishing loss reserves involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on Enact’s loss reserves and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. The sources of uncertainty affecting the estimates are numerous and include factors internal and external to Enact. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external influences include changes in home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on Enact’s reserves, results of operations and financial condition.

117

Table of Contents

Enact establishes reserves to recognize the estimated liability for losses and loss adjustment expenses related to defaults on insured mortgage loans. Loss reserves are established by estimating the number of loans in the inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase.

Enact’s management monitors actual experience, and where circumstances warrant, will revise its assumptions. The liability for loss reserves is reviewed regularly, with changes in estimates of future claims recorded through net income. Estimation of losses is based on historical claim and cure experience and covered exposures and is inherently judgmental. Future developments may result in losses greater or less than the liability for loss reserves provided.

Enact’s loss reserves were $518 million and $519 million as of December 31, 2023 and 2022, respectively. In considering the potential sensitivity of the factors underlying Enact’s best estimate of its mortgage insurance reserves, it is possible that even a relatively small change in the estimated claim or severity rate could have a significant impact on loss reserves and, correspondingly, on our results of operations. For example, based on Enact’s actual experience during the three-year period ended December 31, 2023, a quarterly change of 5% in its average claim rate would change the gross loss reserve amount for such quarter by $75 million and a change of 4% in its average severity rate would change the gross loss reserve amount for such quarter by $19 million.

Valuation of fixed maturity securities.

Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value.

The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the

period-to-period

changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. Additionally, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investments portfolio.

Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2023, 6% of our total fixed maturity securities related to Level 3 fixed maturity securities valued using internal pricing models. See notes 2, 5 and 21 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments.

118

Table of Contents

The following tables summarize the primary sources of data considered when determining the fair value of fixed maturity securities as of December 31:

2023
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$41,311$$41,311$
Broker quotes221221
Internal models5,2492,3742,875
Total fixed maturity securities$46,781$$43,685$3,096
2022
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$41,113$$41,113$
Broker quotes250250
Internal models5,2202,2802,940
Total fixed maturity securities$46,583$$43,393$3,190

Consolidated Balance Sheets

Total assets

. Total assets increased $1,103 million from $89,714 million as of December 31, 2022 to $90,817 million as of December 31, 2023.

Column 1Column 2Column 3Column 4
Invested assets increased $803 million primarily attributable to increases of $490 million in limited partnerships, $198 million in fixed maturity securities and $165 million in other invested assets, partially offset by a decrease of $208 million in commercial mortgage loans in 2023. Limited partnerships increased largely from capital calls in 2023. The increase in fixed maturity securities was predominantly related to tightening credit spreads increasing the fair value of our fixed maturity investment portfolio, partially offset by net sales and maturities in 2023. The increase in other invested assets was primarily related to derivatives and bank loan investments. Commercial mortgage loans decreased mostly due to payments outpacing originations in 2023. We continue to monitor macroeconomic trends and rebalance our investment holdings in commercial real estate.
Column 1Column 2Column 3Column 4
Cash and cash equivalents increased $416 million primarily related to net sales and maturities of fixed maturity securities and commercial mortgage loan payments outpacing originations, partially offset by net withdrawals from our investment contracts and repurchases of Genworth Financial’s common stock in 2023.
Column 1Column 2Column 3Column 4
Deferred acquisition costs decreased $223 million primarily attributable to amortization in our life and long-term care insurance products in 2023.

Total liabilities

. Total liabilities increased $1,154 million from $81,328 million as of December 31, 2022 to $82,482 million as of December 31, 2023.

Column 1Column 2Column 3Column 4
The liability for future policy benefits increased $2,248 million primarily from a decrease in the single-A interest rate used to discount the liability for future policy benefits and aging of our long-term care insurance in-force block, partially offset by the runoff of our life insurance and fixed annuity products. The increase also includes the effects of changes in cash flow assumptions and variances between actual and expected experience. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in cash flow assumptions.

119

Table of Contents

Column 1Column 2Column 3Column 4
Policyholder account balances decreased $1,024 million primarily from surrenders, benefit payments and policy charges in our fixed annuity and universal and term universal life insurance products in 2023, partially offset by an increase in additional insurance liabilities due to changes in cash flow assumptions. See “—Critical Accounting Estimates—Policyholder account balances —additional insurance liabilities” for additional information.
Column 1Column 2Column 3Column 4
Market risk benefit liabilities decreased $123 million mostly related to favorable equity market performance in 2023.

Total equity

. Total equity decreased $51 million from $8,386 million as of December 31, 2022 to $8,335 million as of December 31, 2023.

Column 1Column 2Column 3Column 4
We reported net income available to Genworth Financial, Inc.’s common stockholders of $76 million for the year ended December 31, 2023.
Column 1Column 2Column 3Column 4
Unrealized gains (losses) on investments increased total equity by $1,277 million primarily from tightening credit spreads in 2023.
Column 1Column 2Column 3Column 4
Change in the discount rate used to measure future policy benefits decreased total equity by $1,036 million largely attributable to a decrease in the single-A interest rate used to discount the liability for future policy benefits and related reinsurance recoverables (net of deferred taxes) in 2023.
Column 1Column 2Column 3Column 4
Treasury stock increased $299 million primarily due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other costs paid in connection with acquiring the shares, resulting in a decrease to total equity in 2023.

Liquidity and Capital Resources

Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.

Overview of cash flows—Genworth and subsidiaries

The following table sets forth our condensed consolidated cash flows for the years ended December 31:

(Amounts in millions)202320222021
Net cash from operating activities$597$1,049$437
Net cash from investing activities1,261733896
Net cash used by financing activities(1,443)(1,554)(2,419)
Net increase (decrease) in cash before foreign exchange effect$415$228$(1,086)

Our principal sources of cash include sales of our products and services, income from our investment portfolio and proceeds from sales of investments. As an insurance business, we typically generate positive cash flows from operating activities, as premiums collected from our insurance products and income received from our investments typically exceed policy acquisition costs, benefits and claims paid, redemptions and operating expenses. Our cash flows from operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Positive cash flows from operating activities are then invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions.

120

Table of Contents

2023 compared to 2022

Net cash inflows from operating activities were lower primarily due to higher benefit payments in our long-term care insurance business in 2023, partially offset by net cash disbursements in 2022 associated with the return of cash collateral received from counterparties under our derivative contracts.

Net cash inflows from investing activities were higher mainly due to commercial mortgage loan payments outpacing originations in 2023 compared to originations outpacing payments in 2022, as well as higher net sales and maturities of fixed maturity securities in 2023.

Net cash outflows used by financing activities were lower primarily due to lower repurchases and repayments of Genworth Holdings’ debt in 2023 and a settlement payment related to a Tax Matters Agreement with GE in 2022 that did not recur, partially offset by higher repurchases of Genworth Financial’s common stock in 2023.

Genworth—holding company liquidity

In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (and, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, contributions to subsidiaries, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 18 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. As of December 31, 2023, our principal U.S. life insurance subsidiaries had negative unassigned surplus of approximately $563 million under statutory accounting, and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations. Insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details.

Enact Holdings continues to evaluate its capital allocation strategy to consistently support its existing policyholders, grow its mortgage insurance business, fund attractive new business opportunities and return capital to shareholders. In addition to its quarterly cash dividend program, on November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $75 million of its outstanding common stock, and on August 1, 2023, announced the

121

Table of Contents

authorization of an additional $100 million of common stock repurchases under a new share repurchase program. Genworth Holdings agreed to participate in order to maintain its overall ownership at its current level. As the majority shareholder, Genworth Holdings received $245 million of capital returns from Enact Holdings in 2023, comprised of quarterly dividends, a special dividend and share repurchases. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Enact Holdings’ stock price and trading volume, and general business and market conditions, among other factors.

On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under its existing share repurchase program. Pursuant to the program, during 2023, Genworth Financial repurchased 51,739,098 shares of its common stock at an average price of $5.70 per share for a total of $295 million, excluding excise taxes and other associated costs. In 2024, Genworth Financial also repurchased 4,197,740 shares of its common stock through February 13, 2024 for approximately $25 million, leaving approximately $316 million remaining authorization under the share repurchase program. Further repurchases under the program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or by other means, including through Rule
10b5-1
trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

Our future use of liquidity and capital will prioritize future strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. We expect to continue to provide capital to CareScout to help advance our senior care growth initiatives related to the needs of elderly Americans, as well as their caregivers and families. We may also from time to time seek to repurchase or redeem outstanding debt (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise.

Genworth Holdings had $350 million and $307 million of unrestricted cash and cash equivalents as of December 31, 2023 and 2022, respectively. The increase was principally driven by capital returns from Enact Holdings and intercompany cash tax payments received from Genworth Holdings’ subsidiaries, partially offset by Genworth Financial’s common stock repurchases and debt interest payments in 2023. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months. However, in the third quarter of 2023, we made a federal tax payment based on our projection of current taxable income and utilization of our remaining foreign tax credits, and we expect the amount of intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2024 as compared to the amounts received during 2022 and 2023. We also expect Genworth Holdings’ liquidity to continue to be significantly impacted by the amounts and timing of Genworth Financial’s share repurchases as well as future dividends and other forms of capital returns from Enact Holdings.

We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or from future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.

Capital resources and financing activities

Our current capital resource plans do not include any additional debt offerings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market

122

Table of Contents

conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations,” and “Item 1A—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.” These risks may be exacerbated by the economic impact of current elevated interest rates and overall housing trends.

During 2023 and 2022, Genworth Holdings repurchased $32 million and $143 million, respectively, principal amount of its debt, and in 2022, early redeemed $152 million of its 4.80% senior notes originally scheduled to mature in February 2024. As of December 31, 2023, Genworth Holdings had $856 million principal of outstanding debt, with no maturities due until June 2034.

On October 25, 2023, Genworth Holdings completed a consent solicitation from bondholders representing a majority in principal amount of its 6.50% senior notes due in 2034 (“2034 Notes”) to amend the Replacement Capital Covenant, dated as of November 14, 2006. The amendment permits Genworth Holdings to repay, redeem or repurchase $2,000 principal amount of its floating rate junior subordinated notes due in 2066 (“2066 Notes”) for each $1,000 principal amount of its 2034 Notes repaid, redeemed or repurchased.

In December 2022, the Board of Governors of the Federal Reserve System adopted a final rule that established benchmark rates, based on the Secured Overnight Financing Rate (“SOFR”), that replaced the London Interbank Offered Rate (“LIBOR”) after its elimination on June 30, 2023. Pursuant to the final rule, Genworth Holdings’ 2066 Notes, which had an annual interest rate equal to three-month LIBOR plus 2.0025%, transitioned in the third quarter of 2023 to an annual interest rate equal to the three-month Term SOFR Reference Rate, plus a tenor spread adjustment of 0.26161%, plus an additional spread of 2.0025%. We do not expect this change to have a material impact on our results of operations or liquidity. In addition, given the reduction in Genworth Holdings’ debt and corresponding decrease in debt service costs, we do not expect a significant impact on our liquidity from the rise in interest rates in 2022 and 2023.

On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. As of December 31, 2023, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn. Enact Holdings also has $750 million principal amount of senior notes due in August 2025.

Enact Holdings continually evaluates opportunities based upon market conditions to further increase its financial flexibility including through raising additional capital, restructuring or refinancing some or all of its outstanding debt or pursuing other options such as reinsurance or credit risk transfer transactions. There can be no guarantee that any such opportunities will be available on favorable terms or at all.

Other than its senior notes due in August 2025, Enact Holdings has no material outstanding debt obligations that are expected to affect its liquidity over the next five years. We believe that the operating cash flows generated by Enact Holdings’ mortgage insurance subsidiaries will provide the funds necessary to satisfy its claim payments, operating expenses and taxes.

For further information about our borrowings, refer to note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Regulated insurance subsidiaries

Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 22 in our consolidated financial statements under “Item 8—Financial Statements

123

Table of Contents

and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. Based on estimated statutory results as of December 31, 2023, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $336 million in 2024 without affirmative regulatory approval. However, Enact Holdings may choose not to pay dividends in 2024 at this level as it may retain capital for future growth or to meet regulatory or other capital requirements.

The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Given the challenging macroeconomic environment in 2022 and 2023, employee costs were higher driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these conditions persist for a long period of time, they could have a material adverse impact on our liquidity, results of operations and financial condition. We will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity.

Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. For long-duration coverage products, we generally anticipate a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form
10-K.
For information on discounted and undiscounted expected future benefit payments, see note 10 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.” Our projected payments are principally associated with our long-term care insurance products, for which we expect overall claim costs to continue to increase as the insured individuals in our two largest blocks approach their peak claim years, which are over a decade away. Actual claims on products that provide long-duration coverage typically emerge over many years, change over time and are difficult to accurately predict. Therefore, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of payments.

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2023, our total cash, cash equivalents and invested assets were $62.0 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2023.

Guarantees and other
off-balance
sheet commitments

Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations.

124

Table of Contents

Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies
in-force
prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2023, the risk
in-force
of active policies was approximately $893 million.

Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures.

Genworth Financial and certain of its holding company subsidiaries also provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $67 million and $69 million as of December 31, 2023 and 2022, respectively.

As of December 31, 2023, we were committed to fund $1,530 million in limited partnership investments, $117 million of bank loan investments, $42 million in private placement investments and $13 million in commercial mortgage loan investments.

Supplemental Condensed Consolidating Financial Information

As discussed above in “—Liquidity and Capital Resources,” Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933). Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial. Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in accordance with Rule
13-01
of Regulation
S-X,
we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities.

125

Table of Contents

FY 2022 10-K MD&A

SEC filing source: 0001193125-23-053994.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2023-02-28. Report date: 2022-12-31.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.”

Item 7 of our Annual Report on Form 10-K generally discusses year-to-year comparisons between the years ended December 31, 2022 and 2021. Discussions of information related to 2020 and year-to-year comparisons between 2021 and 2020 are not included in this Form 10-K. Comparative discussions between 2021 and 2020 can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2021.

Overview

Our business

Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products which are no longer sold. We report our business results through three operating business segments: Enact; U.S. Life Insurance; and Runoff. We also have Corporate and Other activities. Our U.S. Life Insurance segment includes long-term care insurance, life insurance and fixed annuity products. The Runoff segment primarily includes variable annuity, variable life insurance and corporate-owned life insurance products, which have not been actively sold since 2011, as well as funding agreements.

Our financial information

The financial information in this Annual Report on Form 10-K has been derived from our consolidated financial statements.

Revenues and expenses

Our revenues consist primarily of the following:

Column 1Column 2Column 3Column 4
Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance.
Column 1Column 2Column 3Column 4
Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees.

Our expenses consist primarily of the following:

Column 1Column 2Column 3Column 4
Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid and reserve activity related to current claims and future policy benefits on insurance and investment products for long-term care insurance, life insurance, accident and health insurance, structured settlements and single premium immediate annuities with life contingencies, and claim costs incurred related to mortgage insurance products.

80

Table of Contents

Column 1Column 2Column 3Column 4
Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances.
Column 1Column 2Column 3Column 4
Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses.
Column 1Column 2Column 3Column 4
Amortization of deferred acquisition costs and intangibles. Amortization of DAC and intangibles consists primarily of the amortization of acquisition costs that are capitalized, PVFP and capitalized software.
Column 1Column 2Column 3Column 4
Interest expense. Interest expense represents interest related to our borrowings that are incurred at Genworth Holdings or Enact Holdings and our former non-recourse funding obligations, as well as interest expense related to the Tax Matters Agreement previously owed to GE and certain reinsurance arrangements being accounted for as deposits.
Column 1Column 2Column 3Column 4
Income taxes. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other activities.
Column 1Column 2Column 3Column 4
Net income from continuing operations attributable to noncontrolling interests. Net income from continuing operations attributable to noncontrolling interests represents the portion of income from continuing operations in a subsidiary attributable to third parties.

The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers.

We allocate corporate expenses to each of our operating segments using various methodologies.

81

Table of Contents

Consolidated Results of Operations

The following table sets forth the consolidated results of operations for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 20212021 vs. 2020
Revenues:
Premiums$3,719$3,435$3,836$2848%$(401)(10)%
Net investment income3,1463,3703,227(224)(7)%1434%
Net investment gains (losses)(17)323492(340)(105)%(169)(34)%
Policy fees and other income659704729(45)(6)%(25)(3)%
Total revenues7,5077,8328,284(325)(4)%(452)(5)%
Benefits and expenses:
Benefits and other changes in policy reserves4,2424,3835,214(141)(3)%(831)(16)%
Interest credited503508549(5)(1)%(41)(7)%
Acquisition and operating expenses, net of deferrals1,3711,22393514812%28831%
Amortization of deferred acquisition costs and intangibles307377463(70)(19)%(86)(19)%
Interest expense106160195(54)(34)%(35)(18)%
Total benefits and expenses6,5296,6517,356(122)(2)%(705)(10)%
Income from continuing operations before income taxes9781,181928(203)(17)%25327%
Provision for income taxes239263230(24)(9)%3314%
Income from continuing operations739918698(179)(19)%22032%
Income (loss) from discontinued operations, net of taxes27(486)(27)(100)%513106%
Net income739945212(206)(22)%733NM(1)
Less: net income from continuing operations attributableto noncontrolling interests1303397NM(1)33NM(1)
Less: net income from discontinued operations attributableto noncontrolling interests834(8)(100)%(26)(76)%
Net income available to Genworth Financial, Inc.’s common stockholders$609$904$178$(295)(33)%$726NM(1)
Net income available to Genworth Financial, Inc.’s common stockholders:
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders$609$885$698$(276)(31)%$18727%
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders19(520)(19)(100)%539104%
Net income available to Genworth Financial, Inc.’s common stockholders$609$904$178$(295)(33)%$726NM(1)
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and

82

Table of Contents

Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.

Use of non-GAAP measures

Reconciliation of net income (loss) to adjusted operating income (loss)

We use non-GAAP financial measures entitled “adjusted operating income (loss)” and “adjusted operating income (loss) per share.” Adjusted operating income (loss) per share is derived from adjusted operating income (loss). Our chief operating decision maker evaluates segment performance and allocates resources on the basis of adjusted operating income (loss). We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, initial gains (losses) on insurance block transactions, restructuring costs and infrequent or unusual non-operating items. Initial gains (losses) on insurance block transactions are defined as gains (losses) on the early extinguishment of non-recourse funding obligations, early termination fees for other financing restructuring and/or initial gains (losses) on reinsurance restructuring for certain blocks of business. We exclude net investment gains (losses) and infrequent or unusual non-operating items because we do not consider them to be related to the operating performance of our segments and Corporate and Other activities. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. Gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, initial gains (losses) on insurance block transactions and restructuring costs are also excluded from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating trends. Infrequent or unusual non-operating items are also excluded from adjusted operating income (loss) if, in our opinion, they are not indicative of overall operating trends.

While some of these items may be significant components of net income (loss) in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss) as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Net investment gains (losses) are also adjusted for DAC and other intangible amortization and certain benefit reserves.

83

Table of Contents

The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31:

(Amounts in millions)202220212020
Net income available to Genworth Financial, Inc.’s common stockholders$609$904$178
Add: net income from continuing operations attributable to noncontrolling interests13033
Add: net income from discontinued operations attributable to noncontrolling interests834
Net income739945212
Less: income (loss) from discontinued operations, net of taxes27(486)
Income from continuing operations739918698
Less: net income from continuing operations attributable to noncontrolling interests13033
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders609885698
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)14(324)(503)
Losses on early extinguishment of debt6459
Initial loss from life block transaction92
Expenses related to restructuring2343
Pension plan termination costs8
Taxes on adjustments(6)33103
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$633$765$310
Column 1Column 2
(1)For the years ended December 31, 2022, 2021 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(3) million, $(1) million and $(11) million, respectively.

During 2022, we paid a pre-tax make-whole premium of $2 million and wrote off $1 million of bond consent fees and deferred borrowing costs related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in February 2024. Prior to the redemption, we repurchased $130 million principal amount of Genworth Holdings’ senior notes due in February 2024 for a pre-tax loss of $4 million. We also repurchased $13 million principal amount of Genworth Holdings’ senior notes due in 2034 for a pre-tax gain of $1 million during the fourth quarter of 2022. During 2021, we paid a pre-tax make-whole premium of $6 million and $20 million related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in September 2021 and August 2023, respectively. We also repurchased $146 million principal amount of Genworth Holdings’ senior notes due in September 2021 for a pre-tax loss of $4 million and repurchased $91 million and $118 million principal amount of Genworth Holdings’ senior notes due in 2023 and 2024, respectively, for a pre-tax loss of $15 million. During 2020, we repurchased $84 million principal amount of Genworth Holdings’ senior notes with 2021 maturity dates for a pre-tax gain of $4 million. In January 2020, we paid a pre-tax make-whole expense of $9 million related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in June 2020 and Rivermont Life Insurance Company I, our indirect wholly-owned special purpose consolidated captive insurance subsidiary, early redeemed all of its $315 million outstanding non-recourse funding obligations originally due in 2050 resulting in a pre-tax loss of $4 million from the write-off of deferred borrowing costs. These transactions were excluded from adjusted operating income as they relate to gains (losses) on the early extinguishment of debt.

In 2021, we recorded a pre-tax loss of $92 million as a result of ceding certain term life insurance policies as part of a life block transaction.

84

Table of Contents

In 2022, 2021 and 2020, we recorded a pre-tax expense of $2 million, $34 million and $3 million, respectively, related to restructuring costs as we continue to evaluate and appropriately size our organizational needs and expenses.

During 2022, we incurred $8 million of pre-tax pension plan termination costs related to one of our defined benefit pension plans. There were no other infrequent or unusual items excluded from adjusted operating income during the periods presented.

Earnings per share

The following table provides basic and diluted earnings per common share for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions, except per share amounts)2022202120202022 vs. 20212021 vs. 2020
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic$1.21$1.75$1.38$(0.54)(31)%$0.3727%
Diluted$1.19$1.72$1.36$(0.53)(31)%$0.3626%
Net income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$1.21$1.78$0.35$(0.57)(32)%$1.43NM(1)
Diluted$1.19$1.76$0.35$(0.57)(32)%$1.41NM(1)
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$1.26$1.51$0.61$(0.25)(17)%$0.90148%
Diluted$1.24$1.48$0.61$(0.24)(16)%$0.87143%
Weighted-average common shares outstanding:
Basic504.5506.9505.2
Diluted511.0514.7511.6
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including stock options, restricted stock units and other equity-based awards.

85

Table of Contents

The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other activities for the years ended December 31:

Increase (decrease) and
percentage change
(Amounts in millions)2022202120202022 vs. 20212021 vs. 2020
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Enact segment$578$520$381$5811%$13936%
U.S. Life Insurance segment:
Long-term care insurance142445237(303)(68)%20888%
Life insurance(148)(269)(247)12145%(22)(9)%
Fixed annuities729178(19)(21)%1317%
U.S. Life Insurance segment6626768(201)(75)%199NM(1)
Runoff segment375443(17)(31)%1126%
Corporate and Other activities(48)(76)(182)2837%10658%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$633$765$310$(132)(17)%$455147%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Executive Summary of Consolidated Financial Results

Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%.

For a discussion of selected financial information and detailed descriptions of operating performance measures see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”

2022 compared to 2021

Column 1Column 2Column 3Column 4
Net income for the years ended December 31, 2022 and 2021 was $609 million and $904 million, respectively, and adjusted operating income was $633 million and $765 million, respectively.
Column 1Column 2Column 3Column 4
Our Enact segment drove our 2022 consolidated financial results, with $578 million of adjusted operating income, an increase of 11% compared to 2021.
Column 1Column 2Column 3Column 4
The increase was primarily attributable to lower losses largely driven by net favorable reserve adjustments of $212 million, consisting of reserve releases of $248 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening of $36 million related to 2022 delinquencies given uncertainty in the current economic environment.
Column 1Column 2Column 3Column 4
This improvement was partially offset by the minority IPO of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6%.
Column 1Column 2Column 3Column 4
The improvement was also partially offset by lower premiums in 2022.
Column 1Column 2Column 3Column 4
Our U.S. Life Insurance segment had adjusted operating income of $66 million and $267 million in 2022 and 2021, respectively.

86

Table of Contents

Column 1Column 2Column 3Column 4
Long-term care insurance:
Column 1Column 2Column 3Column 4
Adjusted operating income in our long-term care insurance business decreased $303 million primarily from higher severity and frequency of new claims, lower net investment income and lower terminations as the pandemic impacts lessened in 2022.
Column 1Column 2Column 3Column 4
The decrease was also attributable to a $49 million less favorable impact in 2022 from in-force rate actions approved and implemented, which included a lower net favorable impact from policyholder benefit reduction elections made in connection with legal settlements, as the implementation of one is materially complete and the implementation of another one began in August 2022.
Column 1Column 2Column 3Column 4
Life insurance:
Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance business decreased $121 million mainly attributable to a favorable unlocking of $34 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2022 compared to an unfavorable unlocking of $70 million in 2021 (see “—Critical Accounting Estimates” for additional information).
Column 1Column 2Column 3Column 4
The decrease was also attributable to lower mortality as the pandemic impacts subsided and lower DAC impairments of $51 million in 2022.
Column 1Column 2Column 3Column 4
These improvements were partially offset by higher lapses in our 20-year term life insurance block written in 2002 entering its post-level premium period in 2022.
Column 1Column 2Column 3Column 4
Fixed annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuities business decreased $19 million mainly attributable to lower net spreads, partially offset by lower DAC amortization and higher mortality in our single premium immediate annuity products in 2022.
Column 1Column 2Column 3Column 4
Our Runoff segment had adjusted operating income of $37 million and $54 million in 2022 and 2021, respectively.
Column 1Column 2Column 3Column 4
The decrease was predominantly due to the impact from unfavorable equity market performance and higher interest rates on our variable annuity products in 2022.
Column 1Column 2Column 3Column 4
Corporate and Other activities had an adjusted operating loss of $48 million and $76 million in 2022 and 2021, respectively.
Column 1Column 2Column 3Column 4
The decrease in the loss was primarily related to lower interest expense, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur.

Significant Developments and Strategic Highlights

The periods under review include, among others, the following significant developments and steps taken in the execution of our strategic priorities.

Enact

Column 1Column 2Column 3Column 4
Persistency and loss performance:
Column 1Column 2Column 3Column 4
Enact’s primary persistency rate was 80% for 2022, a meaningful increase compared to 62% for 2021 from rising interest rates and suppressed mortgage refinancing activity in 2022.

87

Table of Contents

Column 1Column 2Column 3Column 4
Higher persistency offset the decline in new insurance written, leading to an increase in insurance in-force of $21.7 billion during 2022.
Column 1Column 2Column 3Column 4
Enact recorded net favorable after-tax reserve adjustments of $212 million during 2022, primarily related to COVID-19 delinquencies curing at levels above original reserve expectations.
Column 1Column 2Column 3Column 4
PMIERs compliance:
Column 1Column 2Column 3Column 4
Enact’s PMIERs sufficiency ratio was 165% or $2,050 million above the published PMIERs requirements as of December 31, 2022.
Column 1Column 2Column 3Column 4
As of December 31, 2022, Enact had estimated available assets of $5,206 million against $3,156 million net required assets under PMIERs compared to available assets of $5,077 million against $3,074 million net required assets as of December 31, 2021 (PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE restrictions imposed on Enact Holdings).
Column 1Column 2Column 3Column 4
As of December 31, 2022 and 2021, Enact’s PMIERs required assets benefited by $132 million and $390 million, respectively, from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans.
Column 1Column 2Column 3Column 4
Given Genworth’s strengthened financial position, including achieving its strategic priority to reduce its outstanding public debt at Genworth Holdings to approximately $1.0 billion, we believe Genworth satisfied two consecutive quarters of financial metric conditions during the fourth quarter of 2022 related to the GSE Restrictions imposed on Enact. We expect the GSE Restrictions to be lifted in the first quarter of 2023, subject to GSE review and confirmation.

For additional information related to PMIERs, see “Item 1—Business—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.”

Column 1Column 2Column 3Column 4
Dividends and other return of capital:
Column 1Column 2Column 3Column 4
On April 26, 2022, Enact Holdings’ board of directors approved the initiation of a dividend program under which it intends to pay a quarterly cash dividend, subject to a quarterly review by its board of directors.
Column 1Column 2Column 3Column 4
Pursuant to the program, Enact Holdings paid quarterly dividends beginning in the second quarter of 2022, and Genworth Holdings received $57 million during 2022 as the majority shareholder.
Column 1Column 2Column 3Column 4
In the fourth quarter of 2022, Enact Holdings paid a special dividend and Genworth Holdings received $148 million as the majority shareholder.
Column 1Column 2Column 3Column 4
On November 1, 2022, Enact Holdings also announced the approval by its board of directors of a share repurchase program under which Enact Holdings may repurchase up to $75 million of its outstanding common stock. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. Enact Holdings began share repurchases under the program in the fourth quarter of 2022.
Column 1Column 2Column 3Column 4
Liquidity and financial flexibility:
Column 1Column 2Column 3Column 4
On June 30, 2022, Enact Holdings entered into a $200 million unsecured revolving credit facility that remained undrawn as of December 31, 2022.

U.S. Life Insurance

Column 1Column 2Column 3Column 4
Long-term care insurance multi-year in-force rate action plan:
Column 1Column 2Column 3Column 4
We estimate that the cumulative economic benefit of our long-term care insurance multi-year in-force rate action plan through 2022 was approximately $23.5 billion, on a net present value basis, of the total expected amount required of $30.3 billion as of December 31, 2022.

88

Table of Contents

Column 1Column 2Column 3Column 4
We received 139 filing approvals from 35 states during 2022, representing a weighted-average increase of 48% on approximately $1,143 million in annualized in-force premiums, or approximately $549 million of incremental annual premiums. Of that aggregate amount, we are awaiting the final disposition of a small number of the approvals as we work through implementation mechanics.
Column 1Column 2Column 3Column 4
We also submitted 139 new filings in 37 states during 2022 on approximately $1,226 million in annualized in-force premiums.
Column 1Column 2Column 3Column 4
Profits followed by losses in our long-term care insurance business:
Column 1Column 2Column 3Column 4
Future projections in our long-term care insurance block, excluding the acquired block, indicate we have projected profits in earlier periods followed by projected losses in later periods.
Column 1Column 2Column 3Column 4
As a result of this pattern of projected profits followed by projected losses, we ratably accrue additional future policy benefit reserves over the profitable periods by the amounts necessary to offset estimated losses during the periods that follow.
Column 1Column 2Column 3Column 4
As of December 31, 2022 and 2021, the total amount accrued for profits followed by losses was $1.7 billion and $1.3 billion, respectively.
Column 1Column 2Column 3Column 4
Completion of annual long-term care insurance assumption review:
Column 1Column 2Column 3Column 4
In the fourth quarter of 2022, we completed a review of our assumptions and methodologies of our claim reserves and future policy benefits for our long-term care insurance business and completed loss recognition testing.
Column 1Column 2Column 3Column 4
We made no significant changes to our existing claim reserves, as experience in the aggregate was in line with expectations.
Column 1Column 2Column 3Column 4
In aggregate, the 2022 margins for our long-term care insurance business remained in the same range as 2021 of approximately $0.5 billion to $1.0 billion.
Column 1Column 2Column 3Column 4
Completion of annual life insurance assumption review:
Column 1Column 2Column 3Column 4
We also completed a review of our assumptions and methodologies of our life insurance business and completed loss recognition testing in the fourth quarter of 2022.
Column 1Column 2Column 3Column 4
The loss recognition testing margin for our term life insurance products remained positive at over $1.0 billion in 2022.
Column 1Column 2Column 3Column 4
As part of our review in the fourth quarter of 2022, we recorded a $34 million after-tax benefit to net income in our universal and term universal life insurance products primarily related to higher interest rates.

For additional information see “—Critical Accounting Estimates.”

Liquidity and Capital Resources

Column 1Column 2Column 3Column 4
Execution of strategic plan to reduce debt maturities:
Column 1Column 2Column 3Column 4
On September 21, 2022, Genworth Holdings early redeemed the remaining $152 million principal balance of its 4.80% senior notes due in February 2024. This redemption resulted in the achievement of Genworth’s strategic goal of reducing debt at Genworth Holdings to approximately $1.0 billion.
Column 1Column 2Column 3Column 4
In the fourth quarter of 2022, Genworth Holdings repurchased $13 million principal amount of its senior notes due in June 2034.
Column 1Column 2Column 3Column 4
As of December 31, 2022, Genworth Holdings had outstanding principal of $887 million of long-term debt, with no debt maturities until June 2034.

89

Table of Contents

Column 1Column 2Column 3Column 4
During the first half of 2022 and prior to the early redemption, Genworth Holdings repurchased $130 million of its senior notes due in February 2024.

See note 12 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information on our long-term borrowings.

Column 1Column 2Column 3Column 4
Genworth Financial share repurchase program:
Column 1Column 2Column 3Column 4
On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial may repurchase up to $350 million of its outstanding Class A common stock.
Column 1Column 2Column 3Column 4
During 2022, Genworth Financial repurchased 16,173,196 shares of its common stock at an average price of $3.94 per share for a total cash outlay of $64 million.
Column 1Column 2Column 3Column 4
Genworth Financial also repurchased 5,912,297 shares from February 9, 2023 through February 24, 2023 of its common stock at an average price of $6.08 per share for a total cost of $36 million, leaving approximately $250 million that may yet be purchased under the share repurchase program.

Results of Operations and Selected Financial and Operating Performance Measures by Segment

Our chief operating decision maker evaluates segment performance and allocates resources on the basis of adjusted operating income (loss).

Management’s discussion and analysis by segment contains selected operating performance measures including “sales” and “insurance in-force” or “risk in-force” which are commonly used in the insurance industry as measures of operating performance.

Management regularly monitors and reports sales metrics as a measure of volume of new business generated in a period. Sales refer to new insurance written for mortgage insurance products included in our Enact segment. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of insurance policies during a specified period, rather than a measure of revenues or profitability during that period.

Management regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. We consider insurance in-force and risk in-force to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period.

Management regularly monitors and reports a loss ratio for our businesses. For our mortgage insurance businesses included in our Enact segment, the loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. For our long-term care insurance business included in our U.S. Life Insurance segment, the loss ratio is the ratio of benefits and other changes in reserves less tabular interest on reserves less loss adjustment expenses to net earned premiums. We consider the loss ratio to be a measure of underwriting performance in these businesses and helps to enhance the understanding of the operating performance of our businesses.

Management also regularly monitors and reports adjusted operating income available to Genworth Financial, Inc.’s common stockholders attributable to in-force rate actions in the long-term care insurance

90

Table of Contents

business included in our U.S. Life Insurance segment. In-force rate actions include premium rate increases and associated benefit reductions implemented since 2012, which are presented net of estimated premium taxes, commissions, and other expenses on an after-tax basis. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual historical results, including but not limited to, a uniform rate of coinsurance and premium taxes in addition to consistent policyholder behavior over time. Actual policyholder behavior may differ significantly from these assumptions. In addition, estimates exclude reserve updates resulting from profits followed by losses and reserve changes for group products. Management considers adjusted operating income attributable to in-force rate actions to be a measure of our operating performance because it helps bring older generation long-term care insurance blocks closer to a break-even point over time and helps bring the loss ratios on newer long-term care insurance blocks back towards their original pricing.

These operating performance measures enable us to compare our operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources.

Enact segment

Trends and conditions

Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included herein “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.

Mortgage origination activity declined throughout 2022 in response to rising mortgage rates. If interest rates remain high, the refinance market is likely to remain depressed. Housing affordability was challenged in 2022 due to increasing interest rates, low inventory and elevated home prices, modestly offset by rising median family income, according to the National Association of Realtors Housing Affordability Index. Annual home price appreciation slowed throughout 2022, and home prices declined in the second half of the year, according to the FHFA Monthly Purchase-Only House Price Index.

The unemployment rate decreased to 3.5% in December 2022, compared to 3.9% in December 2021, following a decline from its peak of 14.8% in April 2020, bringing unemployment in line with the pre-pandemic level of 3.5% in February 2020. As of December 31, 2022, the number of unemployed Americans was under 6 million, and the number of long term unemployed over 26 weeks was approximately one million. Both of these metrics remain relatively in line with February 2020 levels.

For mortgages insured by the federal government (including those purchased by Fannie Mae and Freddie Mac), forbearance allows borrowers impacted by COVID-19 to temporarily suspend mortgage payments up to 18 months subject to certain limits. Currently, the GSEs do not have a deadline for requesting an initial forbearance. Federal laws and regulations continue to require servicers to discuss loss mitigation options with borrowers before proceeding with foreclosures. These requirements could further extend the foreclosure timeline, which could negatively impact the severity of loss on loans that go to claim.

Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of December 31, 2022, approximately 1.5% or 14,270 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 36% were reported as delinquent compared with approximately 2% or 21,899 of its active primary policies reported in forbearance with

91

Table of Contents

approximately 47% reported as delinquent as of December 31, 2021. Natural disasters, such as hurricanes, often lead to temporary increases in delinquencies in forbearance. While Enact experienced a small increase in delinquencies in the fourth quarter of 2022 related to the recent hurricane impacting the southeastern United States, it did not have a material impact on loss reserves as of December 31, 2022. Enact will continue to monitor the affected areas and support measures enacted by the GSEs, including allowing forbearance, restricting foreclosure actions and providing other forms of mortgage relief for those who experienced property damage.

Total delinquencies decreased during 2022 compared to 2021 as a result of cures outpacing new delinquencies. The 2022 new delinquency rate of 3.8%, while slightly higher than the 2021 new delinquency rate of 3.5%, was in line with Enact’s pre-pandemic levels. The full impact of COVID-19 and its adverse economic effects on Enact’s future business results are difficult to predict. Given the maximum length of forbearance plans, the resolution of a delinquency in a plan may not be known for several quarters. Enact continues to monitor regulatory and government actions and the resolution of forbearance delinquencies. While the associated risks have moderated and delinquencies have declined, it is possible that COVID-19 related forbearance programs could have an adverse impact on Enact’s future results of operations and financial condition.

Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products. On February 25, 2022, the FHFA finalized the rule for the Enterprise Capital Framework, which included technical corrections to its December 17, 2020 rule. Higher GSE capital requirements could lead to increased costs to borrowers of GSE loans, which in turn could shift the market away from the GSEs to the FHA or lender portfolios. Such a shift could result in a smaller market for private mortgage insurance.

In January 2022, the FHFA introduced new upfront fees charged to borrowers for some high-balance and second home loans sold to Fannie Mae and Freddie Mac, which became effective April 1, 2022. Upfront fees for high-balance loans increased between 0.25% and 0.75%, tiered by loan-to-value ratio. For second home loans, the upfront fees increased between 1.125% and 3.875%, also tiered by loan-to-value ratio. To date, Enact has not experienced a significant impact to its business or results of operations as a result of this new pricing framework.

On October 24, 2022, the FHFA announced targeted changes to the GSEs’ guarantee fee pricing by eliminating upfront fees for certain first-time home buyers with income at or below area median income and for certain GSE affordable mortgage products, while implementing targeted increases to the upfront fees for most cash-out refinance loans. The fee reductions went into effect in the fourth quarter of 2022 while the new fees on cash-out refinance loans began February 1, 2023. Enact expects these price changes to have a net positive impact to the private mortgage insurance market.

The FHFA also announced in October 2022 its validation and approval of certain credit score models for use by the GSEs and changed the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores requires lenders to deliver both credit scores for each loan sold to the GSEs. There is currently no implementation deadline, and this is expected to be a multiple year process that will require system and process updates.

In January 2023, the FHFA announced additional updates to its upfront fee structure and pricing matrix. The changes impact purchase and rate-term refinance loans with pricing grids to be broken out by loan purpose and recalibrated to new credit score and loan-to-value ratio categories, along with associated loan attributes. The new pricing matrix also includes new upfront fees for loans with debt-to-income ratios greater than 40%. These changes will go into effect in May 2023. Enact is currently evaluating the impact of these changes but does not expect a significant impact to the private mortgage insurance market.

92

Table of Contents

In February 2023, the Department of Housing and Urban Development announced a 30 basis point reduction of the annual insurance premium charged to borrowers with FHA-insured mortgages in order to reduce the cost of borrowing for eligible lower and middle class homebuyers. This price reduction is expected to have a negative impact on the U.S. private mortgage insurance market but will be partially offset by the effects of the recent FHFA pricing changes referenced above. Enact does not expect the net impact to be material.

The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite enabling it to write new business at returns it views as attractive.

New insurance written of $66.5 billion in 2022 decreased 31% compared to 2021 primarily due to a smaller estimated private mortgage insurance market. The decrease in the estimated private mortgage insurance market was largely driven by lower purchase and refinancing originations due to rising interest rates.

Enact’s primary persistency rate increased to 80% for the year ended December 31, 2022 compared to 62% for the year ended December 31, 2021. The increase in persistency was primarily driven by a decline in the percentage of in-force policies with mortgage rates above current interest rates and offset the decline in new insurance written in 2022, leading to an increase in insurance in-force of $21.7 billion during 2022. Higher persistency impacted business performance trends in several ways, including but not limited to, slowing the recognition of earned premiums due to lower single premium policy cancellations, slowing the amortization of existing reinsurance transactions and the corresponding reduction of PMIERs capital credit, and shifting the concentration of Enact’s primary insurance in-force by policy year. As of December 31, 2022, Enact’s primary insurance in-force had approximately 58% concentration in 2022 and 2021 book years compared to 71% primary insurance in-force concentration in 2021 and 2020 book years as of December 31, 2021.

Net earned premiums decreased in 2022 compared to 2021 primarily from the lapse of older, higher priced policies and from lower single premium policy cancellations, partially offset by insurance in-force growth in 2022. The total number of delinquent loans has declined from the COVID-19 peak in the second quarter of 2020 as borrowers continued to exit forbearance plans and new forbearances declined. During this time, and consistent with prior years, servicers continued the practice of remitting premiums during the early stages of default and Enact refunds the post-delinquent premiums to the insured party if the delinquent loan goes to claim. Enact records a liability and a reduction to net earned premiums for the post-delinquent premiums it expects to refund. The post-delinquent premium liability recorded since the beginning of COVID-19 in the second quarter of 2020 through December 31, 2022 was not significant to the change in earned premiums for those periods as a result of the high concentration of new delinquencies being subject to a servicer reported forbearance plan and the lower estimated claim rate for these loans.

Enact’s loss ratio was (10)% for the year ended December 31, 2022, compared to 13% for the year ended December 31, 2021. The decrease was largely from net favorable reserve adjustments of $268 million in 2022, primarily related to favorable cure performance on COVID-19 delinquencies from 2020 and 2021. During the peak of COVID-19, Enact experienced elevated new delinquencies subject to forbearance plans. Those delinquencies have been curing at levels above Enact’s reserve expectations, which led to releases of $314 million of reserves in 2022. These reserve releases were partially offset by reserve strengthening on certain 2022 delinquencies. Due to uncertainty in the current economic environment, Enact increased the expected claim rate on new delinquencies during 2022. New delinquencies in the fourth quarter of 2022 were recorded at the higher expected claim rate and reserves on delinquencies from prior quarters in 2022 were strengthened by $46 million. In 2021, Enact decreased reserves by $22 million primarily related to positive frequency and severity development on pre-COVID-19 delinquencies.

93

Table of Contents

Enact’s loss reserves continue to be impacted by COVID-19 and remain subject to uncertainty. Borrowers who have experienced a financial hardship including, but not limited to, the loss of income due to the closing of a business or the loss of a job continue to take advantage of available loss mitigation options, including forbearance programs, payment deferral options and other modifications. Loss reserves recorded on these delinquencies require a high degree of estimation due to the level of uncertainty regarding whether delinquencies in forbearance will ultimately cure or result in claim payments, as well as the timing and severity of those payments. The severity of loss on loans that do go to claim may be negatively impacted by the extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of the recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.

New primary delinquencies in 2022 increased compared to 2021. New primary delinquencies of 35,996 contributed $171 million of loss expense in 2022, while Enact incurred $144 million of losses from 32,624 new primary delinquencies in 2021. In determining the loss expense estimate, considerations were given to forbearance and non-forbearance delinquencies, recent cure and claim experience and the prevailing and prospective economic conditions. Approximately 21% of Enact’s primary new delinquencies in 2022 were subject to a forbearance plan as compared to 42% in 2021.

EMICO’s risk-to-capital ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 12.9:1 as of December 31, 2022 compared with a risk-to-capital ratio of 12.3:1 as of December 31, 2021. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.

Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. Since 2020, the GSEs have issued several amendments to PMIERs, which implemented both permanent and temporary revisions to PMIERs. Many of the provisions are no longer applicable, but for loans that became non-performing due to a COVID-19 hardship, PMIERs was temporarily amended with respect to each non-performing loan that (i) had an initial missed monthly payment occurring on or after March 1, 2020 and prior to April 1, 2021 or (ii) is subject to a forbearance plan granted in response to a financial hardship related to COVID-19, the terms of which are materially consistent with terms of forbearance plans offered by the GSEs. The risk-based required asset amount factor for the non-performing loan is the greater of (a) the applicable risk-based required asset amount factor for a performing loan were it not delinquent, and (b) the product of a 0.30 multiplier and the applicable risk-based required asset amount factor for a non-performing loan. In the case of (i) above, absent the loan being subject to a forbearance plan described in (ii) above, the 0.30 multiplier was applicable for no longer than three calendar months beginning with the month in which the loan became a non-performing loan due to having missed two monthly payments. Loans subject to a forbearance plan described in (ii) above include those that are either in a repayment plan or loan modification trial period following the forbearance plan unless reported to the approved insurer that the loan is no longer in such forbearance plan, repayment plan, or loan modification trial period. The PMIERs amendment dated June 30, 2021 further allows loans that enter a forbearance plan due to a COVID-19 hardship on or after April 1, 2021 to remain eligible for extended application of the reduced PMIERs capital factor for as long as the loan remains in forbearance. In addition, the PMIERs amendments made permanent revisions to the risk-based required asset amount factor for non-performing loans for properties located in future FEMA Declared Major Disaster Areas eligible for individual assistance.

94

Table of Contents

In addition, in September 2020, certain GSE Restrictions were imposed with respect to capital on Enact, which will remain in effect until the collective GSE Conditions are met. For additional details related to PMIERs, the PMIERs amendments and the GSE Conditions and Restrictions, see “Item 1—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.”

As of December 31, 2022, Enact had estimated available assets of $5,206 million against $3,156 million net required assets under PMIERs compared to available assets of $5,077 million against $3,074 million net required assets as of December 31, 2021. The sufficiency ratio as of December 31, 2022 and 2021 was 165%, or $2,050 million and $2,003 million, respectively, above the published PMIERS requirements. PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE Restrictions imposed on Enact. Enact’s PMIERs required assets as of December 31, 2022 and 2021 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans. The application of the 0.30 multiplier to all eligible delinquencies provided $132 million and $390 million of benefit to Enact’s PMIERs required assets as of December 31, 2022 and 2021, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier.

Credit risk transfer transactions provided an aggregate of approximately $1,578 million of PMIERs capital credit as of December 31, 2022. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.

On April 26, 2022, Enact Holdings’ board of directors approved the initiation of a quarterly dividend program. Pursuant to the program, Enact Holdings paid quarterly dividends beginning in the second quarter of 2022, and Genworth Holdings received $57 million in 2022 as the majority shareholder. Enact Holdings also paid a special dividend in the fourth quarter of 2022, and Genworth Holdings received $148 million. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition, in November 2022, Enact Holdings announced approval by its board of directors of a share repurchase program under which it may repurchase up to $75 million of its outstanding common stock. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. Enact Holdings began share repurchases under the program in the fourth quarter of 2022.

EMICO completed distributions to Enact Holdings in April 2022 and October 2022, the proceeds of which were used to support Enact Holdings’ cash dividends. Enact Holdings intends to use future EMICO distributions to fund the quarterly dividend as well as to bolster its financial flexibility and potentially return additional capital to shareholders. Returning capital to shareholders, balanced with growth and risk management priorities, remains a key commitment for Enact Holdings, as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, including: supporting its existing policyholders; growing its mortgage insurance business; funding attractive new business opportunities; and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.

95

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Revenues:
Premiums$940$975$971$(35)(4)%
Net investment income1551411331410%
Net investment gains (losses)(2)(2)(4)%
Policy fees and other income246(2)(50)%
Total revenues1,0951,1181,106(23)(2)%
Benefits and expenses:
Benefits and other changes in policy reserves(94)125381(219)(175)%
Acquisition and operating expenses, net of deferrals227230206(3)(1)%
Amortization of deferred acquisition costs and intangibles121521(3)(20)%
Interest expense52511812%
Total benefits and expenses197421626(224)(53)%
Income from continuing operations before income taxes89869748020129%
Provision for income taxes1941481024631%
Income from continuing operations70454937815528%
Less: net income from continuing operations attributable to
noncontrolling interests1303397NM(1)
Income from continuing operations available to Genworth
Financial, Inc.’s common stockholders5745163785811%
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses224%
Expenses related to restructuring33%
Taxes on adjustments(1)(1)(1)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$578$520$381$5811%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2022 compared to 2021

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income increased primarily attributable to lower losses largely driven by net favorable reserve adjustments of $212 million, consisting of reserve releases of $248 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening of $36 million related to 2022 delinquencies given uncertainty in the current economic environment. This improvement was partially offset by the minority IPO of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6%, and lower premiums in 2022.

96

Table of Contents

Revenues

Premiums decreased mainly driven by the lapse of older, higher priced policies and lower single premium policy cancellations, partially offset by higher insurance in-force in 2022 driven by increased persistency.

Net investment income increased primarily due to higher investment yields and higher average invested assets, partially offset by lower income from bond calls in 2022.

Benefits and expenses

Benefits and other changes in policy reserves decreased largely from net favorable reserve adjustments of $268 million, partially offset by higher new delinquencies in 2022. During 2022, Enact released $314 million of reserves primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening on certain 2022 delinquencies. Due to uncertainty in the current economic environment, Enact increased the expected claim rate on new delinquencies during 2022. New delinquencies in the fourth quarter of 2022 were recorded at the higher expected claim rate and reserves on delinquencies from prior quarters in 2022 were strengthened by $46 million. In 2021, Enact decreased reserves by $22 million primarily related to positive frequency and severity development on pre-COVID-19 delinquencies.

Acquisition and operating expenses, net of deferrals, decreased primarily attributable to expenses associated with strategic transaction preparations in 2021 that did not recur.

Amortization of deferred acquisition costs and intangibles decreased primarily due to lower DAC amortization largely from higher persistency in 2022 driven by rising interest rates.

Provision for income taxes. The effective tax rate was 21.6% and 21.3% for the years ended December 31, 2022 and 2021, respectively, consistent with the U.S. corporate federal income tax rate.

Net income from continuing operations attributable to noncontrolling interests. The increase relates to the minority IPO of Enact Holdings on September 16, 2021, which reduced Genworth Financial’s ownership percentage to 81.6%.

Enact selected operating performance measures

The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Primary insurance in-force(1)$248,262$226,514$207,947$21,74810%
Risk in-force:
Primary$62,791$56,881$52,475$5,91010%
Pool79105146(26)(25)%
Total risk in-force$62,870$56,986$52,621$5,88410%
New insurance written$66,485$97,004$99,871$(30,519)(31)%
Column 1Column 2
(1)Primary insurance in-force represents the aggregate unpaid principal balance for loans Enact insures.

97

Table of Contents

2022 compared to 2021

Primary insurance in-force and risk in-force

Primary insurance in-force increased largely from new insurance written. In addition, lower lapses and cancellations drove higher primary persistency, largely as a result of a decline in refinancing activity due to rising interest rates in 2022. The primary persistency rate was 80% and 62% for the years ended December 31, 2022 and 2021, respectively. Total risk in-force increased largely from higher primary insurance in-force.

New insurance written

New insurance written decreased principally due to a smaller estimated private mortgage insurance market in 2022, which was primarily driven by a decline in both purchase and refinancing originations due to rising interest rates.

Loss and expense ratios

The following table sets forth the loss and expense ratios for Enact for the dates indicated:

Years ended December 31,Increase (decrease)
2022202120202022 vs. 2021
Loss ratio(10)%13%39%(23)%
Expense ratio25%25%23%%

The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. The expense ratio is the ratio of general expenses to net earned premiums. In Enact, general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles.

2022 compared to 2021

The loss ratio decreased largely from net favorable reserve adjustments of $268 million, as discussed above, partially offset by higher new delinquencies in 2022. Enact decreased reserves by $22 million in 2021 primarily related to positive frequency and severity development on pre-COVID-19 delinquencies.

The expense ratio remained flat as lower premiums were offset by expenses associated with strategic transaction preparations in 2021 that did not recur.

98

Table of Contents

Mortgage insurance loan portfolio

The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31:

(Amounts in millions)202220212020
Primary insurance in-force by loan-to-value ratio at origination:
95.01% and above$39,509$35,455$34,520
90.01% to 95.00%103,61895,14992,689
85.01% to 90.00%72,13264,54956,341
85.00% and below33,00331,36124,397
Total$248,262$226,514$207,947
Primary risk in-force by loan-to-value ratio at origination:
95.01% and above$11,136$9,907$9,279
90.01% to 95.00%30,07927,60826,774
85.01% to 90.00%17,62115,64413,562
85.00% and below3,9553,7222,860
Total$62,791$56,881$52,475
Primary insurance in-force by credit quality at origination:
Over 760$102,467$89,982$78,488
740—75940,09735,87433,635
720—73934,91631,73030,058
700—71928,86727,35925,870
680—69921,55421,27020,140
660—679(1)10,92610,5499,819
640—6596,0956,1245,935
620—6392,6302,7832,902
6207108431,100
Total$248,262$226,514$207,947
Primary risk in-force by credit quality at origination:
Over 760$25,807$22,489$19,691
740—75910,1549,0098,497
720—7398,9318,0557,673
700—7197,3176,9076,579
680—6995,4285,3345,100
660—679(1)2,7672,6382,442
640—6591,5401,5301,472
620—639665702737
620182217284
Total$62,791$56,881$52,475
Column 1Column 2
(1)Loans with unknown FICO scores are included in the 660-679 category.

The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance in-force was 743 as of December 31, 2022.

99

Table of Contents

Delinquent loans and claims

Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31:

202220212020
Primary insurance:
Insured loans in-force960,306937,350924,624
Delinquent loans19,94324,82044,904
Percentage of delinquent loans (delinquency rate)2.08%2.65%4.86%

The delinquency rate as of December 31, 2022 decreased compared to December 31, 2021 and 2020 primarily from a decline in total delinquencies as cures outpaced new delinquencies.

The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of December 31:

2022
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less8,920$69$50914%
4 - 11 payments6,46616639043%
12 payments or more4,55724424898%
Total19,943$479$1,14742%
2021
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less6,586$35$34010%
4 - 11 payments7,36011142626%
12 payments or more10,87446064372%
Total24,820$606$1,40943%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, incurred but not reported (“IBNR”) and reinsurance reserves.

Total reserves as a percentage of risk in-force as of December 31, 2022 remained relatively flat as both delinquent risk in-force and reserves decreased. Delinquent risk in-force decreased mainly from lower total delinquencies as cures outpaced new delinquencies in 2022, while reserves decreased largely from favorable

100

Table of Contents

reserve adjustments related to COVID-19 delinquencies from 2020 and 2021, partially offset by new delinquencies in 2022.

The number of loans that are delinquent for 12 months or more was elevated as of December 31, 2021 due in large part to borrowers in forbearance plans driven by COVID-19 and decreased in 2022 due to cure activity. Enact’s current reserve estimate assumes that remaining COVID-19 delinquencies will have a higher likelihood of going to claim given the uncertainty around lack of progression through the foreclosure process. While Enact has seen significant cure activity in aged delinquencies, forbearance options continue to exist, so Enact could continue to experience elevated delinquencies in this aged category. Resolution of a delinquency in a forbearance plan, whether it ultimately results in a cure or a claim, is difficult to estimate and may not be known for several quarters, if not longer.

Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender.

Percent of primary risk in-force as of December 31, 2022Percent of direct primary case reserves as of December 31, 2022(1)Delinquency rate as of December 31,
202220212020
By State:
California12%10%2.09%3.17%6.20%
Texas8%7%2.12%2.89%5.82%
Florida(2)8%8%2.54%2.97%6.92%
New York(2)5%13%2.95%3.80%6.92%
Illinois(2)5%6%2.54%3.09%5.21%
Arizona4%2%1.78%2.31%4.54%
Michigan4%3%1.79%1.87%2.93%
North Carolina3%3%1.59%2.18%3.84%
Georgia3%3%2.23%2.94%5.89%
Washington3%3%1.92%2.98%5.37%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
Column 1Column 2
(2)Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed.

101

Table of Contents

Percent of primary risk in-force as of December 31, 2022Percent of direct primary case reserves as of December 31, 2022(1)Delinquency rate as of December 31,
202220212020
By MSA or MD:
Chicago-Naperville, IL MD3%5%2.84%3.68%6.36%
Phoenix, AZ MSA3%2%1.83%2.36%4.63%
New York, NY MD3%8%3.75%5.32%10.25%
Atlanta, GA MSA2%3%2.42%3.28%6.68%
Washington-Arlington, DC MD2%2%1.85%2.96%6.09%
Houston, TX MSA2%3%2.60%3.61%7.59%
Riverside-San Bernardino, CA MSA2%2%2.89%3.42%7.08%
Los Angeles-Long Beach, CA MD2%2%2.18%3.95%7.57%
Dallas, TX MD2%1%1.86%2.31%5.10%
Denver-Aurora-Lakewood, CO MSA2%1%1.12%1.66%3.77%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance, pre-foreclosure sale and deed-in-lieu. These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts.

The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, weighted average mortgage interest rate and delinquency rate as of December 31, 2022:

(Amounts in millions)Weighted average rate(1)Percent of direct primary case reserves(2)Primary insurance in-forcePercent of totalPrimary risk in-forcePercent of totalDelinquency rate
Policy Year
2008 and prior5.70%26%$6,5963%$1,6993%9.61%
2009 to 20144.45%42,113156015.01%
20154.20%32,912178113.61%
20163.91%66,29621,68133.17%
20174.28%76,49531,70833.78%
20184.81%96,83931,73634.63%
20194.24%1116,35274,14372.71%
20203.26%1755,3582214,158221.47%
20213.10%1481,7243320,418321.20%
20224.88%363,5772515,907250.54%
Total portfolio3.84%100%$248,262100%$62,791100%2.08%
Column 1Column 2
(1)Average annual mortgage interest rate weighted by insurance in-force.
Column 1Column 2
(2)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

102

Table of Contents

Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. The largest portion of reserves has shifted to newer book years as a result of COVID-19 given their significant representation of risk in-force. As of December 31, 2022, Enact’s 2015 and newer policy years represented approximately 96% of primary risk in-force and 70% of total direct primary case reserves.

The ratio of the claim paid to the current risk in-force for a loan is referred to as “claim severity.” The current risk in-force is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws. Pre-foreclosure sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 94%, 103% and 106% for the years ended December 31, 2022, 2021 and 2020, respectively. The average claim severity for the year ended December 31, 2022 was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on non-performing loans.

U.S. Life Insurance segment

Trends and conditions

Results of our U.S. life insurance businesses depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves. Many factors can affect the results of our U.S. life insurance businesses. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our U.S. life insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our DAC amortization, reserve levels, results of operations and financial condition.

Our liability for policy and contract claims is reviewed quarterly and we completed a detailed review of our claim reserve assumptions and methodologies for our long-term care insurance business in the fourth quarter of 2022 as discussed further below. In the fourth quarter of 2022, we performed assumption reviews for our U.S. life insurance products, including our long-term care and life insurance products, and completed our loss recognition testing as discussed below. For our 2022 assumption updates, we generally did not include data after 2019 in setting any long-term assumptions, as we do not yet have sufficient information around longer term effects of the pandemic, which is consistent with the approach for our 2021 assumptions. Our review of assumptions, as part of our testing in the fourth quarter of 2022, included assumptions regarding expected claim incidence and terminations, expenses, benefit utilization, mortality, persistency, interest rates and in-force rate actions, among other assumptions. In addition, we performed cash flow testing separately for each of our U.S. life insurance companies on a statutory accounting basis in the fourth quarter of 2022.

Our U.S. life insurance subsidiaries are subject to the NAIC’s RBC standards and other minimum statutory capital and surplus requirements. As of December 31, 2022, the RBC of each of our U.S. life insurance subsidiaries exceeded the level of RBC that would require any of them to take or become subject to any corrective action in their respective domiciliary state, or company action level RBC ratio. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries was approximately 291% and 289% as of December 31, 2022 and 2021, respectively. The slight increase was driven by earnings in our long-term care insurance business mainly from premium rate increases and benefit reductions, including policyholder benefit reduction elections

103

Table of Contents

made in connection with legal settlements, that were mostly offset by high mortality in our life insurance products and unfavorable equity market performance in our variable annuity products.

We continue to face challenges in our principal life insurance subsidiaries, particularly those subsidiaries that rely heavily on long-term care insurance in-force rate actions as a source of earnings and capital. We may see variability in statutory results and a decline in the company action level RBC ratios of these subsidiaries given the time lag between the approval of in-force rate actions versus when the benefits from the in-force rate actions (including increased premiums and associated benefit reductions) are fully realized in our financial results. Additionally, the company action level RBC ratio of our U.S. life insurance subsidiaries would be negatively impacted by future increases in our statutory reserves, including results of life mortality, cash flow testing and assumption reviews, particularly in our long-term care and life insurance products. Future declines in the company action level RBC ratio of our life insurance subsidiaries could result in heightened supervision and regulatory action.

Results of our U.S. life insurance businesses are also impacted by interest rates. Prior to the recent rise in interest rates during 2022, historic low interest rates put pressure on the profitability and returns of our U.S. life insurance businesses as higher yielding investments matured and were replaced with lower-yielding investments. We have sought to manage the impact of low interest rates through asset-liability management, investment in alternative assets, including limited partnerships, as well as interest rate hedging strategies for a portion of our long-term care insurance product cash flows. Additionally, certain products have implicit and explicit rate guarantees or optionality that are significantly impacted by changes in interest rates. During periods of increasing market interest rates, we may increase crediting rates on in-force universal life insurance and fixed annuity products to remain competitive in the marketplace. In addition, rapidly rising interest rates may cause increased unrealized losses on our investment portfolios, increased policy surrenders, withdrawals from life insurance policies and annuity contracts and requests for policy loans, as policyholders and contractholders shift assets into higher yielding investments. Increases in crediting rates, as well as surrenders and withdrawals, could have an adverse effect on our financial condition and results of operations, including the requirement to liquidate fixed-income investments in an unrealized loss position to satisfy surrenders or withdrawals. For a further discussion of the impact of interest rates on our U.S. life insurance businesses, see “Item 7A—Quantitative and Qualitative Disclosures About Market Risk.”

In recent years, our U.S. life insurance businesses have been impacted by COVID-19 as a result of elevated mortality. Our long-term care insurance operating results were favorably impacted by higher mortality in 2021 and 2020. This trend continued into 2022 albeit to a lesser extent, and we have seen mortality levels return to pre-pandemic levels in the latter half of 2022 in our long-term care insurance business. Conversely, higher mortality rates had unfavorable impacts in our life insurance products; however, we have seen lower mortality since the first quarter of 2022. We have also observed minimal impact from COVID-19 in our fixed annuity products. While the ongoing impact of COVID-19 is very difficult to predict, the related outcomes and impact on the U.S. life insurance business currently depend on the after-effects indirectly caused by the pandemic, including supply chain shortages and high inflation, and the shape of the economic recovery. For sensitivities related to lapses and mortality on our U.S. life insurance products, see “—Critical Accounting Estimates.” We will continue to monitor COVID-19 associated impacts and evaluate all of our assumptions that may need updating as a result of longer-term trends related to the pandemic.

Long-term care insurance

The long-term profitability of our long-term care insurance business depends upon how our actual experience compares with our valuation assumptions, including but not limited to morbidity, mortality and persistency. If any of our assumptions prove to be inaccurate, our reserves may be inadequate, which in the past has had, and may in the future have, a material adverse effect on our results of operations, financial condition and business. Results of our long-term care insurance business are also influenced by our ability to achieve in-force rate actions, improve investment yields and manage expenses and reinsurance, among other factors. Changes in

104

Table of Contents

laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, could also impact our long-term care insurance business either positively or negatively.

In the fourth quarter of 2022, we completed loss recognition and cash flow testing and reviewed key assumptions for future policy benefits, or active life reserves, for our long-term care insurance business, including assumptions regarding expected claim incidence and terminations, expenses, benefit utilization, interest rates and in-force rate actions, among other assumptions. As of December 31, 2022, our loss recognition testing margin for our long-term care insurance business, excluding the acquired block, was positive but slightly lower than the 2021 level. We continue to test our acquired block of long-term care insurance separately. In 2022, our loss recognition testing margin for the acquired block was positive and slightly higher than the 2021 level. All key margin testing assumptions were reviewed and updated where appropriate. We refined several assumptions, including reducing our lapse assumption in light of favorable experience from our long-term care insurance legal settlement elections and benefit reductions and updating our interest rate assumption to reflect the impact of the higher interest rate environment. These refinements were not significant and we believe our assumptions are holding up in the aggregate. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and made no significant changes to our 2022 multi-year in-force rate action plan. However, we did increase the value of our assumption for future approvals and benefit reductions based on recent rate increase approval experience, regulatory support and legal settlement results.

We will continue to regularly review our methodologies and assumptions in light of emerging experience and may be required to make adjustments to our long-term care insurance reserves in the future, which could also impact our loss recognition and cash flow testing results. For a discussion of additional information related to margins for our long-term care insurance business, see “—Critical Accounting Estimates—Future policy benefits.”

During the fourth quarter of 2022, we reviewed our assumptions and methodologies relating to our claim reserves of our long-term care insurance business. As part of our review, we considered emerging experience particularly in mortality and benefit utilization, including the impact of increased cost of care due to inflation. In 2022 and 2021, based on the review of our assumptions and methodologies, we did not make any significant changes to our claim reserves. For a discussion of additional information related to changes to our assumptions and methodologies to our long-term care insurance claim reserves, see “—Critical Accounting Estimates—Liability for policy and contract claims.”

As a result of the review of our claim reserves completed in prior years, we have been establishing higher claim reserves on new claims, which has negatively impacted earnings, and we expect this to continue going forward. Also, average claim reserves for new claims are trending higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on our older long-term care insurance blocks of business will continue to decrease as the blocks run off, we are gaining more experience on our larger new blocks of business and expect continued growth in new claims on these blocks as policyholders reach older attained ages with higher likelihood of going on claim.

In our long-term care insurance products, we have experienced higher mortality during COVID-19 which has had a favorable impact on claim reserves and our operating results. Although it is not our practice to track cause of death for long-term care insurance policyholders and claimants, we believe the higher mortality in our long-term care insurance business in early 2022 as well as during 2021 was likely impacted by COVID-19, but we expect the impacts to be temporary. COVID-19 significantly increased mortality on our most vulnerable claimants, which may reduce mortality rates in future periods. To account for this change in experience due to COVID-19, we adjusted the mortality assumption in our claim reserves to reflect the risk of lower claim termination rates on remaining claims. As of December 31, 2022, the balance of our incremental claim reserves associated with COVID-19 mortality was $90 million, which decreased $44 million from the December 31, 2021 balance of $134 million as mortality decreased for most of 2022 as the impacts from the pandemic subsided.

105

Table of Contents

Short-term mortality experience may fluctuate, and we would decrease the COVID-19 mortality adjustment if we continue to experience lower mortality.

We also experienced lower new claims incidence in our long-term care insurance business during COVID-19. However, we expected this to be temporary and that claims incidence experience would ultimately revert to pre-pandemic trends. As a result, we strengthened our IBNR claim reserves during the height of COVID-19. As of December 31, 2022 and 2021, the balance of IBNR claim reserves due to lower claims incidence was $47 million and $75 million, respectively. We are seeing new claims incidence trending back to pre-pandemic levels. In addition, during the pandemic, a larger share of our claimants sought home care instead of facility-based care, and as the impacts of the pandemic subside, we have seen that trend begin to reverse. We continue to utilize virtual assessments to assess eligibility for benefits while in-person assessments have been temporarily discontinued since the onset of COVID-19. We are reviewing the options to resume in-person assessments, with appropriate protocols in place, while having virtual assessments available for those policyholders who would prefer this option. For claimants without the technology to perform virtual assessments, we have alternate options for gathering information. Our long-term care insurance benefit utilization will be monitored for impact, although it is too early to tell the magnitude and/or direction of that impact.

Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including: premium rate increases and associated benefit reductions on our in-force policies; managing expense levels; executing investment strategies targeting higher returns; and enhancing our financial and actuarial analytical capabilities. In addition, we have reached certain legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. The first legal settlement related to certain of our long-term care insurance policies, which represents approximately 20% of our block, was implemented beginning in 2021 and its implementation was materially completed in the second quarter of 2022. Another similar legal settlement on certain of our long-term care insurance policies, which represents 15% of our block, became final on July 29, 2022. We began implementation of this settlement on August 1, 2022, and recognized modest benefits during the fourth quarter of 2022. Because the election mailings occur on the policyholder’s policy anniversary date, the majority of the impacts are expected to be realized in 2023. However, we do not expect the financial impacts of this settlement to be as significant as they were with the first settlement given the smaller policy block size. On February 15, 2023, the court issued final approval on another similar pending settlement on certain of our long-term care insurance policies, which represents 35% of our block. The judgment will become final 30 days after its entry, or upon final resolution of any timely appeal, and we would expect to begin implementation in the second quarter of 2023. While the two new settlements are similar to the previous settlement, their ultimate impact will depend on the policyholder election rates and the types of reduced benefits elected. Given our experience with the first settlement, we expect these additional settlements to result in an overall net favorable impact to our long-term care insurance business. While we expect renewal premiums to decline over time, the settlements could accelerate that decline if policyholders continue to elect non-forfeiture and reduced benefit options, which have predominantly been the most prevalent policyholder elections for these legal settlements. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on in-force rate actions, refer to “—Significant Developments and Strategic Highlights—U.S. Life Insurance” and “Item 1—Business—U.S. Life Insurance—In-force rate actions.”

The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.

Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider litigation against states that decline to approve those actuarially

106

Table of Contents

justified rate increases. In January 2022, we began litigation with two states that have refused to approve actuarially justified rate increases.

Life insurance

Results of our life insurance business are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors. We no longer solicit sales of traditional life insurance products; however, we continue to service our existing retained and reinsured blocks of business.

Mortality levels may deviate each period from historical trends. Overall mortality experience was lower in 2022 compared to 2021. In our life insurance products, COVID-19 deaths also declined in 2022 compared to 2021. We have experienced higher mortality than our then-current and priced-for assumptions in recent years for our universal life insurance block. We have also been experiencing higher mortality related charges resulting from an increase in rates charged by our reinsurance partners reflecting natural block aging and higher mortality compared to expectations.

In the fourth quarters of 2022 and 2021, we performed our annual review of life insurance assumptions and loss recognition testing. Our reviews focused on assumptions for mortality, persistency and interest rates, among other assumptions. Our mortality assumption was updated in 2021 to align with the overall pre-COVID-19 experience in later-duration as well as in targeted blocks such as term universal life insurance, conversion policies and post-level term. As of December 31, 2022, the loss recognition testing margin for our term and whole life insurance products was positive and consistent with the 2021 level.

As part of our annual review of assumptions in the fourth quarter of 2022, we recorded a $34 million after-tax benefit in our universal and term universal life insurance products primarily related to higher interest rates. As part of our review in the fourth quarter of 2021, we recorded a $70 million after-tax expense in our universal and term universal life insurance products primarily related to higher pre-COVID-19 mortality experience.

For the year ended December 31, 2022, in connection with our review of DAC for recoverability, we recorded after-tax charges of $41 million in our universal and term universal life insurance products compared to $92 million after-tax charges in 2021. However, there was no recoverability charge in the fourth quarter of 2022 as a result of our favorable assumption update. For a discussion of additional information related to changes to our assumptions and DAC recoverability related to our life insurance business, see “—Critical Accounting Estimates.”

Our mortality experience for older ages is emerging and we continue to monitor trends in mortality improvement. We will continue to regularly review our mortality assumptions as well as all of our other assumptions in light of emerging experience. We may be required to make adjustments in the future to our assumptions which could impact our life insurance reserves. Any materially adverse changes to our assumptions, including mortality, persistency or interest rates, could have a materially negative impact on our results of operations, financial condition and business. For a discussion of additional information related to changes to our life insurance assumptions, see “—Critical Accounting Estimates.”

Compared to 1998 and prior years, we had a significant increase in term life insurance sales between 1999 and 2009, particularly in 1999 and 2000. The blocks of business issued since 2000 vary in size as compared to the large 1999 and 2000 blocks of business. As our large 10-, 15- and 20-year level premium period term life insurance policies written in 1999 and 2000 transitioned to their post-level guaranteed premium rate period, we experienced lower persistency compared to our pricing and valuation assumptions which accelerated DAC amortization in previous years. Our 20-year level premium period business written in 2002 began to enter its post-level period in 2022 and we experienced elevated DAC amortization, albeit lower than the levels we experienced in 2020 and 2019, due to higher-than-expected lapses as these policies exit the level premium period.

107

Table of Contents

Fixed annuities

Results of our fixed annuities business are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels. We no longer solicit sales of traditional fixed annuity products; however, we continue to service our existing retained and reinsured blocks of business.

We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we could see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.

We have previously had premium deficiencies in our single premium immediate annuity products that resulted in the establishment of additional future policy benefit reserves that were reflected as charges to net income. In 2022 and 2021, the results of our loss recognition testing did not result in a premium deficiency; therefore, our liability for future policy benefits was sufficient. The impacts of future adverse changes in our assumptions could result in the establishment of additional future policy benefit reserves and would be immediately reflected as a charge to earnings. For additional information, see “—Critical Accounting Estimates—Future Policy Benefits.”

For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.

Segment results of operations

The following table sets forth the results of operations relating to our U.S. Life Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Revenues:
Premiums$2,773$2,454$2,858$31913%
Net investment income2,7693,0292,878(260)(9)%
Net investment gains (losses)16329517(313)(95)%
Policy fees and other income543565595(22)(4)%
Total revenues6,1016,3776,848(276)(4)%
Benefits and expenses:
Benefits and other changes in policy reserves4,3014,2304,781712%
Interest credited322346383(24)(7)%
Acquisition and operating expenses, net of deferrals1,07886562021325%
Amortization of deferred acquisition costs and intangibles272340418(68)(20)%
Interest expense5%
Total benefits and expenses5,9735,7816,2071923%
Income from continuing operations before income taxes128596641(468)(79)%
Provision for income taxes55155163(100)(65)%
Income from continuing operations73441478(368)(83)%
Adjustments to income from continuing operations:
Net investment (gains) losses, net (1)(17)(330)(525)31395%
Losses on early extinguishment of debt4%
Initial loss from life block transaction92(92)(100)%
Expenses related to restructuring(1)171(18)(106)%
Pension plan termination costs88NM(2)
Taxes on adjustments347110(44)(94)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$66$267$68$(201)(75)%
Column 1Column 2
(1)For the years ended December 31, 2022, 2021 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million, $(1) million and $(8) million, respectively.
Column 1Column 2
(2)We define “NM” as not meaningful for increases or decreases greater than 200%.

108

Table of Contents

The following table sets forth adjusted operating income (loss) for the businesses included in our U.S. Life Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Long-term care insurance$142$445$237$(303)(68)%
Life insurance(148)(269)(247)12145%
Fixed annuities729178(19)(21)%
Total adjusted operating income available to Genworth Financial, Inc.’s common stockholders$66$267$68$(201)(75)%

2022 compared to 2021

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Column 1Column 2Column 3Column 4
Adjusted operating income in our long-term care insurance business decreased $303 million primarily from higher severity and frequency of new claims, lower net investment income and lower terminations as the pandemic impacts lessened in 2022. The decrease was also attributable to a $49 million less favorable impact in 2022 from in-force rate actions approved and implemented, which included a lower net favorable impact from policyholder benefit reduction elections made in connection with legal settlements, as the implementation of one is materially complete and the implementation of another one began in August 2022.
Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance business decreased $121 million mainly attributable to a favorable unlocking of $34 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2022 compared to an unfavorable unlocking of $70 million in 2021 (see “—Critical Accounting Estimates” for additional information). The decrease was also attributable to lower mortality as the pandemic impacts subsided and lower DAC impairments of $51 million in 2022. These decreases were partially offset by higher lapses in our 20-year term life insurance block written in 2002 entering its post-level premium period in 2022.
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuities business decreased $19 million mainly attributable to lower net spreads, partially offset by lower DAC amortization and higher mortality in our single premium immediate annuity products in 2022.

Revenues

Premiums

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $51 million primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $93 million of increased premiums in 2022 from in-force rate actions approved and implemented.
Column 1Column 2Column 3Column 4
Our life insurance business increased $370 million primarily driven by lower ceded premiums, partially offset by the continued runoff of our in-force blocks in 2022. In 2021, we initially ceded $360 million of certain term life insurance premiums under a new reinsurance treaty as part of a life block transaction.

109

Table of Contents

Net investment income

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $127 million largely from lower income of $169 million in 2022 mostly attributable to limited partnerships, bond calls and commercial mortgage loan prepayments. The decrease was partially offset by higher income of $18 million related to U.S. Government Treasury Inflation Protected Securities (“TIPS”) and higher average invested assets in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $24 million principally related to $19 million of lower bond calls and commercial mortgage loan prepayments, and lower average invested assets in 2022.
Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $109 million largely attributable to lower average invested assets, as well as $35 million of lower bond calls and commercial mortgage loan prepayments in 2022.

Net investment gains (losses)

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $238 million primarily driven by lower net unrealized gains from mark to market adjustments on limited partnerships and changes in the fair value of equity securities in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $69 million primarily due to lower net realized gains on the sale of investment securities in 2022, as well as unrealized losses from changes in the fair value of equity securities and derivative losses in 2022 compared to gains in 2021.

Policy fees and other income. The decrease was largely related to our life insurance business driven mostly by the runoff of our in-force blocks.

Benefits and expenses

Benefits and other changes in policy reserves

Column 1Column 2Column 3Column 4
Our long-term care insurance business increased $344 million primarily due to a less favorable impact of $253 million from reduced benefits in 2022 related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made in connection with legal settlements as the implementation of one is materially complete and the implementation of another one began in August 2022. The increase was also attributable to aging of the in-force block, including higher severity and frequency of new claims, less favorable development on incurred but not reported claims, as well as lower terminations as the impacts of the pandemic lessened in 2022. These increases were partially offset by lower incremental reserves of $244 million recorded in connection with an accrual for profits followed by losses in 2022. To account for the change in experience related to mortality and claim incidence due to COVID-19, we increased claim reserves by $10 million in 2021. As the impacts of COVID-19 lessened, we reduced claim reserves by $72 million in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business increased $135 million largely from higher ceded reinsurance in 2021. We initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction in 2021. The increase was partially offset by lower mortality and a favorable unlocking of $37 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2022 compared to an unfavorable unlocking of $86 million in 2021 (see “—Critical Accounting Estimates—Policyholder account balances” for additional information).
Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $408 million principally from lower assumed reserves as a result of a third-party recapture of $374 million of certain single premium immediate annuity contracts and from higher mortality in 2022.

110

Table of Contents

Interest credited. The decrease in interest credited was driven by declines of $18 million in our fixed annuities products and $6 million in our life insurance products due to lower average account values from block runoff.

Acquisition and operating expenses, net of deferrals

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $131 million principally related to lower premium taxes, commissions and other expenses of $98 million in 2022 associated with our in-force rate action plan, which included expenses related to policyholder benefit reduction elections made in connection with legal settlements as the implementation of one is materially complete and the implementation of another one began in August 2022. The decrease was also attributable to restructuring costs of $12 million in 2021 that did not recur and lower operating costs in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $7 million primarily due to lower reinsurance, operating and restructuring costs in 2022. These decreases were partially offset by a $25 million legal settlement expense, $19 million primarily related to conversion costs associated with an outsourcing arrangement and pension plan termination costs of $8 million in 2022.
Column 1Column 2Column 3Column 4
Our fixed annuities business increased $351 million primarily due to a payment of $365 million related to the recapture of certain single premium immediate annuity contracts by a third party in 2022, partially offset by lower operating costs largely due to block runoff.

Amortization of deferred acquisition costs and intangibles

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $17 million primarily due to lower policy terminations and policies entering paid-up status in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $38 million primarily from lower DAC impairments of $65 million on our universal and term universal life insurance products, as well as lower lapses and mortality in 2022, partially offset by higher lapses in our 20-year term life insurance block written in 2002 entering its post-level premium period.
Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $13 million primarily due to higher interest rates in 2022 that are expected to increase future investment spreads.

Provision for income taxes. The effective tax rate was 43.3% and 26.1% for the years ended December 31, 2022 and 2021, respectively. The increase in the effective tax rate was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income, in relation to lower pre-tax income in 2022.

U.S. Life Insurance selected operating performance measures

Long-term care insurance

As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to bring those blocks closer to a break-even point over time and reduce the strain on earnings and capital. We are also requesting premium rate increases and associated benefit reductions on newer blocks of business, as needed, some of which may be significant, to help bring their loss ratios back towards their original pricing. In aggregate, we estimate that we have achieved approximately $23.5 billion, on a net present value basis, of approved in-force rate increases since 2012. We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases and associated benefit reductions in order to pay future claims.

111

Table of Contents

The following table summarizes the impact from cumulative in-force rate actions on the results of operations of our long-term care insurance business for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Premiums$923$830$746$9311%
Plus: Benefits and other changes in policy reserves(1)659912507(253)(28)%
Less: Acquisition and operating expenses, net of deferrals(2)18428262(98)(35)%
Adjusted operating income before taxes1,3981,4601,191(62)(4)%
Income taxes294307250(13)(4)%
Adjusted operating income(3)$1,104$1,153$941$(49)(4)%
Column 1Column 2
(1)Amounts represent benefit reductions elected by policyholders as an alternative to increased premiums. These amounts reduced benefits and other changes in policy reserves in our long-term care insurance business for the periods indicated.
Column 1Column 2
(2)Amounts include premium taxes, commissions and other expenses associated with our long-term care insurance in-force rate action plan, which included expenses of $104 million and $209 million for the years ended December 31, 2022 and 2021, respectively, related to policyholder benefit reduction elections made in connection with legal settlements. Included in the $104 million and $209 million of expenses for the years ended December 31, 2022 and 2021, respectively, was $96 million and $185 million, respectively, of cash damages. The implementation of one legal settlement is materially complete and the implementation of another one began in August 2022.
Column 1Column 2
(3)Adjusted operating income available to Genworth Financial, Inc.’s common stockholders attributable to in-force rate actions excludes reserve updates resulting from profits followed by losses and reserve changes for group products.

See our results of operations above for additional details.

The following table presents net earned premiums and the loss ratio for our long-term care insurance business for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Net earned premiums:
Individual long-term care insurance(1)$2,405$2,466$2,497$(61)(2)%
Group long-term care insurance134124123108%
Total$2,539$2,590$2,620$(51)(2)%
Loss ratio75%61%71%14%
Column 1Column 2
(1)For the years ended December 31, 2022, 2021 and 2020, amounts include increased premiums of $923 million, $830 million and $746 million, respectively, from in-force rate actions approved and implemented.

The loss ratio is the ratio of benefits and other changes in reserves less tabular interest on reserves less loss adjustment expenses to net earned premiums.

Net earned premiums decreased in 2022 compared to 2021 primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $93 million of increased premiums in 2022 from in-force rate actions approved and implemented.

112

Table of Contents

The loss ratio increased in 2022 compared to 2021 due to higher benefits and other changes in reserves and lower premiums in 2022 as discussed above.

Life insurance

The following table sets forth selected operating performance measures regarding our life insurance business as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Term and whole life insurance
Net earned premiums (1)$234$(136)$238$370NM(2)
Life insurance in-force, net of reinsurance48,16247,29759,9198652%
Life insurance in-force before reinsurance300,145332,793362,082(32,648)(10)%
Term universal life insurance
Net deposits$187$203$217$(16)(8)%
Life insurance in-force, net of reinsurance92,71999,471107,048(6,752)(7)%
Life insurance in-force before reinsurance93,336100,119107,774(6,783)(7)%
Universal life insurance
Net deposits$245$259$269$(14)(5)%
Life insurance in-force, net of reinsurance29,79831,11732,501(1,319)(4)%
Life insurance in-force before reinsurance33,62235,22836,839(1,606)(5)%
Total life insurance
Net earned premiums and deposits (1)$666$326$724$340104%
Life insurance in-force, net of reinsurance170,679177,885199,468(7,206)(4)%
Life insurance in-force before reinsurance427,103468,140506,695(41,037)(9)%
Column 1Column 2
(1)In the fourth quarter of 2021, we initially ceded premiums of $360 million associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
Column 1Column 2
(2)We define “NM” as not meaningful for increases or decreases greater than 200%.

We no longer solicit sales of our traditional life insurance products; however, we continue to service our existing blocks of business.

Term and whole life insurance

Net earned premiums increased in 2022 compared to 2021 mainly attributable to lower ceded premiums in 2022, partially offset by the continued runoff of our in-force blocks. In 2021, we initially ceded $360 million of certain term life insurance premiums under a new reinsurance treaty as part of a life block transaction.

Universal and term universal life insurance

Net deposits decreased in 2022 compared to 2021 primarily attributable to lower renewals in 2022 and from the continued runoff of our in-force blocks.

113

Table of Contents

Fixed annuities

The following table sets forth selected operating performance measures regarding our fixed annuities business as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Account value, beginning of period$10,163$11,815$13,023$(1,652)(14)%
Deposits728380(11)(13)%
Surrenders, benefits and product charges (1)(2,015)(1,976)(1,886)(39)(2)%
Net flows(1,943)(1,893)(1,806)(50)(3)%
Interest credited and investment performance257349405(92)(26)%
Effect of accumulated net unrealized investment gains (losses)(627)(108)193(519)NM(2)
Account value, end of period$7,850$10,163$11,815$(2,313)(23)%
Column 1Column 2
(1)Amount included the recapture of $373 million account value of certain single premium immediate annuities by a third party during 2022.
Column 1Column 2
(2)We define “NM” as not meaningful for increases or decreases greater than 200%.

We no longer solicit sales of our traditional fixed annuity products; however, we continue to service our existing block of business.

Account value as of December 31, 2022 decreased compared to December 31, 2021 driven mostly by surrenders and benefits, which included the recapture of $373 million of certain single premium immediate annuity contracts by a third party in 2022. The decrease compared to December 31, 2021 was also attributable to unfavorable market performance, partially offset by interest credited in 2022.

Runoff segment

Trends and conditions

Results of our Runoff segment are affected primarily by investment performance, interest rate levels, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our Runoff segment can significantly impact our regulatory capital requirements, distributable earnings and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate the impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.

Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity and interest rate market performance and volatility could result in additional gains or losses in these products although associated hedging activities are expected to partially mitigate these impacts.

114

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Runoff segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Revenues:
Net investment income$214$194$210$2010%
Net investment gains (losses)(16)3(26)(19)NM(1)
Policy fees and other income114134130(20)(15)%
Total revenues312331314(19)(6)%
Benefits and expenses:
Benefits and other changes in policy reserves352748830%
Interest credited1811621661912%
Acquisition and operating expenses, net of deferrals425348(11)(21)%
Amortization of deferred acquisition costs and intangibles232023315%
Total benefits and expenses281262285197%
Income from continuing operations before income taxes316929(38)(55)%
Provision for income taxes5134(8)(62)%
Income from continuing operations265625(30)(54)%
Adjustments to income from continuing operations:
Net investment (gains) losses, net (2)14(3)2317NM(1)
Taxes on adjustments(3)1(5)(4)NM(1)
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$37$54$43$(17)(31)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)For the years ended December 31, 2022 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(2) million and $(3) million, respectively.

2022 compared to 2021

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income decreased predominantly due to the impact from unfavorable equity market performance and higher interest rates on our variable annuity products in 2022.

Revenues

Net investment income increased primarily from higher policy loan income in our corporate-owned life insurance products in 2022.

Net investment losses in 2022 were predominantly related to derivative losses, partially offset by gains on embedded derivatives associated with our variable annuity products with GMWBs. Net investment gains in 2021 were predominantly related to gains on embedded derivatives associated with our variable annuity products with GMWBs and net gains from the sale of investment securities, partially offset by derivative losses.

Policy fees and other income decreased principally from lower fee income driven mostly by a decline in the average account values in our variable annuity products in 2022.

115

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves increased primarily attributable to higher GMDB reserves in our variable annuity products due to unfavorable equity market performance and higher interest rates in 2022.

Interest credited increased largely due to our corporate-owned life insurance products in 2022.

Acquisition and operating expenses, net of deferrals, decreased principally from lower commissions and operating costs in our variable annuity products in 2022 due to block runoff.

Amortization of deferred acquisition costs and intangibles increased primarily from higher DAC amortization in our variable annuity products due to unfavorable equity market performance in 2022.

Provision for income taxes. The effective tax rate decreased to 14.9% for the year ended December 31, 2022 from 18.5% for the year ended December 31, 2021. The decrease was primarily attributable to tax benefits from tax favored items in relation to lower pre-tax income in 2022.

Runoff selected operating performance measures

Variable annuity and variable life insurance products

The following table sets forth selected operating performance measures regarding our variable annuity and variable life insurance products as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Account value, beginning of period$4,839$5,001$5,042$(162)(3)%
Deposits161920(3)(16)%
Surrenders, benefits and product charges(463)(607)(559)14424%
Net flows(447)(588)(539)14124%
Interest credited and investment performance(730)426498(1,156)NM(1)
Account value, end of period$3,662$4,839$5,001$(1,177)(24)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

We no longer solicit sales of our variable annuity or variable life insurance products; however, we continue to service our existing blocks of business and accept additional deposits on existing contracts and policies.

Account value as of December 31, 2022 decreased compared to December 31, 2021 primarily related to unfavorable equity market performance and surrenders in 2022.

116

Table of Contents

Funding agreements

The following table presents the account value of our funding agreements as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Account value, beginning of period$250$300$253$(50)(17)%
Deposits150%
Surrenders and benefits(53)(52)(106)(1)(2)%
Net flows(53)(52)44(1)(2)%
Interest credited323150%
Account value, end of period$200$250$300$(50)(20)%

Account value as of December 31, 2022 decreased compared to December 31, 2021 from a principal payment of $50 million.

Corporate and Other Activities

Results of operations

The following table sets forth the results of operations relating to Corporate and Other activities for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Revenues:
Premiums$6$6$7$%
Net investment income866233%
Net investment gains (losses)(15)(7)5(8)(114)%
Policy fees and other income1(2)(1)(100)%
Total revenues(1)616(7)(117)%
Benefits and expenses:
Benefits and other changes in policy reserves14(1)(100)%
Acquisition and operating expenses, net of deferrals247561(51)(68)%
Amortization of deferred acquisition costs and intangibles21(2)(100)%
Interest expense54109172(55)(50)%
Total benefits and expenses78187238(109)(58)%
Loss from continuing operations before income taxes(79)(181)(222)10256%
Benefit for income taxes(15)(53)(39)3872%
Loss from continuing operations(64)(128)(183)6450%
Adjustments to loss from continuing operations:
Net investment (gains) losses157(5)8114%
Losses on early extinguishment of debt6455(39)(87)%
Expenses related to restructuring142(14)(100)%
Taxes on adjustments(5)(14)(1)964%
Adjusted operating loss available to Genworth Financial Inc.’s common stockholders$(48)$(76)$(182)$2837%

117

Table of Contents

2022 compared to 2021

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily related to lower interest expense, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur.

Revenues

The increase in net investment losses was primarily related to net realized losses from the sale of investment securities in 2022 compared to net realized gains in 2021, partially offset by derivative gains in 2022 compared to derivative losses in 2021.

Benefits and expenses

Acquisition and operating expenses, net of deferrals, decreased mainly driven by $24 million of lower make-whole premiums on the early redemption of Genworth Holdings’ senior notes and $15 million of lower net losses related to the repurchase of Genworth Holdings’ senior notes in 2022, as well as $14 million of restructuring costs in 2021 that did not recur.

Interest expense decreased largely driven by the early redemption and repurchase of Genworth Holdings’ senior notes due in September 2021, August 2023 and February 2024, partially offset by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2022.

The decrease in the benefit for income taxes was primarily related to a reduction in uncertain tax positions due to the expiration of certain statute of limitations in 2021 that did not recur, as well as a lower pre-tax loss in 2022.

Investments and Derivative Instruments

General macroeconomic environment

The stability of both the financial markets and global economies in which we operate impacts the sales, revenue growth and profitability trends of our businesses as well as the value of assets and liabilities.

Varied levels of economic performance, coupled with uncertain economic outlooks, war and geopolitical tensions, changes in government policy, including monetary policy, global trade, regulatory and tax reforms, and other changes in market conditions, such as inflation, will continue to influence investment and spending decisions by consumers and businesses as they adjust their consumption, debt, capital and risk profiles in response to these conditions. These trends change as investor confidence in the markets and the outlook for some consumers and businesses shift. As a result, our sales, revenues and profitability trends of certain insurance and investment products as well as the value of assets and liabilities could be impacted going forward. In particular, government responses and displacements caused by COVID-19, including government stimulus, government spending, monetary policies (such as quantitative tightening), the volatility and strength of the capital markets, changes in tax policy and/or in U.S. tax legislation, inflation, including the price of oil, supply chain shortages, international trade and the impact of global financial regulation reform will continue to affect economic and business outlooks, level of interest rates, consumer confidence and consumer behavior moving forward.

During the fourth quarter of 2022, the U.S. Federal Reserve continued to aggressively address elevated inflation by increasing interest rates. The U.S. Federal Reserve increased interest rates by 75 basis points at its meeting held in November 2022 and by 50 basis points in December 2022, with an additional increase of 25 basis points in February 2023, bringing the target range to the highest level since 2007. An imbalance of supply

118

Table of Contents

and demand, a tightening labor market, supply chain disruptions, rising commodity prices and increased housing costs, as well as the Russian invasion of Ukraine and subsequent sanctions from the United States and Western Europe, contributed to the rise in inflation throughout 2022. The consumer price index peaked above 9% during the first half of 2022 but slowed for six consecutive months during the second half of 2022 with annual inflation of 6.5% as of December 31, 2022. A strong labor market partially offset some of the inflationary pressures in the economy, with the unemployment rate in line with pre-COVID-19 levels and job creation steady in the fourth quarter of 2022.

Gross domestic product contracted in the first half of 2022 due in part to elevated inflation pressure on consumers, monetary tightening and persistent supply chain disruptions, but increased modestly in the second half of 2022, reflecting increases in exports and government consumption, as well as consumer spending supported by a strong labor market. Given the persistent high inflation, supply chain disruptions, evolving U.S. Federal Reserve monetary policy, including the expectation of continued higher interest rates, and prolonged geopolitical tensions, it is possible the U.S. economy could fall into a recession in 2023. Specific to Genworth, we continue to closely monitor the operating results and financial position of Enact Holdings, particularly related to emerging housing trends. If housing trends move in an unfavorable direction in contrast to our current projections, our liquidity, financial position and results of operations could be adversely impacted. See “—Enact segment—Trends and conditions” for additional information.

Trends and conditions

Investments

U.S. Treasury yields fluctuated during the fourth quarter of 2022 driven by economic data releases and monetary policy actions by the U.S. Federal Reserve. The U.S. Treasury yield for shorter maturities increased during the fourth quarter of 2022 in line with actual and expected interest rate increases by the U.S. Federal Reserve. The differential between the two-year and ten-year U.S. Treasury yield continued to invert during the fourth quarter of 2022 as the two-year U.S. Treasury yield rose even higher than the ten-year U.S. Treasury yield. The thirty-year U.S. Treasury yield also rose higher than the ten-year U.S. Treasury yield as of December 31, 2022, normalizing the long-term end of the curve.

Credit markets performed well during the fourth quarter of 2022 due to a reduction in interest rate volatility driven by market clarity on monetary policy, as well as reduced macroeconomic pressures as a result of a strong labor market and moderating inflation. The improved economic environment allowed corporate borrowers to access capital markets with an increase in public corporate bond issuance, and investment grade credit spreads were lower during the fourth quarter of 2022.

As of December 31, 2022, our investment portfolio had no direct exposure to Russia or Ukraine. At this time, we do not believe there is a material risk to the valuation of our investment portfolio due to credit losses or direct write-offs that may arise as a result of the conflict.

As of December 31, 2022, our fixed maturity securities portfolio, which was 96% investment grade, comprised 77% of our total invested assets and cash.

Derivatives

As of December 31, 2022, $1.4 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”). The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2022, we posted initial margin of $71 million to our clearing agents, which represented approximately $36 million more than was otherwise required by the clearinghouse. Because our clearing agents

119

Table of Contents

serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings. As of December 31, 2022, $9.6 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $437 million and are holding collateral from counterparties in the amount of $21 million.

In July 2017, the United Kingdom Financial Conduct Authority announced its intention to transition away from London Interbank Offered Rate (“LIBOR”), with its full elimination to occur after 2021. The LIBOR tenors, such as the three-month LIBOR, have various phase-out dates with the last committed publication date of June 30, 2023. The Alternate Reference Rate Committee (“ARRC”), convened by the Board of Governors of the Federal Reserve System and the New York Federal Reserve Bank, has endorsed the Secured Overnight Financing Rate (“SOFR”) as its preferred replacement benchmark for U.S. dollar LIBOR. SOFR is calculated and published by the New York Federal Reserve Bank and reflects the combination of three overnight U.S. Treasury Repo Rates. The rate is different from LIBOR, in that it is a risk-free rate, is backward-looking instead of forward-looking, is a secured rate and currently is available primarily as an overnight rate rather than a one-, three- or six-month rate available for LIBOR.

We completed our assessment of operational readiness for LIBOR cessation related to our various instruments in 2021 and will continue to monitor the process of elimination and replacement of LIBOR, including any new accounting pronouncements that may be issued to provide further transition relief due to the extended cessation dates of certain LIBOR tenors. Since the initial announcement, we have terminated the majority of our LIBOR-based swaps and entered into alternative rate swaps. In anticipation of the elimination of LIBOR, we plan to continue to convert most of our remaining LIBOR-based derivatives in a similar manner. Moreover, we will continue to monitor the developments coming from ARRC, who is expected to authorize the use of an alternative rate to replace the current contractual three-month LIBOR rate applied to Genworth Holdings’ junior subordinated notes due in 2066. Although uncertainty remains surrounding the final cessation and transition away from LIBOR, we do not expect a material adverse impact on our results of operations or financial condition.

Investment results

The following table sets forth information about our investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31:

Increase (decrease)
2022202120202022 vs. 2021
(Amounts in millions)YieldAmountYieldAmountYieldAmountYieldAmount
Fixed maturity securities—taxable4.5%$2,2964.5%$2,4114.7%$2,448%$(115)
Fixed maturity securities—non-taxable4.7%55.6%74.3%6(0.9)%(2)
Equity securities4.0%104.0%94.2%12%1
Commercial mortgage loans4.6%3215.5%3765.0%345(0.9)%(55)
Policy loans10.0%2119.3%1899.5%1990.7%22
Limited partnerships (1)4.7%9915.7%2239.1%72(11.0)%(124)
Other invested assets (2)59.9%26769.7%24156.0%223(9.8)%26
Cash, cash equivalents, restricted cash and short-term investments1.2%20%10.5%151.2%19
Gross investment income before expenses and fees5.0%3,2295.2%3,4575.0%3,320(0.2)%(228)
Expenses and fees(0.2)%(83)(0.1)%(87)(0.1)%(93)(0.1)%4
Net investment income4.8%$3,1465.1%$3,3704.9%$3,227(0.3)%$(224)
Average invested assets and cash$65,160$66,099$65,982$(939)
Column 1Column 2
(1)Limited partnership investments are primarily equity-based and do not have fixed returns by period.
Column 1Column 2
(2)Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.

120

Table of Contents

Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments and securities lending activity, which was included in other invested assets prior to the suspension of our securities lending program in the third quarter of 2021 and was calculated net of the corresponding securities lending liability.

Gross annualized weighted-average investment yields decreased in 2022 compared to 2021 primarily driven by lower net investment income on lower average invested assets. Net investment income included $124 million of lower limited partnership income and $106 million of lower bond calls and commercial mortgage loan prepayments, partially offset by $18 million of higher income related to inflation-driven volatility on TIPS in 2022.

The following table sets forth net investment gains (losses) for the years ended December 31:

(Amounts in millions)202220212020
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains$28$67$471
Realized losses(102)(10)(29)
Net realized gains (losses) on available-for-sale fixed maturity securities(74)57442
Net realized gains (losses) on equity securities sold(7)(1)
Net realized gains (losses) on limited partnerships3
Total net realized investment gains (losses)(74)53441
Net change in allowance for credit losses on available-for-sale fixed maturity securities(6)(5)
Write-down of available-for-sale fixed maturity securities(2)(1)(4)
Net unrealized gains (losses) on equity securities still held(35)14
Net unrealized gains (losses) on limited partnerships71264112
Commercial mortgage loans4(3)(2)
Derivative instruments1714(49)
Other21(5)
Net investment gains (losses)$(17)$323$492

2022 compared to 2021

Column 1Column 2Column 3Column 4
We recorded net realized losses related to the sale of available-for-sale fixed maturity securities of $74 million in 2022 compared to net realized gains of $57 million in 2021 primarily driven by sales of U.S. corporate securities to manage asset exposure and to optimize cash at Genworth Holdings in 2022.
Column 1Column 2Column 3Column 4
We recorded $193 million of lower net unrealized gains on limited partnerships in 2022 compared to 2021 primarily from less favorable private equity market performance in 2022. We also recorded $35 million of net unrealized losses on equity securities during 2022 driven by unfavorable equity market performance.

121

Table of Contents

Investment portfolio

The following table sets forth our cash, cash equivalents and invested assets as of December 31:

20222021
(Amounts in millions)Carrying value% of totalCarrying value% of total
Available-for-sale fixed maturity securities:
Public$31,75753%$42,50158%
Private14,8262417,97924
Equity securities3191198
Commercial mortgage loans, net7,010116,8309
Policy loans2,13932,0503
Limited partnerships2,33141,9003
Other invested assets56618201
Cash, cash equivalents and restricted cash1,79931,5712
Total cash, cash equivalents and invested assets$60,747100%$73,849100%

For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for this line item under “—Consolidated Balance Sheets.” See note 4 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio.

We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2022, approximately 7% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 16 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value.

122

Table of Contents

Fixed maturity securities

As of December 31, 2022, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows:

(Amounts in millions)Amortized cost or costGross unrealized gainsGross unrealized lossesAllowance for credit lossesFair value
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises$3,446$86$(191)$$3,341
State and political subdivisions2,72619(346)2,399
Non-U.S. government73115(101)645
U.S. corporate:
Utilities4,29550(447)3,898
Energy2,45033(221)2,262
Finance and insurance8,00559(871)7,193
Consumer—non-cyclical4,77684(403)4,457
Technology and communications3,26543(361)2,947
Industrial1,31215(130)1,197
Capital goods2,29041(193)2,138
Consumer—cyclical1,75814(155)1,617
Transportation1,16532(97)1,100
Other3253(18)310
Total U.S. corporate29,641374(2,896)27,119
Non-U.S. corporate:
Utilities817(77)740
Energy1,00919(68)960
Finance and insurance2,12430(208)1,946
Consumer—non-cyclical6551(90)566
Technology and communications9974(107)894
Industrial8808(70)818
Capital goods6063(63)546
Consumer—cyclical308(32)276
Transportation39212(29)375
Other93215(58)889
Total non-U.S. corporate8,72092(802)8,010
Residential mortgage-backed1,0597(71)995
Commercial mortgage-backed2,1832(277)1,908
Other asset-backed2,3281(163)2,166
Total available-for-sale fixed maturity securities$50,834$596$(4,847)$$46,583

123

Table of Contents

As of December 31, 2021, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows:

(Amounts in millions)Amortized cost or costGross unrealized gainsGross unrealized lossesAllowance for credit lossesFair value
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises$3,368$1,184$$$4,552
State and political subdivisions2,982474(6)3,450
Non-U.S. government76286(13)835
U.S. corporate:
Utilities4,330783(9)5,104
Energy2,581363(10)2,934
Finance and insurance8,0031,012(24)8,991
Consumer—non-cyclical5,1381,029(8)6,159
Technology and communications3,345476(13)3,808
Industrial1,322175(3)1,494
Capital goods2,334415(4)2,745
Consumer—cyclical1,703203(7)1,899
Transportation1,1222491,371
Other37941(1)419
Total U.S. corporate30,2574,746(79)34,924
Non-U.S. corporate:
Utilities86763(2)928
Energy1,194190(1)1,383
Finance and insurance2,171270(9)2,432
Consumer—non-cyclical66481(2)743
Technology and communications1,085166(1)1,250
Industrial933117(3)1,047
Capital goods64066(1)705
Consumer—cyclical31627(2)341
Transportation42268(1)489
Other1,052169(4)1,217
Total non-U.S. corporate9,3441,217(26)10,535
Residential mortgage-backed1,325116(1)1,440
Commercial mortgage-backed2,435152(3)2,584
Other asset-backed2,13829(7)2,160
Total available-for-sale fixed maturity securities$52,611$8,004$(135)$$60,480

Fixed maturity securities decreased $13.9 billion primarily as a result of a change from net unrealized investment gains in 2021 to net unrealized investment losses in 2022 due to an increase in interest rates, as well as from net sales and maturities in 2022.

124

Table of Contents

Other invested assets

The following table sets forth the carrying values of our other invested assets as of December 31:

20222021
(Amounts in millions)Carrying value% of totalCarrying value% of total
Bank loan investments$46782%$36345%
Derivatives50941450
Short-term investments31263
Other investments468172
Total other invested assets$566100%$820100%

Derivatives decreased largely from an increase in interest rates in 2022. Bank loan investments increased from funding of additional investments, partially offset by principal repayments in 2022.

Derivatives

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for GMWB embedded derivatives, fixed index annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:

(Notional in millions)MeasurementDecember 31, 2021AdditionsMaturities/ terminationsDecember 31, 2022
Derivatives designated as hedges
Cash flow hedges:
Interest rate swapsNotional$7,653$1,109$(220)$8,542
Foreign currency swapsNotional12717144
Total cash flow hedges7,7801,126(220)8,686
Total derivatives designated as hedges7,7801,126(220)8,686
Derivatives not designated as hedges
Equity index optionsNotional1,446946(1,456)936
Financial futuresNotional9464,405(3,948)1,403
Other foreign currency contractsNotional83(83)
Total derivatives not designated as hedges2,4755,351(5,487)2,339
Total derivatives$10,255$6,477$(5,707)$11,025
(Number of policies)MeasurementDecember 31, 2021AdditionsMaturities/ terminationsDecember 31, 2022
Derivatives not designated as hedges
GMWB embedded derivativesPolicies21,804(1,876)19,928
Fixed index annuity embedded derivativesPolicies9,344(2,029)7,315
Indexed universal life embedded derivativesPolicies806(35)771

The increase in the notional value of derivatives was primarily attributable to the addition of interest rate swaps that support our long-term care insurance business and financial futures forecasted to be used to hedge changes in the fair value of MRBs under LDTI effective for us on January 1, 2023, partially offset by the

125

Table of Contents

termination of equity index options used to protect statutory surplus from equity market fluctuations. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to new accounting guidance.

The number of policies related to our embedded derivatives decreased as these products are no longer being offered and continue to runoff.

Critical Accounting Estimates

The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” In addition, the impact of new accounting guidance related to long-duration insurance contracts, commonly known as LDTI, that will be effective for us on January 1, 2023, will include significant changes to our consolidated financial statements. These changes will include updates to our future estimates and assumptions used to measure our insurance assets and liabilities for long-duration insurance contracts beginning on January 1, 2023 and applied to our historic comparative periods that will be re-presented commencing on the Transition Date. However, these changes are not effective for this annual report on Form 10-K, and accordingly, are not included in our critical accounting estimates herein. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

Insurance liabilities and reserves. We calculate and maintain reserves for the estimated future payment of claims to our policyholders and contractholders based on actuarial assumptions and in accordance with U.S. GAAP and industry practice. We build these reserves as the estimated value of those obligations increases, and we release these reserves as those future obligations are paid, experience changes or policies lapse. The reserves we establish reflect estimates and actuarial assumptions and methodologies with regard to our future experience, involve the exercise of significant judgment and are inherently uncertain. Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our reserves as well as the assumptions originally used in pricing our products.

Many factors, and changes in these factors, can affect future experience including, but not limited to: interest rates; investment returns and volatility; economic and social conditions, such as inflation, unemployment, home price appreciation or depreciation, and healthcare experience; policyholder persistency or lapses; insured mortality; insured morbidity; future premium rate increases and associated benefit reductions; expenses; and doctrines of legal liability and damage awards in litigation. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Moreover, we may not be able to mitigate the impact of unexpected adverse experience by increasing premiums and/or other charges to policyholders (where we have the right to do so) or by offering benefit reductions as an alternative to increasing premiums.

Future policy benefits

The liability for future policy benefits is equal to the present value of expected future benefits and expenses, less the present value of expected future net premiums based on assumptions including projected interest rates and investment returns, health care experience, policyholder persistency or lapses, insured mortality, insured morbidity and expenses, all of which are locked-in at the time the policies are issued or acquired. In our long-

126

Table of Contents

term care insurance business, our assumptions used in loss recognition testing also include significant premium rate increases and associated benefit reductions that have been filed and approved or are anticipated to be approved (including premium rate increases and associated benefit reductions not yet filed). The liability for future policy benefits is reviewed at least annually as a part of our loss recognition testing using current assumptions based on the manner of acquiring, servicing and measuring the profitability of the insurance contracts. Loss recognition testing is generally performed at the line of business level, with acquired blocks tested separately. If loss recognition testing indicates a premium deficiency, the liability for future policy benefits is measured using updated assumptions, which become the new locked-in assumptions utilized going forward unless another premium deficiency charge is recorded.

See notes 2 and 9 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to insurance reserves.

Long-term care insurance block, excluding our acquired block

We annually perform loss recognition testing for the liability for future policy benefits for our long-term care insurance products in the aggregate, excluding our acquired block of long-term care insurance, which is tested separately. The results of loss recognition testing are driven by changes to assumptions and methodologies primarily impacting claim termination rates, incidence and benefit utilization rates, mortality and lapse rates, as well as in-force rate actions. Claim termination rates refer to the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. As of December 31, 2022 and 2021, the liability for future policy benefits associated with our long-term care insurance block, excluding the acquired block, was $25.0 billion and $26.6 billion, respectively.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance loss recognition testing margin was as follows for the periods presented:

Other block (excluding the acquired block)Increase (decrease) and percentage change
December 31,
(Amounts in millions)202220212022 vs. 2021
Select estimates and assumptions used in loss recognition testing:
Present value of expected future benefits$49,452$49,495$(43)%
Future in-force rate action assumption$6,800$9,000$(2,200)(24)%
Discount rate assumption5.32%5.25%70/0001%

In 2022 and 2021, the results of our loss recognition testing on our long-term care insurance block, excluding the acquired block, indicated that our DAC was recoverable and reserves were sufficient, with a margin of approximately $400 million to $850 million as of December 31, 2022 compared to approximately $450 million to $900 million as of December 31, 2021. All key assumptions were reviewed in 2022 and 2021 and updated where appropriate. For the fourth quarter of 2022 review, we refined several assumptions, including reducing our lapse assumption in light of favorable experience from our long-term care insurance settlement elections and benefit reductions and updating our interest rate assumption to reflect the impact of the higher interest rate environment. These refinements were not significant, and we believe our assumptions are holding up in the aggregate. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and made no significant changes to our 2022 multi-year in-force rate action plan. However, we did increase the value of our assumption for future approvals and benefit reductions based on recent rate increase approval experience, regulatory support and legal settlement results. As margins remained positive, there was no reserve strengthening required, and therefore no resulting charge to net income.

127

Table of Contents

The decrease in the present value of expected future benefits was primarily attributable to actual benefit reductions in 2022 and expected future benefit reductions associated with our in-force rate action plan (among other factors), mostly offset by unfavorable assumption updates, most notably higher cost of care driven by elevated inflation.

Our assumption for future in-force rate actions is based on our best estimate of the rate increases we expect given our current plans for rate increase filings and our historical experience regarding rate increase approvals. The decrease in future in-force rate actions in 2022 compared to 2021 reflects in-force rate actions approved and implemented during 2022, partially offset by expected future in-force rate actions not yet filed, including in connection with the impacts from assumption updates. An increase in the expected amount of in-force rate actions would favorably impact the results of our long-term care insurance margin testing, whereas any unexpected reduction in the amount of in-force rate actions would negatively impact our margins.

We assume a static discount rate that is in line with our current portfolio yield. This rate represents our expected investment returns based on the portfolio of assets supporting the net U.S. GAAP liability as of the calculation date and, therefore, excludes the impacts of qualifying hedge gains that are not currently amortizing. Because the discount rate is based on our current portfolio yields, changes in interest rates do not impact our loss recognition testing margins unless they result in changes to investment yields. Returns on new investments would need to exceed our current portfolio yield to benefit loss recognition testing margins.

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2022 long-term care insurance loss recognition testing margin:

(Amounts in millions)Other block (excluding the acquired block)
Sensitivities on loss recognition testing: (1)
5% relative increase in future claim costs$(2,475)
10% reduction in benefit of future in-force rate actions$(680)
Discount rate decrease of 25 basis points (2)$(1,125)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another. For example, the increase in claim costs does not include any offsetting impacts from potential future in-force rate actions. Any such offset from in-force rate actions would primarily impact our long-term care insurance block, excluding the acquired block.
Column 1Column 2
(2)The 25 basis point decrease in the discount rate refers to a reduction in our portfolio yields.

Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding expense recognized in net income (loss). Our positive margin for our long-term care insurance block, excluding the acquired block, is dependent on our assumptions regarding our ability to successfully implement our in-force rate action strategy involving premium rate increases and associated benefit reductions. For our long-term care insurance block, excluding the acquired block, any adverse changes in assumptions would only be reflected in net income (loss) as a loss to the extent the margin was reduced below zero.

Profits followed by losses

With respect to our long-term care insurance block, excluding the acquired block, while loss recognition testing supports that in the aggregate our reserves are sufficient, our future projections indicate we have projected profits in earlier periods followed by projected losses in later periods. As a result of this pattern of projected profits followed by projected losses, we have ratably accrued additional future policy benefit reserves over the profitable periods by the amounts necessary to offset estimated losses during the periods that follow. Such

128

Table of Contents

additional reserves are updated each period and calculated based on our estimate of the amount necessary to offset the losses in future periods utilizing expected income and current best estimate assumptions based on actual and anticipated experience, consistent with our loss recognition testing. We adjust the accrual rate prospectively, over the remaining profitable periods, without any catch-up adjustment. During the years ended December 31, 2022 and 2021, we increased our long-term care insurance future policy benefit reserves by $405 million and $649 million, respectively, to accrue for profits followed by losses. As of December 31, 2022 and 2021, the total amount accrued for profits followed by losses was $1.7 billion and $1.3 billion, respectively. The accrual is recorded quarterly and is impacted by the pattern and present value of expected future losses which are updated annually at the time in which we perform loss recognition testing. During the fourth quarter of 2022, we updated our loss recognition testing assumptions, which included changes from our annual assumption review completed in the fourth quarter of 2022, as well as updates to our future in-force rate actions. The present value of expected future losses was approximately $2.3 billion and $2.5 billion as of December 31, 2022 and 2021, respectively. As of December 31, 2022 and 2021, we estimate a factor of approximately 79% and 76%, respectively, of those profits on our long-term care insurance block, excluding the acquired block, will be accrued in the future to offset estimated future losses during later periods. The factor increased compared to December 31, 2021 due mostly to lower actual profits in 2022 resulting in a need to accelerate the accrual for incremental future policy benefits for profits followed by losses.

Acquired block of long-term care insurance

As of December 31, 2022 and 2021, the liability for future policy benefits associated with our acquired block of long-term care insurance was $1.2 billion and $1.6 billion, respectively.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance loss recognition testing margin was as follows for the periods presented:

Acquired blockIncrease (decrease) and percentage change
December 31,
(Amounts in millions)202220212022 vs. 2021
Select estimates and assumptions used in loss recognition testing:
Present value of expected future benefits$1,900$2,118$(218)(10)%
Discount rate assumption5.91%6.06%(15)0/000(2)%

Our acquired block of long-term care insurance had positive margin of approximately $100 million to $150 million as of December 31, 2022 compared to approximately $50 million to $100 million as of December 31, 2021. The margin in 2022 increased primarily from updates to claim severity and incidence, partially offset by lower investment yields due to portfolio rebalancing resulting in an overall reduction in the interest rate used to discount the insurance liabilities.

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2022 long-term care insurance loss recognition testing margin:

(Amounts in millions)Acquired block
Sensitivities on loss recognition testing margin: (1)
5% relative increase in future claim costs$(95)
Discount rate decrease of 25 basis points (2)$(25)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another. For example, the increase in claim costs does not include any incremental adverse impacts from a potential decrease in the discount rate.
Column 1Column 2
(2)The 25 basis point decrease in the discount rate refers to a reduction in our portfolio yields.

129

Table of Contents

Due to the age of our acquired block, it would not benefit significantly from future in-force rate actions; therefore, in-force rate actions are excluded from the significant estimates and assumptions disclosed above.

Term and whole life insurance

Similar to our long-term care insurance products, we annually perform loss recognition testing for the liability for future policy benefits for our term and whole life insurance products in the aggregate, excluding our acquired block, which are tested separately. As of December 31, 2022 and 2021, the liability for future policy benefits associated with our term and whole life insurance products was $1.9 billion and $2.0 billion, respectively.

The risks we face in these products mostly include adverse variations in mortality and lapse assumptions. A summary of certain of our significant estimates used in the calculation of our term and whole life insurance block, excluding the acquired block, loss recognition testing margin was as follows for the periods presented:

Other block (excluding the acquired block)Increase (decrease) and percentage change
December 31,
(Amounts in millions)202220212022 vs. 2021
Select estimates used in loss recognition testing:
Total present value of expected future premiums$2,404$2,612$(208)(8)%
Total present value of expected death benefits and expenses$1,931$2,109$(178)(8)%

As of December 31, 2022 and 2021, we had margin of approximately $300 million to $800 million and a DAC balance of $0.7 billion and $0.8 billion, respectively, on our term and whole life insurance products, excluding the acquired block. The decrease in both the present value of expected future premiums and death benefits and expenses in 2022 was primarily attributable to elevated lapses in 2022.

A summary of certain of our significant estimates used in the calculation of our acquired term and whole life insurance block loss recognition testing margin was as follows for the periods presented:

Acquired blockIncrease (decrease) and percentage change
December 31,
(Amounts in millions)202220212022 vs. 2021
Select estimates used in loss recognition testing:
Total present value of expected future premiums$491$506$(15)(3)%
Total present value of expected death benefits and expenses$302$317$(15)(5)%

As of December 31, 2022 and 2021, we had margin of approximately $100 million to $300 million and a PVFP balance of $69 million and $71 million, respectively, on our acquired block of term and whole life insurance products.

130

Table of Contents

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2022 term and whole life insurance loss recognition testing margin:

(Amounts in millions)Other block (excluding the acquired block)Acquired blockTotal
Sensitivities on loss recognition testing: (1)
2% higher mortality$(55)$(7)$(62)
10% increase in lapses$(252)$(40)$(292)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another.

The sensitivities in the table above are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products.

Single premium immediate annuities

As of December 31, 2022 and 2021, the liability for future policy benefits associated with our single premium immediate annuity products with life contingencies was $10.0 billion and $11.3 billion, respectively. We regularly review our assumptions for these products and perform loss recognition testing at least annually. In 2016, we had a premium deficiency in our single premium immediate annuity products that resulted in the write-off of the entire DAC balance associated with these products. Subsequent to 2016, additional premium deficiencies have occurred in our single premium immediate annuity products that resulted in the establishment of additional future policy benefit reserves and were reflected as losses in net income.

In 2022, 2021 and 2020, the results of our loss recognition testing did not result in a premium deficiency; therefore, our liability for future policy benefits was sufficient, with a margin of approximately $25 million as of December 31, 2022 compared to approximately $85 million as of December 31, 2021. The decrease in the margin was primarily due to lower investment performance in relation to expected benefit payments and a reduction in the discount rate in 2022.

A summary of certain of our significant estimates and assumptions used in the calculation of our single premium immediate annuity products loss recognition testing margin was as follows for the periods presented:

December 31,Increase (decrease) and percentage change
(Amounts in millions)202220212022 vs. 2021
Select estimates and assumptions used in loss recognition testing:
Total present value of expected benefits and expenses$2,920$3,430$(510)(15)%
Reported investment yield5.54%5.79%(25)0/000(4)%

The decrease in the present value of expected benefits and expenses in 2022 was principally related to benefit payments and lower assumed reserves as a result of a third-party recapture of $374 million of certain single premium immediate annuity contracts in 2022, partially offset by the lower discount rate largely due to yield curve inversion during 2022.

131

Table of Contents

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2022 single premium immediate annuity products loss recognition testing margin:

(Amounts in millions)Single premium immediate annuity products
Sensitivities on loss recognition testing: (1)
2% lower mortality$(19)
10 basis point reduction in investment yields$(24)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another.

Policyholder account balances

The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future claims experience, which includes assumptions for insured mortality, interest rates and policyholder persistency or lapses, among other assumptions.

We perform an annual review of assumptions for our universal and term universal life insurance products, typically in the fourth quarter. Our 2022 review resulted in a decrease in the liability for policyholder account balances of $37 million, with a corresponding pre-tax benefit recorded to net income, largely associated with higher interest rates. Our 2021 review resulted in an increase in the liability for policyholder account balances of $87 million, with a corresponding pre-tax loss recorded to net income, predominantly driven by higher pre-COVID-19 mortality. Other assumption updates mostly focused on long-term interest rate trends. Our 2020 review resulted in a decrease in the liability for policyholder account balances of $118 million, with a corresponding pre-tax benefit recorded to net income, primarily due to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products.

As of December 31, 2022 and 2021, we had DAC of $236 million and $—, respectively, and total policyholder account balances including reserves in excess of the contract value of $8.1 billion and $9.0 billion, respectively, related to our universal and term universal life insurance products. The increase in DAC and decrease in policyholder account balances in 2022 compared to 2021 was primarily attributable to a reduction in shadow accounting adjustments associated with an increase in interest rates in 2022. As of December 31, 2022, for our universal and term universal life insurance products, we estimate that a 100 basis point reduction in interest rates from the December 31, 2022 level, or 2% higher mortality, scenarios that we consider to be reasonably possible given historical changes in market conditions and experience on these products, would result in a loss recorded to net income (loss) of approximately $40 million and $42 million, respectively. Adverse experience in persistency could also result in the impairment of PVFP associated with these products as well as the establishment of higher additional benefit reserves. Any favorable changes in these assumptions would result in a reduction in the liability for policyholder account balances.

Liability for policy and contract claims

The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (a) claims that have been

132

Table of Contents

reported to the insurer; (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.

Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss).

The following table sets forth our recorded liability for policy and contract claims as of December 31:

(Amounts in millions)20222021
U.S. Life Insurance segment:
Long-term care insurance$11,380$10,861
Life insurance299308
Fixed annuities1614
Enact segment519641
Runoff segment148
Other mortgage insurance (1)69
Total liability for policy and contract claims$12,234$11,841
Column 1Column 2
(1)Amounts included in Corporate and Other activities.

Long-term care insurance

The liability for policy and contract claims, also known as claim reserves, for our long-term care insurance products represents the present value of the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. Key assumptions include investment returns, health care experience, insured mortality, insured morbidity and expenses. Our discount rate assumption assumes a static discount rate in line with our current portfolio yield.

We review our assumptions and methodologies relating to our claim reserves for our long-term care insurance business annually in the fourth quarter. In the fourth quarter of 2022, as part of our review, we considered emerging experience particularly in mortality and benefit utilization, including the impact of increased cost of care due to inflation. Based on the review of our assumptions and methodologies, we did not make any significant changes to our claim reserves in 2022. During the fourth quarter of 2021, we did not make any significant changes to the assumptions or methodologies relating to our claim reserves based on our review, other than routine updates to investment returns as we typically do each quarter. These updates did not have a significant impact on claim reserve levels. As experience has emerged in the past, we have made resulting changes to our assumptions that have had a material impact on our results of operations and financial position. Our experience will continue to emerge and as a result there is a potential for future assumption reviews to result in further updates.

Mortgage insurance

Estimates of mortgage insurance reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers, using assumptions developed based on past experience and the expectation of future development. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loan moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the reserve for losses associated with the potential claim may also

133

Table of Contents

increase. These inherently judgmental assumptions are established in a respective geography based on historical and expected experience. Enact Holdings has established processes, as well as contractual rights, to ensure it receives timely information from loan servicers to aid in the establishment of its estimates. In addition, when Enact Holdings has obtained sufficient facts and circumstances through its investigative process, it has the unilateral right under its master policies and at law to rescind coverage on the underlying loan certificate as if coverage never existed. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, loss reserves are not established for future claims on insured loans that are not currently in default.

Management of Enact Holdings reviews the loss reserves quarterly for adequacy, and if necessary, updates the assumptions used for estimating and calculating such reserves based on actual experience and historical frequency of claim and severity of loss rates that are applied to the current population of delinquencies. Factors considered in establishing loss reserves include claim frequency patterns (reflecting the loss mitigation actions on such claim patterns), the aged category of the delinquency (i.e., age and progression of delinquency to claim), the severity of loss and loan coverage percentage. The establishment of Enact Holdings’ mortgage insurance loss reserves is subject to inherent uncertainty and requires judgment. The actual amount of the claim payments may vary significantly from the loss reserve estimates. Enact Holdings’ estimates could be adversely affected by several factors, including but not limited to, the development of COVID-19 delinquencies, a deterioration of regional or national economic conditions leading to a reduction in borrowers’ income and thus their ability to make mortgage payments, a drop in housing values that could expose Enact Holdings to greater loss on resale of properties obtained through foreclosure proceedings, extended foreclosure timelines and an adverse change in the effectiveness of loss mitigation actions that could result in an increase in the frequency of expected claim rates. Enact Holdings’ estimates are also affected by the extent of fraud and misrepresentation that are uncovered in the loans that are insured and the coverage upon which Enact Holdings has consequently rescinded or may rescind going forward. Enact Holdings’ loss reserving methodology includes estimates of the number of loans in its delinquency inventory that will be rescinded or modified, as well as estimates of the number of loans for which coverage may be reinstated under certain conditions following a rescission action.

In considering the potential sensitivity of the factors underlying Enact Holdings’ best estimate of its mortgage insurance reserves for losses, it is possible that even a relatively small change in estimated delinquency-to-claim rate (“frequency”) or a relatively small percentage change in estimated claim amount (“severity”) could have a significant impact on reserves and, correspondingly, on results of operations. For example, based on Enact Holdings’ actual experience during the three-year period ended December 31, 2022, a quarterly change of 6% in its average frequency reserve factor would change the gross loss reserve amount for such quarter by approximately $80 million and a change of 6% in its average severity reserve factor would change the gross loss reserve amount for such quarter by approximately $26 million.

Deferred acquisition costs. DAC represents costs that are directly related to the successful acquisition of new and renewal insurance policies and investment contracts which are deferred and amortized over the estimated life of the related insurance policies. These costs primarily include commissions in excess of ultimate renewal commissions and underwriting and contract and policy issuance expenses for policies successfully acquired. DAC is amortized to expense in relation to the anticipated recognition of premiums or gross profits. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

The amortization of DAC for traditional long-duration insurance products (including term life insurance, life-contingent structured settlements and immediate annuities and long-term care insurance) is determined as a level proportion of premiums based on accepted actuarial methods and reasonable assumptions, including related to projected interest rates and investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, established when

134

Table of Contents

the contract or policy is issued. U.S. GAAP requires that assumptions for these types of products not be modified (or unlocked) unless recoverability testing, also known as loss recognition testing, deems them to be inadequate. Amortization is adjusted each period to reflect actual lapses or terminations. Accordingly, we could experience accelerated amortization of DAC and a charge to net income (loss) if policies lapse or terminate earlier than originally assumed, or if we fail recoverability testing.

Amortization of DAC for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for the unlocking of underlying key assumptions including interest rates, policyholder persistency or lapses, insured mortality and expenses. The estimation of expected gross profits is subject to change given the inherent uncertainty as to the underlying key assumptions employed and the long duration of our policy or contract liabilities. Changes in expected gross profits reflecting the unlocking of underlying key assumptions could result in a material increase or decrease in the amortization of DAC depending on the magnitude of the change in underlying assumptions. Significant factors that could result in a material increase or decrease in DAC amortization for these products include material changes in withdrawal or lapse rates, investment spreads or mortality assumptions. For the years ended December 31, 2022, 2021 and 2020, key assumptions were unlocked in our U.S. Life Insurance and Runoff segments to reflect our current expectation of future investment spreads, lapse rates and mortality.

We review DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to net income (loss) is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserves plus the current estimate of expected future gross premiums and interest income for a line of business are less than the current estimate of expected future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for additional DAC amortization or for increased benefit reserves. The evaluation of DAC recoverability is subject to inherent uncertainty and requires significant judgment and estimates to determine the present values of future premiums, estimated gross profits and expected benefits and expenses of our businesses. In 2022, 2021 and 2020, in connection with our review of DAC for recoverability, we wrote off $52 million, $117 million and $63 million, respectively, of DAC in our universal and term universal life insurance products principally due to lower future estimated gross profits.

The following table sets forth the increase (decrease) in amortization of DAC related to unlocking of underlying key assumptions by segment for the years ended December 31:

(Amounts in millions)202220212020
U.S. Life Insurance$(3)$2$48
Enact6
Runoff(2)(2)(2)
Total$(5)$$52

Impacts on DAC from assumption reviews

In the fourth quarter of 2020, as part of our annual review of assumptions, we increased DAC amortization by $48 million in our universal and term universal life insurance products predominantly due to changes in expected gross profits driven mostly by lower projected cost of insurance assessments on our universal life insurance products and a model refinement in our term universal life insurance product related to persistency and grace period timing.

See notes 2 and 6 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to DAC.

135

Table of Contents

Valuation of fixed maturity securities. Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value.

The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the period-to-period changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening of credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. As well, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investments portfolio.

Estimates of fair value for fixed maturity securities are obtained primarily from industry-standard pricing models utilizing observable market inputs. For our less liquid securities, such as our privately placed securities, we utilize independent market data to employ alternative valuation methods commonly used in the financial services industry to estimate fair value. These securities are categorized into a three-level hierarchy based on the observability of the inputs used in estimating the fair value.

Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2022, 6% of our total fixed maturity securities related to Level 3 private fixed maturities valued using internal pricing models. See notes 2, 4 and 16 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments.

The following tables summarize the primary sources of data considered when determining fair value of each class of fixed maturity securities as of December 31:

2022
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$41,113$$41,113$
Broker quotes250250
Internal models5,2202,2802,940
Total fixed maturity securities$46,583$$43,393$3,190
2021
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$53,852$$53,852$
Broker quotes312312
Internal models6,3162,8203,496
Total fixed maturity securities$60,480$$56,672$3,808

136

Table of Contents

Consolidated Balance Sheets

Total assets. Total assets decreased $12,729 million from $99,171 million as of December 31, 2021 to $86,442 million as of December 31, 2022.

Column 1Column 2Column 3Column 4
Cash, cash equivalents and invested assets decreased $13,102 million primarily from decreases of $13,897 million and $254 million in fixed maturity securities and other invested assets, respectively, partially offset by increases of $431 million, $228 million and $180 million in limited partnerships, cash, cash equivalents and restricted cash, and commercial mortgage loans, respectively. The decrease in fixed maturity securities was predominantly related to a decrease in the fair value of our available-for-sale fixed maturities due to rising interest rates and from net sales and maturities in 2022. The decrease in other invested assets was largely driven by lower derivative valuations due to an increase in interest rates. These decreases were partially offset by increases in limited partnerships mainly from capital calls and commercial mortgage loans primarily from originations outpacing repayments in 2022, as well as an increase in cash, cash equivalents and restricted cash. The increase in cash, cash equivalents and restricted cash was largely attributable to net sales and maturities of fixed maturity securities, partially offset by net withdrawals from our investment contracts and the repurchase and early redemption of Genworth Holdings’ senior notes due in 2024 of $282 million in 2022.
Column 1Column 2Column 3Column 4
DAC increased $1,054 million principally attributable to a reduction in shadow accounting adjustments associated with an increase in interest rates in 2022. The reduction in shadow accounting adjustments increased DAC by approximately $1,332 million, mostly in our long-term care insurance business, with an offsetting amount recorded in accumulated other comprehensive income (loss). This increase was partially offset by amortization and by DAC impairments of $52 million in our universal and term universal life insurance products recorded in connection with our periodic reviews of DAC for recoverability.
Column 1Column 2Column 3Column 4
Reinsurance recoverable decreased $378 million mainly attributable to the runoff of our structured settlement products ceded to UFLIC.
Column 1Column 2Column 3Column 4
Deferred tax asset increased $1,225 million largely due to the change in unrealized gains (losses) on investments and derivatives due to rising interest rates, partially offset by the utilization of net operating losses in 2022. In addition, given the change in our unrealized gains (losses) on our fixed maturity securities and forward starting swaps due to rising interest rates and the corresponding reduction in the amount of unrealized capital gains expected to be available in the future to offset our capital loss carryforwards and other capital deferred tax assets, we recorded an additional valuation allowance of $200 million in 2022 through accumulated other comprehensive income (loss) related to deferred tax assets that would produce capital losses.
Column 1Column 2Column 3Column 4
Separate account assets (and liabilities) decreased $1,649 million primarily due to unfavorable equity market performance and surrenders in 2022.

Total liabilities. Total liabilities decreased $7,202 million from $82,905 million as of December 31, 2021 to $75,703 million as of December 31, 2022.

Column 1Column 2Column 3Column 4
Future policy benefits decreased $3,464 million primarily driven by a reduction in shadow accounting adjustments associated with an increase in interest rates in 2022. The reduction in shadow accounting adjustments decreased future policy benefits by approximately $3,181 million, mostly in our long-term care insurance business, with an offsetting amount recorded in accumulated other comprehensive income (loss). The decrease was also attributable to reduced benefits of $668 million related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made in connection with legal settlements in our long-term care insurance business. In addition, we released $371 million of future policy benefits in connection with the recapture of certain single premium immediate annuity contracts by a third

137

Table of Contents

Column 1Column 2
party in 2022. These decreases were partially offset by aging of our long-term care insurance in-force block and higher incremental reserves of $405 million recorded in connection with an accrual for profits followed by losses in 2022.
Column 1Column 2Column 3Column 4
Policyholder account balances decreased $2,241 million largely driven by a reduction in shadow accounting adjustments associated with an increase in interest rates in 2022. The reduction in shadow accounting adjustments decreased policyholder account balances by approximately $908 million in our universal life insurance products, with an offsetting amount recorded in accumulated other comprehensive income (loss). The decrease was also attributable to surrenders and benefits in our single premium deferred annuity products in 2022.
Column 1Column 2Column 3Column 4
Liability for policy and contract claims increased $393 million primarily related to our long-term care insurance business largely attributable to new claims and claim severity as a result of the aging of the in-force block, partially offset by claim terminations and pending claims that did not result in an active claim in 2022. The increase was also partially offset by a decrease in our Enact segment from net favorable reserve adjustments of $268 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening related to 2022 delinquencies given uncertainty in the current economic environment. The net favorable reserve adjustments were partially offset by new delinquencies in 2022.
Column 1Column 2Column 3Column 4
Other liabilities increased $161 million largely driven by a decline in derivative valuations due to an increase in interest rates, partially offset by lower counterparty collateral held from the decline in derivative valuations in 2022.
Column 1Column 2Column 3Column 4
Long-term borrowings decreased $288 million mostly attributable to the repurchase and early redemption of Genworth Holdings’ February 2024 senior notes in 2022. See note 12 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional details.

Total equity. Total equity decreased $5,527 million from $16,266 million as of December 31, 2021 to $10,739 million as of December 31, 2022.

Column 1Column 2Column 3Column 4
We reported net income available to Genworth Financial, Inc.’s common stockholders of $609 million for the year ended December 31, 2022.
Column 1Column 2Column 3Column 4
Unrealized gains (losses) on investments and derivatives qualifying as hedges decreased $5,286 million and $825 million, respectively, primarily from an increase in interest rates in 2022.
Column 1Column 2Column 3Column 4
Treasury stock increased $64 million primarily due to the repurchase of Genworth Financial’s common stock, at cost, in connection with a share repurchase program.

Liquidity and Capital Resources

Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.

138

Table of Contents

Overview of cash flows—Genworth and subsidiaries

The following table sets forth our condensed consolidated cash flows for the years ended December 31:

(Amounts in millions)202220212020
Net cash from operating activities$1,049$437$1,960
Net cash from (used by) investing activities733896(1,153)
Net cash used by financing activities(1,554)(2,419)(1,507)
Net increase (decrease) in cash before foreign exchange effect$228$(1,086)$(700)

Our principal sources of cash include sales of our products and services, income from our investment portfolio and proceeds from sales of investments. As an insurance business, we typically generate positive cash flows from operating activities, as premiums collected from our insurance products and income received from our investments typically exceed policy acquisition costs, benefits paid, redemptions and operating expenses. Our cash flows from operating activities are affected by the timing of premiums, fees and investment income received and benefits and expenses paid. Positive cash flows from operating activities are then invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flow, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; deposits to and maturities of funding agreements; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the acquisition of treasury stock and other capital transactions.

We had higher cash inflows from operating activities in 2022 primarily from lower payments to AXA, partially offset by higher net cash disbursements in connection with the return of cash collateral received from counterparties under our derivative contracts. In addition, in 2021, we made an initial cash payment of $360 million in connection with a new reinsurance agreement under which we ceded certain term life insurance policies. In 2022, we paid AXA $31 million related to estimated future claims, compared to payments of $561 million in 2021 comprised of the full repayment of a secured promissory note issued to AXA of $543 million, including accrued interest, and an $18 million settlement payment associated with underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business.

We had lower cash inflows from investing activities in 2022 mainly due to net proceeds received in 2021 from the sale of Genworth Australia, partially offset by higher net sales and maturities of fixed maturity securities in 2022.

We had lower cash outflows from financing activities in 2022 principally from lower repayment and repurchase of long-term debt and lower net withdrawals from our investment contracts, partially offset by net proceeds from the minority IPO of Enact Holdings in 2021. In 2022, Genworth Holdings repurchased $130 million and early redeemed $152 million principal balance of its senior notes originally due in February 2024 and repurchased $13 million principal amount of its senior notes due in 2034. In 2021, Genworth Holdings repurchased $91 million and $118 million principal amount of its senior notes due in August 2023 and February 2024, respectively, and early redeemed the remaining $309 million of its senior notes originally scheduled to mature in August 2023. Genworth Holdings also repurchased $146 million and early redeemed the remaining $513 million principal balance of its senior notes due in September 2021 and redeemed the $338 million principal balance of its senior notes due in February 2021.

Genworth—holding company liquidity

In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding

139

Table of Contents

company for their respective subsidiaries and do not have any significant operations of their own. Accordingly, our holding companies are highly dependent upon their respective subsidiaries to pay dividends and make other payments to meet their respective obligations. Moreover, management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt.

Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends from their respective subsidiaries, subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. Our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Although the business performance and financial results of our principal U.S. life insurance subsidiaries have improved significantly, as of December 31, 2022, they had negative unassigned surplus of approximately $849 million under statutory accounting and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors (including in the case of the payment of dividends to us, the approval of Enact Holdings’ independent capital committee) are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. In addition, insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details.

The primary uses of funds at Genworth Financial and Genworth Holdings include payment of principal, interest and other expenses on current and any future borrowings or other obligations (including payments to AXA associated with a settlement agreement reported as discontinued operations, payment of holding company general operating expenses (including employee benefits and taxes), payments under current and any future guarantees (including guarantees of certain subsidiary obligations), payment of amounts previously owed to GE under the Tax Matters Agreement, payments to subsidiaries (and, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, contributions to subsidiaries, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 13 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

In November 2008, Genworth Financial’s Board of Directors suspended the payment of dividends to its shareholders and the repurchase of common stock under the Company’s stock repurchase program indefinitely. Given the significant improvement in the results of operations and financial position of Genworth Financial and its subsidiaries, and the $2.1 billion of debt reduction in 2021, on May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial may repurchase up to $350 million of its outstanding Class A common stock. Pursuant to the program, during 2022, Genworth Financial repurchased 16,173,196 shares of its common stock at an average price of $3.94 per share for a total cash outlay of $64 million, including costs paid in connection with acquiring the shares. Genworth Financial also repurchased 5,912,297 shares from February 9, 2023 through February 24, 2023 of its common stock at an average price of $6.08 per share for a total cost of $36 million, leaving approximately $250 million that may yet be purchased under the share repurchase program. Future repurchases under the authorized program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future dividends from Genworth Financial’s ownership in Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or by other means, including through 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

Our future use of liquidity and capital will prioritize future strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases (as discussed above). With the early retirement of Genworth Holdings’ February 2024 debt in the third quarter of 2022, we achieved our deleveraging

140

Table of Contents

goal of reducing debt at Genworth Holdings to approximately $1.0 billion. As of December 31, 2022, Genworth Holdings had outstanding $887 million principal of long-term debt. We may from time to time seek to repurchase or redeem outstanding notes for cash (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise. We expect to provide capital to CareScout to help advance our senior care growth initiatives through fee-based services, advice, consulting and other products related to the needs of elderly Americans, as well as their caregivers and families. We will initially focus on care advice and service offerings that help consumers navigate the complex caregiving challenges in the market, which is less capital intensive than insurance product offerings.

As of December 31, 2022, Genworth Holdings had $307 million of unrestricted cash, cash equivalents and liquid assets. Given the early retirement in the third quarter of 2022 of its senior notes originally due in February 2024, no debt maturities are due until June 2034. For further information about Genworth Holdings’ borrowings, refer to note 12 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” In addition, in February 2022, Genworth Holdings paid AXA the majority of the remaining estimated unprocessed claims, and accordingly, we do not expect to pay AXA any significant amounts over the next twelve months.

We believe Genworth Holdings’ unrestricted cash, cash equivalents and liquid assets provide sufficient liquidity to meet its financial obligations over the next twelve months. However, we anticipate paying federal taxes starting in 2023 or 2024 due to projected taxable income and the utilization of our remaining net operating losses and foreign tax credits; therefore, we expect the amount of intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2023 or 2024 as compared to the amounts received during 2021 and 2022. We also expect Genworth Holdings’ liquidity to be significantly impacted by the amounts and timing of future dividends and other forms of capital returns from Enact Holdings, which will be influenced by economic, regulatory factors and other conditions that affect its business. We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. For example, although interest rates have risen dramatically during 2022, we do not expect a significant impact on our liquidity given the reduction in Genworth Holdings’ debt, which will decrease our future debt service costs. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or from future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.

Enact Holdings continues to evaluate its capital allocation strategy to consistently support its existing policyholders, grow its mortgage insurance business, fund attractive new business opportunities and return capital to shareholders. To this end, on April 26, 2022, Enact Holdings’ board of directors approved the initiation of a quarterly cash dividend program. Pursuant to the program, Enact Holdings paid quarterly dividends beginning in the second quarter of 2022, and Genworth Holdings received $57 million in 2022 as the majority shareholder. In addition, Enact Holdings paid a special dividend in the fourth quarter of 2022 and Genworth Holdings received approximately $148 million as the majority shareholder. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial, and also be dependent on a variety of economic, market and business conditions, among other considerations.

On November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings may repurchase up to $75 million of its outstanding common stock. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. Enact Holdings began share repurchases under the program in the fourth quarter of 2022. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Enact Holdings’ stock price and trading volume, and general business and market conditions, among other factors.

141

Table of Contents

Genworth Holdings—changes in liquidity

Genworth Holdings had $307 million and $331 million of cash and cash equivalents as of December 31, 2022 and 2021, respectively. Genworth Holdings also held $25 million in U.S. government securities as of December 31, 2021, which included approximately $3 million of restricted assets. The decrease in Genworth Holdings’ cash and cash equivalents was principally driven by the $282 million repurchase and early redemption of the principal balance of its senior notes originally due in February 2024, a $55 million payment to GE to satisfy its remaining obligation under the Tax Matters Agreement and the payment of unprocessed claims of $31 million to AXA, partially offset by intercompany cash tax payments received from its subsidiaries and dividends from Enact Holdings in 2022.

During 2022, 2021 and 2020, Genworth Holdings received cash dividends from Enact Holdings of $205 million, $163 million and $437 million, respectively. Dividends paid by Enact Holdings in 2022 and 2021 included a proportionate dividend distribution to minority shareholders. Dividends received by Genworth Holdings in 2020 were from net proceeds received from Enact Holdings’ senior notes issued in August 2020. During the years ended December 31, 2021 and 2020, Genworth Holdings received cash dividends from its international subsidiaries of $370 million and $11 million, respectively. Dividends received by Genworth Holdings in 2021 included the net proceeds from the sale of Genworth Australia.

There were no dividends paid to Genworth Holdings by its domestic life insurance subsidiaries during the years ended December 31, 2022, 2021 and 2020. As discussed above, we do not expect these subsidiaries to pay dividends for the foreseeable future.

Capital resources and financing activities

Our current capital resource plans do not include any additional debt offerings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of their respective subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations,” and “—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.” These risks may be exacerbated by the economic impact of current elevated interest rates and the affordability of homes.

On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. Any borrowings under Enact Holdings’ credit facility will bear interest at a per annum rate equal to a floating rate tied to a standard short-term borrowing index selected at Enact Holdings’ option, plus an applicable margin, pursuant to the terms of the credit agreement. The applicable margin is based on Enact Holdings’ ratings established by certain debt rating agencies for its outstanding debt. Enact Holdings may use borrowings under its credit facility for working capital needs and general corporate purposes, including the execution of dividends to its shareholders and capital contributions to its insurance subsidiaries. Enact Holdings’ credit facility includes customary representations, warranties, covenants, terms and conditions. As of December 31, 2022, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn.

In the fourth quarter of 2022, Genworth Holdings repurchased $13 million principal amount of its 6.50% senior notes due in 2034 for a pre-tax gain of $1 million and paid accrued interest thereon.

On September 21, 2022, Genworth Holdings early redeemed its 4.80% senior notes originally scheduled to mature in February 2024. The senior notes were fully redeemed with a cash payment of $155 million, comprised

142

Table of Contents

of the outstanding principal balance of $152 million, accrued interest of $1 million and a make-whole premium of $2 million. Prior to the early redemption of its 4.80% senior notes due in February 2024, Genworth Holdings repurchased $130 million principal amount of the notes for a pre-tax loss of $4 million in the first half of 2022 and also repurchased $118 million for a pre-tax loss of $6 million in the fourth quarter of 2021, and paid accrued interest thereon.

On December 15, 2021, Genworth Holdings early redeemed its 4.90% senior notes originally scheduled to mature in August 2023. The senior notes were fully redeemed with a cash payment of $334 million, comprised of the outstanding principal balance of $309 million, accrued interest of $5 million and a make-whole premium of $20 million. Prior to the early redemption, Genworth Holdings repurchased $91 million principal amount of its 4.90% senior notes due in September 2021 for a pre-tax loss of $9 million and paid accrued interest thereon.

On July 21, 2021, Genworth Holdings early redeemed its 7.625% senior notes originally scheduled to mature in September 2021. The senior notes were fully redeemed with a cash payment of $532 million, comprised of the outstanding principal balance of $513 million, accrued interest of $13 million and a make-whole premium of $6 million. Prior to the early redemption, Genworth Holdings repurchased $146 million principal amount of its 7.625% senior notes due in September 2021 for a pre-tax loss of $4 million and paid accrued interest thereon.

Genworth Holdings paid its 7.20% senior notes with a principal balance of $338 million at maturity on February 16, 2021. Genworth Holdings’ 7.20% senior notes were fully redeemed with a cash payment of $350 million, comprised of the outstanding principal balance and accrued interest.

Regulated insurance subsidiaries

Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends and distributions are required to be submitted to an insurer’s domiciliary department of insurance for review. Based on estimated statutory results as of December 31, 2022, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $292 million in 2023 without affirmative regulatory approval. However, Enact Holdings may not pay dividends in 2023 at this level as they may need to retain capital for regulatory purposes and preserve capital for future growth or to meet capital requirements.

The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payment of principal and interest on their outstanding debt obligations and income taxes. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. Given the challenging macroeconomic environment, during 2022, employee costs were higher driven in part by high inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. These inflationary impacts have not had a significant impact to date; however, we will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity.

Given our insurance product mix, payments to policyholders for insurance benefits are generally consistent each year with the exception of products that provide long-duration coverage, such as long-term care insurance. For example, our current projections reflect average annual claim payments of approximately $2.5 billion over the next five years primarily driven by surrender and benefit payments associated with fixed annuity products. Actual claims experience on products that provide long-duration coverage typically emerge over many years, change over time and are difficult to accurately predict. Therefore, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Moreover, for long-duration

143

Table of Contents

coverage products, we generally assume a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form 10-K. For example, in 2028 and thereafter, we assume approximately $96.9 billion of claims and benefit payments will be paid to policyholders or approximately 89% of our total undiscounted claims and benefit payments. These assumed payments are principally associated with our long-term care insurance products given their long-duration coverages. These amounts are derived from estimates and actuarial assumptions used in establishing our reserves; however, they have not been discounted to present value like our obligations to policyholders reported in our consolidated balance sheets in accordance with U.S. GAAP, where the liabilities are discounted consistent with the present value concept under accounting guidance related to accounting and reporting by insurance enterprises. Therefore, these undiscounted amounts significantly exceed the liabilities recorded in reserves for future policy benefits and the liability for policy and contract claims. These undiscounted amounts include estimated claims and benefits, policy surrender and commission obligations calculated consistent with U.S. GAAP on in-force long-duration insurance policies and investment contracts and also include estimated claims obligations on mortgage insurance policies in-force and amounts established for recourse and indemnification related to the contract underwriting business in our Enact segment. Due to the significance of the assumptions used in estimating our claim and benefit obligations, these assumed amounts could materially differ from actual results.

Our insurance subsidiaries have used cash flows from operations and investment activities to fund their liquidity requirements. Our insurance subsidiaries’ principal cash inflows from operating activities are derived from premiums, annuity deposits and insurance and investment product fees and other income, including commissions, cost of insurance, mortality, expense and surrender charges, contract underwriting fees, investment management fees, investment income and dividends and distributions from their subsidiaries. The principal cash inflows from investment activities result from maturities and repayments of investments and, as necessary, sales of invested assets.

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2022, our total cash, cash equivalents and invested assets were $60.7 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2022.

Guarantees and other off-balance sheet commitments

Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations.

Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2022, the risk in-force of active policies was approximately $950 million.

144

Table of Contents

Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior and subordinated notes indentures in respect of such senior and subordinated notes.

On March 1, 2021, Genworth Holdings entered into a guarantee agreement with Genworth Financial International Holdings, LLC (“GFIH”) whereby Genworth Holdings agreed to contribute additional capital to GFIH related to certain of its liabilities, or otherwise satisfy or discharge those liabilities. The liabilities include but are not limited to, claims and financial obligations or other liabilities of GFIH that existed immediately prior to the distribution of the net proceeds from the Genworth Australia sale. Pursuant to the agreement, Genworth Holdings paid AXA approximately €15 million ($18 million) in the second quarter of 2021 to settle amounts owed related to underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business.

Genworth Financial and certain of its holding companies also provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $69 million and $10 million as of December 31, 2022 and 2021, respectively. The potential obligations as of December 31, 2022 include amounts associated with leasing agreements related to our new headquarters office. For more information about our new headquarters office, see “Item 2—Properties.”

As of December 31, 2022, we were committed to fund $1,365 million in limited partnership investments, $70 million of bank loan investments which had not yet been drawn, $19 million in private placement investments and $5 million in commercial mortgage loan investments.

Supplemental Condensed Consolidating Financial Information

Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any, and interest on, and all other amounts payable under, the outstanding senior and subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior and subordinated notes indentures in respect of such senior and subordinated notes.

The following supplemental condensed consolidating financial information of Genworth Financial and its direct and indirect subsidiaries has been prepared pursuant to rules regarding the preparation of consolidating financial information of Regulation S-X, as amended by the SEC on March 2, 2020.

The supplemental condensed consolidating financial information presents the condensed consolidating balance sheet information as of December 31, 2022 and 2021 and the condensed consolidating income statement information, condensed consolidating comprehensive income statement information and condensed consolidating cash flow statement information for the years ended December 31, 2022 and 2021.

The supplemental condensed consolidating financial information reflects Genworth Financial (“Parent Guarantor”), Genworth Holdings (“Issuer”) and each of Genworth Financial’s other direct and indirect subsidiaries (the “All Other Subsidiaries”) on a combined basis, none of which guarantee the senior notes or subordinated notes, as well as the eliminations necessary to present Genworth Financial’s financial information on a consolidated basis and total consolidated amounts.

The accompanying supplemental condensed consolidating financial information is presented based on the equity method of accounting for all periods presented. Under this method, investments in subsidiaries are recorded at cost and adjusted for the subsidiaries’ cumulative results of operations, capital contributions and distributions, and other changes in equity. Elimination entries include consolidating and eliminating entries for investments in subsidiaries and intercompany activity.

145

Table of Contents

The following table presents the condensed consolidating balance sheet information as of December 31, 2022:

ParentAll Other
(Amounts in millions)GuarantorIssuerSubsidiariesEliminationsConsolidated
Assets
Investments:
Fixed maturity securities available-for-sale, at fair value (amortized cost of $50,834 and allowance for credit losses of $—)$$$46,583$$46,583
Equity securities, at fair value319319
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4)7,0327,032
Less: Allowance for credit losses(22)(22)
Commercial mortgage loans, net7,0107,010
Policy loans2,1392,139
Limited partnerships2,3312,331
Other invested assets566566
Investments in subsidiaries10,00810,256(20,264)
Total investments10,00810,25658,948(20,264)58,948
Cash, cash equivalents and restricted cash3071,4921,799
Accrued investment income643643
Deferred acquisition costs2,2002,200
Intangible assets241241
Reinsurance recoverable16,49516,495
Less: Allowance for credit losses(60)(60)
Reinsurance recoverable, net16,43516,435
Other assets388324415
Intercompany notes receivable2726(53)
Deferred tax assets62251,1131,344
Separate account assets4,4174,417
Total assets$10,017$10,903$85,839$(20,317)$86,442
Liabilities and equity
Liabilities:
Future policy benefits$$$38,064$$38,064
Policyholder account balances17,11317,113
Liability for policy and contract claims12,23412,234
Unearned premiums584584
Other liabilities771,6581,672
Intercompany notes payable26261(53)
Long-term borrowings8687431,611
Separate account liabilities4,4174,417
Liabilities related to discontinued operations448
Total liabilities3390574,818(53)75,703
Equity:
Common stock14(4)1
Additional paid-in capital11,86912,73418,203(30,937)11,869
Accumulated other comprehensive income (loss)(2,220)(2,220)(1,977)4,197(2,220)
Retained earnings3,098(516)(6,264)6,7803,098
Treasury stock, at cost(2,764)(2,764)
Total Genworth Financial, Inc.’s stockholders’ equity9,9849,9989,966(19,964)9,984
Noncontrolling interests1,055(300)755
Total equity9,9849,99811,021(20,264)10,739
Total liabilities and equity$10,017$10,903$85,839$(20,317)$86,442

146

Table of Contents

The following table presents the condensed consolidating balance sheet information as of December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Assets
Investments:
Fixed maturity securities available-for-sale, at fair value (amortized cost of $52,611 and allowance for credit losses of $—)$$$60,480$$60,480
Equity securities, at fair value198198
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4)6,8566,856
Less: Allowance for credit losses(26)(26)
Commercial mortgage loans, net6,8306,830
Policy loans2,0502,050
Limited partnerships1,9001,900
Other invested assets27793820
Investments in subsidiaries15,51715,626(31,143)
Total investments15,51715,65372,251(31,143)72,278
Cash, cash equivalents and restricted cash3311,2401,571
Accrued investment income647647
Deferred acquisition costs1,1461,146
Intangible assets143143
Reinsurance recoverable16,86816,868
Less: Allowance for credit losses(55)(55)
Reinsurance recoverable, net16,81316,813
Other assets5207176388
Intercompany notes receivable151(16)
Deferred tax assets4555(440)119
Separate account assets6,0666,066
Total assets$15,526$16,761$98,043$(31,159)$99,171
Liabilities and equity
Liabilities:
Future policy benefits$$$41,528$$41,528
Policyholder account balances19,35419,354
Liability for policy and contract claims11,84111,841
Unearned premiums672672
Other liabilities4641,4431,511
Intercompany notes payable1213(16)
Long-term borrowings1,1597401,899
Separate account liabilities6,0666,066
Liabilities related to discontinued operations30434
Total liabilities161,25481,651(16)82,905
Equity:
Common stock14(4)1
Additional paid-in capital11,85812,72418,135(30,859)11,858
Accumulated other comprehensive income (loss)3,8613,8613,906(7,767)3,861
Retained earnings2,490(1,078)(6,709)7,7872,490
Treasury stock, at cost(2,700)(2,700)
Total Genworth Financial, Inc.’s stockholders’ equity15,51015,50715,336(30,843)15,510
Noncontrolling interests1,056(300)756
Total equity15,51015,50716,392(31,143)16,266
Total liabilities and equity$15,526$16,761$98,043$(31,159)$99,171

147

Table of Contents

The following table presents the condensed consolidating income statement information for the year ended December 31, 2022:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Revenues:
Premiums$$$3,719$$3,719
Net investment income23,1443,146
Net investment gains (losses)(17)(17)
Policy fees and other income1660(2)659
Total revenues37,506(2)7,507
Benefits and expenses:
Benefits and other changes in policy reserves4,2424,242
Interest credited503503
Acquisition and operating expenses, net of deferrals3151,3351,371
Amortization of deferred acquisition costs and intangibles307307
Interest expense5553(2)106
Total benefits and expenses31606,440(2)6,529
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries(31)(57)1,066978
Provision (benefit) for income taxes(3)(15)257239
Equity in income of subsidiaries637685(1,322)
Income from continuing operations609643809(1,322)739
Income (loss) from discontinued operations, net of taxes(4)4
Net income609639813(1,322)739
Less: net income from continuing operations attributable to noncontrolling interests130130
Less: net income from discontinued operations attributable to noncontrolling interests
Net income available to Genworth Financial, Inc.’s common stockholders$609$639$683$(1,322)$609

148

Table of Contents

The following table presents the condensed consolidating income statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Revenues:
Premiums$$$3,435$$3,435
Net investment income(3)3,3733,370
Net investment gains (losses)323323
Policy fees and other income(1)7032704
Total revenues(3)(1)7,83427,832
Benefits and expenses:
Benefits and other changes in policy reserves4,3834,383
Interest credited508508
Acquisition and operating expenses, net of deferrals25441,1541,223
Amortization of deferred acquisition costs and intangibles377377
Interest expense(1)109502160
Total benefits and expenses241536,47226,651
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries(27)(154)1,3621,181
Provision (benefit) for income taxes(1)(33)297263
Equity in income of subsidiaries9301,041(1,971)
Income from continuing operations9049201,065(1,971)918
Income from discontinued operations, net of taxes131427
Net income9049331,079(1,971)945
Less: net income from continuing operations attributable to noncontrolling interests3333
Less: net income from discontinued operations attributable to noncontrolling interests88
Net income available to Genworth Financial, Inc.’s common stockholders$904$933$1,038$(1,971)$904

149

Table of Contents

The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2022:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Net income$609$639$813$(1,322)$739
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses(5,286)(5,286)(5,184)10,384(5,372)
Net unrealized gains (losses) on securities with an allowance for credit losses
Derivatives qualifying as hedges(825)(825)(815)1,640(825)
Foreign currency translation and other adjustments303030(60)30
Total other comprehensive income (loss)(6,081)(6,081)(5,969)11,964(6,167)
Total comprehensive loss(5,472)(5,442)(5,156)10,642(5,428)
Less: comprehensive income attributable to noncontrolling interests4444
Total comprehensive loss available to Genworth Financial, Inc.’s common stockholders$(5,472)$(5,442)$(5,200)$10,642$(5,472)

The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Net income$904$933$1,079$(1,971)$945
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses(334)(335)(371)670(370)
Net unrealized gains (losses) on securities with an allowance for credit losses666(12)6
Derivatives qualifying as hedges(186)(186)(215)401(186)
Foreign currency translation and other adjustments(24)(24)14947148
Total other comprehensive income (loss)(538)(539)(431)1,106(402)
Total comprehensive income366394648(865)543
Less: comprehensive income attributable to noncontrolling interests177177
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders$366$394$471$(865)$366

150

Table of Contents

The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2022:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Cash flows from (used by) operating activities:
Net income$609$639$813$(1,322)$739
Less (income) loss from discontinued operations, net of taxes4(4)
Adjustments to reconcile net income to net cash from operating activities:
Equity in income from subsidiaries(637)(685)1,322
Dividends from subsidiaries205(205)
Amortization of fixed maturity securities discounts and premiums3(157)(154)
Net investment (gains) losses1717
Charges assessed to policyholders(596)(596)
Acquisition costs deferred
Amortization of deferred acquisition costs and intangibles307307
Deferred income taxes(6)21922235
Derivative instruments, limited partnerships and other5(340)(335)
Stock-based compensation expense271037
Change in certain assets and liabilities:
Accrued investment income and other assets21(164)(161)
Insurance reserves863863
Current tax liabilities240(43)(1)
Other liabilities, policy and contract claims and other policy-related balances15(1)115129
Cash used by operating activities—discontinued operations(31)(31)
Net cash from operating activities123996381,049
Cash flows from (used by) investing activities:
Proceeds from maturities and repayments of investments:
Fixed maturity securities2,7052,705
Commercial mortgage loans759759
Limited partnerships and other invested assets185185
Proceeds from sales of investments:
Fixed maturity and equity securities2,6582,658
Purchases and originations of investments:
Fixed maturity and equity securities(4,035)(4,035)
Commercial mortgage loans(958)(958)
Limited partnerships and other invested assets(645)(645)
Short-term investments, net25(2)23
Policy loans, net4141
Intercompany notes receivable, net(99)6237
Capital contributions to subsidiaries(3)(6)9
Net cash from (used by) investing activities(3)(80)77937733
Cash flows from (used by) financing activities:
Deposits to universal life and investment contracts606606
Withdrawals from universal life and investment contracts(1,668)(1,668)
Repayment and repurchase of long-term debt(297)(297)
Intercompany notes payable, net649(36)(37)
Treasury stock acquired in connection with share repurchases(64)(64)
Dividends paid to noncontrolling interests(46)(46)
Other, net(9)(55)(21)(85)
Net cash used by financing activities(9)(343)(1,165)(37)(1,554)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net change in cash, cash equivalents and restricted cash(24)252228
Cash, cash equivalents and restricted cash at beginning of period3311,2401,571
Cash, cash equivalents and restricted cash at end of period3071,4921,799
Less cash, cash equivalents and restricted cash of discontinued operations at end of period
Cash, cash equivalents and restricted cash of continuing operations at end of period$$307$1,492$$1,799

151

Table of Contents

The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Cash flows from (used by) operating activities:
Net income$904$933$1,079$(1,971)$945
Less income from discontinued operations, net of taxes(13)(14)(27)
Adjustments to reconcile net income to net cash from (used by) operating activities:
Equity in income from subsidiaries(930)(1,041)1,971
Dividends from subsidiaries552(552)
Amortization of fixed maturity securities discounts and premiums6(182)(176)
Net investment (gains) losses(323)(323)
Charges assessed to policyholders(620)(620)
Acquisition costs deferred(8)(8)
Amortization of deferred acquisition costs and intangibles377377
Deferred income taxes341(51)290
Derivative instruments, limited partnerships and other75(434)(359)
Stock-based compensation expense4040
Change in certain assets and liabilities:
Accrued investment income and other assets(1)9(137)(129)
Insurance reserves642642
Current tax liabilities(5)17(46)(34)
Other liabilities, policy and contract claims and other policy-related balances(13)(40)363310
Cash from (used by) operating activities-discontinued operations(564)73(491)
Net cash from (used by) operating activities(5)275167437
Cash flows from (used by) investing activities:
Proceeds from maturities and repayments of investments:
Fixed maturity securities4,1624,162
Commercial mortgage loans874874
Limited partnerships and other invested assets255255
Proceeds from sales of investments:
Fixed maturity and equity securities2,2732,273
Purchases and originations of investments:
Fixed maturity and equity securities(5,216)(5,216)
Commercial mortgage loans(963)(963)
Limited partnerships and other invested assets(767)(767)
Short-term investments, net1818
Policy loans, net5757
Intercompany notes receivable, net4(1)(3)
Capital contributions to subsidiaries(2)2
Proceeds from sale of business, net of cash transferred270270
Cash used by investing activities-discontinued operations(67)(67)
Net cash from (used by) investing activities(2)4897(3)896
Cash flows from (used by) financing activities:
Deposits to universal life and investment contracts669669
Withdrawals from universal life and investment contracts(2,071)(2,071)
Repayment and repurchase of long-term debt(1,541)(1,541)
Intercompany notes payable, net121(16)3
Proceeds from the sale of subsidiary shares to noncontrolling interests529529
Dividends paid to noncontrolling interests(37)(37)
Other, net(5)(15)5232
Net cash from (used by) financing activities7(1,026)(1,403)3(2,419)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $(1) related to discontinued operations)11
Net change in cash, cash equivalents and restricted cash(747)(338)(1,085)
Cash, cash equivalents and restricted cash at beginning of period1,0781,5782,656
Cash, cash equivalents and restricted cash at end of period3311,2401,571
Less cash, cash equivalents and restricted cash of discontinued operations at end of period
Cash, cash equivalents and restricted cash of continuing operations at end of period$$331$1,240$$1,571

152

Table of Contents

Genworth Financial’s and Genworth Holdings’ insurance subsidiaries are subject to oversight by applicable insurance laws and regulations as to the amount of dividends they may pay to their parent in any year, the purpose of which is to protect affected insurance policyholders and contractholders, not stockholders. Enact Holdings’ ability to pay dividends is limited in part by such regulatory restrictions on its insurance subsidiaries. Dividends paid by Enact Holdings also include a proportionate distribution to minority shareholders. In addition, the GSEs have imposed certain restrictions on Enact Holdings with respect to the amount of holding company liquidity it must retain in connection with its outstanding debt. We believe the conditions set forth by the GSEs in connection to the restrictions were fully satisfied as of December 31, 2022 and expect the GSE Restrictions to be lifted in the first quarter of 2023, subject to GSE review and confirmation. Although the business performance and financial results of our principal U.S. life insurance subsidiaries have improved significantly, as of December 31, 2022, they had negative unassigned surplus of approximately $849 million under statutory accounting and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. For additional information on significant restrictions on dividends by insurance subsidiaries of Genworth Financial and Genworth Holdings, see note 17 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.”

For additional information on Genworth Financial’s capital management plans, including its share repurchase program, see “—Liquidity and Capital Resources.”

FY 2021 10-K MD&A

SEC filing source: 0001193125-22-055674.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2022-02-28. Report date: 2021-12-31.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.”

Item 7 of our Annual Report on Form
10-K
generally discusses

year-to-year

comparisons between the years ended December 31, 2021 and 2020. Other than our “Consolidated Results of Operations–Executive Summary of Consolidated Financial Results” which includes comparative discussions between 2020 and 2019 that have been
re-presented
to report our former Australian mortgage insurance business as discontinued operations, discussions of information related to 2019 and

year-to-year

comparisons between 2020 and 2019 are not included in this Form
10-K.
Other than the aforementioned section
re-presented
to reflect our former Australia mortgage insurance business reported as discontinued operations, comparative discussions between 2020 and 2019 can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form
10-K
for the year ended December 31, 2020.

Overview

Our business

Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage
in-force
blocks of life insurance and annuity products which are no longer sold. We report our business results through three operating business segments: Enact (formerly known as U.S. Mortgage Insurance); U.S. Life Insurance; and Runoff. We also have Corporate and Other activities. Our U.S. Life Insurance segment includes long-term care insurance, life insurance and fixed annuity products. The Runoff segment primarily includes variable annuity, variable life insurance and corporate-owned life insurance products, which have not been actively sold since 2011.

Our financial information

The financial information in this Annual Report on Form
10-K
has been derived from our consolidated financial statements.

Revenues and expenses

Our revenues consist primarily of the following:

Column 1Column 2Column 3Column 4
Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance.
Column 1Column 2Column 3Column 4
Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed

85

Table of Contents

Column 1Column 2
on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees.

Our expenses consist primarily of the following:

Column 1Column 2Column 3Column 4
Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid and reserve activity related to current claims and future policy benefits on insurance and investment products for long-term care insurance, life insurance, accident and health insurance, structured settlements and single premium immediate annuities with life contingencies, and claim costs incurred related to mortgage insurance products.
Column 1Column 2Column 3Column 4
Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances.
Column 1Column 2Column 3Column 4
Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses.
Column 1Column 2Column 3Column 4
Amortization of deferred acquisition costs and intangibles. Amortization of DAC and intangibles consists primarily of the amortization of acquisition costs that are capitalized, PVFP and capitalized software.
Column 1Column 2Column 3Column 4
Interest expense. Interest expense represents interest related to our borrowings that are incurred at Genworth Holdings or Enact Holdings and our non-recourse funding obligations, and interest expense related to the Tax Matters Agreement and certain reinsurance arrangements being accounted for as deposits.
Column 1Column 2Column 3Column 4
Income taxes. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other activities.

The effective tax rates disclosed herein are calculated using rounded numbers. As a result, the percentages shown may differ from an effective tax rate calculated using whole numbers.

We allocate corporate expenses to each of our operating segments using various methodologies, including based on the amount of capital allocated to each operating segment.

86

Table of Contents

Consolidated Results of Operations

The following table sets forth the consolidated results of operations for the periods indicated:

Increase (decrease) and
Years ended December 31,percentage change
(Amounts in millions)2021202020192021 vs. 20202020 vs. 2019
Revenues:
Premiums$3,435$3,836$3,725$(401)(10)%$1113%
Net investment income3,3703,2273,1641434%632%
Net investment gains (losses)32349227(169)(34)%465NM(1)
Policy fees and other income704729789(25)(3)%(60)(8)%
Total revenues7,8328,2847,705(452)(5)%5798%
Benefits and expenses:
Benefits and other changes in policy reserves4,3835,2145,059(831)(16)%1553%
Interest credited508549577(41)(7)%(28)(5)%
Acquisition and operating expenses, net of deferrals1,22393590928831%263%
Amortization of deferred acquisition costs and intangibles377463408(86)(19)%5513%
Interest expense160195231(35)(18)%(36)(16)%
Total benefits and expenses6,6517,3567,184(705)(10)%1722%
Income from continuing operations before income taxes1,18192852125327%40778%
Provision for income taxes2632301393314%9165%
Income from continuing operations91869838222032%31683%
Income (loss) from discontinued operations, net of taxes27(486)148513106%(634)NM(1)
Net income945212530733NM(1)(318)(60)%
Less: net income from continuing operations attributable to noncontrolling interests3333NM(1)%
Less: net income from discontinued operations attributable to noncontrolling interests834187(26)(76)%(153)(82)%
Net income available to Genworth Financial, Inc.’s common stockholders$904$178$343$726NM(1)$(165)(48)%
Net income available to Genworth Financial, Inc.’s common stockholders:
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders$885$698$382$18727%$31683%
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders19(520)(39)539104%(481)NM(1)
Net income available to Genworth Financial, Inc.’s common stockholders$904$178$343$726NM(1)$(165)(48)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and

87

Table of Contents

Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.

Use of
non-GAAP
measures

Reconciliation of net income (loss) to adjusted operating income (loss)

We use
non-GAAP
financial measures entitled “adjusted operating income (loss)” and “adjusted operating income (loss) per share.” Adjusted operating income (loss) per share is derived from adjusted operating income (loss). Our chief operating decision maker evaluates segment performance and allocates resources on the basis of adjusted operating income (loss). We define adjusted operating income (loss) as income (loss) from continuing operations excluding the
after-tax
effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, initial gains (losses) on insurance block transactions, restructuring costs and infrequent or unusual
non-operating
items. Initial gains (losses) on insurance block transactions are defined as gains (losses) on the early extinguishment of
non-recourse
funding obligations, early termination fees for other financing restructuring and/or initial gains (losses) on reinsurance restructuring for certain blocks of business. We exclude net investment gains (losses) and infrequent or unusual
non-operating
items because we do not consider them to be related to the operating performance of our segments and Corporate and Other activities. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. Gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, initial gains (losses) on insurance block transactions and restructuring costs are also excluded from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating trends. Infrequent or unusual
non-operating
items are also excluded from adjusted operating income (loss) if, in our opinion, they are not indicative of overall operating trends.

While some of these items may be significant components of net income (loss) in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss) as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Net investment gains (losses) are also adjusted for DAC and other intangible amortization and certain benefit reserves.

88

Table of Contents

The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31:

(Amounts in millions)202120202019
Net income available to Genworth Financial, Inc.’s common stockholders$904$178$343
Add: net income from continuing operations attributable to noncontrolling interests33
Add: net income from discontinued operations attributable to noncontrolling interests834187
Net income945212530
Less: income (loss) from discontinued operations, net of taxes27(486)148
Income from continuing operations918698382
Less: net income from continuing operations attributable to noncontrolling interests33
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders885698382
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net(1)(324)(503)(38)
(Gains) losses on early extinguishment of debt459
Initial loss from life block transaction92
Expenses related to restructuring3434
Taxes on adjustments331037
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$765$310$355
Column 1Column 2
(1)For the years ended December 31, 2021, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million, $(11) million and $(11) million, respectively.

In 2021, we paid a
pre-tax
make-whole premium of $6 million and $20 million related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in September 2021 and August 2023, respectively. We also repurchased $146 million principal amount of Genworth Holdings’ senior notes with 2021 maturity dates for a
pre-tax
loss of $4 million and repurchased $91 million and $118 million principal amount of Genworth Holdings’ senior notes due in 2023 and 2024, respectively, for a
pre-tax
loss of $15 million. During 2020, we repurchased $84 million principal amount of Genworth Holdings’ senior notes with 2021 maturity dates for a
pre-tax
gain of $4 million. In January 2020, we paid a
pre-tax
make-whole expense of $9 million related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in June 2020 and Rivermont Life Insurance Company I (“Rivermont I”), our indirect wholly-owned special purpose consolidated captive insurance subsidiary, early redeemed all of its $315 million outstanding
non-recourse
funding obligations originally due in 2050 resulting in a
pre-tax
loss of $4 million from the
write-off
of deferred borrowing costs. These transactions were excluded from adjusted operating income as they relate to gains (losses) on the early extinguishment of debt.

In the fourth quarter of 2021, we recorded a
pre-tax
loss of $92 million as a result of ceding certain term life insurance policies as part of a life block transaction.

In 2021, 2020 and 2019, we recorded a
pre-tax
expense of $34 million, $3 million and $4 million, respectively, related to restructuring costs as we continue to evaluate and appropriately size our organizational

89

Table of Contents

needs and expenses. There were no infrequent or unusual items excluded from adjusted operating income during the periods presented.

Earnings per share

The following table provides basic and diluted earnings per common share for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions, except per share amounts)2021202020192021 vs. 20202020 vs. 2019
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic$1.75$1.38$0.76$0.3727%$0.6282%
Diluted$1.72$1.36$0.75$0.3626%$0.6181%
Net income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$1.78$0.35$0.68$1.43NM(1)$(0.33)(49)%
Diluted$1.76$0.35$0.67$1.41NM(1)$(0.32)(48)%
Adjusted operating income available to Genworth
Financial, Inc.’s common stockholders per share:
Basic$1.51$0.61$0.71$0.90147%$(0.10)(14)%
Diluted$1.48$0.61$0.70$0.87143%$(0.09)(13)%
Weighted-average common shares outstanding:
Basic506.9505.2502.9
Diluted514.7511.6509.7
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Diluted weighted-average shares outstanding reflect the effects of potentially dilutive securities including stock options, restricted stock units and other equity-based compensation.

90

Table of Contents

The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other activities for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 20202020 vs. 2019
Adjusted operating income (loss) available to Genworth
Financial, Inc.’s common stockholders:
Enact segment$520$381$568$13936%$(187)(33)%
U.S. Life Insurance segment:
Long-term care insurance4452375720888%180NM(1)
Life insurance(269)(247)(181)(22)(9)%(66)(36)%
Fixed annuities9178691317%913%
U.S. Life Insurance segment26768(55)199NM(1)123NM(1)
Runoff segment5443561126%(13)(23)%
Corporate and Other activities(76)(182)(214)10658%3215%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$765$310$355$455147%$(45)(13)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Executive Summary of Consolidated Financial Results

Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated.

For a discussion of selected financial information and detailed descriptions of operating performance measures see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”

2021 compared to 2020

Column 1Column 2Column 3Column 4
Net income for the years ended December 31, 2021 and 2020 was $904 million and $178 million, respectively, and adjusted operating income was $765 million and $310 million, respectively. Our Enact segment drove our December 31, 2021 consolidated financial results, reporting $520 million of adjusted operating income, an increase of 36% compared to the year ended December 31, 2020. Our U.S. Life Insurance segment reported adjusted operating income of $267 million in 2021 driven mostly by favorable long-term care insurance operating results, which reported adjusted operating income of $445 million for the year ended December 31, 2021, an increase of 88% compared to the year ended December 31, 2020. These improvements were partially offset by an adjusted operating loss of $269 million in our life insurance business. The following is a summary comparison of adjusted operating income (loss) for our segments and Corporate and Other activities:
Column 1Column 2Column 3Column 4
Our Enact segment had adjusted operating income of $520 million and $381 million in 2021 and 2020, respectively.
Column 1Column 2Column 3Column 4
The increase was primarily attributable to lower losses mainly from lower new delinquencies and net favorable reserve adjustments of $17 million in 2021 compared to unfavorable reserve adjustments of $51 million in 2020.
Column 1Column 2Column 3Column 4
These improvements were partially offset by higher interest expense associated with Enact Holdings’ senior notes issued in August 2020, an increase in operating costs and the minority

91

Table of Contents

Column 1Column 2
IPO of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6% and resulted in lower net income of $33 million in 2021.
Column 1Column 2Column 3Column 4
Our U.S. Life Insurance segment had adjusted operating income of $267 million and $68 million in 2021 and 2020, respectively.
Column 1Column 2Column 3Column 4
Long-term care insurance:
Column 1Column 2Column 3Column 4
Adjusted operating income increased $208 million primarily from higher net investment income, as well as higher premiums and reduced benefits of $212 million in 2021 from in-force rate actions approved and implemented, which included a net favorable impact from policyholder benefit reduction elections made as part of a legal settlement.
Column 1Column 2Column 3Column 4
The increase was also attributable to favorable development on incurred but not reported (“IBNR”) claims.
Column 1Column 2Column 3Column 4
The year ended December 31, 2020 included higher claim reserves of $157 million associated with changes to incidence and mortality experience driven by COVID-19, which we believe are temporary.
Column 1Column 2Column 3Column 4
Life insurance:
Column 1Column 2Column 3Column 4
The adjusted operating loss increased $22 million mainly attributable to an unfavorable unlocking of $70 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2021 compared to a favorable unlocking of $60 million in 2020 (see “—Critical Accounting Estimates” for additional information).
Column 1Column 2Column 3Column 4
The higher loss was also attributable to higher mortality in 2021 compared to 2020 and higher DAC impairments of $42 million in 2021 in our universal and term universal life insurance products principally due to lower future estimated gross profits.
Column 1Column 2Column 3Column 4
The higher loss was partially offset by lower lapses primarily associated with our large 20-year term life insurance block written at the end of 2000 as it entered its post-level premium period.
Column 1Column 2Column 3Column 4
Fixed annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income increased $13 million mainly attributable to lower reserves and DAC amortization in our fixed indexed annuities driven by favorable changes in interest rates and equity markets.
Column 1Column 2Column 3Column 4
These improvements were partially offset by lower net spreads in 2021.
Column 1Column 2Column 3Column 4
Our Runoff segment had adjusted operating income of $54 million and $43 million in 2021 and 2020, respectively.
Column 1Column 2Column 3Column 4
The increase was primarily due to favorable equity market and interest rate performance in 2021.
Column 1Column 2Column 3Column 4
These improvements were partially offset by lower investment income in 2021.
Column 1Column 2Column 3Column 4
The year ended December 31, 2020 included an unfavorable assumption update of $5 million.
Column 1Column 2Column 3Column 4
Corporate and Other activities had an adjusted operating loss of $76 million and $182 million in 2021 and 2020, respectively.
Column 1Column 2Column 3Column 4
The decrease in the loss was primarily related to lower interest expense, higher tax benefits of $21 million from a reduction in uncertain tax positions due to the expiration of certain statute of limitations and lower operating costs in 2021.

92

Table of Contents

2020 compared to 2019

Column 1Column 2Column 3Column 4
Net income for the years ended December 31, 2020 and 2019 was $178 million and $343 million, respectively, and adjusted operating income was $310 million and $355 million, respectively. Our U.S. Life Insurance segment reported adjusted operating income of $68 million in 2020 driven mostly by favorable long-term care insurance operating results, which reported adjusted operating income of $237 million for the year ended December 31, 2020, an increase of $180 million compared to the year ended December 31, 2019. This improvement was more than offset by an adjusted operating loss of $247 million in our life insurance business and lower adjusted operating income of $187 million in our Enact segment in 2020 compared to 2019. The following is a summary comparison of adjusted operating income (loss) for our segments and Corporate and Other activities:
Column 1Column 2Column 3Column 4
Our Enact segment had adjusted operating income of $381 million and $568 million in 2020 and 2019, respectively.
Column 1Column 2Column 3Column 4
The decrease was primarily attributable to higher losses largely from new delinquencies driven in large part by a significant increase in borrower forbearance as a result of COVID-19, reserve strengthening of $51 million on existing delinquencies and from lower net benefits from cures and aging of existing delinquencies in 2020.
Column 1Column 2Column 3Column 4
These decreases were partially offset by higher premiums largely driven by higher insurance in-force and an increase in single premium policy cancellations primarily due to higher mortgage refinancing in 2020.
Column 1Column 2Column 3Column 4
The year ended December 31, 2019 included favorable reserve adjustments of $18 million mostly associated with lower expected claim rates and a favorable adjustment of $11 million related to our single premium earnings pattern review.
Column 1Column 2Column 3Column 4
Our U.S. Life Insurance segment had adjusted operating income of $68 million in 2020 compared to an adjusted operating loss of $55 million in 2019.
Column 1Column 2Column 3Column 4
Long-term care insurance:
Column 1Column 2Column 3Column 4
Adjusted operating income increased $180 million primarily from an increase in claim terminations driven mostly by higher mortality, as well as favorable development on IBNR claims and higher investment income in 2020.
Column 1Column 2Column 3Column 4
We also increased reserves by $157 million in 2020 to account for changes to incidence and mortality experience driven by COVID-19.
Column 1Column 2Column 3Column 4
Life insurance:
Column 1Column 2Column 3Column 4
The adjusted operating loss increased $66 million predominantly attributable to higher reserves in our 10-year term universal life insurance block as it entered its post-level premium period during the premium grace period, higher mortality in 2020 compared to 2019, higher lapses primarily associated with our large 20-year term life insurance block as it entered its post-level premium period and a DAC impairment of $50 million in 2020.
Column 1Column 2Column 3Column 4
The higher loss was partially offset by a favorable unlocking of $60 million in our term universal and universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2020 compared to unfavorable unlocking of $107 million in 2019 (see “—Critical Accounting Estimates” for additional information).
Column 1Column 2Column 3Column 4
Fixed annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income increased $9 million predominantly from $39 million of unfavorable charges related to loss recognition testing in 2019 that did not recur (see

93

Table of Contents

Column 1Column 2
“—Critical Accounting Estimates—Future policy benefits” for additional information) and lower interest credited due to block runoff.
Column 1Column 2Column 3Column 4
These improvements were partially offset by lower net spreads in 2020.
Column 1Column 2Column 3Column 4
Our Runoff segment had adjusted operating income of $43 million and $56 million in 2020 and 2019, respectively.
Column 1Column 2Column 3Column 4
The decrease was predominantly due to less favorable equity market performance, an unfavorable assumption update of $5 million and a decline in interest rates in 2020.
Column 1Column 2Column 3Column 4
These decreases were partially offset by higher net spreads in 2020.
Column 1Column 2Column 3Column 4
Corporate and Other activities had an adjusted operating loss of $182 million and $214 million in 2020 and 2019, respectively.
Column 1Column 2Column 3Column 4
The decrease in the loss was primarily related to lower interest expense in 2020.
Column 1Column 2Column 3Column 4
This improvement was partially offset by lower income tax benefits in 2020.

Significant Developments and Strategic Highlights

The periods under review include, among others, the following significant developments and steps taken in the execution of our strategic priorities.

Enact

Column 1Column 2Column 3Column 4
PMIERs compliance:
Column 1Column 2Column 3Column 4
Enact’s PMIERs sufficiency ratio was 165% or $2,003 million above the published PMIERs requirements as of December 31, 2021.
Column 1Column 2Column 3Column 4
As of December 31, 2021, Enact had estimated available assets of $5,077 million against $3,074 million net required assets under PMIERs compared to available assets of $4,588 million against $3,359 million net required assets as of December 31, 2020 (PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE restrictions imposed on Enact Holdings).
Column 1Column 2Column 3Column 4
The increase in the PMIERs sufficiency was driven by a higher volume of credit risk transfer transactions, elevated lapse driven by prevailing low interest rates, business cash flows and lower delinquencies, partially offset by elevated new insurance written.
Column 1Column 2Column 3Column 4
As of December 31, 2021 and 2020, Enact’s PMIERs required assets benefited by $390 million and $1,046 million, respectively, from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans.

For additional information related to PMIERs, see “Item 1—Business—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.”

Column 1Column 2Column 3Column 4
Dividends:
Column 1Column 2Column 3Column 4
Enact Holdings paid a dividend of $163 million to Genworth Holdings in the fourth quarter of 2021.
Column 1Column 2Column 3Column 4
Enact Holdings intends to develop a formal dividend policy and initiate a regular common dividend during 2022.
Column 1Column 2Column 3Column 4
Enact Holdings’ dividend policy is a critical piece in determining Genworth’s future cash flows, and once set, it could help pave the way for returning capital to Genworth Financial shareholders.

94

Table of Contents

U.S. Life Insurance

Column 1Column 2Column 3Column 4
Cumulative economic benefit from in-force rate actions:
Column 1Column 2Column 3Column 4
During 2021, we continued to make strong progress on our long-term care insurance in-force rate action plan.
Column 1Column 2Column 3Column 4
We estimate that the cumulative economic benefit of our long-term care insurance multi-year in-force rate action plan through 2021 was approximately $19.6 billion, on a net present value basis, of the total expected amount required of $28.7 billion.
Column 1Column 2Column 3Column 4
Completion of annual long-term care insurance assumption review:
Column 1Column 2Column 3Column 4
In the fourth quarter of 2021, we completed a review of our assumptions and methodologies of our claim reserves and future policy benefits for our long-term care insurance business and completed loss recognition testing.
Column 1Column 2Column 3Column 4
We made no changes to our existing claim reserves, as experience in the aggregate was in line with expectations.
Column 1Column 2Column 3Column 4
The 2021 U.S. GAAP margins for our long-term care insurance business remained within the range of approximately $0.5 billion to $1.0 billion.
Column 1Column 2Column 3Column 4
Completion of annual life insurance assumption review:
Column 1Column 2Column 3Column 4
We also completed a review of our assumptions and methodologies of our life insurances business and completed loss recognition testing in the fourth quarter of 2021.
Column 1Column 2Column 3Column 4
The loss recognition testing margin for our term life insurance products remained positive in 2021.
Column 1Column 2Column 3Column 4
As part of our review in the fourth quarter of 2021, we recorded a $70 million after-tax expense to net income in our universal and term universal life insurance products primarily related to higher pre-COVID-19 mortality experience.

For additional information see “—Critical Accounting Estimates.”

Column 1Column 2Column 3Column 4
Completion of a life block transaction:
Column 1Column 2Column 3Column 4
In the fourth quarter of 2021, we recorded an after-tax loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction.
Column 1Column 2Column 3Column 4
This transaction generated statutory capital in excess of approximately $170 million for our U.S. life insurance subsidiaries.

Liquidity and Capital Resources

Column 1Column 2Column 3Column 4
Execution of strategic plan to reduce debt maturities:
Column 1Column 2Column 3Column 4
We continue to focus on deleveraging with a goal of reducing debt at Genworth Holdings, the issuer of our outstanding public debt, to approximately $1.0 billion over time.
Column 1Column 2Column 3Column 4
During 2021, Genworth Holdings repaid approximately $2.1 billion of debt and other obligations, including the repayment of the AXA promissory note.
Column 1Column 2Column 3Column 4
As of December 31, 2021, Genworth Holdings had outstanding $1.2 billion of long-term debt, with no debt maturities until February 2024.
Column 1Column 2Column 3Column 4
During the year ended December 31, 2021 and the first quarter of 2022, Genworth Holdings redeemed and repurchased the following:
Column 1Column 2Column 3Column 4
Redemption and repurchase of Genworth Holdings’ August 2023 senior notes. On December 15, 2021, Genworth Holdings early redeemed its remaining 4.90% senior notes

95

Table of Contents

Column 1Column 2
originally scheduled to mature in August 2023. The senior notes were fully redeemed with a cash payment of $334 million, including accrued interest and a make-whole premium. During the fourth quarter of 2021 and prior to the early redemption, Genworth Holdings repurchased $91 million of its August 2023 senior notes for a pre-tax loss of $9 million.
Column 1Column 2Column 3Column 4
Repurchase of Genworth Holdings’ February 2024 senior notes. In the fourth quarter of 2021, Genworth Holdings repurchased $118 million principal amount of its 4.80% senior notes due in February 2024 for a pre-tax loss of $6 million. During the first quarter of 2022 and as of February 18, 2022, Genworth Holdings repurchased $33 million principal amount of its 4.80% senior notes due in February 2024.
Column 1Column 2Column 3Column 4
Redemption and repurchase of Genworth Holdings’ September 2021 senior notes. On July 21, 2021, Genworth Holdings early redeemed its remaining 7.625% senior notes originally scheduled to mature in September 2021. The senior notes were fully redeemed with a cash payment of $532 million, including accrued interest and a make-whole premium. During the first half of 2021 and prior to the early redemption, Genworth Holdings repurchased $146 million principal amount of its September 2021 senior notes for a pre-tax loss of $4 million.
Column 1Column 2Column 3Column 4
Redemption of Genworth Holdings’ February 2021 senior notes. On February 16, 2021, Genworth Holdings redeemed its 7.20% senior notes with a cash payment of $350 million, comprised of the outstanding principal balance and accrued interest.

See note 12 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information on our long-term borrowings.

Column 1Column 2Column 3Column 4
Repayment of the AXA promissory note. In connection with the Genworth Australia sale, Genworth Holdings made a mandatory principal payment to AXA of approximately £176 million ($245 million) in March 2021. The mandatory payment fully repaid the first installment obligation originally due to AXA in June 2022 and partially prepaid the September 2022 installment payment. On September 21, 2021, Genworth Holdings used a portion of the net proceeds from the minority IPO of Enact Holdings to repay the remaining outstanding balance of the secured promissory note of approximately £215 million ($296 million). In addition, in February 2022, Genworth Holdings paid AXA the majority of the remaining unprocessed claims of approximately $30 million.

See note 23 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

Completion of Enact Holdings IPO and Dispositions

Column 1Column 2Column 3Column 4
Completion of minority IPO of Enact Holdings:
Column 1Column 2Column 3Column 4
On September 20, 2021, we completed a minority IPO of Enact Holdings and received net proceeds of approximately $529 million.
Column 1Column 2Column 3Column 4
Following the completion of the minority IPO, Genworth Financial beneficially owns through its subsidiaries approximately 81.6% of the common shares of Enact Holdings.

See note 22 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

Column 1Column 2Column 3Column 4
Sale of our Australian mortgage insurance business:
Column 1Column 2Column 3Column 4
On March 3, 2021, we completed the sale of our entire ownership interest of approximately 52% in Genworth Australia through an underwriting agreement.

96

Table of Contents

Column 1Column 2Column 3Column 4
We sold our approximately 214.3 million shares of Genworth Australia for AUD2.28 per share and received approximately AUD483 million ($370 million) in net cash proceeds.

See note 23 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

Results of Operations and Selected Financial and Operating Performance Measures by Segment

Our chief operating decision maker evaluates segment performance and allocates resources on the basis of adjusted operating income (loss).

Management’s discussion and analysis by segment contains selected operating performance measures including “sales” and “insurance
in-force”
or “risk
in-force”
which are commonly used in the insurance industry as measures of operating performance.

Management regularly monitors and reports sales metrics as a measure of volume of new business generated in a period. Sales refer to new insurance written for mortgage insurance products included in our Enact segment. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of insurance policies during a specified period, rather than a measure of revenues or profitability during that period.

Management regularly monitors and reports insurance
in-force
and risk
in-force
for our Enact segment. Insurance
in-force
is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk
in-force
is based on the coverage percentage applied to the estimated current outstanding loan balance. We consider insurance
in-force
and risk
in-force
to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period.

Management regularly monitors and reports a loss ratio for our businesses. For our U.S. mortgage insurance businesses included in our Enact segment, the loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. For our long-term care insurance business included in our U.S. Life Insurance segment, the loss ratio is the ratio of benefits and other changes in reserves less tabular interest on reserves less loss adjustment expenses to net earned premiums. We consider the loss ratio to be a measure of underwriting performance in these businesses and helps to enhance the understanding of the operating performance of our businesses.

Management also regularly monitors and reports adjusted operating income available to Genworth Financial, Inc.’s common stockholders attributable to
in-force
rate actions in the long-term care insurance business included in our U.S. Life Insurance segment.
In-force
rate actions include premium rate increases and associated benefit reductions implemented since 2012, which are presented net of estimated premium taxes, commissions, and other expenses on an
after-tax
basis. Estimates for
in-force
rate actions reflect certain simplifying assumptions that may vary materially from actual historical results, including but not limited to, a uniform rate of coinsurance and premium taxes in addition to consistent policyholder behavior over time. Actual policyholder behavior may differ significantly from these assumptions. In addition, estimates exclude reserve updates resulting from profits followed by losses. Management considers adjusted operating income attributable to
in-force
rate actions to be a measure of its operating performance because it helps bring older generation long-term care insurance blocks closer to a break-even point over time and helps bring the loss ratios on newer long-term care insurance blocks back towards their original pricing.

These operating performance measures enable us to compare our operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources.

97

Table of Contents

Enact segment

Trends and conditions

Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included herein “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.

The United States economy and consumer confidence continued to improve during 2021 from the adverse economic impacts caused by
COVID-19.
The unemployment rate continued to decrease compared to the beginning of the pandemic and was 3.9% in December 2021. While this unemployment rate is slightly higher compared to the
pre-pandemic
level of 3.5% in February 2020, it is markedly lower than the peak of 14.8% in April 2020. Even after the continued recovery in 2021, the number of unemployed Americans stands at approximately six million, less than one million higher than in February 2020. Among the unemployed, those on temporary layoff continued to decrease to less than one million from a peak of 18 million in April 2020 and the number of permanent job losses decreased to approximately two million. In addition, the number of long term unemployed over 26 weeks has continued to decrease since March 2021, falling to approximately two million in December 2021.

Mortgage origination activity remained robust, fueled by strong home sales and refinancing, and home prices continued to climb, increasing Enact’s average loan amount on new insurance written to $305,000 in 2021 from $276,000 in 2020. Interest rates remained low throughout 2021 but ended the year slightly higher than in 2020. Housing affordability declined as of November 2021 compared to November 2020 due to rising home prices, modestly offset by the low interest rate environment and an increase in median family income according to the National Association of Realtors Housing Affordability Index. Although median family income increased in 2021, it remains below a level that could afford a current median-priced home.

In January 2022, the FHFA introduced new upfront fees charged to borrowers for some high balance and second home loans sold to Fannie Mae and Freddie Mac. Upfront fees for high balance loans will increase between 0.25% and 0.75%, tiered by

loan-to-value

ratio. For second home loans, the upfront fees will increase between 1.125% and 3.875%, also tiered by

loan-to-value

ratio. The new pricing framework will take effect April 1, 2022. Enact does not anticipate this will significantly impact the private mortgage insurance market or its results of operations, including future growth.

The CARES Act requires mortgage servicers to provide up to 180 days of forbearance for borrowers with a federally backed mortgage loan who assert they have experienced a financial hardship related to
COVID-19.
Forbearance may be extended for an additional 180 days up to a year in total or shortened at the request of the borrower. In addition, on February 25, 2021, the FHFA announced that borrowers with a mortgage backed by the GSEs who are in an active
COVID-19
forbearance plan as of February 28, 2021 may request up to two additional forbearance extensions for a maximum of 18 months of total forbearance relief. The CARES Act also provides that furnishers of credit reporting information, including servicers, should continue to report a loan as current to credit reporting agencies if the loan is subject to a payment accommodation, such as forbearance, so long as the borrower abides by the terms of the accommodation. Servicer reported forbearance slowed meaningfully beginning in June 2020 and ended December 2021 with approximately 2% or 21,899 of Enact’s active primary policies reported in a forbearance plan, of which approximately 47% were reported as delinquent. It is difficult to predict the future level of reported forbearance and how many of the policies in a forbearance plan that remain current on their monthly mortgage payment will go delinquent.

The foreclosure moratorium for mortgages that are purchased by the GSEs expired on July 31, 2021. However, on June 28, 2021 the CFPB issued a final rule to amend Regulation X of RESPA, which was aimed at

98

Table of Contents

assisting mortgage borrowers affected by the
COVID-19
emergency. The final rule established temporary procedural changes that require a loss mitigation review prior to a servicer’s first notice or foreclosure filing on certain mortgages. On June 29, 2021, the FHFA announced that servicers were immediately prohibited from making a first notice or foreclosure filing for mortgages backed by the GSEs before they were formally prohibited by the CFPB Regulation X Final Rule that took effect on August 31, 2021. These announcements generally prohibited servicers from starting foreclosures on mortgages purchased by the GSEs until after December 31, 2021.

The pandemic continued to affect Enact’s financial results in 2021 but to a lesser extent than in 2020 as servicer reported forbearance remained elevated but declined compared to 2020. New delinquencies decreased during 2021 compared to 2020 and the annual 2021 new delinquency rate of 3.5% was consistent with Enact’s
pre-pandemic
levels. Despite continued economic recovery during 2021, the full impact of
COVID-19
and its adverse economic effects on Enact’s future business results are difficult to predict. Given the maximum length of forbearance plans, the resolution of a delinquency in a plan may not be known for several quarters. While Enact continues to monitor regulatory and government actions and the resolution of forbearance delinquencies, it is possible the pandemic could have a significant adverse impact on its future results of operations and financial condition.

Market penetration and eventual market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products. On December 17, 2020, the FHFA published the Enterprise Capital Framework, which includes significantly higher regulatory capital requirements for the GSEs over current requirements. However, on September 15, 2021, the FHFA announced a Notice of Proposed Rulemaking to amend the Enterprise Capital Framework, including technical corrections to provisions that were published on December 17, 2020. Higher GSE capital requirements could ultimately lead to increased costs to borrowers of GSE loans, which in turn could shift the market away from the GSEs to the FHA or lender portfolios. Such a shift could result in a smaller market for private mortgage insurance. In conjunction with preparing to release the GSEs from conservatorship, on January 14, 2021, the FHFA and the Treasury Department agreed to amend the PSPAs between the Treasury Department and each of the GSEs to increase the amount of capital each GSE may retain. Among other things, the amendments to the PSPAs limit the number of certain mortgages the GSEs may acquire with two or more prescribed risk factors, including certain mortgages with combined

loan-to-value

ratios above 90%. However, on September 14, 2021, the FHFA and Treasury Department suspended certain provisions of the amendments to the PSPAs, including the limit on the number of mortgages with two or more risk factors that the GSEs may acquire. Such suspensions terminate on the later of one year after September 14, 2021 or six months after the Treasury Department notifies the GSEs of termination. The limit on the number of mortgages with two or more risk factors was based on the market size at the time, and Enact does not expect any material impact to the private mortgage market in the near term.

The CFPB’s QM regulations also include the QM Patch for mortgages that comply with certain prohibitions and limitations and meet the GSE underwriting and product guidelines. Mortgages that meet certain requirements are deemed to be QMs until the earlier of the time in which the GSEs exit the FHFA conservatorship or the mandatory compliance date of the final amendments to the QM Rule. On April 27, 2021, the CFPB promulgated a final rule delaying the mandatory compliance date of the amended QM Rule until October 1, 2022. As provided under the final rule, the prior 43%

debt-to-income-based

QM Rule definition, the new price-based APOR definition and the QM Patch will all remain available to lenders for loan applications received prior to October 1, 2022. However, on April 8, 2021, the GSEs issued notices stating that due to the requirements of the PSPAs they would only acquire loans that meet the new price-based APOR definition set forth under the amended QM Rule for applications received on or after July 1, 2021. Enact believes that loans which previously qualified under the 43%

debt-to-income-based

QM Rule definition and the QM Patch will continue to qualify under the new price-based APOR definition and therefore expects little impact from this change. For more information on this

99

Table of Contents

regulation, see “Item 1—Business—Regulation—Enact—Mortgage Insurance Regulation.” For more information about the potential future impact, see “Item 1A—Risk Factors—Changes to the role of the GSEs or to the charters or business practices of the GSEs, including actions or decisions to decrease or discontinue the use of mortgage insurance, could adversely affect our business, financial condition and results of operations,” and “—Risk Factors—The amount of mortgage insurance written by Enact Holdings could decline significantly if alternatives to private mortgage insurance are used or lower coverage levels of mortgage insurance are selected.”

New insurance written of $97.0 billion in 2021 decreased 3% compared to 2020 primarily due to a smaller estimated private mortgage insurance market. The decrease in the estimated private mortgage insurance available market was primarily driven by lower refinance originations.

Enact’s primary persistency increased to 62% for the year ended December 31, 2021 compared to 59% for the year ended December 31, 2020 but remained below its historic levels of approximately 80%. The increase in persistency was primarily driven by a decline in the percentage of
in-force
policies with mortgage rates above current interest rates. Low persistency has impacted business performance trends in several ways including, but not limited to, offsetting insurance
in-force
growth from new insurance written, accelerating the recognition of earned premiums due to single premium policy cancellations, accelerating the amortization of existing reinsurance transactions reducing their associated PMIERs capital credit and shifting the concentration of Enact’s primary insurance
in-force
to more recent years of policy origination. As of December 31, 2021, Enact’s primary insurance
in-force
has approximately 5% concentration in 2014 and prior book years. More specifically, its 2005 through 2008 book year concentration is approximately 3%. In contrast, Enact’s 2020 book year represents 31% of its primary insurance
in-force
concentration, while its 2021 book year is 40% as of December 31, 2021.

The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite enabling it to write new business at returns it views as attractive.

Net earned premiums increased in 2021 compared to 2020 primarily from insurance
in-force
growth, partially offset by the continued lapse of older higher priced policies, a decrease in single premium policy cancellations and higher ceded premiums due to a higher volume of credit risk transfer transactions in 2021. The total number of delinquent loans has declined from the
COVID-19
peak in the second quarter of 2020 but remains elevated compared to

pre-COVID-19

levels. During this time and consistent with prior years, servicers continued the practice of remitting premiums during the early stages of default. Additionally, Enact has a business practice of refunding the post-delinquent premiums to the insured party if the delinquent loan goes to claim. Enact records a liability and a reduction to net earned premiums for the post-delinquent premiums it expects to refund. The post-delinquent premium liability recorded since the beginning of
COVID-19
in the second quarter of 2020 through 2021 was not significant to the change in earned premiums for those periods as a result of the high concentration of new delinquencies being subject to a servicer reported forbearance plan and the lower estimated claim rate for these loans. As a result of
COVID-19,
certain state insurance regulators required or requested the provision of grace periods of varying lengths to insureds in the event of
non-payment
of premium. Regulators differed greatly in their approaches but generally focused on the avoidance of cancellation of coverage for
non-payment.
While most of these requirements and requests have lapsed, it is possible that some or all of them could be
re-issued
in the event of declarations of new states of emergency that might result from worsening pandemic conditions. Enact currently complies with all state regulatory requirements. If timely payment is not made, future premiums could decrease and the certificate of insurance could be subject to cancellation after 60 days or such longer time as required under applicable law.

Enact’s loss reserves continue to be impacted by
COVID-19.
Borrowers who have experienced a financial hardship including, but not limited to, the loss of income due to the closing of a business or the loss of a job have

100

Table of Contents

taken advantage of available forbearance programs and payment deferral options. During the peak of the pandemic, Enact experienced elevated new delinquencies subject to forbearance plans which may ultimately cure at a higher rate than traditional delinquencies. Unlike a hurricane where the natural disaster occurs at a point in time and the rebuild starts soon after,
COVID-19
brought ongoing displacement to the mortgage insurance market, making it more difficult to determine the effectiveness of forbearance and the resulting claim rates for new delinquencies in forbearance plans. Given this difference, Enact initially leveraged its prior hurricane experience to estimate claim rates, and has recently added cure activity from
COVID-19
related delinquencies as an additional consideration in the establishment of an appropriate claim rate estimate for new delinquencies in forbearance plans that have emerged as a result of
COVID-19.
Approximately 42% of Enact’s primary new delinquencies in 2021 were subject to a forbearance plan as compared to 66% in 2020 and less than 5% in recent quarters prior to
COVID-19.
The severity of loss on loans that do go to claim may be negatively impacted by the extended forbearance timeline, the associated elevated expenses and the higher loan amount of the recent new delinquencies. These negative influences on loss severity could be mitigated in part by further home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.

Enact’s loss ratio was 13% for the year ended December 31, 2021, compared to 39% for the year ended December 31, 2020. The decrease was largely from lower new delinquencies from the improving economy and net favorable reserve adjustments in 2021 compared to unfavorable reserve adjustments in 2020. New primary delinquencies were 32,624 in 2021 compared 85,074 in 2020. Enact decreased reserves by $22 million in 2021 primarily related to positive frequency and severity development on

pre-COVID-19

delinquencies. In 2020, Enact strengthened existing reserves by $65 million primarily driven by the deterioration of early cure emergence patterns impacting claim frequency along with a modest increase in claim severity. In determining the loss expense estimate during 2021, considerations were given to forbearance and
non-forbearance
delinquencies, recent cure and claim experience and the ongoing economic impact due to the pandemic.

GMICO’s

risk-to-capital

ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, GMICO’s domestic insurance regulator, was approximately 12.3:1 as of December 31, 2021 and 2020. GMICO’s

risk-to-capital

ratio remains below the NCDOI’s maximum

risk-to-capital

ratio of 25:1. North Carolina’s calculation of

risk-to-capital

excludes the risk
in-force
for delinquent loans given the established loss reserves against all delinquencies. GMICO’s ongoing

risk-to-capital

ratio will depend principally on the magnitude of future losses incurred by GMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business or capital support provided.

Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. During 2020, the GSEs issued several amendments to PMIERs. The December 4, 2020 version extended the application of reduced PMIERs capital factors to each
non-performing
loan that had an initial missed monthly payment occurring on or after March 1, 2020 and prior to April 1, 2021 and extended the capital preservation period from March 31, 2021 to June 30, 2021. On June 30, 2021, the GSEs issued a revised and restated version of the PMIERs Amendment that replaced the version issued on December 4, 2020. The June 30, 2021 version allows loans that enter a forbearance plan due to a
COVID-19
hardship on or after April 1, 2021 to remain eligible for extended application of the reduced PMIERs capital factor for as long as the loan remains in forbearance. The June 30, 2021 version also extended the capital preservation period through December 31, 2021 with certain exceptions.

In addition, in September 2020, certain GSE Restrictions were imposed with respect to capital on Enact, which will remain in effect until the collective GSE Conditions are met. For additional details related to PMIERs, the PMIERs Amendment and the GSE Conditions and Restrictions, see “Item 1—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.”

101

Table of Contents

As of December 31, 2021, Enact had estimated available assets of $5,077 million against $3,074 million net required assets under PMIERs compared to available assets of $5,126 million against $2,839 million net required assets as of September 30, 2021 and available assets of $4,588 million against $3,359 million net required assets as of December 31, 2020. The sufficiency ratio as of December 31, 2021 was 165% or $2,003 million above the published PMIERs requirements, compared to 181% or $2,287 million above the published PMIERs requirements as of September 30, 2021 and 137% or $1,229 million above the published PMIERs requirements as of December 31, 2020. PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE Restrictions imposed on Enact. The decrease in the PMIERs sufficiency compared to September 30, 2021 was primarily driven by a $200 million dividend paid in the fourth quarter of 2021, new insurance written and amortization of existing reinsurance transactions, partially offset by elevated lapse driven by prevailing low interest rates, business cash flows and lower delinquencies. Enact’s PMIERs required assets as of December 31, 2021, September 30, 2021 and December 31, 2020 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain
non-performing
loans. The application of the 0.30 multiplier to all eligible delinquencies provided $390 million of benefit to Enact’s December 31, 2021 PMIERs required assets compared to $570 million and $1,046 million of benefit as of September 30, 2021 and December 31, 2020, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier.

In January 2022, Enact executed an excess of loss reinsurance transaction with a panel of reinsurers, which will provide approximately $294 million of reinsurance coverage on a portion of current and expected new insurance written for the 2022 book year. Credit risk transfer transactions provided an aggregate of approximately $1,404 million of PMIERs capital credit as of December 31, 2021. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.

Enact Holdings paid dividends of $200 million in December 2021, $163 million of which was paid to Genworth Holdings and the remainder to minority shareholders. Enact Holdings is currently in the process of evaluating its capital return objectives for 2022. Although not yet established, Enact Holdings intends to develop a formal dividend policy and initiate a regular common dividend during 2022. In addition to a regular common dividend, Enact Holdings will also evaluate the potential for an incremental return of capital, contingent upon economic and business performance, including the resolution of forbearance related delinquencies, among other considerations. Any future dividends will also be subject to market conditions, business and regulatory approvals and will include a proportionate dividend distribution to minority shareholders.

102

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Revenues:
Premiums$975$971$856$4%
Net investment income14113311786%
Net investment gains (losses)(2)(4)1250%
Policy fees and other income464(2)(33)%
Total revenues1,1181,106978121%
Benefits and expenses:
Benefits and other changes in policy reserves12538150(256)(67)%
Acquisition and operating expenses, net of deferrals2302061912412%
Amortization of deferred acquisition costs and intangibles152115(6)(29)%
Interest expense511833183%
Total benefits and expenses421626256(205)(33)%
Income from continuing operations before income taxes69748072221745%
Provision for income taxes1481021534645%
Income from continuing operations54937856917145%
Less: net income from continuing operations attributable to noncontrolling interests3333NM(1)
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders51637856913837%
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses24(1)(2)(50)%
Expenses related to restructuring33NM(1)
Taxes on adjustments(1)(1)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$520$381$568$13936%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2021 compared to 2020

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income increased primarily attributable to lower losses mainly from lower new delinquencies and net favorable reserve adjustments of $17 million in 2021 compared to unfavorable reserve adjustments of $51 million in 2020, partially offset by higher interest expense associated with Enact Holdings’ senior notes issued in August 2020, an increase in operating costs and the minority IPO of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6% and resulted in lower net income of $33 million in 2021.

103

Table of Contents

Revenues

Premiums increased mainly attributable to higher insurance
in-force,
partially offset by continued lapse of older higher priced policies due to the current low interest rate environment, lower single premium policy cancellations and higher ceded premiums in 2021.

Net investment income increased primarily due to higher average invested assets and higher income from bond calls, partially offset by lower investment yields in 2021.

Benefits and expenses

Benefits and other changes in policy reserves decreased largely from lower new delinquencies and net favorable reserve adjustments in 2021 compared to unfavorable reserve adjustments in 2020. Losses from new delinquencies decreased $164 million compared to 2020 driven primarily by a significant increase in borrower forbearance in 2020 as a result of
COVID-19
that occurred to a lesser extent in 2021 as the economy began to improve. Enact decreased reserves by $22 million in 2021 primarily related to positive frequency and severity development on

pre-COVID-19

delinquencies. In 2020, Enact strengthened existing reserves by $65 million primarily driven by the deterioration of early cure emergence patterns impacting claim frequency along with a modest increase in claim severity.

Acquisition and operating expenses, net of deferrals, increased primarily attributable to higher operating costs, expenses associated with strategic transaction preparations and restructuring costs in 2021.

Amortization of deferred acquisition costs and intangibles decreased primarily due to accelerated DAC amortization of $6 million in 2020 driven by elevated lapses.

Interest expense increased related to Enact Holdings’ senior notes issued in August 2020.

Provision for income taxes.

The effective tax rate was 21.3% and 21.2% for the years ended December 31, 2021 and 2020, respectively, consistent with the U.S. corporate federal income tax rate.

Net income from continuing operations attributable to noncontrolling interests.

The increase relates to the minority IPO of Enact Holdings on September 16, 2021, which reduced Genworth Financial’s ownership percentage to 81.6%, resulting in lower net income of $33 million in 2021.

Enact selected operating performance measures

The following table sets forth selected operating performance measures regarding Enact as of or for the dates indicated:

As of or for the years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Primary insurance in-force(1)$226,514$207,947$181,785$18,5679%
Risk in-force:
Primary$56,881$52,475$46,246$4,4068%
Pool105146188(41)(28)%
Total risk in-force$56,986$52,621$46,434$4,3658%
New insurance written$97,004$99,871$62,431$(2,867)(3)%
Column 1Column 2
(1)Primary insurance in-force represents the aggregate unpaid principal balance for loans Enact insures. Original loan balances are primarily used to determine premiums.

104

Table of Contents

2021 compared to 2020

Primary insurance
in-force
and risk
in-force

Primary insurance
in-force
increased largely from new insurance written, partially offset by lapses and cancellations as Enact continues to experience persistency below its historic norms. Primary persistency was 62% and 59% for the years ended December 31, 2021 and 2020, respectively. Total risk
in-force
increased largely from higher primary insurance
in-force.

New insurance written

New insurance written decreased principally due to a smaller private mortgage insurance available market in 2021.

Loss and expense ratios

The following table sets forth the loss and expense ratios for Enact for the dates indicated:

Years ended December 31,Increase (decrease)
2021202020192021 vs. 2020
Loss ratio13%39%6%(26)%
Expense ratio25%23%24%2%

The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. The expense ratio is the ratio of general expenses to net earned premiums. In Enact, general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles.

2021 compared to 2020

The loss ratio decreased largely from lower new delinquencies and net favorable reserve adjustments in 2021 compared to unfavorable reserve adjustments in 2020. Losses from new delinquencies decreased $164 million compared to 2020 driven primarily by a significant increase in borrower forbearance in 2020 as a result of
COVID-19
that occurred to a lesser extent in 2021 as the economy began to improve. Enact decreased reserves by $22 million in 2021 primarily related to positive frequency and severity development on

pre-COVID-19

delinquencies. In 2020, Enact strengthened existing reserves by $65 million primarily driven by the deterioration of early cure emergence patterns impacting claim frequency along with a modest increase in claim severity.

The expense ratio increased mainly driven by higher operating costs, expenses associated with strategic transaction preparations and restructuring costs, partially offset by lower DAC amortization in 2021.

105

Table of Contents

Mortgage insurance loan portfolio

The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31:

(Amounts in millions)202120202019
Primary insurance in-force by loan-to-value ratio at origination:
95.01% and above$35,455$34,520$32,502
90.01% to 95.00%95,14992,68983,189
85.01% to 90.00%64,54956,34149,305
85.00% and below31,36124,39716,789
Total$226,514$207,947$181,785
Primary risk in-force by loan-to-value ratio at origination:
95.01% and above$9,907$9,279$8,365
90.01% to 95.00%27,60826,77423,953
85.01% to 90.00%15,64413,56211,933
85.00% and below3,7222,8601,995
Total$56,881$52,475$46,246
Primary insurance in-force by credit quality at origination:
Over 760$89,982$78,488$69,129
740—75935,87433,63529,961
720—73931,73030,05826,184
700—71927,35925,87021,567
680—69921,27020,14016,935
660—679(1)10,5499,8198,504
640—6596,1245,9355,379
620—6392,7832,9022,794
6208431,1001,332
Total$226,514$207,947$181,785
Primary risk in-force by credit quality at origination:
Over 760$22,489$19,691$17,606
740—7599,0098,4977,685
720—7398,0557,6736,717
700—7196,9076,5795,464
680—6995,3345,1004,286
660—679(1)2,6382,4422,113
640—6591,5301,4721,322
620—639702737709
620217284344
Total$56,881$52,475$46,246
Column 1Column 2
(1)Loans with unknown FICO scores are included in the 660-679 category.

The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary risk
in-force
was 741 as of December 31, 2021.

106

Table of Contents

Delinquent loans and claims

Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification, or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31:

202120202019
Primary insurance:
Insured loans in-force937,350924,624851,070
Delinquent loans24,82044,90416,392
Percentage of delinquent loans (delinquency rate)2.65%4.86%1.93%

The delinquency rate as of December 31, 2021 decreased compared to December 31, 2020 primarily from a decline in total delinquencies as the economy continues to recover from
COVID-19
and as cures outpaced new delinquencies. The delinquency rate increased compared to December 31, 2019 primarily as a result of the rise in unemployment and the increase in borrower forbearance driven by
COVID-19.

The following tables set forth primary delinquencies, direct primary case reserves and risk
in-force
by aged missed payment status in Enact’s loan portfolio as of December 31:

2021
(Dollar amounts in millions)DelinquenciesDirect case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less6,586$35$34010%
4 - 11 payments7,36011142626%
12 payments or more10,87446064372%
Total24,820$606$1,40943%
2020
(Dollar amounts in millions)DelinquenciesDirect case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less10,484$43$5498%
4 - 11 payments30,3243311,85318%
12 payments or more4,09614320470%
Total44,904$517$2,60620%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

107

Table of Contents

The total increase in reserves as a percentage of risk
in-force
as of December 31, 2021 was primarily driven by higher reserves in relation to a decrease in delinquent risk
in-force.
Delinquent risk
in-force
decreased mainly from lower total delinquencies as cures outpaced new delinquencies in 2021, while reserves increased primarily from new delinquencies, partially offset by net favorable reserve adjustments related to positive frequency and severity development on

pre-COVID-19

delinquencies in 2021.

As of December 31, 2021, Enact has experienced an increase in loans that are delinquent for 12 months or more due in large part to borrowers entering a forbearance plan over a year ago driven by
COVID-19.
The current reserve estimate assumes that remaining delinquencies will have a higher likelihood of going to claim given foreclosure moratoriums and the uncertainty around the lack of progression through the foreclosure process. Forbearance plans may be extended up to 18 months, therefore, it is possible Enact could experience elevated delinquencies in this aged category during 2022. Resolution of a delinquency in a forbearance plan, whether it ultimately results in a cure or a claim, is difficult to estimate and may not be known for several quarters, if not longer.

Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s risk
in-force
as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender.

Percent of primary risk in-force as of December 31, 2021Percent of direct case reserves as of December 31, 2021(1)Delinquency rate as of December 31,
202120202019
By State:
California11%12%3.17%6.20%1.42%
Texas8%8%2.89%5.82%2.02%
Florida(2)7%9%2.97%6.92%2.13%
New York(2)5%12%3.80%6.92%2.98%
Illinois(2)5%6%3.09%5.21%2.25%
Michigan4%2%1.87%2.93%1.43%
Arizona3%2%2.31%4.54%1.46%
North Carolina3%2%2.18%3.84%1.79%
Pennsylvania(2)3%3%2.38%4.11%2.12%
Washington3%3%2.98%5.37%1.10%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
Column 1Column 2
(2)Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed.

108

Table of Contents

Percent of primary risk in-force as of December 31, 2021Percent of direct case reserves as of December 31, 2021(1)Delinquency rate as of December 31,
202120202019
By MSA or MD:
Chicago-Naperville, IL MD3%4%3.68%6.36%2.50%
Phoenix, AZ MSA3%2%2.36%4.63%1.38%
New York, NY MD3%8%5.32%10.25%3.68%
Atlanta, GA MSA2%3%3.28%6.68%2.14%
Washington DC-Arlington MD2%2%2.96%6.09%1.47%
Houston, TX MSA2%3%3.61%7.59%2.62%
Riverside-San Bernardino, CA MSA2%2%3.42%7.08%2.08%
Los Angeles-Long Beach, CA MD2%3%3.95%7.57%1.35%
Dallas, TX MD2%2%2.31%5.10%1.85%
Nassau County, NY MD2%4%5.55%10.64%3.47%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

The frequency of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance,
pre-foreclosure
sale and

deed-in-lieu.

These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts.

The following table sets forth the dispersion of Enact’s direct primary case reserves and primary insurance
in-force
and risk
in-force
by year of policy origination, weighted average mortgage interest rate and delinquency rate as of December 31, 2021:

(Amounts in millions)Weighted average rate(1)Percent of direct case reserves(2)Primary insurance in-forcePercent of totalPrimary risk in-forcePercent of totalDelinquency rate
Policy Year
2004 and prior6.20%2%$541%$154%13.24%
2005 to 20085.58%227,65531,958310.23%
2009 to 20134.32%21,404137015.54%
20144.49%31,965153415.51%
20154.17%54,48821,19724.24%
20163.89%88,99742,38843.69%
20174.26%108,96242,32444.78%
20184.78%139,26342,33045.93%
20194.20%1921,730105,454103.89%
20203.23%1469,9633117,574311.50%
20213.08%291,5464022,598400.37%
Total portfolio3.52%100%$226,514100%$56,881100%2.65%
Column 1Column 2
(1)Average annual mortgage interest rate weighted by insurance in-force.
Column 1Column 2
(2)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

109

Table of Contents

For policy years after 2008, the average annual mortgage interest rate has been consistently below 5%, with its lowest point at 3.08% for policy year 2021. Loss reserves in policy years 2005 through 2008 are outsized compared to their representation of risk
in-force.
The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. The largest portion of loss reserves has shifted to newer book years as a result of
COVID-19
given their significant representation of risk
in-force.
As of December 31, 2021, Enact’s 2014 and newer policy years represented approximately 96% of primary risk
in-force
and 74% of total direct primary case reserves.

The ratio of the claim paid to the current risk
in-force
for a loan is referred to as “claim severity.” The current risk
in-force
is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws.
Pre-foreclosure
sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 103%, 106% and 112% for the years ended December 31, 2021, 2020 and 2019, respectively. The average claim severities do not include the effects of agreements on
non-performing
loans.

U.S. Life Insurance segment

COVID-19

The most significant impact in our U.S. life insurance businesses from
COVID-19
in 2021 and 2020 was related to continued elevated mortality. Our long-term care insurance operating results were favorably impacted by higher mortality in 2021 and 2020. Conversely, higher mortality rates had unfavorable impacts in our life insurance products and we have observed minimal impact from
COVID-19
in our fixed annuity products. Our products were also negatively impacted by the continued low interest rate environment, particularly as it related to loss recognition testing and asset adequacy analysis in 2021 and 2020.

In our long-term care insurance products, we have experienced higher mortality during
COVID-19
which has had a favorable impact on claim reserves and our operating results. Although it is not our practice to track cause of death for policyholders and claimants, we believe the favorable results of our long-term care insurance business in 2021 and 2020 were likely impacted by
COVID-19,
but we expect the impacts to be temporary. We believe
COVID-19
has accelerated mortality on our most vulnerable claimants, which may reduce mortality rates in future periods as the impacts of the pandemic subside. Therefore, in the fourth quarter of 2020 and the first quarter of 2021, we strengthened our claim reserves to adjust the mortality assumption by $91 million and $67 million, respectively, to account for the lower future claim termination rates expected on remaining claims. However, during the second quarter of 2021, we experienced lower mortality as the impacts of
COVID-19
lessened and we did not establish any additional claim reserves but reduced a portion of the
COVID-19
mortality adjustment. As of December 31, 2021, the balance of our incremental claim reserves associated with
COVID-19
mortality was $134 million. As
COVID-19
continues to develop, short-term mortality experience may fluctuate, and we would decrease the
COVID-19
mortality adjustment if we experience lower mortality.

We have also experienced lower new claims incidence in our long-term care insurance business during
COVID-19;
however, we do not expect this to be permanent but rather a temporary reduction while

shelter-in-place

and social distancing protocols are in effect and that claims incidence experience will ultimately resemble previous trends. As a result, we have strengthened our IBNR claim reserves during
COVID-19
by $75 million through December 31, 2021. New claims incidence remains below
pre-pandemic
levels and near-term incidence may continue to be impacted by
COVID-19.
We continue to utilize virtual assessments to assess eligibility for benefits while
in-person
assessments have been temporarily discontinued during
COVID-19.
We

110

Table of Contents

are reviewing the options to resume
in-person
assessments, with appropriate protocols in place, while having virtual assessments available for those policyholders who would prefer this option. For claimants without the technology to perform virtual assessments, we have alternate options for gathering information. Our long-term care insurance benefit utilization will be monitored for impact, although it is too early to tell the magnitude and/or direction of that impact.

Additionally, our U.S. life insurance companies are dependent on the approval of actuarially justified
in-force
rate actions in our long-term care insurance business, including those rate actions which were previously filed and are currently pending review and approval. We have experienced some delays and could experience additional delays in receiving approvals of these rate actions during
COVID-19;
however, these delays did not have a significant impact on our financial results in 2021 or during 2020.

We have continued to provide customer service to our policyholders during this uncertain time and are available to address questions or concerns regarding their policies. We are continually assessing our operational processes and monitoring potential impacts to morbidity due to
COVID-19.

We continue to actively monitor cash and highly liquid investment positions in each of our U.S. life insurance companies against operating targets that are designed to ensure that we will have the cash necessary to meet our obligations as they come due. The targets are set based on stress scenarios that have the effect of increasing our expected cash outflows and decreasing our expected cash inflows. Liquidity risk is assessed by comparing subsidiary cash to potential cash needs under a stressed liquidity scenario. The stressed scenario reflects potential policyholder surrenders, variability of normal operating cash flow and potential increases in collateral requirements under our cleared derivative program.

While the ongoing impact of
COVID-19
is very difficult to predict, the related outcomes and impact on the U.S. life insurance business will depend on the length and severity of the pandemic and shape of the economic recovery. Further declines in interest rates as well as equity market volatility as a result of
COVID-19
would increase reserves and capital requirements in our U.S. life insurance business. For sensitivities related to interest rates, lapses and mortality on our U.S. life insurance products, see “— Critical Accounting Estimates.” We will continue to monitor
COVID-19
impacts and evaluate all of our assumptions that may need updating as a result of longer-term trends related to the pandemic. See “Item 1A—Risk
Factors—COVID-19
could materially adversely affect our financial condition and results of operations.”

Trends and conditions

Results of our U.S. life insurance businesses depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves. Many factors can affect the results of our U.S. life insurance businesses. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our U.S. life insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our DAC amortization, reserve levels, results of operations and financial condition.

Our liability for policy and contract claims is reviewed quarterly and we completed a detailed review of our claim reserve assumptions and methodologies for our long-term care insurance business in the fourth quarter of 2021 as discussed further below. In the fourth quarter of 2021, we performed assumption reviews for our U.S. life insurance products, including our long-term care and life insurance products, and completed our loss recognition testing as discussed below. For our 2021 assumption updates, we are generally not including data from 2020 in setting any long-term assumptions, as we do not yet have sufficient information around longer term effects of the pandemic. Our review of assumptions, as part of our testing in the fourth quarter of 2021, included

111

Table of Contents

expected claim incidence and terminations, benefit utilization trend, mortality, persistency, interest rates and
in-force
rate actions, among other assumptions. In addition, we performed cash flow testing separately for each of our U.S. life insurance companies on a statutory accounting basis in the fourth quarter of 2021.

Our U.S. life insurance subsidiaries are subject to the NAIC’s RBC standards and other minimum statutory capital and surplus requirements. The RBC of each of our U.S. life insurance subsidiaries exceeded the level of RBC that would require any of them to take or become subject to any corrective action in their respective domiciliary state as of December 31, 2021. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries was approximately 289% and 229% as of December 31, 2021 and 2020, respectively. The increase was largely driven by higher statutory earnings in our long-term care insurance business mainly driven by claim experience, premium rate increases and benefit reductions, including policyholder benefit reduction elections made as part of a legal settlement, as well as in our variable annuity products from favorable interest rates and equity markets.

We continue to face challenges in our principal life insurance subsidiaries, particularly those subsidiaries that rely heavily on long-term care insurance
in-force
rate actions as a source of earnings and capital. We may see variability in statutory results and a decline in the RBC ratios of these subsidiaries given the time lag between the approval of
in-force
rate actions versus when the benefits from the
in-force
rate actions (including increased premiums and associated benefit reductions) are fully realized in our financial results. Additionally, the RBC ratio of our U.S. life insurance subsidiaries would be negatively impacted by future increases in our statutory reserves, including results of Actuarial Guideline 38, cash flow testing and assumption reviews, particularly in our long-term care insurance business. Future declines in the RBC ratio of our life insurance subsidiaries could result in heightened supervision and regulatory action.

Results of our U.S. life insurance businesses are also impacted by interest rates. Low interest rates put pressure on the profitability and returns of these businesses as higher yielding investments mature and are replaced with lower-yielding investments. We seek to manage the impact of low interest rates through asset-liability management, investment in alternative assets, including limited partnerships, as well as interest rate hedging strategies for a portion of our long-term care insurance product cash flows. Additionally, certain products have implicit and explicit rate guarantees or optionality that are significantly impacted by changes in interest rates. For a further discussion of the impact of interest rates on our U.S. life insurance businesses, see “Item 7A—Quantitative and Qualitative Disclosures About Market Risk.”

Long-term care insurance

The long-term profitability of our long-term care insurance business depends upon how our actual experience compares with our valuation assumptions, including but not limited to morbidity, mortality and persistency. If any of our assumptions prove to be inaccurate, our reserves may be inadequate, which in the past has had, and may in the future have, a material adverse effect on our results of operations, financial condition and business. Results of our long-term care insurance business are also influenced by our ability to achieve
in-force
rate actions, improve investment yields and manage expenses and reinsurance, among other factors. Changes in regulations or government programs, including long-term care insurance rate action legislation, regulation and/or practices, could also impact our long-term care insurance business either positively or negatively.

In the fourth quarter of 2021, we completed loss recognition and cash flow testing and reviewed key assumptions for future policy benefits, or active life reserves, for our long-term care insurance business, including expected claim incidence and terminations, expenses, interest rates, benefit utilization trend and
in-force
rate actions, among other assumptions. The most significant update to our long-term care insurance assumptions included an unfavorable update to the benefit utilization trend, which drove significant updates to our
in-force
rate action plan, and assumptions related thereto. Given the expected future increases in cost of care, we expect our long-term benefit utilization to trend higher than previously assumed. Prior to this update, we had assumed that the long-term benefit utilization would improve over time. Based on our experience, it has not

112

Table of Contents

improved as much as we predicted, largely due to cost of care growth driven by both broad-based inflation and minimum wage increases in some large states, among other factors. Therefore, we have increased the outlook for our future benefit utilization trend.

As of December 31, 2021, our loss recognition testing margin for our long-term care insurance business, excluding the acquired block, was positive and slightly higher than the 2020 level. We continue to test our acquired block of long-term care insurance separately. In 2021, our loss recognition testing margin for the acquired block was positive but slightly lower than the 2020 level. We will continue to regularly review our methodologies and assumptions in light of emerging experience and may be required to make adjustments to our long-term care insurance reserves in the future, which could also impact our loss recognition and cash flow testing results. For a discussion of additional information related to margins for our long-term care insurance business, see “—Critical Accounting Estimates—Future policy benefits.”

During the fourth quarter of 2021, we reviewed our assumptions and methodologies relating to our claim reserves of our long-term care insurance business. Based on our review, we did not make any significant changes to the assumptions or methodologies, other than routine updates to investment returns as we typically do each quarter. The prior year claim reserve review, which we completed during the fourth quarter of 2020, had a modest net benefit primarily related to assumption updates to claim incidence and claim and policy terminations, based on our current long-term view of these assumptions. For a discussion of additional information related to changes to our assumptions and methodologies to our long-term care insurance claim reserves, see “—Critical Accounting Estimates—Liability for policy and contract claims.”

As a result of the review of our claim reserves completed in prior years, we have been establishing higher claim reserves on new claims, which has negatively impacted earnings and we expect this to continue going forward. Also, average claim reserves for new claims are trending higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. In addition, although new claim counts on our older long-term care insurance blocks of business will continue to decrease as the blocks run off, we are gaining more experience on our larger new blocks of business and expect continued growth in new claims on these blocks as policyholders reach older attained ages with higher likelihood of going on claim.

Given the ongoing challenges in our long-term care insurance business, we continue pursuing initiatives to improve the risk and profitability profile of our business including: premium rate increases and associated benefit reductions on our
in-force
policies; managing expense levels; executing investment strategies targeting higher returns; and enhancing our financial and actuarial analytical capabilities. Executing on our multi-year long-term care insurance
in-force
rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on
in-force
rate actions, refer to “Significant Developments and Strategic Highlights—U.S. Life Insurance” and “Item 1—Business—U.S. Life
Insurance—In-force
rate actions.”

The approval process for
in-force
rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.

In 2019, the NAIC established the Long-Term Care Insurance (EX) Task Force to address efforts to create a national standard for reviewing and approving long-term care insurance rate increase requests. This task force is charged with developing a consistent national approach for reviewing rate increase requests that result in actuarially appropriate increases being granted by the states in a timely manner and eliminates cross-state rate subsidization, among others. In December 2021, the Task Force adopted its framework for the multi-state rate

113

Table of Contents

review process and shifted its focus to monitoring the impact of this new process on state rate reviews. We are currently evaluating our participation in the multi-state review process for our upcoming filings.

Life insurance

Results of our life insurance business are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors. We no longer solicit sales of traditional life insurance products; however, we continue to service our existing retained and reinsured blocks of business.

Mortality levels may deviate each period from historical trends. Overall mortality experience was higher in 2021 compared to 2020, attributable in part to
COVID-19.
We have experienced higher mortality than our then-current and
priced-for
assumptions in recent years for our universal life insurance blocks. We have also been experiencing higher mortality related charges resulting from an increase in rates charged by our reinsurance partners reflecting natural block aging and higher mortality compared to expectations.

In the fourth quarters of 2021 and 2020, we performed our annual review of life insurance assumptions and loss recognition testing. Our reviews focused on assumptions for mortality, interest rates and persistency, among other assumptions. Our mortality assumption was updated to align with the overall

pre-COVID-19

experience in later-duration as well as in targeted blocks such as term universal life insurance, conversion policies and post-level term. As of December 31, 2021, the loss recognition testing margin for our term and whole life insurance products was positive and consistent with the 2020 level.

As part of our review in the fourth quarter of 2021, we recorded a $70 million
after-tax
expense to net income in our universal and term universal life insurance products primarily related to higher

pre-COVID-19

mortality experience. As part of our review in the fourth quarter of 2020, we recorded a $60 million
after-tax
benefit in our term universal and universal life insurance products primarily from favorable assumption updates. The favorable updates in our term universal life insurance product in 2020 were primarily driven by a model refinement related to persistency and grace period timing. Other 2020 assumption updates mostly focused on future cost of insurance rates and long-term trends in mortality, persistency and interest rates.

For the year ended December 31, 2021, in connection with our review of DAC for recoverability, we recorded
after-tax
charges of $92 million in our universal and term universal life insurance products compared to a $50 million
after-tax
charge in 2020. For a discussion of additional information related to changes to our assumptions and DAC recoverability related to our life insurance business, see “—Critical Accounting Estimates.”

Our mortality experience for older ages is emerging and we continue to monitor trends in mortality improvement. We will continue to regularly review our mortality assumptions as well as all of our other assumptions in light of emerging experience. We may be required to make further adjustments in the future to our assumptions which could impact our universal and term universal life insurance reserves or the loss recognition testing results of our term life insurance products. Any further materially adverse changes to our assumptions, including mortality, persistency or interest rates, could have a materially negative impact on our results of operations, financial condition and business. For a discussion of additional information related to changes to our life insurance assumptions, see “—Critical Accounting Estimates.”

Compared to 1998 and prior years, we had a significant increase in term life insurance sales between 1999 and 2009, particularly in 1999 and 2000. The blocks of business issued since 2000 vary in size as compared to the large 1999 and 2000 blocks of business. As our large
10-
and
15-year
level premium period term life insurance policies written in 1999 and 2000 transitioned to their post-level guaranteed premium rate period, we experienced lower persistency compared to our pricing and valuation assumptions which accelerated DAC amortization in previous years. As our large
20-year
level premium period business written in 1999 entered its

114

Table of Contents

post-level period, we experienced higher lapses resulting in accelerated DAC amortization in 2019. This trend continued in the first quarter of 2020 for the 1999 block, as it reached the end of its level premium period. Additionally, we experienced a similar trend with the
20-year
level premium period business written in 2000 as it entered its post-level period during 2020 and into the first quarter of 2021 due to the
60-day
grace period. If lapse experience on future
10-,

15-
and
20-year
level premium period blocks emerges similar to our large
20-year
level premium period business written in 1999 and 2000, we would expect volatility in DAC amortization if persistency is lower than original assumptions, which would reduce profitability in our term life insurance products. However, going forward, given our smaller block sizes and reinsurance agreements in place, we would expect the impact to DAC amortization on policies entering the post-level period to be lower than what we experienced in 2019 and 2020. We have also taken actions to mitigate potentially unfavorable impacts through the use of reinsurance, particularly for certain term life insurance policies issued between 2001 and 2004.

Fixed annuities

Results of our fixed annuities business are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels. We no longer solicit sales of traditional fixed annuity products; however, we continue to service our existing retained and reinsured blocks of business.

We monitor and change crediting rates on fixed annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, if interest rates remain at current levels or decrease, we could see declines in spreads which impact the margins on our products, particularly our single premium immediate annuity products. We had premium deficiencies in our single premium immediate annuity products in 2016 through 2019 that resulted in the establishment of additional future policy benefit reserves that were reflected as charges to net income. In 2021 and 2020, the results of our loss recognition testing did not result in a premium deficiency; therefore, our liability for future policy benefits was sufficient. If investment performance deteriorates or interest rates decrease or remain at the current levels for an extended period of time, we could incur additional charges in the future. The impacts of future adverse changes in our assumptions could result in the establishment of additional future policy benefit reserves and would be immediately reflected as a loss if our margin for this block is again reduced below zero. Any favorable variation would result in additional margin and higher income recognized over the remaining duration of the
in-force
block but would not have an immediate benefit to net income. For additional information, see “—Critical Accounting Estimates—Future Policy Benefits.”

For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.

115

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our U.S. Life Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Revenues:
Premiums$2,454$2,858$2,861$(404)(14)%
Net investment income3,0292,8782,8521515%
Net investment gains (losses)32951782(188)(36)%
Policy fees and other income565595643(30)(5)%
Total revenues6,3776,8486,438(471)(7)%
Benefits and expenses:
Benefits and other changes in policy reserves4,2304,7814,979(551)(12)%
Interest credited346383419(37)(10)%
Acquisition and operating expenses, net of deferrals86562060424540%
Amortization of deferred acquisition costs and intangibles340418372(78)(19)%
Interest expense517(5)(100)%
Total benefits and expenses5,7816,2076,391(426)(7)%
Income from continuing operations before income taxes59664147(45)(7)%
Provision for income taxes15516334(8)(5)%
Income from continuing operations44147813(37)(8)%
Adjustments to income from continuing operations:
Net investment (gains) losses, net(2)(330)(525)(89)19537%
Gains (losses) on early extinguishment of debt4(4)(100)%
Initial loss from life block transaction9292NM(1)
Expenses related to restructuring171316NM(1)
Taxes on adjustments4711018(63)(57)%
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$267$68$(55)$199NM(1)
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)For the years ended December 31, 2021, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million, $(8) million and $(7) million, respectively.

116

Table of Contents

The following table sets forth adjusted operating income (loss) for the businesses included in our U.S. Life Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Long-term care insurance$445$237$57$20888%
Life insurance(269)(247)(181)(22)(9)%
Fixed annuities9178691317%
Total adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders$267$68$(55)$199NM(1)
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2021 compared to 2020

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Column 1Column 2Column 3Column 4
Adjusted operating income in our long-term care insurance business increased $208 million primarily from higher net investment income, as well as higher premiums and reduced benefits of $212 million in 2021 from in-force rate actions approved and implemented, which included a net favorable impact from policyholder benefit reduction elections made as part of a legal settlement. The increase was also attributable to favorable development on IBNR claims. The year ended December 31, 2020 included higher claim reserves of $157 million associated with changes to incidence and mortality experience driven by COVID-19, which we believe are temporary.
Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance business increased $22 million mainly attributable to an unfavorable unlocking of $70 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2021 compared to a favorable unlocking of $60 million in 2020 (see “—Critical Accounting Estimates” for additional information). The higher loss was also attributable to higher mortality in 2021 compared to 2020 and higher DAC impairments of $42 million in 2021 in our universal and term universal life insurance products principally due to lower future estimated gross profits. The higher loss was partially offset by lower lapses primarily associated with our large 20-year term life insurance block written at the end of 2000 as it entered its post-level premium period.
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuities business increased $13 million mainly attributable to lower reserves and DAC amortization in our fixed indexed annuities driven by favorable changes in interest rates and equity markets, partially offset by lower net spreads in 2021.

Revenues

Premiums

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $30 million primarily driven by policy terminations and policies entering paid-up status in 2021, partially offset by $84 million of increased premiums in 2021 from in-force rate actions approved and implemented.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $374 million mainly attributable to higher ceded reinsurance in 2021. We initially ceded $360 million of certain term life insurance premiums under a new reinsurance treaty as part of a life block transaction in the fourth quarter of 2021. The decrease was also attributable to the continued runoff of our term and whole life insurance products in 2021.

117

Table of Contents

Net investment income

Column 1Column 2Column 3Column 4
Our long-term care insurance business increased $231 million largely from higher income of $218 million in 2021 mostly from limited partnerships, U.S. Government Treasury Inflation Protected Securities (“TIPS”) and bond calls. The increase was also attributable to higher average invested assets in 2021.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $16 million principally related to lower yields in 2021.
Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $64 million largely attributable to lower average invested assets in 2021 due to block runoff.

Net investment gains (losses)

Column 1Column 2Column 3Column 4
Net investment gains in our long-term care insurance business decreased $282 million principally due to net gains from the sale of U.S. government securities in 2020 due to portfolio rebalancing and asset exposure management that did not recur, partially offset by higher unrealized gains from changes in the fair value of equity securities in 2021.
Column 1Column 2Column 3Column 4
Net investment gains in our life insurance business increased $54 million predominantly from higher net gains from the sale of investment securities and higher unrealized gains from changes in the fair value of equity securities in 2021.
Column 1Column 2Column 3Column 4
Net investment losses in our fixed annuities business decreased $40 million primarily related to lower net derivative losses in 2021.

Policy fees and other income.

The decrease was mostly attributable to our life insurance business primarily driven by the runoff of our
in-force
blocks. The year ended December 31, 2020 included an unfavorable unlocking of $6 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2020.

Benefits and expenses

Benefits and other changes in policy reserves

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $298 million primarily due to a more favorable impact of $405 million from reduced benefits in 2021 related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made as part of a legal settlement, and from favorable development on IBNR claims. Given our assumption that COVID-19 accelerated mortality on our most vulnerable claimants and temporarily decreased the number of new claims submitted, we increased claim reserves by $199 million in 2020. In 2021, as the impacts of COVID-19 lessened, we modestly strengthened our claim reserves by $10 million to account for changes to incidence and mortality experience driven by COVID-19. These decreases were partially offset by aging of the in-force block and higher incremental reserves of $347 million recorded in connection with an accrual for profits followed by losses in 2021. The year ended December 31, 2020 included a $17 million net favorable impact from the completion of our annual review of assumptions and methodologies.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $226 million principally related to higher ceded reinsurance in 2021. We initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction in the fourth quarter of 2021. This decrease was partially offset by an unfavorable unlocking of $86 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2021 compared to a favorable unlocking of $124 million in 2020 (see “—Critical Accounting Estimates—Policyholder account balances” for additional information). Mortality was also higher in 2021 compared to 2020 attributable in part to COVID-19.

118

Table of Contents

Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $27 million principally from lower reserves in our fixed indexed annuities driven by favorable interest rate and equity market changes in 2021 compared to an unfavorable market in 2020.

Interest credited.

The decrease in interest credited was driven by declines of $24 million and $13 million in our fixed annuities and life insurance products, respectively, due to lower average account values from block runoff and lower crediting rates in 2021.

Acquisition and operating expenses, net of deferrals

Column 1Column 2Column 3Column 4
Our long-term care insurance business increased $219 million principally related to higher premium taxes, commissions and other expenses of $220 million in 2021 associated with our in-force rate action plan, which included expenses related to policyholder benefit reduction elections made as part of a legal settlement.
Column 1Column 2Column 3Column 4
Our life insurance business increased $26 million predominately from reinsurance costs recorded in connection with a life block transaction completed in the fourth quarter of 2021.

Amortization of deferred acquisition costs and intangibles

Column 1Column 2Column 3Column 4
Our long-term care insurance business increased $21 million principally from policy terminations and policies entering paid-up status in 2021.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $77 million primarily attributable to higher prior year lapses in our 20-year term life insurance block written in 2000 and a less unfavorable unlocking of $40 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2021 compared to 2020. These decreases were partially offset by higher DAC impairments of $54 million in 2021 in our universal and term universal life insurance products principally due to lower future estimated gross profits.
Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $22 million primarily related to lower DAC amortization reflecting the impact of favorable market changes in 2021.

Interest expense.

The decrease in interest expense was due to our life insurance business principally related to the early redemption of
non-recourse
funding obligations, partially offset by the
write-off
of $4 million in deferred borrowing costs in 2020.

Provision for income taxes.

The effective tax rate was 26.1% and 25.5% for the years ended December 31, 2021 and 2020, respectively. The increase in the effective tax rate is primarily attributable to higher tax expense on forward starting swaps settled prior to the enactment of the TCJA, which are tax effected at 35% as they are amortized into net investment income, in relation to lower
pre-tax
income in 2021.

U.S. Life Insurance selected operating performance measures

Long-term care insurance

As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to bring those blocks closer to a break-even point over time and reduce the strain on earnings and capital. We are also requesting premium rate increases and associated benefit reductions on newer blocks of business, as needed, some of which will be significant, to help bring their loss ratios back towards their original pricing. In aggregate, we estimate that we have achieved approximately $19.6 billion, on a net present value basis, of approved
in-force
rate increases since 2012. The $19.6 billion we have achieved has grown significantly since 2020 due in part to the value of our 2021 rate action approvals of $2.3 billion. Additionally,

119

Table of Contents

the benefit utilization trend assumption update for higher cost of care growth increased the value of the benefit reductions in connection with our previously achieved rate actions by $2.8 billion. We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases and associated benefit reductions in order to pay future claims.

The following table summarizes the impact from cumulative
in-force
rate actions on the results of operations of our long-term care insurance business for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Premiums$830$746$632$8411%
Plus: Benefits and other changes in policy reserves(2)91250761440580%
Less: Acquisition and operating expenses, net of deferrals(3)2826252220NM(1)
Adjusted operating income before taxes1,4601,1911,19426923%
Income taxes3072502515723%
Adjusted operating income(4)$1,153$941$943$21223%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)Amounts represent benefit reductions elected by policyholders as an alternative to increased premiums. These amounts reduced benefits and other changes in policy reserves in our long-term care insurance business for the periods indicated.
Column 1Column 2
(3)Amounts include premium taxes, commissions and other expenses associated with our long-term care insurance in-force rate action plan, which included expenses of $209 million related to policyholder benefit reduction elections made as part of a legal settlement for the year ended December 31, 2021. Included in the $209 million of expenses was $185 million related to cash damages.
Column 1Column 2
(4)Adjusted operating income available to Genworth Financial, Inc.’s common stockholders attributable to in-force rate actions excludes reserve updates resulting from profits followed by losses.

See our results of operations above for additional details.

The following table presents net earned premiums and the loss ratio for our long-term care insurance business for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Net earned premiums:
Individual long-term care insurance(1)$2,466$2,497$2,464$(31)(1)%
Group long-term care insurance12412311911%
Total$2,590$2,620$2,583$(30)(1)%
Loss ratio61%71%77%(10)%
Column 1Column 2
(1)For the years ended December 31, 2021, 2020 and 2019, amounts include increased premiums of $830 million, $746 million and $632 million, respectively, from in-force rate actions approved and implemented.

The loss ratio is the ratio of benefits and other changes in reserves less tabular interest on reserves less loss adjustment expenses to net earned premiums.

120

Table of Contents

2021 compared to 2020

Net earned premiums decreased in 2021 primarily driven by policy terminations and policies entering
paid-up
status, partially offset by $84 million of increased premiums in 2021 from
in-force
rate actions approved and implemented.

The loss ratio decreased in 2021 due to the lower benefits and other changes in reserves as discussed above.

Life insurance

The following table sets forth selected operating performance measures regarding our life insurance business as of or for the dates indicated:

As of or for years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Term and whole life insurance
Net earned premiums(1)$(136)$238$278$(374)(157)%
Life insurance in-force, net of reinsurance47,29759,91981,644(12,622)(21)%
Life insurance in-force before reinsurance332,793362,082399,887(29,289)(8)%
Term universal life insurance
Net deposits$203$217$228$(14)(6)%
Life insurance in-force, net of reinsurance99,471107,048112,720(7,577)(7)%
Life insurance in-force before reinsurance100,119107,774113,487(7,655)(7)%
Universal life insurance
Net deposits$259$269$360$(10)(4)%
Life insurance in-force, net of reinsurance31,11732,50133,917(1,384)(4)%
Life insurance in-force before reinsurance35,22836,83938,566(1,611)(4)%
Total life insurance
Net earned premiums and deposits(1)$326$724$866$(398)(55)%
Life insurance in-force, net of reinsurance177,885199,468228,281(21,583)(11)%
Life insurance in-force before reinsurance468,140506,695551,940(38,555)(8)%
Column 1Column 2
(1)In the fourth quarter of 2021, we ceded premiums of $360 million associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.

We no longer solicit sales of our traditional life insurance products; however, we continue to service our existing blocks of business.

2021 compared to 2020

Term and whole life insurance

Net earned premiums decreased primarily attributable to higher ceded reinsurance in 2021. We initially ceded $360 million of certain term life insurance premiums under a new reinsurance treaty as part of a life block transaction in the fourth quarter of 2021. The decrease in net earned premiums was also attributable to the continued runoff of our term life insurance products. Life insurance
in-force
also decreased as a result of the continued runoff of our term life insurance products, including from 2020 lapse experience in our large
20-year
term life insurance block written in 2000.

Universal and term universal life insurance

Net deposits decreased in 2021 primarily attributable to the continued runoff of our
in-force
blocks.

121

Table of Contents

Fixed annuities

The following table sets forth selected operating performance measures regarding our fixed annuities as of or for the dates indicated:

As of or for years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Account value, beginning of period$11,815$13,023$14,348$(1,208)(9)%
Deposits83808534%
Surrenders, benefits and product charges(1,976)(1,886)(2,137)(90)(5)%
Net flows(1,893)(1,806)(2,052)(87)(5)%
Interest credited and investment performance349405486(56)(14)%
Effect of accumulated net unrealized investment gains (losses)(108)193241(301)(156)%
Account value, end of period$10,163$11,815$13,023$(1,652)(14)%

We no longer solicit sales of our traditional fixed annuity products; however, we continue to service our existing block of business.

2021 compared to 2020

Account value as of December 31, 2021 decreased compared to December 31, 2020 as surrenders and benefits exceeded favorable market performance and interest credited.

Runoff segment

Trends and conditions

Results of our Runoff segment are affected primarily by investment performance, interest rate levels, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our Runoff segment can significantly impact our regulatory capital requirements, distributable earnings and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate the impacts. In addition, we may consider reinsurance opportunities to further mitigate volatility in results and manage capital in the future.

Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity and interest rate market performance and volatility could result in additional gains or losses in these products although associated hedging activities are expected to partially mitigate these impacts.

122

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Runoff segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Revenues:
Net investment income$194$210$187$(16)(8)%
Net investment gains (losses)3(26)(25)29112%
Policy fees and other income13413014043%
Total revenues331314302175%
Benefits and expenses:
Benefits and other changes in policy reserves274827(21)(44)%
Interest credited162166158(4)(2)%
Acquisition and operating expenses, net of deferrals534852510%
Amortization of deferred acquisition costs and intangibles202318(3)(13)%
Total benefits and expenses262285255(23)(8)%
Income from continuing operations before income taxes69294740138%
Provision for income taxes13489NM(1)
Income from continuing operations56253931124%
Adjustments to income from continuing operations:
Net investment (gains) losses, net(2)(3)2321(26)(113)%
Taxes on adjustments1(5)(4)6120%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$54$43$56$1126%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)For the years ended December 31, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(3) million and $(4) million, respectively.

2021 compared to 2020

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income increased primarily due to favorable equity market and interest rate performance, partially offset by lower investment income in 2021. The year ended December 31, 2020 included an unfavorable assumption update of $5 million.

Revenues

Net investment income decreased largely due to lower average invested assets in our variable annuity products and lower policy loan income in our corporate-owned life insurance products in 2021.

The change to net investment gains in 2021 from net investment losses in 2020 was primarily related to gains on embedded derivatives associated with our variable annuity products with GMWBs in 2021 compared to losses in 2020, partially offset by derivative losses in 2021 compared to derivative gains in 2020.

Policy fees and other income increased principally from higher fee income driven mostly by an increase in the average account values in our variable annuity products in 2021.

123

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves decreased primarily attributable to lower GMDB reserves in our variable annuity products due to favorable equity market and interest rate performance. The year ended December 31, 2020 included an unfavorable assumption update of $7 million.

Interest credited decreased largely due to our corporate-owned life insurance products in 2021.

Acquisition and operating expenses, net of deferrals, increased mainly from higher commissions in our variable annuity products in 2021.

Amortization of deferred acquisition costs and intangibles decreased mainly related to lower DAC amortization in our variable annuity products principally from favorable equity market performance in 2021.

Provision for income taxes.

The effective tax rate increased to 18.5% for the year ended December 31, 2021 from 14.5% for the year ended December 31, 2020. The increase was primarily attributable to tax benefits from tax favored items in relation to higher
pre-tax
income in 2021.

Runoff selected operating performance measures

Variable annuity and variable life insurance products

The following table sets forth selected operating performance measures regarding our variable annuity and variable life insurance products as of or for the dates indicated:

As of or for the years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Account value, beginning of period$5,001$5,042$4,918$(41)(1)%
Deposits192025(1)(5)%
Surrenders, benefits and product charges(607)(559)(640)(48)(9)%
Net flows(588)(539)(615)(49)(9)%
Interest credited and investment performance426498739(72)(14)%
Account value, end of period$4,839$5,001$5,042$(162)(3)%

We no longer solicit sales of our variable annuity or variable life insurance products; however, we continue to service our existing blocks of business and accept additional deposits on existing contracts and policies.

2021 compared to 2020

Account value as of December 31, 2021 decreased compared to December 31, 2020 primarily related to surrenders, partially offset by favorable equity market performance in 2021.

124

Table of Contents

Funding agreements

The following table presents the account value of our funding agreements as of or for the dates indicated:

As of or for the years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Account value, beginning of period$300$253$381$4719%
Deposits150(150)(100)%
Surrenders and benefits(52)(106)(136)5451%
Net flows(52)44(136)(96)NM(1)
Interest credited238(1)(33)%
Account value, end of period$250$300$253$(50)(17)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2021 compared to 2020

Account value as of December 31, 2021 decreased compared to December 31, 2020 mainly attributable to a maturity payment in 2021.

125

Table of Contents

Corporate and Other Activities

Results of operations

The following table sets forth the results of operations relating to Corporate and Other activities for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2021202020192021 vs. 2020
Revenues:
Premiums$6$7$8$(1)(14)%
Net investment income668%
Net investment gains (losses)(7)5(31)(12)NM(1)
Policy fees and other income1(2)23150%
Total revenues616(13)(10)(63)%
Benefits and expenses:
Benefits and other changes in policy reserves143(3)(75)%
Acquisition and operating expenses, net of deferrals7561621423%
Amortization of deferred acquisition costs and intangibles2131100%
Interest expense109172214(63)(37)%
Total benefits and expenses187238282(51)(21)%
Loss from continuing operations before income taxes(181)(222)(295)4118%
Benefit for income taxes(53)(39)(56)(14)(36)%
Loss from continuing operations(128)(183)(239)5530%
Adjustments to loss from continuing operations:
Net investment (gains) losses7(5)3112NM(1)
(Gains) losses on early extinguishment of debt45540NM(1)
Expenses related to restructuring142112NM(1)
Taxes on adjustments(14)(1)(7)(13)NM(1)
Adjusted operating loss available to Genworth Financial Inc.’s common stockholders$(76)$(182)$(214)$10658%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2021 compared to 2020

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily related to lower interest expense, higher tax benefits of $21 million from a reduction in uncertain tax positions due to the expiration of certain statute of limitations and lower operating costs in 2021.

Revenues

The change to net investment losses in 2021 from net investment gains in 2020 was predominantly related to higher derivative losses and lower net realized gains from the sale of investment securities in 2021.

Benefits and expenses

Acquisition and operating expenses, net of deferrals, increased mainly driven by a $19 million loss in 2021 related to the repurchase of Genworth Holdings’ senior notes compared to a $4 million gain in 2020, higher

126

Table of Contents

make-whole premiums of $17 million related to the early redemption of Genworth Holdings’ senior notes and higher restructuring costs of $12 million in 2021, partially offset by lower operating costs.

Interest expense decreased largely from the redemption of Genworth Holdings’ senior notes due in February 2021, the repurchase and early redemption of Genworth Holdings’ senior notes due in September 2021 and from a lower floating rate of interest on our junior subordinated notes.

The increase in the benefit for income taxes was primarily related to a reduction in uncertain tax positions due to the expiration of certain statute of limitations, partially offset by a lower
pre-tax
loss in 2021.

Investments and Derivative Instruments

General macroeconomic environment

The stability of both the financial markets and global economies in which we operate impacts the sales, revenue growth and profitability trends of our businesses as well as the value of assets and liabilities.

Varied levels of economic performance, coupled with uncertain economic outlooks, changes in government policy, global trade, regulatory and tax reforms, and other changes in market conditions, such as inflation, will continue to influence investment and spending decisions by consumers and businesses as they adjust their consumption, debt, capital and risk profiles in response to these conditions, including as a result of
COVID-19.
These trends change as investor confidence in the markets and the outlook for some consumers and businesses shift. As a result, our sales, revenues and profitability trends of certain insurance and investment products as well as the value of assets and liabilities could be impacted going forward. In particular, factors such as the length of
COVID-19
and the speed of the economic recovery, government responses to
COVID-19
(such as government stimulus), government spending, monetary policies (such as tightening quantitative easing), the volatility and strength of the capital markets, changes in tax policy and/or in U.S. tax legislation, inflation, international trade and the impact of global financial regulation reform will continue to affect economic and business outlooks, level of interest rates, consumer confidence and consumer behavior moving forward.

The U.S. Federal Reserve is expected to combat high inflation through changes in its monetary policy, including through raising the benchmark prime lending rate. During the fourth quarter of 2021, the U.S. Federal Reserve maintained interest rates near zero as the U.S. economy continued to recover from the negative impact of
COVID-19.
During its November 2021 meeting, the U.S. Federal Reserve announced it would begin tapering its asset purchases and announced in its December 2021 meeting that it would accelerate this reduction in January 2022 with a targeted end to its asset purchase program by March 2022. The U.S. Federal Reserve also revised its interest rate forecast during its December 2021 meeting and now projects three 25 basis point rate increases in 2022, with the first expected as early as March 2022. The U.S. economy continued to show signs of recovery from
COVID-19
during the fourth quarter of 2021, demonstrated by gross domestic product growth of 6.9%. However, supply chain disruptions, rising commodity prices and a tightening labor market have elevated inflationary pressures in the U.S. economy. Crude oil prices reached a seven-year high in October 2021 and the unemployment rate decreased to 3.9% as of December 31, 2021 but labor participation continues to be suppressed. The December 2021 consumer price index reported the highest annual U.S. inflation rate in nearly 40 years, which influenced the U.S. Federal Reserve’s policy changes during the fourth quarter of 2021.

Although inflation continued to trend higher throughout 2021, it did not have a material effect on our 2021 results of operations. However, persistently high inflation may impact future healthcare costs and the cost of care in our long-term care insurance business. Several assumptions were updated as part of our U.S. life insurance business annual assumption review, including benefit utilization, or cost of care growth. Prior to the completion of our U.S. life insurance business annual assumption review, we had assumed that long-term benefit utilization would improve over time. However, given the high inflation and minimum wage increases in some large states, we now expect long-term benefit utilization to trend higher than we previously assumed.

127

Table of Contents

The U.S. and international governments, the U.S. Federal Reserve, other central banks and other legislative and regulatory bodies have taken certain actions in response to
COVID-19
to support the global economy and capital markets. These policies and actions have generally been supportive to the worldwide economy; however, in spite of these supportive policies the U.S. economy contracted in 2020 and the world economy fell into a recession. Gross domestic product rebounded sharply in 2021 due in part to the continued rollout of the vaccine and the tempered
re-opening
of the U.S. economy. However, given the potential for future actions to be taken to mitigate the risk of a virus
re-emergence
due to variants, or due to high inflation and supply chain disruptions, it is possible the U.S. economy could fall into a recession. Moreover, we continue to closely monitor the operating results and financial position of Enact Holdings, particularly related to new delinquency trends and whether borrowers in a forbearance plan ultimately cure or result in a claim payment. Furthermore, rising interest rates may impact mortgage origination volume which could impede Enact Holdings’ financial progress, including its ability to return capital through dividends to Genworth. If these trends move in an unfavorable direction in contrast to our current projections, our liquidity, financial position and results of operations could be adversely impacted.

Trends and conditions

Investments

U.S. Treasury yields fluctuated during the fourth quarter of 2021 largely due to expected changes in the U.S. Federal Reserve’s monetary policy, inflation concerns and the new
COVID-19
omicron variant. The U.S. Treasury yield curve flattened significantly at the end of the fourth quarter of 2021, with the
two-year
and three-year Treasury yields increasing, mostly from expectations of interest rate increases by the U.S. Federal Reserve, and the
30-year
Treasury yield decreasing slightly. During the fourth quarter of 2021, the
10-year
Treasury yield fell before slowly recovering as fears of the
COVID-19
omicron variant’s economic impacts subsided, ending the fourth quarter of 2021 in line with the yield as of September 30, 2021.

Credit markets were resilient at the beginning of the fourth quarter of 2021, but as interest rate and equity volatility increased towards the end of 2021, credit spreads began to widen modestly. The onset of the
COVID-19
omicron variant in late November 2021 widened credit spreads to its highest levels in 2021 but spreads tightened again as both equity markets and interest rates stabilized. Despite added macroeconomic volatility, driven mostly by the
COVID-19
omicron variant, the shift in U.S. Federal Reserve policy, political gridlock and rising geopolitical tension, investment grade credit spreads remained near post-financial crisis lows throughout 2021. Higher yields in the United States, compared to the rest of the global market, continued to make the United States credit market attractive to both domestic and foreign investors.

As of December 31, 2021, we did not have any modifications or extensions of commercial mortgage loans that were considered troubled debt restructurings. Modified loans represented less than 1% of our total loan portfolio as of December 31, 2021, as borrowers have sought additional relief related to
COVID-19.
We are working with individual borrowers impacted by
COVID-19
to provide alternative forms of relief for a specified period of time. The modified loan population continues to decrease as modification terms expire and property valuations stabilize. Most of our borrowers are current on payments and we did not experience a significant impact from troubled debt restructurings in 2021.

As of December 31, 2021, our fixed maturity securities portfolio, which was 95% investment grade, comprised 82% of our total invested assets and cash.

Derivatives

As of December 31, 2021, $946 million notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”). The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2021, we posted initial margin of $67 million to our clearing agents, which represented

128

Table of Contents

$33 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings. As of December 31, 2021, $9.3 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $469 million and are holding collateral from counterparties in the amount of $308 million.

In July 2017, the United Kingdom Financial Conduct Authority announced its intention to transition away from LIBOR, with its full elimination to occur after 2021. The LIBOR tenors, such as the three-month LIBOR, have various
phase-out
dates with the last committed publication date of June 30, 2023. The Alternate Reference Rate Committee (“ARRC”), convened by the Board of Governors of the Federal Reserve System and the New York Federal Reserve Bank, has endorsed the Secured Overnight Financing Rate (“SOFR”) as its preferred replacement benchmark for U.S. dollar LIBOR. SOFR is calculated and published by the New York Federal Reserve Bank and reflects the combination of three overnight U.S. Treasury Repo Rates. The rate is different from LIBOR, in that it is a risk-free rate, is backward-looking instead of forward-looking, is a secured rate and currently is available primarily as an overnight rate rather than a
1-,

3-
or
6-month
rate available for LIBOR. Upon the announcement, we formed a working group comprised of finance, investments, derivative, and tax professionals, as well as lawyers (the “Working Group”) to evaluate contracts and perform analysis of our LIBOR-based derivative instrument and investment exposure, as well as debt (including subordinated debt and Federal Home Loan Bank loans), reinsurance agreements and institutional products within the Runoff segment, as a result of the elimination of LIBOR. The Working Group took inventory of all investments with LIBOR exposure and developed a transition plan for the nearly 400 instruments identified.

We have completed our assessment of operational readiness for LIBOR cessation related to our various instruments and our Working Group will continue to monitor the process of elimination and replacement of LIBOR, including any new accounting pronouncements that may be issued to provide further transition relief due to the extended cessation dates of certain LIBOR tenors. Since the initial announcement, we have terminated the majority of our LIBOR-based swaps and entered into alternative rate swaps. In anticipation of the elimination of LIBOR, we plan to continue to convert our remaining LIBOR-based derivatives in a similar manner. In addition, our
non-recourse
funding obligations with interest rates based on
one-month
LIBOR were redeemed in January 2020. Moreover, we will continue to monitor the developments coming from ARRC, who is expected to authorize the use of an alternative rate to replace the current contractual three-month LIBOR rate applied to Genworth Holdings’ junior subordinated notes due in 2066. Although uncertainty remains surrounding the final cessation and transition away from LIBOR, we do not expect a material adverse impact on our results of operations or financial condition.

129

Table of Contents

Investment results

The following table sets forth information about our investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31:

Increase (decrease)
2021202020192021 vs. 2020
(Amounts in millions)YieldAmountYieldAmountYieldAmountYieldAmount
Fixed maturity securities—taxable4.5%$2,4114.7%$2,4484.7%$2,444(0.2)%$(37)
Fixed maturity securities—non-taxable5.6%74.3%66.1%81.3%1
Equity securities4.0%94.2%126.2%12(0.2)%(3)
Commercial mortgage loans5.5%3765.0%3455.0%3480.5%31
Policy loans9.3%1899.5%1998.9%180(0.2)%(10)
Limited partnerships(1)15.7%2239.1%728.5%446.6%151
Other invested assets(2)69.7%24156.0%22356.2%19013.7%18
Cash, cash equivalents, restricted cash and short-term investments%10.5%151.6%33(0.5)%(14)
Gross investment income before expenses and fees5.2%3,4575.0%3,3205.1%3,2590.2%137
Expenses and fees(0.1)%(87)(0.1)%(93)(0.2)%(95)%6
Net investment income5.1%$3,3704.9%$3,2274.9%$3,1640.2%$143
Average invested assets and cash$66,099$65,982$64,091$117
Column 1Column 2
(1)Limited partnership investments are primarily equity-based and do not have fixed returns by period.
Column 1Column 2
(2)Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.

Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments and securities lending activity, which is included in other invested assets and is calculated net of the corresponding securities lending liability.

Annualized weighted-average investment yields increased in 2021 compared to 2020 primarily driven by higher investment income on slightly higher average invested assets. Net investment income included higher income of $151 million from limited partnerships, $48 million from bond calls and commercial mortgage loan prepayments and $45 million of higher income related to inflation-driven volatility on TIPS in 2021.

130

Table of Contents

The following table sets forth net investment gains (losses) for the years ended December 31:

(Amounts in millions)202120202019
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains$67$471$90
Realized losses(10)(29)(38)
Net realized gains (losses) on available-for-sale fixed maturity securities5744252
Net realized gains (losses) on equity securities sold(7)(1)
Net realized gains (losses) on limited partnerships31
Total net realized investment gains (losses)5344153
Impairments:
Total other-than-temporary impairments(1)
Portion of other-than-temporary impairments included in other comprehensive income (loss)
Net other-than-temporary impairments(1)
Net change in allowance for credit losses on available-for-sale fixed maturity securities(6)(5)
Write-down of available-for-sale fixed maturity securities(1)(4)
Net unrealized gains (losses) on equity securities still held1414
Net unrealized gains (losses) on limited partnerships26411228
Commercial mortgage loans(3)(2)(2)
Derivative instruments14(49)(70)
Other1(5)5
Net investment gains (losses)$323$492$27

2021 compared to 2020

Column 1Column 2Column 3Column 4
We recorded net gains related to the sale of available-for-sale fixed maturity securities of $57 million in 2021 primarily from sales of U.S. corporate securities. Net gains related to the sale of available-for-sale fixed maturity securities of $442 million in 2020 were primarily driven by the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment.
Column 1Column 2Column 3Column 4
We recorded higher net unrealized gains of $152 million on limited partnership investments in 2021 compared to 2020 primarily driven by higher average limited partnership investments, as well as favorable performance of private equity investments in 2021.
Column 1Column 2Column 3Column 4
Net investment gains related to derivatives of $14 million in 2021 were primarily associated with embedded derivatives related to our indexed universal life insurance products, partially offset by losses from decreases in the values of investments used to protect statutory surplus from equity market fluctuations and losses associated with embedded derivatives related to our fixed indexed annuity products.

Net investment losses related to derivatives of $49 million in 2020 were primarily associated with embedded derivatives related to our fixed indexed annuity and runoff variable annuity products.

131

Table of Contents

Investment portfolio

The following table sets forth our cash, cash equivalents, restricted cash and invested assets as of December 31:

20212020
(Amounts in millions)Carrying value% of totalCarrying value% of total
Available-for-sale fixed maturity securities:
Public$42,50158%$44,77658%
Private17,9792418,71924
Equity securities198386
Commercial mortgage loans, net6,83096,7439
Policy loans2,05031,9783
Limited partnerships1,90031,0491
Other invested assets82011,0502
Cash, cash equivalents and restricted cash1,57122,5613
Total cash, cash equivalents, restricted cash and invested assets$73,849100%$77,262100%

For a discussion of the change in cash, cash equivalents, restricted cash and invested assets, see the comparison for this line item under “—Consolidated Balance Sheets.” See note 4 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio.

We hold fixed maturity and equity securities, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2021, approximately 6% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 16 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value.

132

Table of Contents

Fixed maturity securities

As of December 31, 2021, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as

available-for-sale

were as follows:

(Amounts in millions)Amortized cost or costGross unrealized gainsGross unrealized lossesAllowance for credit lossesFair value
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises$3,368$1,184$$$4,552
State and political subdivisions2,982474(6)3,450
Non-U.S. government76286(13)835
U.S. corporate:
Utilities4,330783(9)5,104
Energy2,581363(10)2,934
Finance and insurance8,0031,012(24)8,991
Consumer—non-cyclical5,1381,029(8)6,159
Technology and communications3,345476(13)3,808
Industrial1,322175(3)1,494
Capital goods2,334415(4)2,745
Consumer—cyclical1,703203(7)1,899
Transportation1,1222491,371
Other37941(1)419
Total U.S. corporate30,2574,746(79)34,924
Non-U.S. corporate:
Utilities86763(2)928
Energy1,194190(1)1,383
Finance and insurance2,171270(9)2,432
Consumer—non-cyclical66481(2)743
Technology and communications1,085166(1)1,250
Industrial933117(3)1,047
Capital goods64066(1)705
Consumer—cyclical31627(2)341
Transportation42268(1)489
Other1,052169(4)1,217
Total non-U.S. corporate9,3441,217(26)10,535
Residential mortgage-backed1,325116(1)1,440
Commercial mortgage-backed2,435152(3)2,584
Other asset-backed2,13829(7)2,160
Total available-for-sale fixed maturity securities$52,611$8,004$(135)$$60,480

133

Table of Contents

As of December 31, 2020, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as

available-for-sale

were as follows:

(Amounts in millions)Amortized cost or costGross unrealized gainsGross unrealized lossesAllowance for credit lossesFair value
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises$3,401$1,404$$$4,805
State and political subdivisions2,622544(1)3,165
Non-U.S. government728130(4)854
U.S. corporate:
Utilities4,226970(2)5,194
Energy2,532367(16)2,883
Finance and insurance7,7981,306(2)9,102
Consumer—non-cyclical5,1151,323(1)6,437
Technology and communications3,1426193,761
Industrial1,3702321,602
Capital goods2,4565352,991
Consumer—cyclical1,6632841,947
Transportation1,198304(2)1,500
Other39545440
Total U.S. corporate29,8955,985(23)35,857
Non-U.S. corporate:
Utilities83884922
Energy1,172209(1)1,380
Finance and insurance2,130353(6)(1)2,476
Consumer—non-cyclical662112(1)773
Technology and communications1,0622291,291
Industrial9691591,128
Capital goods51067(1)576
Consumer—cyclical33141(1)371
Transportation48388(1)570
Other1,0882361,324
Total non-U.S. corporate9,2451,578(11)(1)10,811
Residential mortgage-backed(1)1,6982111,909
Commercial mortgage-backed2,759231(13)(3)2,974
Other asset-backed3,06955(4)3,120
Total available-for-sale fixed maturity securities$53,417$10,138$(56)$(4)$63,495
Column 1Column 2
(1)Fair value included $8 million collateralized by Alt-A residential mortgage loans.

Fixed maturity securities decreased $3.0 billion principally from a decrease in net unrealized gains related to an increase in interest rates, as well as sales, maturities and repayments exceeding purchases in 2021.

134

Table of Contents

Other invested assets

The following table sets forth the carrying values of our other invested assets as of December 31:

20212020
(Amounts in millions)Carrying value% of totalCarrying value% of total
Derivatives$41450%$57455%
Bank loan investments3634534433
Short-term investments263454
Securities lending collateral676
Other investments172202
Total other invested assets$820100%$1,050100%

Derivatives decreased largely from an increase in interest rates and terminations in 2021. Securities lending collateral decreased due to our suspension of the securities lending program in 2021.

Derivatives

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for GMWB embedded derivatives, fixed index annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:

(Notional in millions)MeasurementDecember 31, 2020AdditionsMaturities/ terminationsDecember 31, 2021
Derivatives designated as hedges
Cash flow hedges:
Interest rate swapsNotional$8,178$$(525)$7,653
Foreign currency swapsNotional127127
Total cash flow hedges8,305(525)7,780
Total derivatives designated as hedges8,305(525)7,780
Derivatives not designated as hedges
Interest rate swapsNotional4,674(4,674)
Equity index optionsNotional2,0001,438(1,992)1,446
Financial futuresNotional1,1043,887(4,045)946
Other foreign currency contractsNotional1,18625(1,128)83
Total derivatives not designated as hedges8,9645,350(11,839)2,475
Total derivatives$17,269$5,350$(12,364)$10,255
(Number of policies)MeasurementDecember 31, 2020AdditionsMaturities/ terminationsDecember 31, 2021
Derivatives not designated as hedges
GMWB embedded derivativesPolicies23,713(1,909)21,804
Fixed index annuity embedded derivativesPolicies12,778(3,434)9,344
Indexed universal life embedded derivativesPolicies842(36)806

The decrease in the notional value of derivatives was primarily attributable to the termination of interest rate swaps used to protect statutory capital from interest rate fluctuations, the termination of foreign currency

135

Table of Contents

derivatives previously entered into to hedge payments to AXA under the promissory note that was fully repaid in the third quarter of 2021 and the termination of interest rate swaps used to hedge interest rate fluctuations on Genworth Holdings’ junior subordinated notes.

The number of policies related to our embedded derivatives decreased as these products are no longer being offered and continue to runoff.

Critical Accounting Estimates

The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.”

Insurance liabilities and reserves

.

We calculate and maintain reserves for the estimated future payment of claims to our policyholders and contractholders based on actuarial assumptions and in accordance with U.S. GAAP and industry practice. We build these reserves as the estimated value of those obligations increases, and we release these reserves as those future obligations are paid, experience changes or policies lapse. The reserves we establish reflect estimates and actuarial assumptions and methodologies with regard to our future experience, involve the exercise of significant judgment and are inherently uncertain. Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our reserves as well as the assumptions originally used in pricing our products.

Many factors, and changes in these factors, can affect future experience including, but not limited to: interest rates; investment returns and volatility; economic and social conditions, such as inflation, unemployment, home price appreciation or depreciation, and healthcare experience; policyholder persistency or lapses; insured mortality; insured morbidity; future premium rate increases and associated benefit reductions; expenses; and doctrines of legal liability and damage awards in litigation. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Moreover, we may not be able to mitigate the impact of unexpected adverse experience by increasing premiums and/or other charges to policyholders (where we have the right to do so) or by offering benefit reductions as an alternative to increasing premiums.

Future policy benefits

The liability for future policy benefits is equal to the present value of expected future benefits and expenses, less the present value of expected future net premiums based on assumptions including projected interest rates and investment returns, health care experience, policyholder persistency or lapses, insured mortality, insured morbidity and expenses, all of which are
locked-in
at the time the policies are issued or acquired. In our long-term care insurance business, our assumptions used in loss recognition testing also include significant premium rate increases and associated benefit reductions that have been filed and approved or are anticipated to be approved (including premium rate increases and associated benefit reductions not yet filed). The liability for future policy benefits is reviewed at least annually as a part of our loss recognition testing using current assumptions based on the manner of acquiring, servicing and measuring the profitability of the insurance contracts. Loss recognition testing is generally performed at the line of business level, with acquired blocks and certain reinsured blocks tested separately. Changes in how we manage certain polices could require separate loss recognition testing and could result in future charges to net income. If loss recognition testing indicates a

136

Table of Contents

premium deficiency, the liability for future policy benefits is measured using updated assumptions, which become the new
locked-in
assumptions utilized going forward unless another premium deficiency charge is recorded.

See notes 2 and 9 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to insurance reserves.

Long-term care insurance block, excluding our acquired block

We annually perform loss recognition testing for the liability for future policy benefits for our long-term care insurance products in the aggregate, excluding our acquired block of long-term care insurance, which is tested separately. The results of loss recognition testing are driven by changes to assumptions and methodologies primarily impacting claim termination rates, incidence and benefit utilization rates, mortality and lapse rates, as well as
in-force
rate actions. Claim termination rates refer to the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. As of December 31, 2021 and 2020, the liability for future policy benefits associated with our long-term care insurance block, excluding the acquired block, was $26.6 billion and $26.9 billion, respectively.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance loss recognition testing margin was as follows for the periods presented:

Other Block (Excluding the Acquired Block)Increase (decrease) and percentage change
December 31,
(Amounts in millions)202120202021 vs. 2020
Select estimates and assumptions used in loss recognition testing:
Present value of expected future benefits$49,495$50,840$(1,345)(3)%
Future in-force rate action assumption$9,000$8,000$1,00013%
Discount rate assumption5.25%5.34%(9)0⁄000(2)%

In 2021 and 2020, the results of our loss recognition testing on our long-term care insurance block, excluding the acquired block, indicated that our DAC was recoverable and reserves were sufficient, with a margin of approximately $450 million to $900 million as of December 31, 2021 compared to approximately $400 million to $800 million as of December 31, 2020. The margin in 2021 included updates for lapse, mortality, incidence, expenses, interest rates and benefit utilization (including cost of care growth), among others.

The decrease in the present value of expected future benefits was primarily attributable to actual benefit reductions in 2021 and expected future benefit reductions associated with our
in-force
rate action plan (among other factors). The decrease was partially offset by assumption updates, most notably long-term benefit utilization, which we expect to trend higher than previously assumed due in part to higher cost of care growth driven by inflation.

Our assumption for future
in-force
rate actions is based on our best estimate of the rate increases we expect given our current plans for rate increase filings and our historical experience regarding rate increase approvals. The increase in future rate actions in 2021 was the result of expected future
in-force
rate actions not yet filed, including in connection with the impacts from assumption updates, partially offset by
in-force
rate actions approved and implemented during 2021. An increase in the expected amount of
in-force
rate actions would favorably impact the results of our long-term care insurance margin testing, whereas any unexpected reduction in the amount of
in-force
rate actions would negatively impact our margins and could result in a premium deficiency.

137

Table of Contents

We assume a static discount rate that is in line with our current portfolio yield. This rate represents our expected investment returns based on the portfolio of assets supporting the net U.S. GAAP liability as of the calculation date and, therefore, excludes the impacts of qualifying hedge gains that are not currently amortizing. Because the discount rate is based on our current portfolio yields, changes in interest rates do not impact our loss recognition testing margins unless they result in changes to investment yields. Returns on new investments would need to exceed our current portfolio yield to benefit loss recognition testing margins.

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2021 long-term care insurance loss recognition testing margin:

(Amounts in millions)Other Block (Excluding the Acquired Block)
Sensitivities on loss recognition testing(1):
5% relative increase in future claim costs$(2,475)
10% reduction in benefit of future in-force rate actions$(900)
Discount rate decrease of 25 basis points(2)$(1,150)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another. For example, the increase in claim costs does not include any offsetting impacts from potential future in-force rate actions. Any such offset from in-force rate actions would primarily impact our long-term care insurance block, excluding the acquired block.
Column 1Column 2
(2)The 25 basis point decrease in the discount rate refers to a reduction in our portfolio yields.

Any future adverse changes in our assumptions could result in both the impairment of DAC associated with our long-term care insurance products as well as the establishment of additional future policy benefit reserves. Any favorable variation would result in additional margin and higher income recognized over the remaining duration of the
in-force
block. Our positive margin for our long-term care insurance block, excluding the acquired block, is dependent on our assumptions regarding our ability to successfully implement our
in-force
rate action strategy involving premium rate increases and associated benefit reductions. For our long-term care insurance block, excluding the acquired block, any adverse changes in assumptions would only be reflected in net income as a loss to the extent the margin was reduced below zero.

Profits followed by losses

With respect to our long-term care insurance block, excluding the acquired block, while loss recognition testing supports that in the aggregate our reserves are sufficient, our future projections indicate we have projected profits in earlier periods followed by projected losses in later periods. As a result of this pattern of projected profits followed by projected losses, we will ratably accrue additional future policy benefit reserves over the profitable periods, currently expected to be through 2031, by the amounts necessary to offset estimated losses during the periods that follow. Such additional reserves are updated each period and calculated based on our estimate of the amount necessary to offset the losses in future periods utilizing expected income and current best estimate assumptions based on actual and anticipated experience, consistent with our loss recognition testing. We adjust the accrual rate prospectively, over the remaining profitable periods, without any
catch-up
adjustment. During the years ended December 31, 2021 and 2020, we increased our long-term care insurance future policy benefit reserves by $649 million and $302 million, respectively, to accrue for profits followed by losses. As of December 31, 2021 and 2020, the total amount accrued for profits followed by losses was $1,274 million and $625 million, respectively. The accrual is recorded quarterly and is impacted by the pattern and present value of expected future losses which are updated annually at the time in which we perform loss recognition testing. During the fourth quarter of 2021, we updated our loss recognition testing assumptions, which included changes from our annual assumption review completed in the fourth quarter of 2021 as well as updates to our future
in-force
rate actions. The present value of expected future losses was approximately $2.5 billion and $2.1 billion as of December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, we estimate a factor of

138

Table of Contents

approximately 76% of those profits on our long-term care insurance block, excluding the acquired block, will be accrued in the future to offset estimated future losses during later periods. The factor was unchanged compared to December 31, 2020 due mostly to higher actual profits in 2021 resulting in a larger increase in accrued future policy benefits for profits followed by losses, as well as updates to our future
in-force
rate actions, offset by the updated profit pattern from our annual review of assumptions completed in the fourth quarter of 2021. There may be future adjustments to this estimate reflecting any variety of new and adverse trends that could result in increases to future policy benefit reserves for our profits followed by losses accrual, and such future increases could possibly be material to our results of operations and financial condition and liquidity.

Acquired block of long-term care insurance

In 2014, we had a premium deficiency in our acquired block of long-term care insurance; therefore, our assumptions that were updated in connection with the premium deficiency have remained
locked-in.
These updated assumptions will remain
locked-in
unless, and until such time as, another premium deficiency occurs. As of December 31, 2021 and 2020, the liability for future policy benefits associated with our acquired block of long-term care insurance was $1.6 billion and $1.9 billion, respectively.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance loss recognition testing margin was as follows for the periods presented:

Acquired BlockIncrease (decrease) and percentage change
December 31,
(Amounts in millions)202120202021 vs. 2020
Select estimates and assumptions used in loss recognition testing:
Present value of expected future benefits$2,118$2,403$(285)(12)%
Discount rate assumption6.06%6.44%(38)0⁄000(6)%

Our acquired block of long-term care insurance had positive margin of approximately $50 million to $100 million as of December 31, 2021 compared to approximately $100 million to $200 million as of December 31, 2020. The margin in 2021 included updates for most assumptions; however, the change in the discount rate was the most impactful to the overall decrease in the 2021 margin compared to 2020.

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2021 long-term care insurance loss recognition testing margin:

(Amounts in millions)Acquired Block
Sensitivities on loss recognition testing margin(1):
5% relative increase in future claim costs$(106)
Discount rate decrease of 25 basis points(2)$(28)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another. For example, the increase in claim costs does not include any incremental adverse impacts from a potential decrease in the discount rate.
Column 1Column 2
(2)The 25 basis point decrease in the discount rate refers to a reduction in our portfolio yields.

Due to the age of our acquired block, it would not benefit significantly from future
in-force
rate actions, and therefore, there is a higher likelihood that adverse changes in our assumptions would result in an additional premium deficiency. The impacts of future adverse changes in our assumptions resulting in another premium deficiency would result in the establishment of additional future policy benefit reserves and would be immediately reflected in net income as a loss if our margin for this block is again reduced below zero. Any favorable variation would result in additional margin and higher income recognized over the remaining duration of the
in-force
block but would not have an immediate benefit to net income.

139

Table of Contents

Term and whole life insurance

Similar to our long-term care insurance products, we annually perform loss recognition testing for the liability for future policy benefits for our term and whole life insurance products in the aggregate, excluding our acquired block and certain reinsured blocks, which are tested separately. As of December 31, 2021 and 2020, the liability for future policy benefits associated with our term and whole life insurance products was $2.0 billion and $2.1 billion, respectively.

The risks we face in these products mostly include adverse variations in mortality and lapse assumptions. Adverse experience in one or all of these risks could result in the DAC associated with our term and whole life insurance products, excluding our acquired block, and PVFP associated with our acquired block of term and whole life insurance products to no longer be fully recoverable and could require establishment of additional future policy benefit reserves. Any favorable variation would result in additional margin and higher income recognized over the remaining duration of the
in-force
block.

A summary of certain of our significant estimates used in the calculation of our term and whole life insurance loss recognition testing margin was as follows for the periods presented:

Other Block (Excluding the Acquired Block and Certain Reinsured Blocks)Increase (decrease) and percentage change
December 31,
(Amounts in millions)202120202021 vs. 2020
Select estimates used in loss recognition testing:
Total present value of expected future premiums$2,612$2,657$(45)(2)%
Total present value of expected death benefits and expenses$2,109$2,115$(6)%

As of December 31, 2021 and 2020, we had margin of approximately $300 million to $800 million, and a DAC balance of $0.8 billion and $1.1 billion, respectively, on our term and whole life insurance products, excluding the acquired block and certain reinsured blocks. In 2021, we updated many of our assumptions, including emerging mortality experience. The decrease in both the present value of expected future premiums and death benefits and expenses in 2021 was primarily attributable to higher mortality experience. If our margin is reduced below zero for our term and whole life insurance products, excluding our acquired block and certain reinsured blocks, we would amortize DAC up to the amount of DAC recorded on our balance sheet and if DAC was fully written off, establish additional future policy benefit reserves, either of which would result in a charge to net income.

A summary of certain of our significant estimates used in the calculation of our term and whole life

insurance loss recognition testing margin was as follows for the periods presented:

Acquired BlockIncrease (decrease) and percentage change
December 31,
(Amounts in millions)202120202021 vs. 2020
Select estimates used in loss recognition testing:
Total present value of expected future premiums$506$521$(15)(3)%
Total present value of expected death benefits and expenses$317$332$(15)(5)%

As of December 31, 2021 and 2020, we had margin of approximately $100 million to $300 million, and a PVFP balance of $71 million and $73 million, respectively, on our acquired block of term and whole life insurance products. If our margin is reduced below zero for our acquired block of term and whole life insurance

140

Table of Contents

products, we would amortize PVFP up to the amount of PVFP recorded on our balance sheet and if PVFP was fully written off, establish additional future policy benefit reserves, either of which would result in a charge to net income.

In the fourth quarter of 2021, we ceded certain term life insurance policies as part of a life block transaction. As of December 31, 2021, the margin associated with this block was positive but not significant and has a DAC balance of $224 million. If the margin of this block is reduced below zero, we would amortize DAC up to the amount of DAC recorded on our balance sheet and if DAC was fully written off, establish additional future policy benefit reserves, either of which would result in a charge to net income.

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2021 term and whole life insurance loss recognition testing margin:

(Amounts in millions)Other Block (Excluding the Acquired Block and Certain Reinsured Blocks)Acquired BlockTotal
Sensitivities on loss recognition testing(1):
2% higher mortality$(59)$(8)$(67)
10% increase in lapses$(265)$(41)$(306)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another.

The sensitivities in the table above are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products.

Fixed immediate annuities

As of December 31, 2021 and 2020, the liability for future policy benefits associated with our fixed annuity products with life contingencies was $11.3 billion and $11.8 billion, respectively. We regularly review our assumptions for these products and perform loss recognition testing at least annually. In 2016, we had a premium deficiency in our single premium immediate annuity products that resulted in the
write-off
of the entire DAC balance associated with these products. Subsequent to 2016, additional premium deficiencies have occurred in our single premium immediate annuity products that resulted in the establishment of additional future policy benefit reserves and were reflected as losses in net income.

In 2019, we determined we had an additional premium deficiency in our single premium immediate annuity products as a result of loss recognition testing. We increased our future policy benefit reserves by $39 million and recognized a corresponding loss in net income associated with the 2019 test. The premium deficiency test results were primarily driven by the low interest rate environment and updated assumptions. These updated assumptions resulting from our 2019 loss recognition testing will remain
locked-in
until such time as we determine another premium deficiency exists.

In 2021 and 2020, the results of our loss recognition testing did not result in a premium deficiency; therefore, our liability for future policy benefits was sufficient, with a margin of approximately $85 million as of December 31, 2021 compared to approximately $130 million as of December 31, 2020. The decrease in the margin in 2021 was primarily due to a change in our mortality assumption.

141

Table of Contents

A summary of certain of our significant estimates and assumptions used in the calculation of our fixed immediate annuity products loss recognition testing margin was as follows for the periods presented:

Increase (decrease) and
December 31,percentage change
(Amounts in millions)202120202021 vs. 2020
Select estimates and assumptions used in loss recognition testing:
Total present value of expected benefits and expenses$3,430$3,610$(180)(5)%
Reported investment yield5.79%5.86%(7)0⁄000(1)%

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2021 fixed immediate annuity products loss recognition testing margin:

(Amounts in millions)Fixed Immediate Annuity Products
Sensitivities on loss recognition testing(1):
2% lower mortality$(20)
10 basis point reduction in investment yields$(26)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another.

Currently, these reductions are not sufficient to reduce our margin for this block below zero. However, if our margin for this block is again reduced below zero, the impacts of future adverse changes in our assumptions would result in the establishment of additional future policy benefit reserves and would be immediately reflected as a loss in net income. Any favorable variation would result in additional margin and higher income recognized over the remaining duration of the
in-force
block but would not have an immediate benefit to net income.

Policyholder account balances

The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future claims experience, which includes assumptions for insured mortality, interest rates and policyholder persistency or lapses, among other assumptions.

We perform an annual review of assumptions for our universal and term universal life insurance products, typically in the fourth quarter. Our 2021 review resulted in an increase in the liability for policyholder account balances of $87 million, with a corresponding
pre-tax
loss recorded to net income, predominantly driven by higher

pre-COVID-19

mortality. Other assumption updates mostly focused on long-term interest rate trends. Our 2020 review resulted in a decrease in the liability for policyholder account balances of $118 million, with a corresponding
pre-tax
benefit recorded to net income, primarily due to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. Our 2019 review resulted in an increase in the liability for policyholder account balances of $72 million with a corresponding
pre-tax
loss recorded to net income. The 2019 test results were predominantly impacted by emerging mortality experience, lower expected growth in interest rates and a prolonged low interest rate environment.

142

Table of Contents

As of December 31, 2021 and 2020, we had DAC of $— and $245 million, respectively, and total policyholder account balances including reserves in excess of the contract value of $9.0 billion and $9.7 billion, respectively, related to our universal and term universal life insurance products. The decrease in DAC and policyholder account balances in 2021 compared to 2020 was primarily attributable to shadow accounting adjustments associated with a decrease in unrealized gains in 2021. As of December 31, 2021, for our universal and term universal life insurance products, we estimate that a 100 basis point reduction in interest rates from the December 31, 2021 level, or 2% higher mortality, scenarios that we consider to be reasonably possible given historical changes in market conditions and experience on these products, would result in a loss recorded to net income of approximately $35 million and $40 million, respectively. Adverse experience in persistency could also result in the DAC amortization associated with these products to be accelerated as well as the establishment of higher additional benefit reserves. Any favorable changes in these assumptions would result in lower DAC amortization as well as a reduction in the liability for policyholder account balances.

Liability for policy and contract claims

The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (a) claims that have been reported to the insurer; (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.

Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income.

The following table sets forth our recorded liability for policy and contract claims as of December 31:

(Amounts in millions)20212020
U.S. Life Insurance segment:
Long-term care insurance$10,861$10,518
Life insurance308378
Fixed annuities1412
Enact segment641555
Runoff segment812
Other mortgage insurance(1)911
Total liability for policy and contract claims$11,841$11,486
Column 1Column 2
(1)Amounts included in Corporate and Other activities.

Long-term care insurance

The liability for policy and contract claims, also known as claim reserves, for our long-term care insurance products represents the present value of the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. Key assumptions include investment returns, health care experience, insured mortality, insured morbidity and expenses. Our discount rate assumption assumes a static discount rate in line with our current portfolio yield.

During the fourth quarter of 2021, we reviewed our assumptions and methodologies relating to our claim reserves for our long-term care insurance business but did not make any significant changes to the assumptions

143

Table of Contents

or methodologies, other than routine updates to investment returns as we typically do each quarter. These updates did not have a significant impact on claim reserve levels. During the fourth quarter of 2020, we reviewed our assumptions and methodologies relating to our claim reserves of our long-term care insurance business and made certain changes to our assumptions or methodologies, particularly those assumptions used to calculate our IBNR reserves. In total, these updates reduced our liability for policy and contract claims by $38 million. As experience has emerged in the past, we have made resulting changes to our assumptions that have had a material impact on our results of operations and financial position. Our experience will continue to emerge and as a result there is a potential for future assumption reviews to result in further updates.

Mortgage insurance

Estimates of mortgage insurance reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers, using assumptions developed based on past experience and the expectation of future development. The estimates are determined using either a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques, or a case-based approach, in which each individual delinquent loan is reviewed and a best-estimate loss is determined based on the status of the insured loan and an estimation of net sale proceeds from the disposition of the mortgaged property. Assumptions also include provisions for loans within Enact Holdings’ delinquency inventory that will be rescinded or modified (collectively referred to as “loss mitigation actions”) based on the effects that such loss mitigation actions have had on Enact Holdings’ historical claim frequency rates, including an estimate for reinstatement of previously rescinded coverage. Each of these inherently judgmental assumptions is established in a respective geography based on historical and expected experience. Enact Holdings has established processes, as well as contractual rights, to ensure it receives timely information from loan servicers to aid in the establishment of its estimates. In addition, when Enact Holdings has obtained sufficient facts and circumstances through its investigative process, it has the unilateral right under its master policies and at law to rescind coverage on the underlying loan certificate as if coverage never existed. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, loss reserves are not established for future claims on insured loans that are not currently in default.

Management of Enact Holdings reviews the loss reserves quarterly for adequacy, and if necessary, updates the assumptions used for estimating and calculating such reserves based on actual experience and historical frequency of claim and severity of loss rates that are applied to the current population of delinquencies. Factors considered in establishing loss reserves include claim frequency patterns (reflecting the loss mitigation actions on such claim patterns), the aged category of the delinquency (i.e., age and progression of delinquency to claim), the severity of loss and loan coverage percentage. The establishment of Enact Holdings’ mortgage insurance loss reserves is subject to inherent uncertainty and requires judgment. The actual amount of the claim payments may vary significantly from the loss reserve estimates. Enact Holdings’ estimates could be adversely affected by several factors, including but not limited to, whether borrowers in forbearance due to

COVID-19

will ultimately cure or result in a claim payment, a deterioration of regional or national economic conditions leading to a reduction in borrowers’ income and thus their ability to make mortgage payments, a drop in housing values that could expose Enact Holdings to greater loss on resale of properties obtained through foreclosure proceedings and an adverse change in the effectiveness of loss mitigation actions that could result in an increase in the frequency of expected claim rates. Enact Holdings’ estimates are also affected by the extent of fraud and misrepresentation that are uncovered in the loans that are insured and the coverage upon which Enact Holdings has consequently rescinded or may rescind going forward. Enact Holdings’ loss reserving methodology includes estimates of the number of loans in its delinquency inventory that will be rescinded or modified, as well as estimates of the number of loans for which coverage may be reinstated under certain conditions following a rescission action.

In considering the potential sensitivity of the factors underlying Enact Holdings’ best estimate of its mortgage insurance reserves for losses, it is possible that even a relatively small change in estimated

delinquency-to-claim

rate (“frequency”) or a relatively small percentage change in estimated claim amount

144

Table of Contents

(“severity”) could have a significant impact on reserves and, correspondingly, on results of operations. For example, based on Enact Holdings actual experience during the three-year period ended December 31, 2021, a quarterly change of 6% in its average frequency reserve factor would change the gross loss reserve amount for such quarter by approximately $95 million and a change of 4% in its average severity reserve factor would change the gross loss reserve amount for such quarter by approximately $24 million.

Deferred acquisition costs.

DAC represents costs that are directly related to the successful acquisition of new and renewal insurance policies and investment contracts which are deferred and amortized over the estimated life of the related insurance policies. These costs primarily include commissions in excess of ultimate renewal commissions and underwriting and contract and policy issuance expenses for policies successfully acquired. DAC is subsequently amortized to expense in relation to the anticipated recognition of premiums or gross profits.

The amortization of DAC for traditional long-duration insurance products (including term life insurance, life-contingent structured settlements and immediate annuities and long-term care insurance) is determined as a level proportion of premiums based on accepted actuarial methods and reasonable assumptions, including related to projected interest rates and investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain
in-force
from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, established when the contract or policy is issued. U.S. GAAP requires that assumptions for these types of products not be modified (or unlocked) unless recoverability testing, also known as loss recognition testing, deems them to be inadequate. Amortization is adjusted each period to reflect actual lapses or terminations. Accordingly, we could experience accelerated amortization of DAC and a charge to net income if policies lapse or terminate earlier than originally assumed, or if we fail recoverability testing.

Amortization of DAC for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for the unlocking of underlying key assumptions including interest rates, policyholder persistency or lapses, insured mortality and expenses. The estimation of expected gross profits is subject to change given the inherent uncertainty as to the underlying key assumptions employed and the long duration of our policy or contract liabilities. Changes in expected gross profits reflecting the unlocking of underlying key assumptions could result in a material increase or decrease in the amortization of DAC depending on the magnitude of the change in underlying assumptions. Significant factors that could result in a material increase or decrease in DAC amortization for these products include material changes in withdrawal or lapse rates, investment spreads or mortality assumptions. For the years ended December 31, 2021, 2020 and 2019, key assumptions were unlocked in our U.S. Life Insurance and Runoff segments to reflect our current expectation of future investment spreads, lapse rates and mortality.

We review DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to net income is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserves plus the current estimate of expected future gross premiums and interest income for a line of business are less than the current estimate of expected future benefits and expenses (including any unamortized DAC), a charge to net income is recorded for additional DAC amortization or for increased benefit reserves. The evaluation of DAC recoverability is subject to inherent uncertainty and requires significant judgment and estimates to determine the present values of future premiums, estimated gross profits and expected benefits and expenses of our businesses. In 2021 and 2020, in connection with our review of DAC for recoverability, we wrote off $117 million and $63 million, respectively, of DAC in our universal and term universal life insurance products principally due to lower future estimated gross profits.

The amortization of DAC for mortgage insurance is based on expected gross margins. Expected gross margins, defined as premiums less losses, are set based on assumptions for future persistency and loss

145

Table of Contents

development of the business. These assumptions are updated for actual experience to date or as our expectations of future experience are revised based on experience studies. Due to the inherent uncertainties in making assumptions about future events, materially different experience from expected results in persistency or loss development could result in a material increase or decrease to DAC amortization.

The DAC amortization methodology for our variable products (variable annuities and variable universal life insurance) includes a long-term average appreciation assumption of 7.5% to 8.0%. When actual returns vary from the expected 7.5% to 8.0%, we assume a reversion to the expected return over a three-year period.

The following table sets forth the increase (decrease) in amortization of DAC related to unlocking of underlying key assumptions by segment for the years ended December 31:

(Amounts in millions)202120202019
U.S. Life Insurance$2$48$58
Enact6
Runoff(2)(2)(2)
Total$$52$56

Impacts on DAC from assumption reviews

In the fourth quarter of 2020, as part of our annual review of assumptions, we increased DAC amortization by $48 million in our universal and term universal life insurance products predominantly due to changes in expected gross profits driven mostly by lower projected cost of insurance assessments on our universal life insurance products and a model refinement in our term universal life insurance product related to persistency and grace period timing. In the fourth quarter of 2019, as part of our annual review of assumptions, we increased DAC amortization by $58 million in our universal and term universal life insurance products, reflecting updated assumptions primarily related to the lower interest rate environment.

In the fourth quarter of 2020, as part of a periodic review of assumptions, our Enact segment increased DAC amortization by $6 million primarily driven by elevated lapses in 2020. For the years ended December 31, 2021 and 2019, no assumptions were unlocked in our Enact segment.

See notes 2 and 6 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to DAC.

Valuation of fixed maturity securities.

Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value.

The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the

period-to-period

changes in fair value may vary significantly due to changing interest rates, external macroeconomic, and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening of credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. As well, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investments portfolio.

Estimates of fair value for fixed maturity securities are obtained primarily from industry-standard pricing models utilizing observable market inputs. For our less liquid securities, such as our privately placed securities,

146

Table of Contents

we utilize independent market data to employ alternative valuation methods commonly used in the financial services industry to estimate fair value. These securities are categorized into a three-level hierarchy based on the observability of the inputs used in estimating the fair value.

Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2021, 6% of our total fixed maturity securities related to Level 3 private fixed maturities valued using internal pricing models. See notes 2, 4 and 16 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments.

The following tables summarize the primary sources of data considered when determining fair value of each class of fixed maturity securities as of December 31:

2021
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$53,852$$53,852$
Broker quotes312312
Internal models6,3162,8203,496
Total fixed maturity securities$60,480$$56,672$3,808
2020
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$57,229$$57,229$
Broker quotes730730
Internal models5,5362,1773,359
Total fixed maturity securities$63,495$$59,406$4,089

Consolidated Balance Sheets

Total assets

. Total assets decreased $6,576 million from $105,747 million as of December 31, 2020 to $99,171 million as of December 31, 2021.

Column 1Column 2Column 3Column 4
Cash, cash equivalents, restricted cash and invested assets decreased $3,413 million primarily from decreases of $3,015 million, $990 million and $230 million in fixed maturity securities, cash, cash equivalents, restricted cash and other invested assets, respectively. The decrease in fixed maturity securities was predominantly related to a decrease in unrealized gains due to an increase in interest rates and from net sales in 2021. The decrease in cash, cash equivalents and restricted cash was largely related to net withdrawals from our investment contracts, the redemption and repurchase of certain Genworth Holdings’ senior notes, including the full redemption of senior notes originally scheduled to mature in September 2021 and August 2023, and payments of $564 million to AXA primarily associated with a secured promissory note. These decreases to cash were partially offset by net proceeds of approximately $529 million and $370 million received from the minority IPO of Enact Holdings and the sale of Genworth Australia, respectively, and by net sales of investment securities in

147

Table of Contents

Column 1Column 2
2021. The decrease in other invested assets was predominantly driven by the termination of certain derivative contracts, lower derivative asset valuations due to an increase in interest rates and from the suspension of our securities lending program in 2021 that resulted in lower cash collateral.
Column 1Column 2Column 3Column 4
DAC decreased $341 million principally attributable to DAC impairments in our universal and term universal life insurance products. During 2021 and in connection with our periodic reviews of DAC for recoverability, we wrote off $117 million of DAC in our universal and term universal life insurance products due principally to lower future estimated gross profits. The decrease was also attributable to lapses in our life insurance products and higher policy terminations in our long-term care insurance business in 2021.
Column 1Column 2Column 3Column 4
Deferred tax asset increased $54 million largely due to a decrease in unrealized gains on derivatives and investments and from deferred tax assets of $87 million and $54 million recorded in connection with the sale of Genworth Australia and the minority IPO of Enact Holdings, respectively, partially offset by a net deferred tax liability based on pre-tax earnings.
Column 1Column 2Column 3Column 4
Assets related to discontinued operations decreased $2,817 million due to the sale and deconsolidation of Genworth Australia in 2021.

Total liabilities

. Total liabilities decreased $7,022 million from $89,927 million as of December 31, 2020 to $82,905 million as of December 31, 2021.

Column 1Column 2Column 3Column 4
Future policy benefits decreased $1,167 million primarily driven by shadow accounting adjustments associated with a decrease in unrealized gains in 2021. The shadow accounting adjustments decreased future policy benefits by approximately $1,270 million, mostly in our long-term care insurance business, with an offsetting amount recorded in other comprehensive income (loss). The decrease was also attributable to reduced benefits of $920 million in 2021 related to in-force actions approved and implemented, which included policyholder benefit reduction elections made as part of a legal settlement in our long-term care insurance business. Net outflows driven by surrenders and benefits in our single premium immediate annuity products and runoff of our term life insurance products, including from higher lapses in 2021, also drove the decrease. These decreases were partially offset by aging of our long-term care insurance in-force block and higher incremental reserves of $649 million recorded in connection with an accrual for profits followed by losses in 2021.
Column 1Column 2Column 3Column 4
Policyholder account balances decreased $2,149 million largely attributable to surrenders and benefits in our deferred annuity products and from scheduled maturities of certain funding agreements in our universal life insurance and institutional products in 2021. The decrease was also attributable to shadow accounting adjustments associated with a decrease in unrealized gains in 2021. The shadow accounting adjustments decreased policyholder account balances by approximately $503 million, mostly in our universal life insurance products, with an offsetting amount recorded in other comprehensive income (loss). These decreases were partially offset by higher reserves of $87 million associated with an unfavorable unlocking in our term universal and universal life insurance products related to our annual review of assumptions in 2021.
Column 1Column 2Column 3Column 4
Liability for policy and contract claims increased $355 million largely related to our long-term care insurance business primarily attributable to new claims and claim severity as a result of the aging of the in-force block and a $10 million increase to claim reserves to account for changes to incidence and mortality experience driven by COVID-19, which we believe are temporary. The increase was also attributable to our Enact segment primarily driven by new delinquencies, partially offset by net favorable reserve adjustments related to positive frequency and severity development on pre-COVID-19 delinquencies in 2021. These increases were also partially offset by fewer pending claims in our life insurance business and higher claim terminations in our long-term care insurance business in 2021.
Column 1Column 2Column 3Column 4
Long-term borrowings decreased $1,504 million mainly attributable to the redemption of Genworth Holdings’ senior notes due in February 2021, September 2021 and August 2023, and from the

148

Table of Contents

Column 1Column 2
repurchase of $118 million of Genworth Holdings’ February 2024 senior notes in the fourth quarter of 2021. See note 12 in our consolidated financial statements under “Item 8 —Financial Statements and Supplementary Data” for additional details.
Column 1Column 2Column 3Column 4
Liabilities related to discontinued operations decreased $2,336 million predominantly from the sale and deconsolidation of Genworth Australia, which also resulted in a mandatory payment of approximately $247 million, including accrued interest, to AXA under the secured promissory note in 2021. In addition, during the third quarter of 2021, Genworth Holdings repaid the remaining outstanding balance of the secured promissory note due to AXA of approximately $296 million. See note 23 in our consolidated financial statements under “Item 8 —Financial Statements and Supplementary Data” for additional details.

Total equity

. Total equity increased $446 million from $15,820 million as of December 31, 2020 to $16,266 million as of December 31, 2021.

Column 1Column 2Column 3Column 4
We reported net income available to Genworth Financial, Inc.’s common stockholders of $904 million for the year ended December 31, 2021.
Column 1Column 2Column 3Column 4
Unrealized gains on investments and derivatives qualifying as hedges decreased $354 million and $186 million, respectively, primarily from an increase in interest rates in 2021.
Column 1Column 2Column 3Column 4
Additional paid-in capital decreased $150 million largely attributable to the IPO of 18.4% of Enact Holdings in September 2021.
Column 1Column 2Column 3Column 4
Noncontrolling interests increased $254 million related to the IPO of 18.4% of Enact Holdings in September 2021, partially offset by the deconsolidation of the ownership interest attributable to noncontrolling interests of Genworth Australia recorded in connection with the final disposition in March 2021.

Liquidity and Capital Resources

Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating needs.

Overview of cash flows—Genworth and subsidiaries

The following table sets forth our condensed consolidated cash flows for the years ended December 31:

(Amounts in millions)202120202019
Net cash from operating activities$437$1,960$2,079
Net cash from (used by) investing activities896(1,153)1,301
Net cash used by financing activities(2,419)(1,507)(2,217)
Net increase (decrease) in cash before foreign exchange effect$(1,086)$(700)$1,163

Our principal sources of cash include sales of our products and services, income from our investment portfolio and proceeds from sales of investments. As an insurance business, we typically generate positive cash flows from operating activities, as premiums collected from our insurance products and income received from our investments typically exceed policy acquisition costs, benefits paid, redemptions and operating expenses. Our cash flows from operating activities are affected by the timing of premiums, fees and investment income received and benefits and expenses paid. Positive cash flows from operating activities are then invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flow, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to the issuance of, and redemptions and benefit payments on,

149

Table of Contents

universal life insurance and investment contracts; deposits from Federal Home Loan Banks; the issuance of debt and equity securities; the repayment or repurchase of borrowings and
non-recourse
funding obligations; and other capital transactions.

We had lower cash inflows from operating activities in 2021 primarily from an initial cash payment of $360 million made in connection with a new reinsurance agreement under which we ceded certain term life insurance policies, higher payments to AXA and from lower collateral received from counterparties related to our derivative positions. During 2021, we fully repaid a secured promissory note plus accrued interest of $543 million due to AXA and settled an unrelated liability for $18 million associated with underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business. During 2020, we paid AXA $269 million comprised of an interim litigation payment, an initial amount under the settlement agreement reached in July 2020 and interest on the secured promissory note.

We had cash inflows from investing activities in 2021 largely from net sales of fixed maturity securities and net proceeds from the sale of Genworth Australia, partially offset by net capital calls on limited partnerships. We had cash outflows from investing activities in 2020 mainly from net purchases of fixed maturity and equity securities and net capital calls on limited partnerships, partially offset by commercial mortgage loan repayments outpacing originations and policy loan repayments.

We had higher cash outflows from financing activities in 2021 principally from higher repayment and repurchase of long-term debt, partially offset by net proceeds of $529 million from the minority IPO of Enact Holdings completed on September 20, 2021 and lower net withdrawals from our investment contracts. In 2021, Genworth Holdings repurchased $91 million and $118 million principal amount of its 4.90% senior notes due in 2023 and its 4.80% senior notes due in 2024, respectively, and early redeemed the remaining $309 million of its 4.90% senior notes originally scheduled to mature in August 2023. Genworth Holdings also repurchased $146 million and early redeemed the remaining $513 million principal balance of its 7.625% senior notes originally due in September 2021 and redeemed $338 million principal balance of its 7.20% senior notes due in February 2021. In 2020, Genworth Holdings redeemed $397 million of its senior notes due in June 2020, Rivermont I early redeemed its $315 million
non-recourse
funding obligations originally due in 2050 and Genworth Holdings repurchased $84 million principal amount of its senior notes with 2021 maturity dates. We also received net proceeds of $738 million in 2020 from the issuance of Enact Holdings’ senior notes due in 2025.

Genworth—holding company liquidity

In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Accordingly, our holding companies are highly dependent upon their respective subsidiaries to pay dividends and make other payments to meet their respective obligations. Moreover, management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt.

Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends from their respective subsidiaries, subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. Our liquidity is highly dependent on the performance of Enact Holdings and its ability to pay dividends to us as anticipated. Although the business performance and financial results of our U.S. life insurance subsidiaries have improved significantly, they currently have negative unassigned surplus of approximately $1.0 billion under statutory accounting and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors (including in the case of the payment of dividends to us, the approval of Enact Holdings’ independent capital committee) are subject to and may be limited by the interests of Enact

150

Table of Contents

Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. In addition, insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details.

The primary use of funds at Genworth Financial and Genworth Holdings include payment of principal, interest and other expenses on current and any future borrowings or other obligations (including payments to AXA associated with claims still being processed reported as discontinued operations), payment of holding company general operating expenses (including employee benefits and taxes), payments under current and any future guarantees (including guarantees of certain subsidiary obligations), payment of amounts owed to GE under the Tax Matters Agreement, payments to subsidiaries (and, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, contributions to subsidiaries, repurchases of debt securities and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 13 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

Our future use of liquidity and capital will prioritize reducing overall indebtedness of Genworth Holdings. Our goal is to reduce debt at Genworth Holdings to approximately $1.0 billion over time. We may from time to time seek to repurchase or redeem outstanding notes for cash (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise. We currently seek to address our indebtedness over time through repurchases, redemptions and/or repayments at maturity.

In November 2008, Genworth Financial’s Board of Directors suspended the payment of dividends to its shareholders and the repurchase of common stock under the Company’s stock repurchase program indefinitely. Given the significant improvement in the operating and financial performance of Genworth Financial and its subsidiaries, and the $2.1 billion of debt reduction in 2021, Genworth Financial’s Board of Directors will consider implementing a new share repurchase program and new dividend policy later in 2022. Any future capital management considerations are primarily dependent on the repayment of Genworth Holdings’ February 2024 debt and Enact Holdings’ future dividend policy. If Genworth Financial’s Board of Directors ultimately decides to approve a new share repurchase program or new dividend policy, any amounts used for the purpose of returning capital to Genworth Financial’s shareholders will be dependent on many factors. These factors will include, in addition to any other factors that may arise in the future, the receipt of dividends from Enact Holdings, intercompany cash tax payments from operating subsidiaries, Genworth’s operating results and financial condition, the capital requirements of our subsidiaries, legal requirements, regulatory constraints, debt obligations of Genworth Holdings and Enact Holdings, our credit and financial strength ratings, the capital needs of our subsidiaries for future growth and other factors Genworth Financial’s Board of Directors deems relevant.

As of December 31, 2021, Genworth Holdings had $353 million of unrestricted cash, cash equivalents and liquid assets. Genworth Holdings received net cash proceeds of $370 million and $529 million from the sale of Genworth Australia in March 2021 and the minority IPO of Enact Holdings in September 2021, respectively, of which $543 million was used to prepay the outstanding principal balance and accrued interest of the AXA promissory note originally due in 2022. In addition, on December 15, 2021, Genworth Holdings early redeemed its 4.90% senior notes originally scheduled to mature in August 2023.

As of December 31, 2021, Genworth Holdings had $282 million of senior notes due in February 2024, thereafter, no debt maturities are due until June 2034. During the first quarter of 2022 and as of February 18, 2022, Genworth Holdings repurchased $33 million principal amount of its senior notes due in February 2024, and may early repay the remaining outstanding balance of its senior notes due in February 2024 with cash on hand, expected dividends from Enact Holdings and/or intercompany cash tax payments from its subsidiaries. Interest payments on Genworth Holdings’ remaining senior notes are forecasted to be approximately $65 million due between January 2022 through March 2023. For further information about our borrowings, refer to note 12 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” In

151

Table of Contents

addition, in February 2022, Genworth Holdings paid AXA the majority of the remaining unprocessed claims of approximately $30 million, and accordingly, has no significant amounts due to AXA over the next twelve months.

We believe Genworth Holdings’ unrestricted cash, cash equivalents and liquid assets provide sufficient liquidity to meet its financial obligations and maintain business operations for one year from the date the financial statements are issued based on relevant conditions and events that are known and reasonably estimable, including current cash and management actions in the normal course. Furthermore, we believe Genworth Holdings has adequate liquidity to meet its future financial obligations in 2023 and thereafter; however, we do expect intercompany cash tax payments from Genworth Holdings’ subsidiaries to be lower over the next few years as compared to the amounts received during 2021. Otherwise, we do not anticipate any current known trends, demands or contractual commitments resulting in our liquidity, including Genworth Holdings, significantly increasing or decreasing in future periods. However, the impact of
COVID-19
is very difficult to predict. It may preclude Enact Holdings from returning capital to us through dividends and could adversely impact our overall liquidity and ability to raise capital. Enact Holdings intends to develop a formal dividend policy and initiate a regular common dividend during 2022. Future dividends are dependent on a variety of economic and business conditions, including the resolution of forbearance related delinquencies. Enact Holdings’ dividend policy is a critical piece in determining Genworth’s future cash flows. We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or from future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant. Additionally, Genworth Financial will continue to evaluate market influences on the valuation of Genworth Holdings’ senior debt and expects to consider additional opportunities to repurchase debt over time. However, we cannot predict with certainty the impact to us from future disruptions in the credit markets or any future downgrades by one or more of the rating agencies of the financial strength ratings of our insurance company subsidiaries and/or the credit ratings of Genworth Holdings’ debt.

Genworth Holdings—changes in liquidity

Genworth Holdings had $331 million and $1,078 million of cash, cash equivalents and restricted cash as of December 31, 2021 and 2020, respectively, which included $46 million of restricted cash equivalents as of December 31, 2020. Genworth Holdings also held $25 million in U.S. government securities as of December 31, 2021 and 2020, which included approximately $3 million and $25 million, respectively, of restricted assets. The decrease in Genworth Holdings’ cash, cash equivalents and restricted cash was principally driven by the repayment and repurchase of long-term debt, including payments of $564 million to AXA reported as discontinued operations, partially offset by net proceeds from the Genworth Australia sale and the minority IPO of Enact Holdings, and dividends from Enact Holdings. Genworth Holdings early redeemed its 4.90% senior notes originally scheduled to mature in August 2023 for a total cash payment of $334 million. Prior to the early redemption, Genworth Holdings repurchased $91 million of its 4.90% senior notes due in August 2023 and $118 million of its 4.80% senior notes due in 2024. Genworth Holdings also repurchased $146 million and early redeemed the remainder of its 7.625% senior notes due in September 2021 with a total cash payment of $532 million. In addition, Genworth Holdings repurchased and repaid its 7.20% senior notes due in February 2021 for $350 million. For additional details on the decrease in cash, cash equivalents and restricted cash, see below under “—Capital resources and financing activities.”

On March 3, 2021, we completed the sale of Genworth Australia and received net proceeds of approximately AUD483 million ($370 million). The sale of Genworth Australia resulted in a mandatory payment of approximately £178 million ($247 million) related to the outstanding secured promissory note issued to AXA, including accrued interest of $2 million. On September 21, 2021, Genworth Holdings used a portion of the $529 million net proceeds from the minority IPO of Enact Holdings to repay the remaining outstanding balance of the secured promissory note of approximately £215 million ($296 million). In addition, pursuant to a

152

Table of Contents

guarantee agreement with Genworth Financial International Holdings, LLC (“GFIH”) discussed below in “—Guarantees and other
off-balance
sheet commitments,” Genworth Holdings paid AXA approximately €15 million ($18 million) in the second quarter of 2021 to settle amounts owed related to underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business.

During the years ended December 31, 2021, 2020 and 2019, Genworth Holdings received cash dividends from its international subsidiaries of $370 million, $11 million and $1,486 million, respectively. Dividends received by Genworth Holdings in 2021 include the net proceeds from the sale of Genworth Australia. Our international subsidiaries had to preserve capital due to the adverse impacts caused by

COVID-19

and accordingly reduced the amount of dividends paid to Genworth Holdings during 2020. Dividends received by Genworth Holdings in 2019 included $1,235 million of net proceeds related to the sale of Genworth Canada.

During 2021 and 2020, Genworth Holdings received cash dividends from Enact Holdings of $163 million and $437 million, respectively. In 2019 and prior to an internal company reorganization, Enact Holdings paid cash dividends of $250 million directly to Genworth Financial. Dividends paid by Enact Holdings in 2021 included a proportionate dividend distribution to minority shareholders. Dividends received by Genworth Holdings in 2020 were from net proceeds received from Enact Holdings’ senior notes issued in August 2020. Enact Holdings’ board of directors evaluates economic and business conditions, including the resolution of forbearance related delinquencies, to determine the amount and timing of future dividends. Future dividends are also subject to market conditions, business performance, business and regulatory approvals, among other considerations, and will include a proportionate dividend distribution to minority shareholders.

There were no dividends paid to Genworth Holdings by its domestic life insurance subsidiaries during the years ended December 31, 2021, 2020 or 2019. Although the business performance and financial results of our U.S. life insurance subsidiaries have improved significantly, they currently have negative unassigned surplus of approximately $1.0 billion under statutory accounting and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future.

Capital resources and financing activities

Our current capital resource plans do not include any additional debt offerings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of their respective subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations,” and “—Risk Factors— Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.” These risks may be exacerbated by the economic impact of
COVID-19.

On December 15, 2021, Genworth Holdings early redeemed its 4.90% senior notes originally scheduled to mature in August 2023. The senior notes were fully redeemed with a cash payment of $334 million, comprised of the outstanding principal balance of $309 million, accrued interest of $5 million and a make-whole premium of $20 million. Prior to the early redemption, Genworth Holdings repurchased $91 million principal amount of its 4.90% senior notes due in September 2021 for a
pre-tax
loss of $9 million and paid accrued interest thereon.

In the fourth quarter of 2021, Genworth Holdings repurchased $118 million of its 4.80% senior notes due in 2024 for a
pre-tax
loss of $6 million and paid accrued interest thereon. During the first quarter of 2022 and as of February 18, 2022, Genworth Holdings repurchased $33 million of its 4.80% senior notes due in 2024.

On July 21, 2021, Genworth Holdings early redeemed its 7.625% senior notes originally scheduled to mature in September 2021. The senior notes were fully redeemed with a cash payment of $532 million, comprised of the outstanding principal balance of $513 million, accrued interest of $13 million and a make-

153

Table of Contents

whole premium of $6 million. Prior to the early redemption, Genworth Holdings repurchased $146 million principal amount of its 7.625% senior notes due in September 2021 for a
pre-tax
loss of $4 million and paid accrued interest thereon.

Genworth Holdings paid its 7.20% senior notes with a principal balance of $338 million at maturity on February 16, 2021. Genworth Holdings’ 7.20% senior notes were fully redeemed with a cash payment of $350 million, comprised of the outstanding principal balance and accrued interest.

On August 21, 2020, Enact Holdings issued $750 million of its 6.50% senior notes due in 2025. Interest on the notes is payable semi-annually in arrears on February 15 and August 15 of each year. The notes mature on August 15, 2025. Enact Holdings may redeem the notes, in whole or in part, at any time prior to February 15, 2025 at its option, by paying a make-whole premium, plus accrued and unpaid interest. At any time on or after February 15, 2025, Enact Holdings may redeem the notes, in whole or in part, at its option, at 100% of the principal amount, plus accrued and unpaid interest. The notes contain customary events of default, which subject to certain notice and cure conditions, can result in the acceleration of the principal and accrued interest on the outstanding notes if Enact Holdings breaches the terms of the indenture.

During 2020, Genworth Holdings repurchased $84 million principal amount of its senior notes with 2021 maturity dates for a
pre-tax
gain of $4 million. In March 2020, Genworth Holdings repaid a $200 million intercompany note due to GLIC with a maturity date of March 31, 2020.

On January 21, 2020, Genworth Holdings early redeemed $397 million of its 7.70% senior notes originally scheduled to mature in June 2020 using cash proceeds received from the sale of Genworth Canada. The senior notes were fully redeemed with a cash payment of $409 million, comprised of the outstanding principal balance, accrued interest and a make-whole premium of $9 million.

In January 2020, upon receipt of approval from the Director of Insurance of the State of South Carolina, Rivermont I, our indirect wholly-owned special purpose consolidated captive insurance subsidiary, redeemed all $315 million of its outstanding
non-recourse
funding obligations due in 2050. The early redemption resulted in a
pre-tax
loss of $4 million from the
write-off
of deferred borrowing costs.

Regulated insurance subsidiaries

Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends in excess of prescribed limits are deemed “extraordinary” and require insurance regulatory approval. Based on estimated statutory results as of December 31, 2021, in accordance with applicable dividend restrictions, Enact Holdings could pay ordinary dividends of approximately $70 million in 2022. However, Enact Holdings may not pay dividends in 2022 at this level as they may need to retain capital for regulatory purposes, including as a result of
COVID-19,
and preserve capital for future growth or to meet capital requirements.

The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payment of principal and interest on their outstanding debt obligations and income taxes. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements.

Given our insurance product mix, payments to policyholders for insurance benefits are generally consistent each year with the exception of products that provide long-duration coverage, such as long-term care insurance. For example, our current projections reflect average annual claim payments of approximately $2.5 billion over the next five years primarily driven by surrender and benefit payments associated with fixed annuity products. Actual claims experience on products that provide long-duration coverage typically emerge over many years, change over time and are difficult to accurately predict. Therefore, we cannot determine with precision the

154

Table of Contents

ultimate amounts we will pay for actual claims or the timing of those payments. Moreover, for long-duration coverage products, we generally assume a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form
10-K.
For example, in 2027 and thereafter, we assume approximately $99.3 billion of claims and benefit payments will be paid to policyholders or approximately 89% of our total undiscounted claims and benefit payments. These assumed payments are principally associated with our long-term care insurance products given their long-duration coverages. These amounts are derived from estimates and actuarial assumptions used in establishing our reserves; however, they have not been discounted to present value like our obligations to policyholders reported in our consolidated balance sheets in accordance with U.S. GAAP, where the liabilities are discounted consistent with the present value concept under accounting guidance related to accounting and reporting by insurance enterprises. Therefore, these undiscounted amounts significantly exceed the liabilities recorded in reserves for future policy benefits and the liability for policy and contract claims. These undiscounted amounts include estimated claims and benefits, policy surrender and commission obligations calculated consistent with U.S. GAAP on
in-force
long-duration insurance policies and investment contracts and also include estimated claims obligations on mortgage insurance policies
in-force
and amounts established for recourse and indemnification related to the contract underwriting business in our Enact segment. Due to the significance of the assumptions used in estimating our claim and benefit obligations, these assumed amounts could materially differ from actual results.

Our insurance subsidiaries have used cash flows from operations and investment activities to fund their liquidity requirements. Our insurance subsidiaries’ principal cash inflows from operating activities are derived from premiums, annuity deposits and insurance and investment product fees and other income, including commissions, cost of insurance, mortality, expense and surrender charges, contract underwriting fees, investment management fees and dividends and distributions from their subsidiaries. The principal cash inflows from investment activities result from maturities and repayments of investments and, as necessary, sales of invested assets.

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2021, our total cash, cash equivalents, restricted cash and invested assets were $73.8 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 39% of the carrying value of our total cash, cash equivalents, restricted cash and invested assets as of December 31, 2021.

Guarantees and other
off-balance
sheet commitments

Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations.

Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies
in-force
prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2021, the risk
in-force
of active policies was approximately $1.1 billion.

155

Table of Contents

Genworth Holdings has a Tax Matters Agreement with GE, our former parent company, which represents an obligation of Genworth Holdings to GE. The balance of the fixed portion of the obligation was $29 million as of December 31, 2021. Genworth Financial and Genworth Holdings have joint and several guarantees associated with this Tax Matters Agreement.

Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes and outstanding subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior and subordinated notes indentures in respect of such senior and subordinated notes.

On March 1, 2021, Genworth Holdings entered into a guarantee agreement with GFIH whereby Genworth Holdings agreed to contribute additional capital to GFIH related to certain of its liabilities, or otherwise satisfy or discharge those liabilities. The liabilities include but are not limited to, claims and financial obligations or other liabilities of GFIH that existed immediately prior to the distribution of the net proceeds from the Genworth Australia sale. Pursuant to the agreement, Genworth Holdings paid AXA approximately €15 million ($18 million) in the second quarter of 2021 to settle amounts owed related to underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business.

Genworth Financial and certain of its holding companies also provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $10 million and $4 million as of December 31, 2021 and 2020, respectively.

As of December 31, 2021, we were committed to fund $28 million in commercial mortgage loan investments, $141 million of bank loan investments which had not yet been drawn, $1,185 million in limited partnership investments and $97 million in private placement investments.

156

Table of Contents

Supplemental Condensed Consolidating Financial Information

Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any, and interest on, and all other amounts payable under, each outstanding series of senior notes and outstanding subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior and subordinated notes indentures in respect of such senior and subordinated notes.

The following supplemental condensed consolidating financial information of Genworth Financial and its direct and indirect subsidiaries has been prepared pursuant to rules regarding the preparation of consolidating financial information of
Regulation S-X,
as amended by the SEC on March 2, 2020.

The supplemental condensed consolidating financial information presents the condensed consolidating balance sheet information as of December 31, 2021 and 2020 and the condensed consolidating income statement information, condensed consolidating comprehensive income statement information and condensed consolidating cash flow statement information for the years ended December 31, 2021 and 2020.

The supplemental condensed consolidating financial information reflects Genworth Financial (“Parent Guarantor”), Genworth Holdings (“Issuer”) and each of Genworth Financial’s other direct and indirect subsidiaries (the “All Other Subsidiaries”) on a combined basis, none of which guarantee the senior notes or subordinated notes, as well as the eliminations necessary to present Genworth Financial’s financial information on a consolidated basis and total consolidated amounts.

The accompanying supplemental condensed consolidating financial information is presented based on the equity method of accounting for all periods presented. Under this method, investments in subsidiaries are recorded at cost and adjusted for the subsidiaries’ cumulative results of operations, capital contributions and distributions, and other changes in equity. Elimination entries include consolidating and eliminating entries for investments in subsidiaries and intercompany activity.

157

Table of Contents

The following table presents the condensed consolidating balance sheet information as of December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Assets
Investments:
Fixed maturity securities available-for-sale, at fair value (amortized cost of $52,611 and allowance for credit losses of $—)$$$60,480$$60,480
Equity securities, at fair value198198
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4)6,8566,856
Less: Allowance for credit losses(26)(26)
Commercial mortgage loans, net6,8306,830
Policy loans2,0502,050
Limited partnerships1,9001,900
Other invested assets27793820
Investments in subsidiaries15,51715,626(31,143)
Total investments15,51715,65372,251(31,143)72,278
Cash, cash equivalents and restricted cash3311,2401,571
Accrued investment income647647
Deferred acquisition costs1,1461,146
Intangible assets143143
Reinsurance recoverable16,86816,868
Less: Allowance for credit losses(55)(55)
Reinsurance recoverable, net16,81316,813
Other assets5207176388
Intercompany notes receivable151(16)
Deferred tax assets4555(440)119
Separate account assets6,0666,066
Total assets$15,526$16,761$98,043$(31,159)$99,171
Liabilities and equity
Liabilities:
Future policy benefits$$$41,528$$41,528
Policyholder account balances19,35419,354
Liability for policy and contract claims11,84111,841
Unearned premiums672672
Other liabilities4641,4431,511
Intercompany notes payable1213(16)
Long-term borrowings1,1597401,899
Separate account liabilities6,0666,066
Liabilities related to discontinued operations30434
Total liabilities161,25481,651(16)82,905
Equity:
Common stock14(4)1
Additional paid-in capital11,85812,72418,135(30,859)11,858
Accumulated other comprehensive income (loss)3,8613,8613,906(7,767)3,861
Retained earnings2,490(1,078)(6,709)7,7872,490
Treasury stock, at cost(2,700)(2,700)
Total Genworth Financial, Inc.’s stockholders’ equity15,51015,50715,336(30,843)15,510
Noncontrolling interests1,056(300)756
Total equity15,51015,50716,392(31,143)16,266
Total liabilities and equity$15,526$16,761$98,043$(31,159)$99,171

158

Table of Contents

The following table presents the condensed consolidating balance sheet information as of December 31, 2020:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Assets
Investments:
Fixed maturity securities available-for-sale, at fair value (amortized cost of $53,417 and allowance for credit losses of $4)$$$63,495$$63,495
Equity securities, at fair value386386
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4)6,7746,774
Less: Allowance for credit losses(31)(31)
Commercial mortgage loans, net6,7436,743
Policy loans1,9781,978
Limited partnerships1,0491,049
Other invested assets679831,050
Investments in subsidiaries15,35816,673(32,031)
Total investments15,35816,74074,634(32,031)74,701
Cash, cash equivalents and restricted cash1,0781,4832,561
Accrued investment income655655
Deferred acquisition costs1,4871,487
Intangible assets157157
Reinsurance recoverable16,86416,864
Less: Allowance for credit losses(45)(45)
Reinsurance recoverable, net16,81916,819
Other assets2146256404
Intercompany notes receivable19(19)
Deferred tax assets13767(715)65
Separate account assets6,0816,081
Assets related to discontinued operations2,8172,817
Total assets$15,373$18,750$103,674$(32,050)$105,747
Liabilities and equity
Liabilities:
Future policy benefits$$$42,695$$42,695
Policyholder account balances21,50321,503
Liability for policy and contract claims11,48611,486
Unearned premiums775775
Other liabilities551561,4031,614
Intercompany notes payable19(19)
Long-term borrowings2,6657383,403
Separate account liabilities6,0816,081
Liabilities related to discontinued operations5811,7892,370
Total liabilities553,40286,489(19)89,927
Equity:
Common stock13(3)1
Additional paid-in capital12,00812,89018,562(31,452)12,008
Accumulated other comprehensive income (loss)4,4254,4264,499(8,925)4,425
Retained earnings1,584(1,968)(6,681)8,6491,584
Treasury stock, at cost(2,700)(2,700)
Total Genworth Financial, Inc.’s stockholders’ equity15,31815,34816,383(31,731)15,318
Noncontrolling interests802(300)502
Total equity15,31815,34817,185(32,031)15,820
Total liabilities and equity$15,373$18,750$103,674$(32,050)$105,747

159

Table of Contents

The following table presents the condensed consolidating income statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Revenues:
Premiums$$$3,435$$3,435
Net investment income(3)3,3733,370
Net investment gains (losses)323323
Policy fees and other income(1)7032704
Total revenues(3)(1)7,83427,832
Benefits and expenses:
Benefits and other changes in policy reserves4,3834,383
Interest credited508508
Acquisition and operating expenses, net of deferrals25441,1541,223
Amortization of deferred acquisition costs and intangibles377377
Interest expense(1)109502160
Total benefits and expenses241536,47226,651
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries(27)(154)1,3621,181
Provision (benefit) for income taxes(1)(33)297263
Equity in income of subsidiaries9301,041(1,971)
Income from continuing operations9049201,065(1,971)918
Income from discontinued operations, net of taxes131427
Net income9049331,079(1,971)945
Less: net income from continuing operations attributable to noncontrolling interests3333
Less: net income from discontinued operations attributable to noncontrolling interests88
Net income available to Genworth Financial, Inc.’s common stockholders$904$933$1,038$(1,971)$904

160

Table of Contents

The following table presents the condensed consolidating income statement information for the year ended December 31, 2020:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Revenues:
Premiums$$$3,836$$3,836
Net investment income(3)53,228(3)3,227
Net investment gains (losses)6486492
Policy fees and other income3730(4)729
Total revenues(3)148,280(7)8,284
Benefits and expenses:
Benefits and other changes in policy reserves5,2145,214
Interest credited549549
Acquisition and operating expenses, net of deferrals316898935
Amortization of deferred acquisition costs and intangibles463463
Interest expense117526(7)195
Total benefits and expenses321817,150(7)7,356
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries(35)(167)1,130928
Provision (benefit) for income taxes(2)(41)273230
Equity in income of subsidiaries210912(1,122)
Income from continuing operations177786857(1,122)698
Income (loss) from discontinued operations, net of taxes1(573)86(486)
Net income178213943(1,122)212
Less: net income from continuing operations attributable to noncontrolling interests
Less: net income from discontinued operations attributable to noncontrolling interests3434
Net income available to Genworth Financial, Inc.’s common stockholders$178$213$909$(1,122)$178

161

Table of Contents

The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Net income$904$933$1,079$(1,971)$945
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses(334)(335)(371)670(370)
Net unrealized gains (losses) on securities with an allowance for credit losses666(12)6
Derivatives qualifying as hedges(186)(186)(215)401(186)
Foreign currency translation and other adjustments(24)(24)14947148
Total other comprehensive income (loss)(538)(539)(431)1,106(402)
Total comprehensive income366394648(865)543
Less: comprehensive income attributable to noncontrolling interests177177
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders$366$394$471$(865)$366

The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2020:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Net income$178$213$943$(1,122)$212
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses764765765(1,530)764
Net unrealized gains (losses) on securities with an allowance for credit losses(6)(6)(6)12(6)
Derivatives qualifying as hedges209209241(450)209
Foreign currency translation and other adjustments252555(50)55
Total other comprehensive income (loss)9929931,055(2,018)1,022
Total comprehensive income1,1701,2061,998(3,140)1,234
Less: comprehensive income attributable to noncontrolling interests6464
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders$1,170$1,206$1,934$(3,140)$1,170

162

Table of Contents

The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Cash flows from (used by) operating activities:
Net income$904$933$1,079$(1,971)$945
Less income from discontinued operations, net of taxes(13)(14)(27)
Adjustments to reconcile net income to net cash from (used by) operating activities:
Equity in income from subsidiaries(930)(1,041)1,971
Dividends from subsidiaries552(552)
Amortization of fixed maturity securities discounts and premiums6(182)(176)
Net investment (gains) losses(323)(323)
Charges assessed to policyholders(620)(620)
Acquisition costs deferred(8)(8)
Amortization of deferred acquisition costs and intangibles377377
Deferred income taxes341(51)290
Derivative instruments, limited partnerships and other75(434)(359)
Stock-based compensation expense4040
Change in certain assets and liabilities:
Accrued investment income and other assets(1)9(137)(129)
Insurance reserves642642
Current tax liabilities(5)17(46)(34)
Other liabilities, policy and contract claims and other policy-related balances(13)(40)363310
Cash from (used by) operating activities—discontinued operations(564)73(491)
Net cash from (used by) operating activities(5)275167437
Cash flows from (used by) investing activities:
Proceeds from maturities and repayments of investments:
Fixed maturity securities4,1624,162
Commercial mortgage loans874874
Limited partnerships and other invested assets255255
Proceeds from sales of investments:
Fixed maturity and equity securities2,2732,273
Purchases and originations of investments:
Fixed maturity and equity securities(5,216)(5,216)
Commercial mortgage loans(963)(963)
Limited partnerships and other invested assets(767)(767)
Short-term investments, net1818
Policy loans, net5757
Intercompany notes receivable, net4(1)(3)
Capital contributions to subsidiaries(2)2
Proceeds from sale of business, net of cash transferred270270
Cash used by investing activities—discontinued operations(67)(67)
Net cash from (used by) investing activities(2)4897(3)896
Cash flows from (used by) financing activities:
Deposits to universal life and investment contracts669669
Withdrawals from universal life and investment contracts(2,071)(2,071)
Repayment and repurchase of long-term debt(1,541)(1,541)
Intercompany notes payable, net121(16)3
Proceeds from sale of subsidiary shares to noncontrolling interests529529
Dividends paid to noncontrolling interests(37)(37)
Other, net(5)(15)5232
Net cash from (used by) financing activities7(1,026)(1,403)3(2,419)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $(1) related to discontinued operations)11
Net change in cash, cash equivalents and restricted cash(747)(338)(1,085)
Cash, cash equivalents and restricted cash at beginning of period1,0781,5782,656
Cash, cash equivalents and restricted cash at end of period3311,2401,571
Less cash, cash equivalents and restricted cash of discontinued operations at end of period
Cash, cash equivalents and restricted cash of continuing operations at end of period$$331$1,240$$1,571

163

Table of Contents

The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2020:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Cash flows from operating activities:
Net income$178$213$943$(1,122)$212
Less (income) loss from discontinued operations, net of taxes(1)573(86)486
Adjustments to reconcile net income to net cash from operating activities:
Equity in income from subsidiaries(210)(912)1,122
Dividends from subsidiaries437(437)
Amortization of fixed maturity securities discounts and premiums6(163)(157)
Net investment (gains) losses(6)(486)(492)
Charges assessed to policyholders(646)(646)
Acquisition costs deferred(3)(3)
Amortization of deferred acquisition costs and intangibles463463
Deferred income taxes(1)21217228
Derivative instruments, limited partnerships and other(70)(42)(112)
Stock-based compensation expense3939
Change in certain assets and liabilities:
Accrued investment income and other assets216(105)(5)(92)
Insurance reserves1,2171,217
Current tax liabilities(1)41(34)6
Other liabilities, policy and contract claims and other policy-related balances11307845830
Cash from (used by) operating activities-discontinued operations(258)239(19)
Net cash from operating activities172821,6611,960
Cash flows from (used by) investing activities:
Proceeds from maturities and repayments of investments:
Fixed maturity securities3,6373,637
Commercial mortgage loans744744
Limited partnerships and other invested assets182182
Proceeds from sales of investments:
Fixed maturity and equity securities3,0403,040
Purchases and originations of investments:
Fixed maturity and equity securities(7,763)(7,763)
Commercial mortgage loans(547)(547)
Limited partnerships and other invested assets(449)(449)
Short-term investments, net45(10)35
Policy loans, net190190
Intercompany notes receivable, net(10)(16)200(174)
Capital contributions to subsidiaries(2)2
Cash used by investing activities-discontinued operations(222)(222)
Net cash from (used by) investing activities(12)29(996)(174)(1,153)
Cash flows used by financing activities:
Deposits to universal life and investment contracts862862
Withdrawals from universal life and investment contracts(2,282)(2,282)
Redemption of non-recourse funding obligations(315)(315)
Proceeds from the issuance of long-term debt738738
Repayment and repurchase of long-term debt(490)(490)
Intercompany notes payable, net(190)16174
Other, net(5)(14)17(2)
Cash used by financing activities-discontinued operations(18)(18)
Net cash used by financing activities(5)(694)(982)174(1,507)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $18 related to discontinued operations)1515
Net change in cash, cash equivalents and restricted cash(383)(302)(685)
Cash, cash equivalents and restricted cash at beginning of period1,4611,8803,341
Cash, cash equivalents and restricted cash at end of period1,0781,5782,656
Less cash, cash equivalents and restricted cash of discontinued operations at end of period9595
Cash, cash equivalents and restricted cash of continuing operations at end of period$$1,078$1,483$$2,561

164

Table of Contents

As of December 31, 2021, Genworth Financial’s and Genworth Holdings’ subsidiaries had restricted net assets of $15.4 billion and $15.6 billion, respectively. For additional information on Genworth Financial’s capital management plans, including a potential new dividend policy, see “Part II—Item 5—Dividends.”

For additional information on significant restrictions on dividends by subsidiaries of Genworth Financial and Genworth Holdings, see note 17 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.”